<?xml version="1.0" encoding="ISO-8859-1"?><COCHRANE_REVIEW DESCRIPTION="For publication Issue 9, 2012" DOI="10.1002/14651858.CD004418.pub3" GROUP_ID="ARI" ID="429903030909053275" MERGED_FROM="" MODIFIED="2012-07-26 08:05:16 +0100" MODIFIED_BY="Liz Dooley" REVIEW_NO="A090" REVMAN_SUB_VERSION="5.1.7" REVMAN_VERSION="5" SPLIT_FROM="" STAGE="R" STATUS="A" TYPE="INTERVENTION" VERSION_NO="13.0">
<COVER_SHEET MODIFIED="2012-07-23 23:47:08 +0100" MODIFIED_BY="Liz Dooley">
<TITLE MODIFIED="2010-07-26 14:29:23 +1000" MODIFIED_BY="Liz Dooley">Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults</TITLE>
<CONTACT MODIFIED="2012-07-23 23:47:08 +0100" MODIFIED_BY="Liz Dooley"><PERSON ID="57699841507811608866110527024944" ROLE="AUTHOR"><FIRST_NAME>Noa</FIRST_NAME><LAST_NAME>Eliakim-Raz</LAST_NAME><EMAIL_1>noaeliakim@gmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Medicine E</DEPARTMENT><ORGANISATION>Beilinson Hospital, Rabin Medical Center</ORGANISATION><ADDRESS_1>39 Jabotinski Street</ADDRESS_1><CITY>Petah Tikva</CITY><ZIP>49100</ZIP><COUNTRY CODE="IL">Israel</COUNTRY><PHONE_1>+972 5 2509 1313</PHONE_1></ADDRESS></PERSON></CONTACT>
<CREATORS MODIFIED="2012-07-23 23:47:08 +0100" MODIFIED_BY="Liz Dooley"><PERSON ID="57699841507811608866110527024944" ROLE="AUTHOR"><FIRST_NAME>Noa</FIRST_NAME><LAST_NAME>Eliakim-Raz</LAST_NAME><EMAIL_1>noaeliakim@gmail.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Medicine E</DEPARTMENT><ORGANISATION>Beilinson Hospital, Rabin Medical Center</ORGANISATION><ADDRESS_1>39 Jabotinski Street</ADDRESS_1><CITY>Petah Tikva</CITY><ZIP>49100</ZIP><COUNTRY CODE="IL">Israel</COUNTRY><PHONE_1>+972 5 2509 1313</PHONE_1></ADDRESS></PERSON><PERSON ID="DF01004C82E26AA201DAB7D8FF669BD7" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Eyal</FIRST_NAME><LAST_NAME>Robenshtok</LAST_NAME><EMAIL_1>robensht@gmail.com</EMAIL_1><EMAIL_2>Eyalr2@clalit.org.il</EMAIL_2><ADDRESS><DEPARTMENT>Sackler School of Medicine, Tel Aviv University</DEPARTMENT><ORGANISATION>Ramat Aviv and Endocrinology and Metabolism Institute</ORGANISATION><ADDRESS_1>39 Jabotinski Street</ADDRESS_1><CITY>Petah Tikva</CITY><ZIP>49100</ZIP><COUNTRY CODE="IL">Israel</COUNTRY><PHONE_1>+972 50 406 5545</PHONE_1><PHONE_2>+972 3 937 6501</PHONE_2></ADDRESS></PERSON><PERSON ID="12334" ROLE="AUTHOR"><FIRST_NAME>Daphna</FIRST_NAME><LAST_NAME>Shefet</LAST_NAME><EMAIL_1>Dshefet@yahoo.com</EMAIL_1><ADDRESS><DEPARTMENT>Department of Medicine E</DEPARTMENT><ORGANISATION>Beilinson Hospital, Rabin Medical Center</ORGANISATION><ADDRESS_1>39 Jabotinski Street</ADDRESS_1><CITY>Petah Tikva</CITY><ZIP>49100</ZIP><COUNTRY CODE="IL">Israel</COUNTRY><PHONE_1>+972 3 937 6500</PHONE_1><PHONE_2>+972 3 937 6506</PHONE_2><FAX_1>+972 3 937 6512</FAX_1></ADDRESS></PERSON><PERSON ID="13692" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Anat</FIRST_NAME><LAST_NAME>Gafter-Gvili</LAST_NAME><POSITION>Physician</POSITION><EMAIL_1>gn44@bezeqint.net</EMAIL_1><ADDRESS><DEPARTMENT>Department of Medicine E</DEPARTMENT><ORGANISATION>Beilinson Hospital, Rabin Medical Center</ORGANISATION><ADDRESS_1>39 Jabotinski Street</ADDRESS_1><CITY>Petah Tikva</CITY><ZIP>49100</ZIP><COUNTRY CODE="IL">Israel</COUNTRY><PHONE_1>+972 3 937 6508</PHONE_1><FAX_1>+972 3 927 6512</FAX_1></ADDRESS></PERSON><PERSON ID="13736" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Liat</FIRST_NAME><LAST_NAME>Vidal</LAST_NAME><EMAIL_1>VidalL2@clalit.org.il</EMAIL_1><EMAIL_2>vidallit@yahoo.com</EMAIL_2><ADDRESS><DEPARTMENT>Department of Medicine E</DEPARTMENT><ORGANISATION>Beilinson Hospital, Rabin Medical Center</ORGANISATION><ADDRESS_1>39 Jabotinski Street</ADDRESS_1><CITY>Petah Tikva</CITY><ZIP>49100</ZIP><COUNTRY CODE="IL">Israel</COUNTRY><PHONE_1>+972 3 937 6501</PHONE_1><FAX_1>+972 3 937 6512</FAX_1></ADDRESS></PERSON><PERSON ID="12314" ROLE="AUTHOR"><PREFIX>Dr</PREFIX><FIRST_NAME>Mical</FIRST_NAME><LAST_NAME>Paul</LAST_NAME><EMAIL_1>paulm@post.tau.ac.il</EMAIL_1><EMAIL_2>mica@zahav.net.il; MichalP2@clalit.org.il; paulm@post.tau.ac.il</EMAIL_2><ADDRESS><DEPARTMENT>Infectious Diseases Unit</DEPARTMENT><ORGANISATION>Sackler Faculty of Medicine</ORGANISATION><ADDRESS_1>Tel Aviv University</ADDRESS_1><CITY>Tel Aviv</CITY><ZIP>49100</ZIP><COUNTRY CODE="IL">Israel</COUNTRY><PHONE_1>+972 3 937 7512</PHONE_1><FAX_1>+972 3 937 6513</FAX_1></ADDRESS></PERSON><PERSON ID="12295" ROLE="AUTHOR"><PREFIX>Prof</PREFIX><FIRST_NAME>Leonard</FIRST_NAME><LAST_NAME>Leibovici</LAST_NAME><POSITION>Head</POSITION><EMAIL_1>leibovic@post.tau.ac.il</EMAIL_1><EMAIL_2>leibovici@clalit.org.il</EMAIL_2><ADDRESS><DEPARTMENT>Department of Medicine E</DEPARTMENT><ORGANISATION>Beilinson Hospital, Rabin Medical Center</ORGANISATION><ADDRESS_1>39 Jabotinski Street</ADDRESS_1><CITY>Petah Tikva</CITY><ZIP>49100</ZIP><COUNTRY CODE="IL">Israel</COUNTRY><PHONE_1>+972 3 937 6501</PHONE_1><PHONE_2>+972 3 937 6506</PHONE_2><FAX_1>+972 3 937 6505</FAX_1></ADDRESS></PERSON></CREATORS>
<DATES MODIFIED="2012-05-06 10:30:12 +1000" MODIFIED_BY="[Empty name]">
<UP_TO_DATE>
<DATE DAY="16" MONTH="4" YEAR="2012"/>
</UP_TO_DATE>
<LAST_SEARCH>
<DATE DAY="16" MONTH="4" YEAR="2012"/>
</LAST_SEARCH>
<NEXT_STAGE>
<DATE DAY="16" MONTH="4" YEAR="2014"/>
</NEXT_STAGE>
<PROTOCOL_PUBLISHED ISSUE="4" YEAR="2003"/>
<REVIEW_PUBLISHED ISSUE="2" YEAR="2005"/>
<LAST_CITATION_ISSUE ISSUE="1" YEAR="2008"/>
</DATES>
<WHATS_NEW MODIFIED="2012-07-18 12:09:15 +1000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2012-07-18 12:09:15 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="16" MONTH="4" YEAR="2012"/>
<DESCRIPTION>
<P>Searches updated. Three new trials were included (<LINK REF="STD-Hatipoglu-2010" TYPE="STUDY">Hatipoglu 2010</LINK>; <LINK REF="STD-Hong_x002d_yun-2007" TYPE="STUDY">Hong-yun 2007</LINK>; <LINK REF="STD-Kohno-2011" TYPE="STUDY">Kohno 2011</LINK>) and three new trials were excluded (<LINK REF="STD-Chokshi-2007" TYPE="STUDY">Chokshi 2007</LINK>; <LINK REF="STD-Ott--2008" TYPE="STUDY">Ott 2008</LINK>; <LINK REF="STD-Sujata-2008" TYPE="STUDY">Sujata 2008</LINK>). After integrating the data from the new included studies, no significant changes were noted in any of the comparisons evaluated. Our conclusions and recommendations for further research remain unchanged</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="NEW_CITATION_OLD_CONCLUSIONS" MODIFIED="2012-07-18 12:08:48 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="14" MONTH="9" YEAR="2011"/>
<DESCRIPTION>
<P>A new author joined the team to lead the update of this review</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</WHATS_NEW>
<HISTORY MODIFIED="2010-02-22 08:15:02 +1000" MODIFIED_BY="[Empty name]">
<WHATS_NEW_ENTRY EVENT="AMENDMENT" MODIFIED="2010-02-22 08:15:02 +1000" MODIFIED_BY="[Empty name]">
<DATE DAY="22" MONTH="6" YEAR="2008"/>
<DESCRIPTION>
<P>Converted to new review format.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-08-15 19:56:41 +1000" MODIFIED_BY="Liz Dooley">
<DATE DAY="12" MONTH="11" YEAR="2007"/>
<DESCRIPTION>
<P>In the 2007 update, one new study was included and six new studies were excluded. After integrating the data from the new included study, no significant changes were noted in all comparisons evaluated. Our conclusions and recommendations for further research remain unchanged.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
<WHATS_NEW_ENTRY EVENT="UPDATE" MODIFIED="2008-06-23 10:23:10 +1000" MODIFIED_BY="Liz Dooley">
<DATE DAY="20" MONTH="1" YEAR="2005"/>
<DESCRIPTION>
<P>Searches conducted.</P>
</DESCRIPTION>
</WHATS_NEW_ENTRY>
</HISTORY>
<SOURCES_OF_SUPPORT MODIFIED="2012-07-04 05:10:35 +1000" MODIFIED_BY="[Empty name]">
<INTERNAL_SOURCES>
<SOURCE>
<NAME>Rabin Medical Center - Beilinson Campus</NAME>
<COUNTRY CODE="IL">Israel</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</INTERNAL_SOURCES>
<EXTERNAL_SOURCES MODIFIED="2012-07-04 05:10:35 +1000" MODIFIED_BY="[Empty name]">
<SOURCE>
<NAME>EU 5th Framework: TREAT project (grant number: 1999-11459)</NAME>
<COUNTRY CODE="NONE">Not specified</COUNTRY>
<DESCRIPTION/>
</SOURCE>
<SOURCE MODIFIED="2012-07-04 05:10:35 +1000" MODIFIED_BY="[Empty name]">
<NAME>The Rothschild-Caesarea Foundation &#8220;Optimal antibiotic treatment of moderate to severe infections: Integration of PCR technology and medical informatics/artificial intelligence&#8221;</NAME>
<COUNTRY CODE="NONE">Not specified</COUNTRY>
<DESCRIPTION/>
</SOURCE>
</EXTERNAL_SOURCES>
</SOURCES_OF_SUPPORT>
<MESH_TERMS VERIFIED="NO"/>
<KEYWORDS/>
</COVER_SHEET>
<MAIN_TEXT MODIFIED="2012-07-24 08:43:10 +1000" MODIFIED_BY="[Empty name]">
<SUMMARY MODIFIED="2012-07-23 10:30:02 +1000" MODIFIED_BY="[Empty name]">
<TITLE MODIFIED="2012-01-12 10:56:12 +1000" MODIFIED_BY="[Empty name]">Initial antibiotic treatment for coverage of 'atypical' pathogens for community-acquired pneumonia in hospitalized adults</TITLE>
<SUMMARY_BODY MODIFIED="2012-07-23 10:30:02 +1000" MODIFIED_BY="[Empty name]">
<P>Pneumonia is a serious lung infection and is usually treated with antibiotics. Bacteria which cause community-acquired pneumonia (CAP, pneumonia contracted outside healthcare settings) are traditionally divided into 'typical' and 'atypical', each dictating a different antibiotic treatment. Atypical bacteria include, <I>Legionella pneumophila </I>(<I>L. pneumophila</I>)<I>, Mycoplasma pneumoniae</I> (<I>M</I>. <I>pneumoniae</I>)<I> </I>and <I>Chlamydia pneumoniae </I>(<I>C. pneumoniae</I>). The main 'typical' agent causing CAP is <I>Streptococcus pneumoniae </I>(<I>S. pneumoniae</I>)<I>. </I>It is usually not possible to determine which of the many potential agents is the cause of CAP, so that antibiotic treatment is empirical, customarily covering both typical and atypical bacteria. While typical coverage is essential, the necessity of the atypical coverage has not been proven. In the previous version of this review we showed that there was no advantage to the atypical arm. Given the persisting inconsistency between current guidelines for treatment of pneumonia and the available evidence, we undertook to update this systematic review.</P>
<P>This Cochrane review looked at trials comparing antibiotic regimens with atypical coverage to those without, limited to hospitalized adults with CAP. We included 28 trials, involving 5939 patients. For the regimens tested, no advantage was found for regimens covering atypical bacteria in the major outcomes tested - mortality and clinical efficacy. There was no significant difference between the groups in the frequency of total adverse events, or those requiring discontinuation of treatment. However, gastrointestinal events were less common in the atypical arm.</P>
<P>There are limitations to this review in that a single study compared the addition of the atypical antibiotic to a typical antibiotic, the major question in clinical practice; most compared a single atypical antibiotic to a single typical antibiotic. Seventeen of the 27 trials were open label, 21 of the 27 studies were sponsored by pharmaceutical companies of which all but one was conducted by the manufacturer of the atypical antibiotic.</P>
</SUMMARY_BODY>
</SUMMARY>
<ABSTRACT MODIFIED="2012-07-18 13:28:36 +1000" MODIFIED_BY="[Empty name]">
<ABS_BACKGROUND MODIFIED="2011-12-06 14:00:05 +1000" MODIFIED_BY="Liz Dooley">
<P>Community-acquired pneumonia (CAP) is caused by various pathogens, traditionally divided into 'typical' and 'atypical'. Initial antibiotic treatment of CAP is usually empirical, customarily covering both typical and atypical pathogens. To date, no sufficient evidence exists to support this broad coverage, while limiting coverage is bound to reduce toxicity, resistance and expense.</P>
</ABS_BACKGROUND>
<ABS_OBJECTIVES MODIFIED="2012-07-18 13:28:36 +1000" MODIFIED_BY="[Empty name]">
<P>The main objective was to estimate the mortality and proportion with treatment failure using regimens containing atypical antibiotic coverage compared to those that had typical coverage only. Secondary objectives included the assessment of adverse events.</P>
</ABS_OBJECTIVES>
<ABS_SEARCH_STRATEGY MODIFIED="2012-05-06 10:35:32 +1000" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) Issue 3, 2012 which includes the Acute Respiratory Infection Group's Specialized Register, MEDLINE (January 1966 to April week 1, 2012) and EMBASE (January 1980 to April 2012).</P>
</ABS_SEARCH_STRATEGY>
<ABS_SELECTION_CRITERIA MODIFIED="2012-03-21 10:23:50 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized controlled trials (RCTs) of adult patients hospitalized due to CAP, comparing antibiotic regimens with atypical coverage (quinolones, macrolides, tetracyclines, chloramphenicol, streptogramins or ketolides) to a regimen without atypical antibiotic coverage.</P>
</ABS_SELECTION_CRITERIA>
<ABS_DATA_COLLECTION MODIFIED="2012-07-18 12:15:45 +1000" MODIFIED_BY="[Empty name]">
<P>Two review authors independently assessed the risk of bias and extracted data from included trials. We estimated risk ratios (RRs) with 95% confidence intervals (CIs). We assessed heterogeneity using a Chi<SUP>2</SUP> test.</P>
</ABS_DATA_COLLECTION>
<ABS_RESULTS MODIFIED="2012-07-18 12:39:38 +1000" MODIFIED_BY="[Empty name]">
<P>We included 28 trials, encompassing 5939 randomized patients. The atypical antibiotic was administered as monotherapy in all but three studies. Only one study assessed a beta-lactam combined with a macrolide compared to the same beta-lactam. There was no difference in mortality between the atypical arm and the non-atypical arm (RR 1.14; 95% CI 0.84 to 1.55), RR &lt; 1 favors the atypical arm. The atypical arm showed an insignificant trend toward clinical success and a significant advantage to bacteriological eradication, which disappeared when evaluating methodologically high quality studies alone. Clinical success for the atypical arm was significantly higher for <I>Legionella pneumophilae</I> (<I>L. pneumophilae</I>) and non-significantly lower for pneumococcal pneumonia. There was no significant difference between the groups in the frequency of (total) adverse events, or those requiring discontinuation of treatment. However, gastrointestinal events were less common in the atypical arm (RR 0.70; 95% CI 0.53 to 0.92). Although the trials assessed different antibiotics, no significant heterogeneity was detected in the analyses.</P>
</ABS_RESULTS>
<ABS_CONCLUSIONS MODIFIED="2012-01-12 10:56:11 +1000" MODIFIED_BY="[Empty name]">
<P>No benefit of survival or clinical efficacy was shown with empirical atypical coverage in hospitalized patients with CAP. This conclusion relates mostly to the comparison of quinolone monotherapy to beta-lactams. Further trials, comparing beta-lactam monotherapy to the same combined with a macrolide, should be performed.</P>
</ABS_CONCLUSIONS>
</ABSTRACT>
<BODY MODIFIED="2012-07-24 08:43:10 +1000" MODIFIED_BY="[Empty name]">
<BACKGROUND MODIFIED="2012-07-23 16:57:45 +1000" MODIFIED_BY="[Empty name]">
<CONDITION MODIFIED="2012-07-18 12:35:47 +1000" MODIFIED_BY="[Empty name]">
<P>Community acquired pneumonia (CAP) is a common clinical disease with considerable mortality and overwhelming economic burden. The Pneumonia Patient Outcomes Research Team (PORT) has developed a prediction scheme utilizing clinical variables to stratify CAP patients into five mortality risk classes, by which 30-day mortality has been estimated up to 9.3% and 31.1% for patients stratified to risk class IV and V, respectively (<LINK REF="REF-Fine-1997" TYPE="REFERENCE">Fine 1997</LINK>).<B> </B>The CURB-65 score is based on five easily measurable factors (confusion, urea, respiratory rate, blood pressure and age), by which 30-day mortality has been estimated up to 17%, 41.5% and 57% for patients with three, four or five risk factors, respectively (<LINK REF="REF-Lim-2003" TYPE="REFERENCE">Lim 2003</LINK>). Although <I>Streptococcus pneumoniae</I> (<I>S. pneumoniae)</I> is the leading cause of CAP, frequency of other agents, especially those designated 'atypical pathogens' (<I>Legionella pneumophilae</I> (<I>L. pneumophilae), Mycoplasma pneumoniae (M. pneumoniae)</I> and <I>Chlamydia pneumoniae (C. pneumoniae</I>)), varies with geographical area, age groups and diagnostic means available. Distinctions between typical and atypical organisms is significant, as the latter share intracellularity and are treated with specific antibiotic drugs. The causing agent cannot be clearly sorted to either group by any clinical, radiological or laboratory parameter (<LINK REF="REF-Donowitz-2000" TYPE="REFERENCE">Donowitz 2000</LINK>; <LINK REF="REF-Levison-2001" TYPE="REFERENCE">Levison 2001</LINK>). As the microbiological diagnosis is often unknown, initial antibiotic treatment of CAP is largely empirical.</P>
</CONDITION>
<INTERVENTION MODIFIED="2012-07-18 12:45:34 +1000" MODIFIED_BY="[Empty name]">
<P>All major guidelines for treatment of CAP divide patients into three subgroups: outpatients, hospitalized patients on a general ward and hospitalized patients in intensive care units (ICUs). Major guidelines recommend in general, an antibiotic regimen covering both typical and atypical pathogens in hospitalized CAP patients (<LINK REF="REF-BTS-2001" TYPE="REFERENCE">BTS 2001</LINK>; <LINK REF="REF-Hedlund-2005" TYPE="REFERENCE">Hedlund 2005</LINK>; <LINK REF="REF-Lim-2009" TYPE="REFERENCE">Lim 2009</LINK>; <LINK REF="REF-Mandell-2000" TYPE="REFERENCE">Mandell 2000</LINK>; <LINK REF="REF-Mandell-2007" TYPE="REFERENCE">Mandell 2007</LINK>; <LINK REF="REF-Niederman-2001" TYPE="REFERENCE">Niederman 2001</LINK>; <LINK REF="REF-Woodhead-2005" TYPE="REFERENCE">Woodhead 2005</LINK>; <LINK REF="REF-Woodhead-2011" TYPE="REFERENCE">Woodhead 2011</LINK>). Suggested regimens include extended spectrum cephalosporins, beta-lactams (BLs) or beta-lactam/beta-lactamase inhibitors (BL/BLIs), all combined with macrolides, or a single agent with broad coverage, i.e. fluoroquinolones. The British Thoracic Society (BTS) guidelines support this recommendation in view of a high percentage of atypical pathogens, particularly <I>L. pneumophilae,</I> in hospitalized patients in the UK (higher, incidentally, than in North America or Europe). The American Thoracic Society (ATS) reserves recommendation of atypical coverage to clinical circumstances, although conceding elsewhere that clinical presentation cannot establish etiology. All guidelines support extensive antibiotic coverage for ICU patients, noting the prevalence as well as high mortality rates of pneumonia caused by <I>L. pneumophilae </I>in that population. Admittedly, these guidelines are based on insufficient evidence, as there have been only few randomized controlled trials (RCTs) assessing CAP treatment protocols.</P>
</INTERVENTION>
<THEORY MODIFIED="2012-07-23 16:57:45 +1000" MODIFIED_BY="[Empty name]">
<P>Most trials comparing different treatment arms were performed to evaluate a specific drug, frequently a macrolide or a fluoroquinolone. Several of these trials (incidentally) compared regimens with and without atypical antibiotic coverage and found results to be generally equal (<LINK REF="STD-Aubier-1998" TYPE="STUDY">Aubier 1998</LINK>; <LINK REF="STD-Tremolieres-1998" TYPE="STUDY">Tremolieres 1998</LINK>). A meta-analysis by <LINK REF="REF-Mills-2005" TYPE="REFERENCE">Mills 2005</LINK> compared typical antibiotic coverage with BL to atypical coverage in non-severe pneumonia and found no advantage of antibiotics with atypical coverage over BLs (risk ratio (RR) 0.97; 95% CI 0.87 to 1.07), a lower failure rate in <I>L. pneumophilae</I> (RR 0.4; 0.19 to 0.85), and equivalence for <I>M. pneumoniae </I>and <I>C. pneumoniae</I>. Furthermore, a large percentage of atypical pneumonia cases have been shown to be dual infections, usually in combination with a typical pathogen (<LINK REF="REF-Donowitz-2000" TYPE="REFERENCE">Donowitz 2000</LINK>). In view of these data, one must wonder what the true role of atypical agents in the treatment of pneumonia really is. If patients improve regardless of atypical coverage, should this coverage be routinely included? Furthermore, a RCT by <LINK REF="REF-Malhotra_x002d_Kumar-2007" TYPE="REFERENCE">Malhotra-Kumar 2007</LINK> showed by obtaining pharyngeal swabs from patients before and after treatment with macrolides versus placebo, that macrolide use is the single most important driver of the emergence of macrolide resistance, and therefore the effect of prescribing macrolides is of ecological importance.</P>
<P>In the previous version of this systematic review (<LINK REF="REF-Robenshtok-2008" TYPE="REFERENCE">Robenshtok 2008</LINK>), 25 RCTs were found comparing a treatment regimen with atypical antibiotic coverage to one without such coverage. No trials comparing an atypical antibiotic in combination with a non-atypical antibiotic (the regimen currently recommended in all guidelines) versus the non-atypical antibiotic alone were found. There was no difference in mortality between the atypical arm and the non-atypical arm. The atypical arm showed an insignificant trend toward clinical success and a significant advantage to bacteriological eradication, which disappeared when evaluating methodologically high quality studies alone. A large systematic review that included observational studies, evaluated the superiority of atypical coverage to non-atypical coverage regimens (<LINK REF="REF-Oosterheert-2003" TYPE="REFERENCE">Oosterheert 2003</LINK>). Significant reduction in mortality with atypical coverage was found in six of the eight selected studies. However, these studies were non-experimental cohort studies and outcomes showed several inconsistencies. Using propensity analysis, we showed that the major pitfall of such observational studies is the marked difference between patients prescribed non-atypical coverage and those prescribed a regimen including atypical coverage, a difference that precludes the comparison of these treatment regimens in observational studies (<LINK REF="REF-Paul-2007" TYPE="REFERENCE">Paul 2007</LINK>). Expanding coverage to atypical pathogens is bound to increase toxicity, resistance and cost. Moreover, this broad coverage might be at the expense of efficacy of pneumococcal coverage (<LINK REF="REF-Johansen-2000" TYPE="REFERENCE">Johansen 2000</LINK>).</P>
</THEORY>
<IMPORTANCE MODIFIED="2012-01-12 10:56:17 +1000" MODIFIED_BY="[Empty name]">
<P>Given the persisting inconsistency between current guidelines and the available evidence, we undertook to update this systematic review of hospitalized adults with CAP. The review encompassed all trials which compared treatment regimens with versus without atypical antibiotic coverage, in order to evaluate the efficacy and need of atypical coverage in this subset of patients.</P>
</IMPORTANCE>
</BACKGROUND>
<OBJECTIVES MODIFIED="2012-07-18 13:28:58 +1000" MODIFIED_BY="[Empty name]">
<OL>
<LI>To evaluate mortality and proportion with treatment failure using regimens containing atypical antibiotic coverage compared to those without (typical coverage only).</LI>
</OL>
<SUBSECTION>
<HEADING LEVEL="2">Secondary objectives</HEADING>
<OL>
<LI>To evaluate treatment failure with regimens containing atypical antibiotic coverage compared to those without (typical coverage only).</LI>
<LI>To evaluate the frequency of adverse effects associated with different types of antibiotic treatment.</LI>
<LI>To evaluate mortality and treatment failure of regimens containing atypical antibiotic coverage for patients with identified atypical pathogens.</LI>
<LI>To evaluate mortality and treatment failure of regimens containing atypical antibiotic coverage for patients with identified <I>S. pneumoniae</I>.</LI>
</OL>
</SUBSECTION>
</OBJECTIVES>
<METHODS MODIFIED="2012-07-24 08:42:40 +1000" MODIFIED_BY="[Empty name]">
<SELECTION_CRITERIA MODIFIED="2012-07-23 16:52:36 +1000" MODIFIED_BY="[Empty name]">
<CRIT_STUDIES MODIFIED="2012-07-23 16:52:36 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized controlled trials (RCTs) or quasi-RCTs. We excluded trials with a dropout rate of over 30%.</P>
</CRIT_STUDIES>
<CRIT_PARTICIPANTS MODIFIED="2012-07-18 13:31:02 +1000" MODIFIED_BY="[Empty name]">
<P>Adult patients hospitalized due to suspected CAP. We did not consider patients with major immunosuppressive state(s) (i.e. malignancy, cystic fibrosis, HIV) for inclusion on this review.</P>
</CRIT_PARTICIPANTS>
<CRIT_INTERVENTIONS MODIFIED="2012-07-18 13:35:12 +1000" MODIFIED_BY="[Empty name]">
<P>Studies comparing antibiotic therapy with atypical coverage to antibiotic therapy without atypical coverage. Regimens containing the following drugs, were considered atypical coverage.</P>
<OL>
<LI>Macrolides: including erythromycin, roxithromycin, azithromycin and clarithromycin.</LI>
<LI>Fluoroquinolone: including ciprofloxacin, ofloxacin, levofloxacin, trovafloxacin, moxifloxacin and grepafloxacin.</LI>
<LI>Tetracyclines: including tetracycline, doxycycline, tigecycline and minocycline.</LI>
<LI>Chloramphenicol.</LI>
<LI>Streptogramins: including pristinamycin and quinupristin-dalfopristin.</LI>
<LI>Ketolides: including telithromycin (ketek, recently withdrawn from Food and Drug Administration (FDA) approval) (<LINK REF="REF-Ross-2007" TYPE="REFERENCE">Ross 2007</LINK>; <LINK REF="REF-Soreth-2007" TYPE="REFERENCE">Soreth 2007</LINK>).</LI>
</OL>
<P>We included other drugs within the antibiotic classes listed above, if identified by our searches. We considered regimens lacking the above drugs as non-atypical coverage.<BR/>we reviewed both oral and intravenous (IV) therapies (whether comparing oral to oral, IV to oral or IV to IV).</P>
</CRIT_INTERVENTIONS>
<CRIT_OUTCOMES MODIFIED="2012-07-18 13:35:34 +1000" MODIFIED_BY="[Empty name]">
<CRIT_OUTCOMES_PRIMARY MODIFIED="2012-07-18 13:35:34 +1000" MODIFIED_BY="[Empty name]">
<OL>
<LI>Overall mortality at the end of the study and up to 30 days following the end of treatment.</LI>
</OL>
</CRIT_OUTCOMES_PRIMARY>
<CRIT_OUTCOMES_SECONDARY MODIFIED="2012-01-12 10:54:04 +1000" MODIFIED_BY="[Empty name]">
<OL>
<LI>Number of patients with treatment failure, as defined in the study.</LI>
<LI>Number of patients in whom bacteriological eradication was achieved.</LI>
<LI>Number of patients who needed mechanical ventilation during hospital stay.</LI>
<LI>Mean duration of hospital stay.</LI>
<LI>Number of patients excluded from outcome assessment after randomizations.</LI>
<LI>Number of patients who developed superinfection or resistance to the studied drug, defined as isolation of a pathogen or a colonizing micro-organism resistant to the study drug, during or after antibiotic treatment.</LI>
<LI>Mean duration to regaining previous functional capacity.</LI>
</OL>
<SUBSECTION>
<HEADING LEVEL="4">Adverse events</HEADING>
<OL>
<LI>Any serious adverse events that were fatal, life-threatening, or requiring prolongation of existing hospitalization.</LI>
<LI>Any adverse events that required discontinuation of medication.</LI>
</OL>
</SUBSECTION>
</CRIT_OUTCOMES_SECONDARY>
</CRIT_OUTCOMES>
</SELECTION_CRITERIA>
<SEARCH_METHODS MODIFIED="2012-07-18 13:51:11 +1000" MODIFIED_BY="[Empty name]">
<ELECTRONIC_SEARCHES MODIFIED="2012-07-18 13:49:55 +1000" MODIFIED_BY="[Empty name]">
<P>For this update we searched the Cochrane Central Register of Controlled Trials (CENTRAL) 2012, Issue 3, part of <I>The Cochrane Library, </I>www.thecochranelibrary.com (accessed 16 April 2012), which includes the Acute Respiratory Infection Group's Specialized Register, MEDLINE (June 2007 to April Week 1, 2012) and EMBASE (June 2007 to April 2012). </P>
<P>We used the search strategy in <LINK REF="APP-01" TYPE="APPENDIX">Appendix 1</LINK> to search CENTRAL and MEDLINE. We combined the MEDLINE search with the Cochrane Highly Sensitive Search Strategy for identifying randomized trials in MEDLINE: sensitivity- and precision-maximizing version (2008 revision) Ovid format (<LINK REF="REF-Lefebvre-2011" TYPE="REFERENCE">Lefebvre 2011</LINK>). We adapted the search for EMBASE (<LINK REF="APP-02" TYPE="APPENDIX">Appendix 2</LINK>). </P>
<P>We inspected the references of all identified studies for more trials. In addition to this, we contacted the first or corresponding author of each included trial and researchers active in the field for information regarding unpublished trials or complementary information on their own trial. We imposed no language or publication restrictions.</P>
<P>See <LINK REF="APP-03" TYPE="APPENDIX">Appendix 3</LINK> for details of previous searches.</P>
</ELECTRONIC_SEARCHES>
<OTHER_SEARCHES MODIFIED="2012-07-18 13:51:11 +1000" MODIFIED_BY="[Empty name]">
<P>In addition, we searched ClinicalTrials.gov (www.clinicaltrials.gov/) and FDA new drug approval documents for ongoing or unpublished trials (last searched 1 May, 2012).</P>
</OTHER_SEARCHES>
</SEARCH_METHODS>
<DATA_COLLECTION MODIFIED="2012-07-24 08:42:40 +1000" MODIFIED_BY="[Empty name]">
<STUDY_SELECTION MODIFIED="2012-07-18 13:54:38 +1000" MODIFIED_BY="[Empty name]">
<P>Two review authors (DS, ER in the original review (<LINK REF="REF-Shefet-2005" TYPE="REFERENCE">Shefet 2005</LINK>); ER, AG in the 2008 update (<LINK REF="REF-Robenshtok-2008" TYPE="REFERENCE">Robenshtok 2008</LINK>); NER, ER in this current update) independently inspected each reference identified by the search and applied the inclusion criteria. For possible relevant articles, or in cases of disagreement between the two review authors, we obtained the full article and inspected it independently. A third review author (MP) checked the article in cases where resolving disagreement by discussion was not possible. When required,<B> </B>we contacted the trial authors of the study for clarification. We documented justifications for excluding studies from the review.</P>
</STUDY_SELECTION>
<DATA_EXTRACTION MODIFIED="2012-07-18 13:59:09 +1000" MODIFIED_BY="[Empty name]">
<P>Two review authors (DS, ER in the original review (<LINK REF="REF-Shefet-2005" TYPE="REFERENCE">Shefet 2005</LINK>); ER, AG in the 2008 update (<LINK REF="REF-Robenshtok-2008" TYPE="REFERENCE">Robenshtok 2008</LINK>); NER, ER in this current update) independently extracted data from the included trials. A third review author (MP) extracted the data in case of disagreement between the two review authors. We discussed the data extraction, documented decisions and, where necessary, we contacted the trial authors for clarification.</P>
<P>We identified trials by the name of the first author and year in which the trial was first published and ordered chronologically. We extracted, checked and recorded the following data.</P>
<SUBSECTION>
<HEADING LEVEL="3">Trial characteristics</HEADING>
<P>1. Year(s) and country/countries of study.<BR/>2. Trial sponsor.<BR/>3. Publication status: published in journal; abstract/proceeding; unpublished.<BR/>4. Intention-to-treat (ITT) analysis: performed; possible to extract; efficacy analysis.<BR/>5. Randomization methods: allocation generation; concealment; blinding.<BR/>6. Failure definition: including time of failure assessment.<BR/>7. Study follow-up duration.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Patient characteristics</HEADING>
<P>8. Number of patients randomized and evaluated, per group.<BR/>9. Age: mean or median.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Infection characteristics</HEADING>
<P>10. Number of patients with documented typical pathogen.<BR/>11. Number of patients with documented atypical pathogen.<BR/>12. Number of patients with infections caused by bacteria resistant to the administered antibiotic regimen.<BR/>13. Patients with <I>S. pneumococcus, L. pneumophilae </I>and <I>Mycoplasma </I>infections.<BR/>14. Severity of the disease (as classified by PORT).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Intervention characteristics</HEADING>
<P>15. Antibiotics type, dose and route of administration.<BR/>16. Treatment duration.<BR/>17. Treatment modifications.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Measures of outcome, extracted as number of patients per group</HEADING>
<P>18. Overall mortality at end of study follow-up.<BR/>19. Bacteriological eradication.<BR/>20. Treatment failure: as defined in study, with and without treatment modifications.<BR/>21. Mechanical ventilation.<BR/>22. Adverse events: life-threatening events, events necessitating specific medical treatment, events requiring cessation of treatment.</P>
</SUBSECTION>
</DATA_EXTRACTION>
<QUALITY_ASSESSMENT MODIFIED="2012-07-24 08:42:17 +1000" MODIFIED_BY="[Empty name]">
<P>Two review authors (DS, ER in the original review (<LINK REF="REF-Shefet-2005" TYPE="REFERENCE">Shefet 2005</LINK>); ER, AG in the 2008 update (<LINK REF="REF-Robenshtok-2008" TYPE="REFERENCE">Robenshtok 2008</LINK>); NER, ER in this current update) assessed the risk of bias in trials fulfilling the review inclusion criteria. We used the 'Risk of bias' tool (<LINK REF="REF-Higgins-2011" TYPE="REFERENCE">Higgins 2011</LINK>) to assess methodological quality according to: sequence generation, allocation concealment, blinding, incomplete outcome data addressed, free of selective reporting and free of other bias. A third review author (MP) was responsible for resolving disagreements.</P>
<P>We assessed risk of bias by allocation concealment (low risk of bias - adequate allocation concealment; unclear allocation concealment; high risk of bias - inadequate allocation concealment, i.e. quasi-randomized studies).<BR/>We graded randomization similarly (low risk - table of random numbers, computer generated or coin tossing; unclear; high risk - anything else) and did the same for blinding (low risk - triple-blinded or double-blinded; high risk - patient-blinded or no blinding; and unclear when there was not enough data).</P>
</QUALITY_ASSESSMENT>
<EFFECT_MEASURES MODIFIED="2012-07-24 08:42:23 +1000" MODIFIED_BY="[Empty name]">
<P>We analyzed dichotomous data by calculating the RR for each trial with the uncertainty in each result being expressed using 95% CIs.</P>
</EFFECT_MEASURES>
<UNIT_OF_ANALYSIS MODIFIED="2012-07-24 08:42:30 +1000" MODIFIED_BY="[Empty name]">
<P>We analyzed studies with non-standard designs as follows.</P>
<OL>
<LI>Cluster-randomized trials: this design would not be appropriate to evaluate antibiotic treatment for CAP.</LI>
<LI>Cross-over trials: this design would not be appropriate to evaluate antibiotic treatment for CAP.</LI>
<LI>Studies with multiple treatment groups: we assessed intervention groups for relevance for our review. If more than two groups were relevant, we combined groups to create a single pair-wise comparison.</LI>
</OL>
</UNIT_OF_ANALYSIS>
<MISSING_DATA MODIFIED="2012-07-18 14:09:49 +1000" MODIFIED_BY="[Empty name]">
<P>We contacted the original trial authors for missing data and requested additional information. We assumed the data to be missing at random if additional data were unavailable. We noted missing data in the 'Risk of bias' table and performed a sensitivity analysis.</P>
<P>We did not include the data in the meta-analysis in cases of missing standard deviations.</P>
</MISSING_DATA>
<HETEROGENEITY_ASSESSMENT MODIFIED="2012-07-18 14:10:31 +1000" MODIFIED_BY="[Empty name]">
<P>We initially assessed heterogeneity in the results of the trials by inspection of graphical presentations and by calculating a test of heterogeneity (Chi<SUP>2</SUP> test). We had anticipated between-trial variation in estimation of morbidity and mortality for those patients who were hospitalized on a general ward or in ICU, if trials were performed in different geographical areas and among different age groups or if per different drug regimens were assessed. We performed subgroup analyses in order to assess the impact of these possible sources of heterogeneity on the main results.</P>
</HETEROGENEITY_ASSESSMENT>
<BIAS_ASSESSMENT MODIFIED="2012-07-18 14:10:49 +1000" MODIFIED_BY="[Empty name]">
<P>We examined a funnel plot estimating the precision of trials (plots of logarithm of the RR for efficacy against the sample size) in order to estimate potential asymmetry.</P>
</BIAS_ASSESSMENT>
<DATA_SYNTHESIS MODIFIED="2012-07-18 14:11:40 +1000" MODIFIED_BY="[Empty name]">
<P>We used a fixed-effect model throughout the review. We compared the fixed-effect model to a random-effects model when we observed significant heterogeneity between the trials (P &lt; 0.10). Continuous data were not available for analysis in this review.</P>
</DATA_SYNTHESIS>
<SUBGROUP_ANALYSIS MODIFIED="2012-07-24 08:42:40 +1000" MODIFIED_BY="[Empty name]">
<P>We performed subgroup analysis to assess the impact of the various treatment regimens, to analyze treatment effects on particular patient groups, and to investigate for heterogeneity. We planned to analyze mortality and clinical failure only on the following subgroups.</P>
<OL>
<LI>Type of antimicrobial agent in the atypical arm: quinolones, macrolides, combination of quinolones and macrolides, and others.</LI>
<LI>Age: under or over 65 years.</LI>
<LI>Geographical area: Europe, North America, and others.</LI>
<LI>Methodology: allocation generation, allocation concealment, blinding, and ITT analysis.</LI>
<LI>Type of bacteria: <I>S. pneumoniae, </I>atypical pathogens, and legionella.</LI>
<LI>Sponsoship: sponsored, non-sponsored, and unclear sponsorship.</LI>
</OL>
</SUBGROUP_ANALYSIS>
<SENSITIVITY_ANALYSIS MODIFIED="2012-07-18 14:15:28 +1000" MODIFIED_BY="[Empty name]">
<P>We performed sensitivity analyses in order to assess the robustness of the findings to different aspects of the trials' methodology: allocation concealment (adequate or unclear), randomizations, blinding, exclusions after randomizations (reported or not reported), sample size (up to 100 or more than 100 patients), and length of follow-up (up to one month or one to 12 months).</P>
</SENSITIVITY_ANALYSIS>
</DATA_COLLECTION>
</METHODS>
<RESULTS MODIFIED="2012-07-24 08:43:10 +1000" MODIFIED_BY="[Empty name]">
<STUDY_DESCRIPTION MODIFIED="2012-07-24 08:43:01 +1000" MODIFIED_BY="[Empty name]">
<SEARCH_RESULTS MODIFIED="2012-07-18 14:37:38 +1000" MODIFIED_BY="[Empty name]">
<P>In this 2012 update we retrieved 1301 records from the electronic database searches. The CENTRAL search identified 304 records, MEDLINE identified 594 records and the EMBASE search identified 823 records. We evaluated all records for this update. We did not evaluate further any studies in which the abstract suggested comparator antibiotic regimens incompatible with the inclusion criteria. We similarly excluded studies of outpatients, nosocomial (hospital-acquired) infections, respiratory tract infections other than pneumonia and non-randomized studies.</P>
<P>We retrieved 66 publications for full-text inspection, of which we excluded 38.</P>
</SEARCH_RESULTS>
<INCLUDED_STUDIES_DESCR MODIFIED="2012-07-24 08:43:01 +1000" MODIFIED_BY="[Empty name]">
<P>Thirty publications fulfilled our inclusion criteria. Two were substudies of a parallel publication (Allegra 1995 of <LINK REF="STD-Rizzato-1997" TYPE="STUDY">Rizzato 1997</LINK>; Jardim 2003 of <LINK REF="STD-Petitpretz-2001" TYPE="STUDY">Petitpretz 2001</LINK>). Thus, we included 28 trials in the review. We identified three new studies in the 2012 update (<LINK REF="STD-Hatipoglu-2010" TYPE="STUDY">Hatipoglu 2010</LINK>; <LINK REF="STD-Hong_x002d_yun-2007" TYPE="STUDY">Hong-yun 2007</LINK>; <LINK REF="STD-Kohno-2011" TYPE="STUDY">Kohno 2011</LINK>). Two were published as abstracts only. We requested additional information from nearly all the trial authors, seven of whom responded.</P>
<P>Study details can be found in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table. The studies were performed between 1982 and 2011. Sixteen were multicentered. Fifteen were performed in Europe, three in North America and ten in other countries (Japan, Argentina and South Africa) or multicontinental. Twenty-one of the included trials were in English (including two abstracts, one of which was probably originally in Chinese), three in Japanese, two in French, one in Spanish and one in German. The studies encompassed 5939 randomized patients, of whom 5444 patients could be evaluated for our primary outcome analysis (overall mortality). The number of participants was 100 or lower in nine trials and over 100 in 19 trials (range 40 to 808 participants). All trials were restricted to adults (defined as aged above 18 years, and in one case above 16 years (<LINK REF="STD-Tremolieres-1998" TYPE="STUDY">Tremolieres 1998</LINK>). The mean age in 14 studies was under 65 and in nine studies over 65, two of which were preformed in nursing homes (<LINK REF="STD-Hirata_x002d_Dulas-1991" TYPE="STUDY">Hirata-Dulas 1991</LINK>; <LINK REF="STD-Peterson-1988" TYPE="STUDY">Peterson 1988</LINK>) and one was restricted per definition to patients over 70 (<LINK REF="STD-Romanelli-2002" TYPE="STUDY">Romanelli 2002</LINK>). Five studies did not report the mean age.</P>
<P>The inclusion criteria in most studies were adults hospitalized with CAP. Three trials included outpatients (<LINK REF="STD-Chuard-1989" TYPE="STUDY">Chuard 1989</LINK>; <LINK REF="STD-Petitpretz-2001" TYPE="STUDY">Petitpretz 2001</LINK>; <LINK REF="STD-Tremolieres-1998" TYPE="STUDY">Tremolieres 1998</LINK>), who comprised less than 25% of patients. A fourth study (<LINK REF="STD-Lode-1995" TYPE="STUDY">Lode 1995</LINK>) stated that most patients were hospitalized, without further clarification. Nine of 24 studies included patients with either nosocomial pneumonia (three studies) or bronchitis (six studies), in addition to patients with CAP. In six studies (<LINK REF="STD-Carbon-1992" TYPE="STUDY">Carbon 1992</LINK>; <LINK REF="STD-Feldman-2001" TYPE="STUDY">Feldman 2001</LINK>; <LINK REF="STD-Hirata_x002d_Dulas-1991" TYPE="STUDY">Hirata-Dulas 1991</LINK>; <LINK REF="STD-Miki-1984" TYPE="STUDY">Miki 1984</LINK>; <LINK REF="STD-Norrby-1998" TYPE="STUDY">Norrby 1998</LINK>; <LINK REF="STD-Peterson-1988" TYPE="STUDY">Peterson 1988</LINK>), CAP patients consisted of over 60% (and in three of which, over 90%) of the patients. In two studies (<LINK REF="STD-Gleadhill-1986" TYPE="STUDY">Gleadhill 1986</LINK>; <LINK REF="STD-Kobayashi-1984" TYPE="STUDY">Kobayashi 1984</LINK>) results were given and analyzed separately for the CAP population. In the ninth study (<LINK REF="STD-Khan-1989" TYPE="STUDY">Khan 1989</LINK>), the distribution of nosocomial pneumonia versus CAP was unclear. However, the excellent results in a senior population suggest a low rate of nosocomial pneumonia. Two studies were carried out in nursing homes (<LINK REF="STD-Hirata_x002d_Dulas-1991" TYPE="STUDY">Hirata-Dulas 1991</LINK>; <LINK REF="STD-Peterson-1988" TYPE="STUDY">Peterson 1988</LINK>).</P>
<P>Pneumonia was defined by a combination of clinical signs, chest X-ray (sole criteria in two studies - <LINK REF="STD-Bohte-1995" TYPE="STUDY">Bohte 1995</LINK>; <LINK REF="STD-Vanderdonckt--1990" TYPE="STUDY">Vanderdonckt 1990</LINK> - and absent in five), laboratory (white blood count, 12 studies) and/or bacteriological evidence (six studies, in one as a necessary condition) (<LINK REF="STD-Zeluff-1988" TYPE="STUDY">Zeluff 1988</LINK>). The adjusted mean rate of bacteriological documentation was 47% in 20 studies that reported on the number of patients with bacteriological confirmation. Four studies were restricted to severe pneumonia (<LINK REF="STD-Fourrier-1986" TYPE="STUDY">Fourrier 1986</LINK>; <LINK REF="STD-Khan-1989" TYPE="STUDY">Khan 1989</LINK>; <LINK REF="STD-Rizzato-1997" TYPE="STUDY">Rizzato 1997</LINK>; <LINK REF="STD-Vanderdonckt--1990" TYPE="STUDY">Vanderdonckt 1990</LINK>). In contrast, three studies excluded severe infections (<LINK REF="STD-Carbon-1992" TYPE="STUDY">Carbon 1992</LINK>; <LINK REF="STD-Kalbermatter-2000" TYPE="STUDY">Kalbermatter 2000</LINK>; <LINK REF="STD-Lephonte-2004" TYPE="STUDY">Lephonte 2004</LINK>). Four studies included suspected pneumococcal infection (<LINK REF="STD-Bohte-1995" TYPE="STUDY">Bohte 1995</LINK>; <LINK REF="STD-Lephonte-2004" TYPE="STUDY">Lephonte 2004</LINK>; <LINK REF="STD-Petitpretz-2001" TYPE="STUDY">Petitpretz 2001</LINK>; <LINK REF="STD-Zeluff-1988" TYPE="STUDY">Zeluff 1988</LINK>), the latter was done exclusively in gold-miners and subsequently evaluated only the proven cases; a fifth study excluded suspected cases of atypical pneumonia (<LINK REF="STD-Tremolieres-1998" TYPE="STUDY">Tremolieres 1998</LINK>). Eleven studies provided the percentage of patients with chronic obstructive pulmonary disease (COPD) (most others included the data in combination with other major co morbidities). In eight studies, up to a quarter of the patients were previously diagnosed with COPD. In three, the number of COPD patients exceeded 30% (up to 52.5%, <LINK REF="STD-Rizzato-1997" TYPE="STUDY">Rizzato 1997</LINK>). None of the studies included a comparison of COPD patients and/or smokers to non-COPD patients and/or non-smokers.</P>
<P>The specific antibiotic regimens used are detailed in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> table. The atypical arm consisted of a quinolone in 21 studies, a macrolide in five and pristinamycine in one study. In the remaining study, patients were randomized to one of three arms - quinolone, macrolide and a non-atypical regimen, and the two former arms were evaluated together (<LINK REF="STD-Lode-1995" TYPE="STUDY">Lode 1995</LINK>). In all but three studies, the atypical arm was given as a monotherapy. In one case quinolone was combined with teicoplanin (<LINK REF="STD-Rizzato-1997" TYPE="STUDY">Rizzato 1997</LINK>) and in the second, macrolide was combined with either cephalosporin or an aminoglycoside (AG) (the two arms evaluated together, <LINK REF="STD-Romanelli-2002" TYPE="STUDY">Romanelli 2002</LINK>), the third is an abstract assessing the addition of an atypical antibiotic to a BL (<LINK REF="STD-Hatipoglu-2010" TYPE="STUDY">Hatipoglu 2010</LINK>). The drugs were administered orally in all but eight studies, of which most switched to oral administration within a few days.</P>
<P>The non-atypical arm consisted of BLs or cephalosporins: BL in nine cases, BL/BLI in three cases, cephalosporin in 11 cases, carbapenems in two cases and penicillin in one. One study had two non-atypical arms, cephalosporin or a BL/BLI, which were evaluated together (<LINK REF="STD-Kalbermatter-2000" TYPE="STUDY">Kalbermatter 2000</LINK>). Another study compared the atypical arm to 'customary antibiotic therapy', including BL, anti-staphylococcal drugs, cephalosporin and AG (<LINK REF="STD-Fourrier-1986" TYPE="STUDY">Fourrier 1986</LINK>). All BLs, one cephalosporin and two BL/BLI (12 studies) were administered orally, one cephalosporin was given intra-muscularly and the remaining drugs (15 studies) were administered intravenously.</P>
<P>Comparisons included: quinolone to BL (eight), BL/BLI (one), cephalosporin (nine, eight as quinolone monotherapy), carbapenem (one) or various non-atypical drugs (two); macrolide to penicillin (one), BL/BLI (one), cephalosporin (one) or to carbapenems (two, one as macrolide monotherapy); quinolone and macrolide to BL/BLI (one). One study compared pristinamycine with amoxycillin. One comparison of combination cephalosporin-macrolide to cephalosporin monotherapy was found.</P>
<P>The main outcome measure in all studies was clinical failure. Six studies mandated radiological resolution for success definition and one asked for bacteriological eradication. In four studies definition of success was unclear. None of the studies named mortality as a primary outcome.</P>
<P>Twenty-one trials assessed bacteriological failure, defined by eradication. Some reported results per patients, whereas others by pathogens (occasionally more than one pathogen per patient). Most took follow-up bacteriological specimens only from those patients found initially positive. Only 10 studies performed serology tests for atypical pathogens, one of which found all tests negative (<LINK REF="STD-Vogel-1991" TYPE="STUDY">Vogel 1991</LINK>). Four studies were evaluated for atypical pathogens eradication rate while the other six did not fully report bacteriological success rates.</P>
<P>Adverse events were addressed in all studies but the two abstracts. Two studies failed to report the number of events per treatment arm (<LINK REF="STD-Hirata_x002d_Dulas-1991" TYPE="STUDY">Hirata-Dulas 1991</LINK>; <LINK REF="STD-Lode-1995" TYPE="STUDY">Lode 1995</LINK>), the latter reporting the number of events in the comparator arms alone. Data relating specifically to antibiotic-associated diarrhoea were scarce and did not permit reliable evaluation.</P>
<P>Seven studies assessed duration of hospital stay, none reported standard deviations. Two of these studies reported mean deviations. Therefore, continuous data was not available for analysis in this review.</P>
</INCLUDED_STUDIES_DESCR>
<EXCLUDED_STUDIES_DESCR MODIFIED="2012-07-23 16:52:42 +1000" MODIFIED_BY="[Empty name]">
<P>We retrieved 66 publications for full-text inspection, of which we excluded 38 (<LINK TAG="CHARACTERISTICS_OF_EXCLUDED_STUDIES" TYPE="SECTION">Characteristics of excluded studies</LINK> table). Reasons for exclusion (occasionally more than one per study) included: studies addressing outpatients (11), allowance of atypical antibiotics in the non-atypical arm (12), nosocomial infections (5), double publication or pooled data (5), studies addressing only patients with bronchitis (2) and a dropout rate of over 30% (1). Six excluded studies investigated general severe infections, including but not exclusively, pneumonia. The percentage of pneumonia cases was usually small, some may have been nosocomial and the data were not always given separately per site of infection. One was a retrospective observational cohort study.</P>
</EXCLUDED_STUDIES_DESCR>
</STUDY_DESCRIPTION>
<STUDY_QUALITY MODIFIED="2012-07-24 08:43:06 +1000" MODIFIED_BY="[Empty name]">
<P>The overall risk of bias is presented graphically in <LINK REF="FIG-01" TYPE="FIGURE">Figure 1</LINK> and summarized in <LINK REF="FIG-02" TYPE="FIGURE">Figure 2</LINK>.
</P>
<ALLOCATION MODIFIED="2012-07-23 10:47:59 +1000" MODIFIED_BY="[Empty name]">
<P>Adequate allocation concealment was reported in 7 out of 28 studies. Insufficient information was available for the other studies. Allocation generation was adequate in 10 out of 28 studies. No information was available for 18 studies. All studies of adequate allocation concealment were also of adequate allocation generation.</P>
</ALLOCATION>
<BLINDING MODIFIED="2012-07-04 08:07:08 +1000" MODIFIED_BY="[Empty name]">
<P>Ten studies were double-blind, one was single-blinded and the remaining (17 out of 28) were open label.</P>
</BLINDING>
<EXCLUSIONS MODIFIED="2012-07-24 08:43:06 +1000" MODIFIED_BY="[Empty name]">
<P>We separated between three levels of possible bias as follows.</P>
<OL>
<LI>Studies performed by ITT.</LI>
<LI>Per-protocol studies, in which the number of dropouts was given per study arm.</LI>
<LI>Per-protocol studies, in which the number of dropouts was reported or could be calculated but not given per study arm.</LI>
</OL>
<P>As mentioned above, the primary outcome in all studies was clinical success. Seven studies reported results by ITT (type 1). Fifteen additional studies reported the number of dropouts per study arm (type 2), permitting re-analysis by ITT assuming failure for all dropouts. Six studies did not refer to dropouts (type 3) and were analyzed by evaluated patients only in the sensitivity analysis. Mortality was not a primary outcome and was usually reported in the safety analysis. Thirteen studies recounted information regarding overall mortality by ITT (type 1), while 11 provided data per-protocol. One study does not specifically mention deaths (<LINK REF="STD-Kobayashi-1984" TYPE="STUDY">Kobayashi 1984</LINK>), as is the case for the two abstracts (<LINK REF="STD-Hatipoglu-2010" TYPE="STUDY">Hatipoglu 2010</LINK>; <LINK REF="STD-Hong_x002d_yun-2007" TYPE="STUDY">Hong-yun 2007</LINK>). Twenty-five of the 27 studies could be evaluated for mortality, encompassing 5444 of 5939 randomized patients (91.6%).</P>
<P>Twenty studies reported bacteriological eradication rates, encompassing 2310 patients/isolates. All but five trials reported on adverse events per treatment arm, including 4918 patients. None of the trials mentioned duration to regaining previous functional capacity, nor were there sufficient data regarding the number of patients who required mechanical ventilation.</P>
<P>Five studies assessed duration of hospital stay, two of these reported mean duration stay (<LINK REF="STD-Hirata_x002d_Dulas-1991" TYPE="STUDY">Hirata-Dulas 1991</LINK>; <LINK REF="STD-Rizzato-1997" TYPE="STUDY">Rizzato 1997</LINK>); one reported median duration (<LINK REF="STD-Norrby-1998" TYPE="STUDY">Norrby 1998</LINK>); and the rest reported the total number of days in hospital (<LINK REF="STD-Chuard-1989" TYPE="STUDY">Chuard 1989</LINK>; <LINK REF="STD-Romanelli-2002" TYPE="STUDY">Romanelli 2002</LINK>). Only one study (<LINK REF="STD-Rizzato-1997" TYPE="STUDY">Rizzato 1997</LINK>) reported standard deviation. Therefore, continuous data were not available for analysis in this review.</P>
<P>Follow-up duration was specified in 22 studies (81%), of which 16 studies (59%) defined a specific time for outcome measurement. Follow-up ranged from immediately after completion of treatment to three months after.</P>
</EXCLUSIONS>
<SELECTIVE_REPORTING MODIFIED="2012-07-23 10:58:45 +1000" MODIFIED_BY="[Empty name]">
<P>We did not find any specific concerns over selective. All trials defined clinical success or failure as their primary outcome and reported on it. Mortality was not reported as a separate outcome in methods but was reported in results as a safety measure or otherwise. Specific data are reported for each study in the <LINK TAG="CHARACTERISTICS_OF_INCLUDED_STUDIES" TYPE="SECTION">Characteristics of included studies</LINK> tables.</P>
</SELECTIVE_REPORTING>
<OTHER_BIAS_SOURCES MODIFIED="2012-07-23 10:59:41 +1000" MODIFIED_BY="[Empty name]">
<P>At least 21 of the 27 studies were sponsored by pharmaceutical companies; all but one of these manufactured the atypical drug.</P>
<P>Two of the studies included in this review were abstracts, with data extracted only from the abstracts and no further data were available. Randomization and allocation concealment procedures in these trials are unknown. One of the abstracts was published in the Chinese journal <I>Chinese Journal of Antibiotics</I> (<LINK REF="STD-Hong_x002d_yun-2007" TYPE="STUDY">Hong-yun 2007</LINK>) but we could not obtain its full-text. We failed to contact the authors of this abstract, and therefore we have no detailed information about randomizations and allocation concealment in this study.</P>
</OTHER_BIAS_SOURCES>
</STUDY_QUALITY>
<INTERVENTION_EFFECTS MODIFIED="2012-07-24 08:43:10 +1000" MODIFIED_BY="[Empty name]">
<SUBSECTION>
<HEADING LEVEL="3">Overall mortality (Analyses 1.1 to 1.7)</HEADING>
<P>Twenty-five of the 27 studies could be evaluated for mortality, encompassing 5444 of 5939 randomized patients (91.6%). Six studies reported no deaths, 12 reported a mortality rate between 0.4% to 5%, six reported a rate of 5% to 8%, and one study reported a 25% mortality rate (<LINK REF="STD-Fourrier-1986" TYPE="STUDY">Fourrier 1986</LINK>). In three studies, two of which were abstracts, mortality was not mentioned (<LINK REF="STD-Hatipoglu-2010" TYPE="STUDY">Hatipoglu 2010</LINK>; <LINK REF="STD-Hong_x002d_yun-2007" TYPE="STUDY">Hong-yun 2007</LINK>; <LINK REF="STD-Kobayashi-1984" TYPE="STUDY">Kobayashi 1984</LINK>). The adjusted mean mortality rate was 3.5%. None of the deaths according to the authors were related to the drug treatment.</P>
<P>There was no significant difference between the atypical arm and the non-atypical arm in the overall mortality rate (RR 1.14; 95% CI 0.84 to 1.55, <LINK REF="CMP-001.01" TYPE="ANALYSIS">Analysis 1.1</LINK>). The difference remained non-significant when evaluating quinolone therapy (RR 0.98; 95% CI 0.69 to 1.39) and macrolide therapy (RR 1.25; 95% CI 0.52 to 3.01) alone. No heterogeneity was seen for the overall comparison (Chi<SUP>2 </SUP>test = 8.34, df =17, P = 0.96, I<SUP>2 </SUP>statistic = 0%).</P>
<P>Mortality was further analyzed by patient characteristics: age (mean age older or younger than 65 years); and geographical area (Europe, North America or other). Neither comparison disclosed a significant difference (<LINK REF="CMP-001.02" TYPE="ANALYSIS">Analysis 1.2</LINK> and <LINK REF="CMP-001.03" TYPE="ANALYSIS">Analysis 1.3</LINK>, respectively). Overall mortality in both arms was similar when analyzing studies by randomizations generation, allocation concealment and blinding (<LINK REF="CMP-001.04" TYPE="ANALYSIS">Analysis 1.4</LINK>, <LINK REF="CMP-001.05" TYPE="ANALYSIS">Analysis 1.5</LINK> and <LINK REF="CMP-001.06" TYPE="ANALYSIS">Analysis 1.6</LINK>, respectively), as well as in the ITT analysis (<LINK REF="CMP-001.07" TYPE="ANALYSIS">Analysis 1.7</LINK>). The effect of sponsorship by pharmaceutical companies could not be evaluated, as in the non-sponsored trials there was no mortality. In the funnel plot for overall mortality, which included 19 trials in which mortality was more than zero, results are symmetrically centered around the combined RR (<LINK REF="FIG-03" TYPE="FIGURE">Figure 3</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Clinical failure (Analyses 1.8 to 1.18)</HEADING>
<P>Clinical failure was the primary outcome in all 28 studies, comprising 5419 patients (of 5939 randomized). A non-significant trend toward an advantage to the atypical arm was observed combining all studies (RR 0.93; 95% CI 0.84 to 1.04) (<LINK REF="CMP-001.08" TYPE="ANALYSIS">Analysis 1.8</LINK>). No heterogeneity for the total results was seen (Chi<SUP>2 </SUP>test = 29.53, df = 24, P = 0.2, I<SUP>2 </SUP>statistic = 18.7%). When evaluating the different atypical regimens, quinolone monotherapy showed non-significant advantage (RR 0.89; 95% CI 0.79 to 1.02) while macrolide monotherapy showed non-significant disadvantage (RR 1.11; 95% CI 0.76 to 1.62). The non-significant advantage of the atypical arm was seen in young patients (mean age &lt; 65 years: RR 0.93; 95% CI 0.81 to 1.06) as well as older patients (mean age older than 65 years: RR 0.91; 95% CI 0.75 to 1.10) (<LINK REF="CMP-001.09" TYPE="ANALYSIS">Analysis 1.9</LINK>). The advantage was statistically significant in the European studies (RR 0.85; 95% CI 0.74 to 0.98) but not in studies carried out elsewhere (<LINK REF="CMP-001.10" TYPE="ANALYSIS">Analysis 1.10</LINK>).</P>
<P>There was no advantage to atypical treatment in studies of high methodological quality. There was no difference in clinical efficacy when combining studies that scored A in randomizations generation (RR 0.99; 95% CI 0.82 to 1.19) or allocation concealment (RR 0.99; 95% CI 0.82 to 1.19). Studies of B score accentuated an advantage toward the atypical arm (<LINK REF="CMP-001.11" TYPE="ANALYSIS">Analysis 1.11</LINK>; <LINK REF="CMP-001.12" TYPE="ANALYSIS">Analysis 1.12</LINK>). Rates of clinical failure were similar in trials sponsored by pharmaceutical companies (RR 0.97; 95% CI 0.86 to 1.08, 21 trials) and non-sponsored trials (RR 1.02; 95% CI 0.64 to 1.62, 3 trials) (<LINK REF="CMP-001.18" TYPE="ANALYSIS">Analysis 1.18</LINK>).</P>
<P>We performed an ITT versus per-protocol design sensitivity analysis, counting all dropouts as failures in the ITT group (<LINK REF="CMP-001.14" TYPE="ANALYSIS">Analysis 1.14</LINK>). No significant differences between type 1 (RR 0.92; 95% CI 0.76 to 1.12), type 2 (RR 0.94; 95% CI 0.84 to 1.05) or type 3 (RR 0.85; 95% CI 0.63 to 1.15) studies, although type 3 studies showed a higher effect estimate for atypical treatment.</P>
<P>Clinical failure with macrolide antibiotic treatment was the only comparison in which heterogeneity was detected (Chi<SUP>2 </SUP>test = 6.68, df = 3, P = 0.08, I<SUP>2 </SUP>statistic<SUP> </SUP>= 55.1%). Re-analysis done by the random-effects model did not alter results.</P>
<P>Clinical failure rates were evaluated per pathogens isolated. Of the 1021 pneumococcal pneumonia cases reported, there was a non-significant advantage to the non-atypical arm (RR 1.22; 95% CI 0.88 to 1.7, <LINK REF="CMP-001.15" TYPE="ANALYSIS">Analysis 1.15</LINK>). Data were insufficient to distinctively analyze cases of pneumococcal bacteraemia. In contrast to <I>S. pneumoniae</I>, there was a non-significant advantage to the atypical arm in the treatment of atypical pathogens (RR 0.52; 95% CI 0.24 to 1.10, <LINK REF="CMP-001.16" TYPE="ANALYSIS">Analysis 1.16</LINK>). Eradication of <I>L. pneumophilae</I> in particular was highly significant, with a RR of 0.17 and a narrow CI (0.05 to 0.63), although only 43 cases were available (<LINK REF="CMP-001.17" TYPE="ANALYSIS">Analysis 1.17</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Bacteriological failure (Analyses 1.19 to 1.20)</HEADING>
<P>Twenty studies reported bacteriological eradication rates, encompassing 2310 patients/isolates (mixed results, as each study used different measures, see above). There was a statistically significant advantage to bacteriological eradication in the atypical treatment arm (RR 0.80; 95% CI 0.65 to 0.98, <LINK REF="CMP-001.19" TYPE="ANALYSIS">Analysis 1.19</LINK>). No heterogeneity was seen (Chi<SUP>2 </SUP>test<SUP> </SUP>= 12.4, df = 18, P = 0.0.83, I<SUP>2 </SUP>statistic<SUP> </SUP>= 0%). When considering only the high quality studies ('A' score in allocation generation), no significant difference was detected in bacteriological eradication between the two treatment arms (RR 0.90; 95% CI 0.61 to 1.32, <LINK REF="CMP-001.20" TYPE="ANALYSIS">Analysis 1.20</LINK>). Again, no heterogeneity was seen (Chi<SUP>2 </SUP>test<SUP> </SUP>= 1.35, df = 6, P = 0.97, I<SUP>2 </SUP>statistic<SUP> </SUP>= 0%). Only five studies reported super-infections, with numbers too small for statistical assessment.</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Adverse events (Analyses 1.21 to 1.23)</HEADING>
<P>All but five trials reported on adverse events per treatment arm, including 4918 patients. Total adverse events (<LINK REF="CMP-001.21" TYPE="ANALYSIS">Analysis 1.21</LINK>) were similar in both treatment arms (RR 1.02; 95% CI 0.93 to 1.13). No heterogeneity was seen (Chi<SUP>2 </SUP>test<SUP> </SUP>= 39.93, df = 21, P = 0.009, I<SUP>2 </SUP>statistic = 29.8%). Gastrointestinal events (<LINK REF="CMP-001.22" TYPE="ANALYSIS">Analysis 1.22</LINK>) were reported in 16 studies and were significantly less common in the atypical arm (RR 0.7; 95% CI 0.53 to 0.92). However, definition of gastrointestinal events differed, some including abdominal pain and some diarrhoea alone, thereby excluding an accurate comparison of the frequency of antibiotic-associated diarrhoea. Both arms were nearly equal with regard to adverse events requiring discontinuation (RR 1.01; 95% CI 0.72 to 1.41, <LINK REF="CMP-001.23" TYPE="ANALYSIS">Analysis 1.23</LINK>).</P>
</SUBSECTION>
<SUBSECTION>
<HEADING LEVEL="3">Other outcomes</HEADING>
<P>Treatment duration was conveyed in 14 studies and was almost uniformly 10 days, with no difference between the arms. None of the trials mentioned duration to regaining previous functional capacity, nor were there sufficient data regarding the number of patients who required mechanical ventilation.</P>
</SUBSECTION>
</INTERVENTION_EFFECTS>
</RESULTS>
<DISCUSSION MODIFIED="2012-07-24 08:43:10 +1000" MODIFIED_BY="[Empty name]">
<SUMMARY_OF_RESULTS MODIFIED="2012-07-23 12:16:02 +1000" MODIFIED_BY="[Empty name]">
<P>The primary outcome we assessed was overall mortality. There was no difference between the atypical arm and the non-atypical arm with respect to this outcome. This did not change when analyzing results per population characteristics or methodology. There was a non-significant trend toward clinical success in the atypical arm, accentuated with quinolone monotherapy. The advantage disappeared when evaluating high-quality methodological studies alone (i.e. studies that had a low risk of selection bias). A significant advantage in bacteriological eradication was detected in the atypical arm, especially in reference to <I>L. pneumophilae </I>eradication. This advantage was not demonstrated in an analysis restricted to studies with adequate allocation generation. There was no statistically significant difference in the frequency of total adverse events between the two groups, although less gastrointestinal events were noted in the atypical arm.</P>
<P>Failure was commonly defined as lack of clinical improvement, deterioration, relapse and/or modifications of the antibiotic treatment. These endpoints are subjective and should therefore be studied with care, especially as many are non-blinded. Although pharmaceutical companies producing the atypical antibiotic sponsored most studies, the point estimate for sponsored and non-sponsored trials for clinical failure is similar. The similar response of the young and old is somewhat surprising, as one might anticipate that younger people would benefit more from atypical coverage, given a higher prevalence of atypical pneumonia in this age group. Perhaps this prevalence diminishes in the hospitalized population. A higher <I>L. pneumophilae</I> prevalence in the elder population may also explain the similarity.</P>
</SUMMARY_OF_RESULTS>
<APPLICABILITY_OF_FINDINGS MODIFIED="2012-07-23 12:17:13 +1000" MODIFIED_BY="[Empty name]">
<P>Mortality data were obtained for 91.6% of randomized patients. The overall mortality in included studies (adjusted mean 3.5%) was lower than reported in the literature (MedisGroups overall mortality of 10.6% (<LINK REF="REF-Iezzoni-1988" TYPE="REFERENCE">Iezzoni 1988</LINK>); PORT validation cohort inpatient mortality of 8.0% (<LINK REF="REF-Fine-1997" TYPE="REFERENCE">Fine 1997</LINK>)). This is surprising in view of the fact that 12 of the 27 studies target relatively severe pneumonia cases (two studies conducted in nursing homes, one excluding patients under 70 years of age, three including suspected or proven pneumococcal pneumonia (the fourth excluded severe cases), one excluding suspected atypical cases, four restricted to clinically severe pneumonia and one restricted to moderate-severe pneumonia (see above). The low mortality rate is not a result of under-reporting, as mortality data were almost complete. Mortality was not a primary outcome in any of the studies, although it is obviously the most significant outcome in a potentially lethal infectious episode.</P>
</APPLICABILITY_OF_FINDINGS>
<QUALITY_OF_EVIDENCE MODIFIED="2012-07-24 08:43:10 +1000" MODIFIED_BY="[Empty name]">
<P>The atypical arm's advantage in bacteriological eradication could not be explained by the coverage of atypical pathogens alone: results of clinical success in those cases were equivocal and their proven share of events was small. As demonstrated above, its reliability is questionable, since it became insignificant in the evaluation of high quality studies. One should note that the atypical arm was usually a new drug (tested by the manufacturer) and therefore expected resistance rates were small, compared to the typical arm which comprised of BL or cephalosporins. Furthermore, most publications date to the early 1990s, while new resistant trends have emerged since then (for example increasing pneumococcal resistance to quinolones). The clinical advantage of <I>L. pneumophilae </I>coverage is not surprising. It is interesting to note that cases of atypical pneumonia (including <I>L. pneumophilae</I>) often resolved even in the treatment arm lacking atypical coverage. Only a minority were co-infections with typical pathogens.</P>
<P>The total of adverse events did not differ significantly between treatment arms. Gastrointestinal side effects were studied separately in order to try and assess frequency of antibiotic-associated diarrhoea after BL or cephalosporin treatment and were found to be significantly more prevalent in the non-atypical arm. However, the trials differed in definition of events to a point that precludes this assessment.</P>
<P>We had set off to investigate the contribution of atypical coverage to empiric treatment of CAP in hospitalized patients. The most suitable study for our purpose is one comparing a BL or cephalosporin with the same BL or cephalosporin combined with a macrolide or a quinolone. The last update found no such trials. In this update we found only a single abstract assessing directly the addition of an atypical antibiotic to a BL, which found no positive effect on treatment success rates with the addition of atypical coverage (<LINK REF="STD-Hatipoglu-2010" TYPE="STUDY">Hatipoglu 2010</LINK>). The need to add a macrolide to a BL therapy is a common dilemma manifested within the guidelines themselves. Our meta-analysis is therefore chiefly based on comparison of BL or cephalosporin regimens to atypical monotherapy, mainly quinolone monotherapy. Regarding this comparison, we found no advantage to atypical coverage in terms of mortality or clinical success. The relatively low mortality rates in the existing hospitalized CAP trials included in the mortality analysis, further limits our conclusion.</P>
</QUALITY_OF_EVIDENCE>
<POTENTIAL_BIASES MODIFIED="2011-10-19 06:57:02 +1000" MODIFIED_BY="[Empty name]">
<P>Inclusion of abstracts and studies with missing data might have introduced bias.</P>
</POTENTIAL_BIASES>
<AGREEMENT MODIFIED="2012-01-12 11:14:20 +1000" MODIFIED_BY="[Empty name]">
<P>The objective of our study was to assess the efficacy and need of adding antibiotic coverage for atypical pathogens in hospitalized patients with CAP, in terms of mortality and successful treatment.</P>
<P>All major guidelines for treatment of CAP recommend in general, an antibiotic regimen covering both typical and atypical pathogens in hospitalized CAP patients (<LINK REF="REF-BTS-2001" TYPE="REFERENCE">BTS 2001</LINK>; <LINK REF="REF-Hedlund-2005" TYPE="REFERENCE">Hedlund 2005</LINK>; <LINK REF="REF-Lim-2009" TYPE="REFERENCE">Lim 2009</LINK>; <LINK REF="REF-Mandell-2000" TYPE="REFERENCE">Mandell 2000</LINK>; <LINK REF="REF-Mandell-2007" TYPE="REFERENCE">Mandell 2007</LINK>; <LINK REF="REF-Niederman-2001" TYPE="REFERENCE">Niederman 2001</LINK>; <LINK REF="REF-Woodhead-2005" TYPE="REFERENCE">Woodhead 2005</LINK>). Admittedly, these guidelines are based on insufficient evidence, as there have been only few randomized controlled trials assessing CAP treatment protocols. Most trials comparing different treatment arms were performed to evaluate a specific drug, frequently a macrolide or a fluoroquinolone. Several of these trials (incidentally) compared regimens with and without atypical antibiotic coverage and found results to be generally equal (<LINK REF="STD-Aubier-1998" TYPE="STUDY">Aubier 1998</LINK>; <LINK REF="STD-Tremolieres-1998" TYPE="STUDY">Tremolieres 1998</LINK>).</P>
<P>A large systematic review that included observational studies, evaluated the superiority of atypical coverage to non-atypical coverage regimens (<LINK REF="REF-Oosterheert-2003" TYPE="REFERENCE">Oosterheert 2003</LINK>). Significant reduction in mortality with atypical coverage was found in six of the eight selected studies. However, these studies were non-randomized cohort studies and outcomes showed several inconsistencies. Using propensity analysis, we showed that the major pitfall of such observational studies is the marked difference between patients prescribed non-atypical coverage and those prescribed a regimen including atypical coverage, a difference that precludes the comparison of these treatment regimens in observational studies (<LINK REF="REF-Paul-2007" TYPE="REFERENCE">Paul 2007</LINK>). Expanding coverage to atypical pathogens is bound to increase toxicity, resistance and cost. Moreover, this broad coverage might be at the expense of efficacy of pneumococcal coverage (<LINK REF="REF-Johansen-2000" TYPE="REFERENCE">Johansen 2000</LINK>).</P>
<P>We conclude that no benefit of survival or clinical efficacy was shown to empirical atypical coverage in hospitalized patients with CAP. Further randomized controlled trials, comparing BL or cephalosporins therapy to BL or cephalosporins combined with a macrolide in this population, using mortality as its primary outcome, should be performed.</P>
</AGREEMENT>
</DISCUSSION>
<CONCLUSIONS MODIFIED="2012-07-23 12:25:07 +1000" MODIFIED_BY="[Empty name]">
<IMPLICATIONS_PRACTICE MODIFIED="2012-07-23 12:23:36 +1000" MODIFIED_BY="[Empty name]">
<P>No benefit of survival or clinical efficacy was shown to empirical atypical coverage in hospitalized patients with CAP. This conclusion relates mostly to the comparison of quinolone monotherapy with BL monotherapy.</P>
</IMPLICATIONS_PRACTICE>
<IMPLICATIONS_RESEARCH MODIFIED="2012-07-23 12:25:07 +1000" MODIFIED_BY="[Empty name]">
<P>A RCT of a BL monotherapy compared to the same BL combined with a macrolide or a quinolone in hospitalized patients with CAP should be performed. Until then, the major regimen recommended in current guidelines remains unsubstantiated by evidence. The trial should have adequate randomizations generation and concealment and should report patient relevant outcomes (<LINK REF="REF-FDA-2009" TYPE="REFERENCE">FDA 2009</LINK>) and mortality. The trial should include patients with severe pneumonia, compatible (as regards severity) to those observed in sound observational studies.</P>
</IMPLICATIONS_RESEARCH>
</CONCLUSIONS>
</BODY>
<ACKNOWLEDGEMENTS MODIFIED="2012-03-21 11:03:57 +1000" MODIFIED_BY="[Empty name]">
<P>We thank the trial authors who responded to our requests: Dr. Claude Carbon, Dr. Francois Fourrier, Dr. Daniel Genne, Dr. Hartmut Lode, Dr. Phillip Peterson, Dr. Patrick Petitpretz and Dr. Jose Sifuentes Osornio. We are indebted to Dr. Karla Soares-Weiser for her guidance. We would like to thank Dr. Gabriel Izbicki for his translation from German and to Ms. Rika Fujia for obtaining and translating the Japanese articles. Warm thanks to the Cochrane Acute Respiratory Infections Group editorial team for their guidance throughout the review (Liz Dooley, Managing Editor) and the help devising and conducting the search (Sarah Thorning, Trials Search Co-ordinator). We wish to thank the following people for commenting on this latest updated draft: Linda Hornbeek, Richard Taggart, Theo Verheij,<B> </B>Nelcy Rodriguez and Allen Cheng.</P>
</ACKNOWLEDGEMENTS>
<CONFLICT_OF_INTEREST MODIFIED="2008-06-23 10:21:20 +1000" MODIFIED_BY="Liz Dooley">
<P>None known.</P>
</CONFLICT_OF_INTEREST>
<CONTRIBUTIONS MODIFIED="2012-07-23 12:31:08 +1000" MODIFIED_BY="[Empty name]">
<P>Noa Eliakim Raz (NER) co-ordinated this updated review, guided by Leonard Leibovic (LL).<BR/>NER and Eyal Robenshtok (ER) were responsible for data collection, writing to trial authors for additional information and organizing retrieval of papers.<BR/>NER and ER were responsible for undertaking searches.<BR/>NER, ER, Daphna Shefet (DS), Anat Gafter-Gvili (AG) and Mical Paul (MP) were responsible for screening search results, abstracting data from papers, screening retrieved papers against inclusion criteria and appraising quality of papers (the latter review author was in-charge in case of disagreement).<BR/>NER was responsible for entering data into Review Manager 5 (RevMan).<BR/>All review authors participated in analysis and interpretation of data.<BR/>NER and ER were responsible for writing the review.<BR/>
</P>
</CONTRIBUTIONS>
<PRO_REV_DIFF/>
<PUBLIC_NOTES/>
</MAIN_TEXT>
<STUDIES_AND_REFERENCES MODIFIED="2012-07-24 08:37:53 +1000" MODIFIED_BY="[Empty name]">
<STUDIES MODIFIED="2012-07-23 16:49:51 +1000" MODIFIED_BY="[Empty name]">
<INCLUDED_STUDIES MODIFIED="2012-07-23 16:49:51 +1000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Aubier-1998" MODIFIED="2012-07-23 14:20:28 +1000" MODIFIED_BY="[Empty name]" NAME="Aubier 1998" YEAR="1998">
<REFERENCE MODIFIED="2012-07-23 14:20:28 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Aubier, M., R. Verster, et al. (1998). &amp;quot;Once-daily sparfloxacin versus high-dosage amoxicillin in the treatment of community-acquired, suspected pneumococcal pneumonia in adults. Sparfloxacin European Study Group.&amp;quot; Clin Infect Dis 26(6): 1312-20.&lt;/p&gt;" NOTES_MODIFIED="2012-07-23 14:20:28 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aubier M, Verster R, Regamey C, Geslin P, Vercken JB; Sparfloxacin European Study Group</AU>
<TI>Once-daily sparfloxacin versus high-dosage amoxicillin in the treatment of community-acquired, suspected pneumococcal pneumonia in adults</TI>
<SO>Clinical Infectious Diseases</SO>
<YR>1998</YR>
<VL>26</VL>
<NO>6</NO>
<PG>1312-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Bohte-1995" MODIFIED="2011-12-06 10:37:03 +1000" MODIFIED_BY="[Empty name]" NAME="Bohte 1995" YEAR="1995">
<REFERENCE MODIFIED="2011-12-06 10:37:03 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Bohte, R., J. W. van't Wout, et al. (1995). &amp;quot;Efficacy and safety of azithromycin versus benzylpenicillin or erythromycin in community-acquired pneumonia.&amp;quot; Eur J Clin Microbiol Infect Dis 14(3): 182-7.&lt;/p&gt;" NOTES_MODIFIED="2011-12-06 10:37:03 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bohte R, van't Wout JW, Lobatto S, Blusse van Oud Alblas A, Boekhout M, Nauta EH, et al</AU>
<TI>Efficacy and safety of azithromycin versus benzylpenicillin or erythromycin in community-acquired pneumonia</TI>
<SO>European Journal of Clinical Microbiology and Infectious Diseases</SO>
<YR>1995</YR>
<VL>14</VL>
<NO>3</NO>
<PG>182-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Carbon-1992" NAME="Carbon 1992" YEAR="1992">
<REFERENCE NOTES="&lt;p&gt;Carbon, C., P. Leophonte, et al.&amp;quot;Efficacy and safety of temafloxacin versus those of amoxicillin in hospitalized adults with community-acquired pneumonia.&amp;quot; Antimicrob Agents Chemother 36(4): 833-9.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Carbon C, Lephonte P, Petitpretz P, Chauvin JP, Hazebroucq J</AU>
<TI>Efficacy and safety of temafloxacin versus those of amoxicillin in hospitalized adults with community-acquired pneumonia</TI>
<SO>Antimicrobial Agents and Chemotherapy</SO>
<YR>1992</YR>
<VL>36</VL>
<NO>4</NO>
<PG>833-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chuard-1989" NAME="Chuard 1989" YEAR="1989">
<REFERENCE NOTES="&lt;p&gt;Chuard, C. and C. Regamey (1989). &amp;quot;[Effect and tolerance of ofloxacin in bronchopulmonary infections in comparison with amoxicillin].&amp;quot; Schweiz Med Wochenschr 119(52): 1913-6.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chuard C, Regamey C</AU>
<TI>Effect and tolerance of ofloxacin in bronchopulmonary infections in comparison with amoxicillin</TI>
<SO>Schweizerische Medizinische Wochenschrift</SO>
<YR>1989</YR>
<VL>119</VL>
<NO>52</NO>
<PG>1913-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Feldman-2001" NAME="Feldman 2001" YEAR="2001">
<REFERENCE NOTES="&lt;p&gt;Feldman C, White H, O'Grady J, Flitcroft A, Briggs A, Richards G. An open, randomised, multi-centre study comparing the safety and efficacy of sitafloxacin and imipenem/cilastatin in the intravenous treatment of hospitalised patients with pneumonia. Int J Antimicrob Agents. 2001 Mar;17(3):177-88&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Feldman C, White H, O'Grady J, Flitcroft A, Briggs A, Richards G</AU>
<TI>An open, randomised, multi-centre study comparing the safety and efficacy of sitafloxacin and imipenem/cilastatin in the intravenous treatment of hospitalised patients with pneumonia</TI>
<SO>International Journal of Antimicrobial Agents</SO>
<YR>2001</YR>
<VL>17</VL>
<NO>3</NO>
<PG>177-88</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fourrier-1986" MODIFIED="2012-07-23 14:23:37 +1000" MODIFIED_BY="[Empty name]" NAME="Fourrier 1986" YEAR="1986">
<REFERENCE MODIFIED="2012-07-23 14:23:37 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Fourrier, F., C. Chopin, et al. (1986). &amp;quot;Initial antibiotherapy in severe bacterial bronchopneumopathies. Randomized study of a new quinolone: pefloxacin&amp;quot; Press Med 15(26): 1240.&lt;/p&gt;" NOTES_MODIFIED="2012-07-23 14:23:37 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fourrier F, Chopin C, Lestavel P, Savage C</AU>
<TI>Initial antibiotherapy in severe bacterial bronchopneumopathies. Randomized study of a new quinolone: pefloxacin</TI>
<SO>La Presse Medicale</SO>
<YR>1986</YR>
<VL>15</VL>
<NO>26</NO>
<PG>1240</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Genne-1997" MODIFIED="2012-07-23 14:25:30 +1000" MODIFIED_BY="[Empty name]" NAME="Genne 1997" YEAR="1997">
<REFERENCE MODIFIED="2012-07-23 14:25:30 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Genne, D., H. H. Siegrist, et al. (1997). &amp;quot;Clarithromycin versus amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia.&amp;quot; Eur J Clin Microbiol Infect Dis 16(11): 783-8.&lt;/p&gt;" NOTES_MODIFIED="2012-07-23 14:25:30 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Genné D, Siegrist HH, Humair L, Janin-Jaquat B, de Torrenté A</AU>
<TI>Clarithromycin versus amoxicillin-clavulanic acid in the treatment of community-acquired pneumonia</TI>
<SO>European Journal of Clinical Microbiology and Infectious Diseases</SO>
<YR>1997</YR>
<VL>16</VL>
<NO>11</NO>
<PG>783-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Gleadhill-1986" NAME="Gleadhill 1986" YEAR="1986">
<REFERENCE NOTES="&lt;p&gt;Gleadhill, I. C., W. P. Ferguson, et al. (1986). &amp;quot;Efficacy and safety of ciprofloxacin in patients with respiratory infections in comparison with amoxycillin.&amp;quot; J Antimicrob Chemother 18 Suppl D: 133-8.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Gleadhill IC, Ferguson WP, Lowry RC</AU>
<TI>Efficacy and safety of ciprofloxacin in patients with respiratory infections in comparison with amoxycillin</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>1986</YR>
<VL>18</VL>
<NO>Supp D</NO>
<PG>133-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="UNPUB" ID="STD-Hatipoglu-2010" MODIFIED="2012-07-23 14:34:53 +1000" MODIFIED_BY="[Empty name]" NAME="Hatipoglu 2010" YEAR="2010">
<REFERENCE MODIFIED="2012-07-23 14:34:53 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="CONFERENCE_PROC">
<AU>Hatipoglu ON, Uysal S, Altiay G, Sut N, Tabakoglu E</AU>
<TI>The effect of addition of macrolide to a beta-lactam antibiotic on treatment success in patients with moderately severe community acquired pneumonia (Abstract)</TI>
<SO>Proceedings of the European Respiratory Society Annual Congress; 2010 September 18-22; Barcelona, Spain</SO>
<YR>2010</YR>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hirata_x002d_Dulas-1991" NAME="Hirata-Dulas 1991" YEAR="1991">
<REFERENCE NOTES="&lt;p&gt;Hirata-Dulas CA, Stein DJ, Guay DR, Gruninger RP, Peterson PK. A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections. J Am Geriatr Soc 1991;39(10): 979-85.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hirata-Dulas CA, Stein DJ, Guay DR, Gruninger RP, Peterson PK</AU>
<TI>A randomized study of ciprofloxacin versus ceftriaxone in the treatment of nursing home-acquired lower respiratory tract infections</TI>
<SO>Journal of the American Geriatrics Society</SO>
<YR>1991</YR>
<VL>39</VL>
<NO>10</NO>
<PG>979-85</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hong_x002d_yun-2007" MODIFIED="2012-03-23 07:27:59 +1000" MODIFIED_BY="[Empty name]" NAME="Hong-yun 2007" NOTES="&lt;p&gt;Abstract only - no page or vol number&lt;/p&gt;" NOTES_MODIFIED="2012-03-23 07:27:59 +1000" NOTES_MODIFIED_BY="[Empty name]" YEAR="2006">
<REFERENCE MODIFIED="2012-01-12 11:11:03 +1000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hong-yun L, Chao Q, Qian L, Qun F</AU>
<TI>Observation of the therapeutic effects of gatifloxacin on community acquired pneumonia</TI>
<SO>Chinese Journal of Antibiotics</SO>
<YR>2007</YR>
<NO>5</NO>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kalbermatter-2000" NAME="Kalbermatter 2000" YEAR="2000">
<REFERENCE NOTES="&lt;p&gt;Kalbermatter, V., D. Bagilet, et al. (2000). &amp;quot;[Oral levofloxacin versus intravenous ceftriaxone and amoxicillin/clavulanic acid in the treatment of community-acquired pneumonia that requires hospitalization].&amp;quot; Med Clin (Barc) 115(15): 561-3.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kalbermatter V, Bagilet D, Diab M, Javkin E</AU>
<TI>Oral levofloxacin versus intravenous ceftriaxone and amoxicillin/clavulanic acid in the treatment of community-acquired pneumonia that requires hospitalization</TI>
<SO>Medicina Clinica</SO>
<YR>2000</YR>
<VL>115</VL>
<NO>15</NO>
<PG>561-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Khan-1989" NAME="Khan 1989" YEAR="1989">
<REFERENCE NOTES="&lt;p&gt;Khan et al 1989: Sequential intravenous-oral administration of ciprofloxacin vs ceftazidime in serious bacterial respiratory tract infections. Chest 96(3) 453-6&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Khan FA, Basir R</AU>
<TI>Sequential intravenous-oral administration of ciprofloxacin vs ceftazidime in serious bacterial respiratory tract infections</TI>
<SO>Chest</SO>
<YR>1989</YR>
<VL>96</VL>
<NO>3</NO>
<PG>453-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kobayashi-1984" MODIFIED="2011-12-06 10:36:19 +1000" MODIFIED_BY="[Empty name]" NAME="Kobayashi 1984" YEAR="1984">
<REFERENCE MODIFIED="2011-12-06 10:36:19 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Kobayashi, H., K. Takamura, et al. (1984). &amp;quot;[Comparison of DL-8280 and amoxicillin in the treatment of respiratory tract infections].&amp;quot; Kansenshogaku Zasshi 58(6): 525-55.&lt;/p&gt;" NOTES_MODIFIED="2011-12-06 10:36:19 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kobayashi H, Takamura K, Kono K, Onodera S, Sasaki N, Nagahama F, et al</AU>
<TI>Comparison of DL-8280 and amoxicillin in the treatment of respiratory tract infections</TI>
<SO>Kansenshogaku Zasshi</SO>
<YR>1984</YR>
<VL>58</VL>
<NO>6</NO>
<PG>525-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kohno-2011" MODIFIED="2012-07-04 08:14:56 +1000" MODIFIED_BY="[Empty name]" NAME="Kohno 2011" YEAR="2011">
<REFERENCE MODIFIED="2012-07-04 08:14:56 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kohno S, Watanabe A, Aoki N, Niki Y, Kadota J, Fujita J, et al</AU>
<TI>Clinical phase III comparative study of intravenous levofloxacin and ceftriaxone in community-acquired pneumonia treatment</TI>
<SO>Japanese Journal of Chemotherapy</SO>
<YR>2011</YR>
<VL>59</VL>
<PG>32-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lephonte-2004" NAME="Lephonte 2004" YEAR="2004">
<REFERENCE NOTES="&lt;p&gt;Leophonte P, File T, Feldman C Gemifloxacin once daily for 7 days compared to amoxicillin/clavulanic acid thrice daily for 10 days for the treatment of community-acquired pneumonia of suspected pneumococcal origin. Respir Med. 2004 Aug;98(8):708-20. &lt;/p&gt;&lt;p&gt;Respir Med. 2004 Aug;98(8):708-20&lt;br&gt;&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leophonte P, File T, Feldman C</AU>
<TI>Gemifloxacin once daily for 7 days compared to amoxicillin/clavulanic acid thrice daily for 10 days for the treatment of community-acquired pneumonia of suspected pneumococcal origin</TI>
<SO>Respiratory Medicine</SO>
<YR>2004</YR>
<VL>98</VL>
<NO>8</NO>
<PG>708-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lode-1995" MODIFIED="2012-07-23 14:40:08 +1000" MODIFIED_BY="[Empty name]" NAME="Lode 1995" YEAR="1995">
<REFERENCE MODIFIED="2012-07-23 14:40:08 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Lode, H., J. Garau, et al. (1995). &amp;quot;Treatment of community-acquired pneumonia: a randomized comparison of sparfloxacin, amoxycillin-clavulanic acid and erythromycin.&amp;quot; Eur Respir J 8(12): 1999-2007.&lt;/p&gt;" NOTES_MODIFIED="2012-07-23 14:40:08 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lode H, Garau J, Grassi C, Hosie J, Huchon G, Legakis N, et al</AU>
<TI>Treatment of community-acquired pneumonia: a randomized comparison of sparfloxacin, amoxycillin-clavulanic acid and erythromycin</TI>
<SO>European Respiratory Journal</SO>
<YR>1995</YR>
<VL>8</VL>
<NO>12</NO>
<PG>1999-2007</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Miki-1984" MODIFIED="2011-12-06 10:37:31 +1000" MODIFIED_BY="[Empty name]" NAME="Miki 1984" YEAR="1984">
<REFERENCE MODIFIED="2011-12-06 10:37:31 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Miki, F., A. Saito, et al. (1984). &amp;quot;[Comparative study of the effectiveness of enoxacin and amoxicillin in bacterial pneumonia by a double blind method].&amp;quot; Kansenshogaku Zasshi 58(10): 1083-113.&lt;/p&gt;" NOTES_MODIFIED="2011-12-06 10:37:31 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Miki F, Saito A, Tomizawa M, Nakayama I, Takebe K, Takashima T, et al</AU>
<TI>Comparative study of the effectiveness of enoxacin and amoxicillin in bacterial pneumonia by a double blind method</TI>
<SO>Kansenshogaku Zasshi</SO>
<YR>1984</YR>
<VL>58</VL>
<NO>10</NO>
<PG>1083-113</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Norrby-1998" NAME="Norrby 1998" YEAR="1998">
<REFERENCE NOTES="&lt;p&gt;Norrby SR, Petermann W, Willcox PA, Vetter N, Salewski E. A comparative study of levofloxacin and ceftriaxone in the treatment of hospitalized patients with pneumonia. Scand J Infect Dis 1998; 30(4): 397-404.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Norrby SR, Petermann W, Willcox PA, Vetter N, Salewski E</AU>
<TI>A comparative study of levofloxacin and ceftriaxone in the treatment of hospitalized patients with pneumonia</TI>
<SO>Scandinavian Journal of Infectious Diseases</SO>
<YR>1998</YR>
<VL>30</VL>
<NO>4</NO>
<PG>397-404</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Peterson-1988" MODIFIED="2011-12-06 10:37:43 +1000" MODIFIED_BY="[Empty name]" NAME="Peterson 1988" YEAR="1988">
<REFERENCE MODIFIED="2011-12-06 10:37:43 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Peterson PK et al 1988; Prospective study of lower respiratory tract infections in an extended-care nursing home program: potential role of oral ciprofloxacin. Am J Med 85(2): 164-71&lt;/p&gt;" NOTES_MODIFIED="2011-12-06 10:37:43 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Peterson PK, Stein D, Guay DR, Logan G, Obaid S, Gruninger R, et al</AU>
<TI>Prospective study of lower respiratory tract infections in an extended-care nursing home program: potential role of oral ciprofloxacin</TI>
<SO>American Journal of Medicine</SO>
<YR>1988</YR>
<VL>85</VL>
<NO>2</NO>
<PG>164-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Petitpretz-2001" MODIFIED="2012-07-23 14:42:02 +1000" MODIFIED_BY="[Empty name]" NAME="Petitpretz 2001" YEAR="2001">
<REFERENCE MODIFIED="2012-07-23 14:41:55 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Jardim JR, Rico G, de la Roza C, Obispo E, Urueta J, Wolff M, Miravitlles M; Grupo de Estudio Latinoamericano CAP. A comparison of moxifloxacin and amoxicillin in the treatment of community-acquired pneumonia in Latin America: results of a multicenter clinical trial. Archives de Bronchoneumologia 2003;39(9):387-9.&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" NOTES_MODIFIED="2012-07-23 14:41:55 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Jardim JR, Rico G, de la Roza C, Obispo E, Urueta J, Wolff M, et al</AU>
<TI>A comparison of moxifloxacin and amoxicillin in the treatment of community-acquired pneumonia in Latin America: results of a multicenter clinical trial</TI>
<SO>Archives de Bronchoneumologia</SO>
<YR>2003</YR>
<VL>39</VL>
<NO>9</NO>
<PG>387-93</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-07-23 14:42:02 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Petitpretz, P., P. Arvis, et al. (2001). &amp;quot;Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults.&amp;quot; Chest 119(1): 185-95.&lt;/p&gt;" NOTES_MODIFIED="2012-07-23 14:42:02 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Petitpretz P, Arvis P, Marel M, Moita J, Urueta J; CAP5 Moxifloxacin Study Group</AU>
<TI>Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults</TI>
<SO>Chest</SO>
<YR>2001</YR>
<VL>119</VL>
<NO>1</NO>
<PG>185-95</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rizzato-1997" MODIFIED="2012-07-23 14:46:23 +1000" MODIFIED_BY="[Empty name]" NAME="Rizzato 1997" YEAR="1997">
<REFERENCE MODIFIED="2012-07-23 14:42:18 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Allegra L, Berni F, Boisisio E, Clini V, Dal Negro R, Damato S, et al</AU>
<TI>Efficacy of the teicoplanin-ciprofloxacin combination in high risk community acquired pneumonia: Comparison to ceftriaxone in a multicenter study</TI>
<SO>Internista</SO>
<YR>1995</YR>
<VL>31</VL>
<PG>39-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-07-23 14:44:54 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;abstract only&lt;/p&gt;" NOTES_MODIFIED="2012-07-23 14:44:54 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Montemurro L, Rizzato G; Multicenter Study Group</AU>
<TI>The teicoplanin-ciprofloxacin combination versus ceftriaxone in community acquired pneumonia of elderly and patients with underlying diseases</TI>
<SO>European Respiratory Journal</SO>
<YR>1993</YR>
<VL>7</VL>
<NO>Supp 18</NO>
<PG>170</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE MODIFIED="2012-07-23 14:46:23 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Rizzato (1997). Efficacy and tolerability of teicoplanin-ciprofloxacin combination in severe community-acquired pneumonia. Comparison with ceftriaxone in a multicentre Italian study. Clinical drug investigation 14(5): 337-345.&lt;/p&gt;" NOTES_MODIFIED="2012-07-23 14:46:23 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rizzato G, Allegra L: Multicentre Italian Study Group (co-ordinated by Centro Thorax)</AU>
<TI>Efficacy and tolerability of teicoplanin-ciprofloxacin combination in severe community-acquired pneumonia. Comparison with ceftriaxone in a multicentre Italian study</TI>
<SO>Clinical Drug Investigation</SO>
<YR>1997</YR>
<VL>14</VL>
<NO>5</NO>
<PG>337-45</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Romanelli-2002" MODIFIED="2011-12-06 10:38:03 +1000" MODIFIED_BY="[Empty name]" NAME="Romanelli 2002" YEAR="2002">
<REFERENCE MODIFIED="2011-12-06 10:38:03 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Romanelli (2002). &amp;quot;Carbapenems in the treatment of severe community-acquired pneumonia in hospitalized elderly patients: a comparative study against standard therapy.&amp;quot; journal of chemotherapy 14(6): 609-617.&lt;/p&gt;" NOTES_MODIFIED="2011-12-06 10:38:03 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Romanelli G, Cravarezza P, Pozzi A, Franchino L, Ravizzola G, Zulli R, et al</AU>
<TI>Carbapenems in the treatment of severe community-acquired pneumonia in hospitalized elderly patients: a comparative study against standard therapy</TI>
<SO>Journal of Chemotherapy</SO>
<YR>2002</YR>
<VL>14</VL>
<NO>6</NO>
<PG>609-17</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tremolieres-1998" MODIFIED="2012-07-23 16:49:51 +1000" MODIFIED_BY="[Empty name]" NAME="Tremolieres 1998" YEAR="1998">
<REFERENCE MODIFIED="2012-07-23 16:49:51 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;There is an article regarding cost-effectiveness based on this data: Williams D, Hopkins S: Safety of Trovafloxacin in treatment of lower respiratory tract infections. Eur J Clin Infect Dis 1998 17:454-458&lt;/p&gt;" NOTES_MODIFIED="2012-07-23 16:49:51 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tremolieres F, de Kock F, Pluck N, Daniel R</AU>
<TI>Trovafloxacin versus high-dose amoxicillin (1g three times daily) in the treatment of community-acquired bacterial pneumonia</TI>
<SO>European Journal of Clinical Microbiology and Infectious Diseases</SO>
<YR>1998</YR>
<VL>17</VL>
<NO>6</NO>
<PG>447-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Tremolieres-2005" NAME="Tremolieres 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Tremolieres F, Mayaud C, Mouton Y, Weber P, Dellatolas F, Caulin E</AU>
<TI>Efficacy and safety of pristinamycin vs amoxicillin in community acquired pneumonia in adults</TI>
<SO>Pathologie-biologie (Paris)</SO>
<YR>2005</YR>
<VL>53</VL>
<NO>8-9</NO>
<PG>503-10</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vanderdonckt--1990" MODIFIED="2011-12-06 10:38:15 +1000" MODIFIED_BY="[Empty name]" NAME="Vanderdonckt  1990" YEAR="1990">
<REFERENCE MODIFIED="2011-12-06 10:38:15 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vanderdonckt J</AU>
<TI>Comparison of pefloxacin with ceftazidime in severe bronchopulmonary infections</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>1990</YR>
<VL>26</VL>
<NO>Suppl B</NO>
<PG>111-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Vogel-1991" MODIFIED="2011-12-06 10:38:24 +1000" MODIFIED_BY="[Empty name]" NAME="Vogel 1991" YEAR="1991">
<REFERENCE MODIFIED="2011-12-06 10:38:24 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Vogel, F. and H. Lode (1991). &amp;quot;The use of oral temafloxacin compared with a parenteral cephalosporin in hospitalized patients with pneumonia.&amp;quot; J Antimicrob Chemother 28 Suppl C: 81-6.&lt;/p&gt;" NOTES_MODIFIED="2011-12-06 10:38:24 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Vogel F, Lode H</AU>
<TI>The use of oral temafloxacin compared with a parenteral cephalosporin in hospitalized patients with pneumonia</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>1991</YR>
<VL>28</VL>
<NO>Supp C</NO>
<PG>81-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Zeluff-1988" MODIFIED="2012-07-23 14:48:55 +1000" MODIFIED_BY="[Empty name]" NAME="Zeluff 1988" YEAR="1988">
<REFERENCE MODIFIED="2012-07-23 14:48:55 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Zeluff, B. J., P. Lowe, et al. (1988). &amp;quot;Evaluation of roxithromycin (RU-965) versus cephradine in pneumococcal pneumonia.&amp;quot; Eur J Clin Microbiol Infect Dis 7(1): 69-71.&lt;/p&gt;" NOTES_MODIFIED="2012-07-23 14:48:55 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Zeluff BJ, Lowe P, Koorhof HJ, Gentry LO</AU>
<TI>Evaluation of roxithromycin (RU-965) versus cephradine in pneumococcal pneumonia</TI>
<SO>European Journal of Clinical Microbiology and Infectious Diseases</SO>
<YR>1988</YR>
<VL>7</VL>
<NO>1</NO>
<PG>69-71</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</INCLUDED_STUDIES>
<EXCLUDED_STUDIES MODIFIED="2012-07-23 15:07:09 +1000" MODIFIED_BY="[Empty name]">
<STUDY DATA_SOURCE="PUB" ID="STD-Ailani-1999" MODIFIED="2012-07-23 14:49:33 +1000" MODIFIED_BY="[Empty name]" NAME="Ailani 1999" YEAR="1999">
<REFERENCE MODIFIED="2012-07-23 14:49:33 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ailani RK, Agastya G, Ailani RK, Mukunda BN, Shekar R</AU>
<TI>Doxycycline is a cost-effective therapy for hospitalized patients with community-acquired pneumonia</TI>
<SO>Archives of Internal Medicine</SO>
<YR>1999</YR>
<VL>159</VL>
<NO>3</NO>
<PG>266-70</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Aubier-1996" MODIFIED="2011-12-06 10:38:47 +1000" MODIFIED_BY="[Empty name]" NAME="Aubier 1996" YEAR="1996">
<REFERENCE MODIFIED="2011-12-06 10:38:47 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Aubier M, Lode H, Gialdroni-Grassi G, Huchon G, Hosie J, Legakis N, Regamey C, Segev S, Vester R, Wijnands WJ, Tolstuchow N. Sparfloxacin for the treatment of community-acquired pneumonia: a pooled data analysis of two studies. J Antimicrob Chemother. 1996 May;37 Suppl A:73-82. &lt;br&gt;emailed 13/1/04: reference for the second article (probably aubier 98, already included)&lt;/p&gt;" NOTES_MODIFIED="2011-12-06 10:38:47 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Aubier M, Lode H, Gialdroni-Grassi G, Huchon G, Hosie J, Legakis N, et al</AU>
<TI>Sparfloxacin for the treatment of community-acquired pneumonia: a pooled data analysis of two studies</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>1996</YR>
<VL>37</VL>
<NO>Suppl A</NO>
<PG>73-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Chokshi-2007" MODIFIED="2011-12-28 22:01:29 +1000" MODIFIED_BY="[Empty name]" NAME="Chokshi 2007" YEAR="2007">
<REFERENCE MODIFIED="2011-12-28 22:01:29 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Chokshi R, Restrepo MI, Weeratunge N, Frei CR, Anzueto A, Mortensen EM</AU>
<TI>Monotherapy versus combination antibiotic therapy for patients with bacteremic Streptococcus pneumoniae community-acquired pneumonia</TI>
<SO>European Journal of Clinical Microbiology and Infectious Diseases</SO>
<YR>2007</YR>
<VL>26</VL>
<NO>7</NO>
<PG>447-51</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Donowitz-1997" MODIFIED="2011-12-06 10:38:57 +1000" MODIFIED_BY="[Empty name]" NAME="Donowitz 1997" YEAR="1997">
<REFERENCE MODIFIED="2011-12-06 10:38:57 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Donowitz, G. R., M. L. Brandon, et al. (1997). &amp;quot;[V] Sparfloxacin versus cefaclor in the treatment of patients with community-acquired pneumonia: a randomized, double-masked, comparative, multicenter study.&amp;quot; 19(5): 936-53.&lt;/p&gt;" NOTES_MODIFIED="2011-12-06 10:38:57 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Donowitz GR, Brandon ML, Salisbury JP, Harman CP, Tipping DM, Urick AE, et al</AU>
<TI>Sparfloxacin versus cefaclor in the treatment of patients with community-acquired pneumonia: a randomized, double-masked, comparative, multicenter study</TI>
<SO>Clinical Therapeutics</SO>
<YR>1997</YR>
<VL>19</VL>
<NO>5</NO>
<PG>936-53</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fass-1989" MODIFIED="2012-07-04 08:16:05 +1000" MODIFIED_BY="Liz Dooley" NAME="Fass 1989" YEAR="1989">
<REFERENCE MODIFIED="2012-07-04 08:16:05 +1000" MODIFIED_BY="Liz Dooley" NOTES="&lt;p&gt;A letter wa sent to author, wishing to affirm whether it is indeed nosocomial infections (d/t pathogens and clinical outcome). 10/03&lt;/p&gt;" NOTES_MODIFIED="2012-07-04 08:16:05 +1000" NOTES_MODIFIED_BY="Liz Dooley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fass RJ, Plouffe JF, Russell JA</AU>
<TI>IV/oral ciprofloxacin vs ceftazidime in the treatment of serious infections</TI>
<SO>American Journal of Medicine</SO>
<YR>1989</YR>
<VL>87</VL>
<NO>5A</NO>
<PG>164-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-File-1997" MODIFIED="2011-12-30 05:40:47 +1000" MODIFIED_BY="[Empty name]" NAME="File 1997" YEAR="1997">
<REFERENCE MODIFIED="2011-12-30 05:40:47 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>File TM, Segreti J, Dunbar L, Player R, Kohler R, Williams RR, et al</AU>
<TI>A multicenter, randomized study comparing the efficacy and safety of intravenous and/or oral levofloxacin versus ceftriaxone and/or cefuroxime axetil in treatment of adults with community-acquired pneumonia</TI>
<SO>Antimicrobial Agents and Chemotherapy</SO>
<YR>1997</YR>
<VL>41</VL>
<NO>9</NO>
<PG>1965-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fink-1994" MODIFIED="2012-07-23 14:51:01 +1000" MODIFIED_BY="[Empty name]" NAME="Fink 1994" YEAR="1994">
<REFERENCE MODIFIED="2012-07-23 14:51:01 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Fink, M. P., D. R. Snydman, et al. (1994). &amp;quot;Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.&amp;quot; Antimicrob Agents Chemother 38(3): 547-57.&lt;/p&gt;" NOTES_MODIFIED="2012-07-23 14:51:01 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fink MP, Snydman DR, Niederman MS, Leeper KV Jr, Johnson RH, Heard SO, et al; The Severe Pneumonia Study Group</AU>
<TI>Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin</TI>
<SO>Antimicrobial Agents and Chemotherapy</SO>
<YR>1994</YR>
<VL>38</VL>
<NO>3</NO>
<PG>547-57</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Fong-1995" MODIFIED="2012-07-23 14:52:57 +1000" MODIFIED_BY="[Empty name]" NAME="Fong 1995" YEAR="1995">
<REFERENCE MODIFIED="2012-07-23 14:52:57 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;waiting for the author to confirm this is outpatients (journal obtainable only from canada, email sent 16q3q2004&lt;/p&gt;" NOTES_MODIFIED="2012-07-23 14:52:57 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Fong IW, Laforge J, Dubois J, Small D, Grossman R, Zakhari R; The Canadian Bronchitis Study Group</AU>
<TI>Clarithromycin versus cefaclor in lower respiratory tract infections</TI>
<SO>Clinical and Investigative Medicine. Médecine Clinique et Experimentale</SO>
<YR>1995</YR>
<VL>18</VL>
<NO>2</NO>
<PG>131-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Geijo-Martinez-2002" MODIFIED="2011-12-06 10:39:32 +1000" MODIFIED_BY="[Empty name]" NAME="Geijo Martinez 2002" YEAR="2002">
<REFERENCE MODIFIED="2011-12-06 10:39:32 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Geijo Martinez MP, Diaz de Tuesta Chow-Quan AM, Herranz CR, Gomez Criado C, Dimas Nunez JF, Saiz Garcia F. Levofloxacin versus beta-lactamic therapy in community acquired pneumonia that requires hospitalisation. [Levofloxacino frente a betalactamicos en el tratamiento de la neumonia adquirida en la comunidad con ingreso hospitalario.] Anales de Medicina Interna 19 (12); 2002: 609-11.&lt;/p&gt;&lt;p&gt;&lt;/p&gt;" NOTES_MODIFIED="2011-12-06 10:39:32 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Geijo Martinez MP, Diaz de Tuesta, Chow-Quan AM, Herranz CR, Gomez Criado C, Dimas Nunez JF, et al</AU>
<TI>Levofloxacin versus beta-lactamic therapy in community acquired pneumonia that requires hospitalisation</TI>
<TO>Levofloxacino frente a betalactamicos en el tratamiento de la neumonia adquirida en la comunidad con ingreso hospitalario</TO>
<SO>Anales de Medicina Interna</SO>
<YR>2002</YR>
<VL>19</VL>
<NO>12</NO>
<PG>609-11</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hagberg-2002" NAME="Hagberg 2002" YEAR="2002">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Hagberg L, Torres A, van Rensburg D, Leroy B, Rangaraju M, Ruuth E</AU>
<TI>Efficacy and tolerability of once-daily telithromycin compared with high-dose amoxicillin for treatment of community-acquired pneumonia</TI>
<SO>Infection</SO>
<YR>2002</YR>
<VL>30</VL>
<NO>6</NO>
<PG>378-86</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Hoepelman-1993" MODIFIED="2012-07-23 14:54:24 +1000" MODIFIED_BY="[Empty name]" NAME="Hoepelman 1993" YEAR="1993">
<REFERENCE MODIFIED="2012-07-23 14:54:24 +1000" MODIFIED_BY="[Empty name]" PRIMARY="YES" TYPE="JOURNAL_ARTICLE">
<AU>Hoepelman AI, Sips AP, van Helmond JL, van Barneveld PW, Neve AJ, Zwinkels M, et al</AU>
<TI>A single-blind comparison of three-day azithromycin and ten-day co-amoxiclav treatment of acute lower respiratory tract infections</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>1993</YR>
<VL>31</VL>
<NO>Suppl E</NO>
<PG>147-52</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Katz-2004" NAME="Katz 2004" YEAR="">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Katz E, Larsen LS, Fogarty CM, Hamed K, Song J, Choudhri S</AU>
<TI>Safety and efficacy of sequential i.v. to p.o. moxifloxacin versus conventional combination therapies for the treatment of community-acquired pneumonia in patients requiring initial i.v. therapy</TI>
<SO>Journal of Emergency Medicine</SO>
<YR>2004</YR>
<VL>27</VL>
<NO>4</NO>
<PG>395-405</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Khajotia-1990" NAME="Khajotia 1990" YEAR="1990">
<REFERENCE NOTES="&lt;p&gt;Khajotia R, Drlicek M, Vetter N. A comparative study of ofloxacin and amoxycillin/clavulanate in hospitalized patients with lower respiratory tract infections. Antimicrob Chemother. 1990 Nov;26 Suppl D:83-91.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Khajotia R, Drlicek M, Vetter N</AU>
<TI>A comparative study of ofloxacin and amoxycillin/clavulanate in hospitalized patients with lower respiratory tract infections</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>1990</YR>
<VL>26</VL>
<NO>Suppl D</NO>
<PG>83-91</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kinasewitz-1991" MODIFIED="2012-07-23 14:55:35 +1000" MODIFIED_BY="[Empty name]" NAME="Kinasewitz 1991" YEAR="1991">
<REFERENCE MODIFIED="2012-07-23 14:55:35 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Kinasewitz et al: 1991 Azithromycin versus cefaclor in the treatment of acute bacterial pneumonia. Eur J Clin Microbiol Infect Dis Oct;10(10):872-7&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2012-07-23 14:55:35 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kinasewitz G, Wood RG</AU>
<TI>Azithromycin versus cefaclor in the treatment of acute bacterial pneumonia</TI>
<SO>European Journal of Clinical Microbiology and Infectious Diseases</SO>
<YR>1991</YR>
<VL>10</VL>
<NO>10</NO>
<PG>872-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Krumpe-1999" MODIFIED="2012-07-23 14:55:57 +1000" MODIFIED_BY="[Empty name]" NAME="Krumpe 1999" YEAR="1999">
<REFERENCE MODIFIED="2012-07-23 14:55:57 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Krumpe, P. E., S. Cohn, et al. (1999). &amp;quot;Intravenous and oral mono- or combination-therapy in the treatment of severe infections: ciprofloxacin versus standard antibiotic therapy. Ciprofloxacin Study Group.&amp;quot; J Antimicrob Chemother 43 Suppl A: 117-28.&lt;/p&gt;" NOTES_MODIFIED="2012-07-23 14:55:57 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Krumpe PE, Cohn S, Garreltes J, Ramirez J, Coulter H, Haverstock D, et al; Ciprofloxacin Study Group</AU>
<TI>Intravenous and oral mono- or combination-therapy in the treatment of severe infections: ciprofloxacin versus standard antibiotic therapy</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>1999</YR>
<VL>43</VL>
<NO>Supp A</NO>
<PG>117-28</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Kuzman-2005" NAME="Kuzman 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Kuzman I, Dakovic-Rode O, Oremus M, Banaszak AM</AU>
<TI>Clinical efficacy and safety of a short regimen of azithromycin sequential therapy vs standard cefuroxime sequential therapy in the treatment of community-acquired pneumonia: an international, randomized, open-label study</TI>
<SO>Journal of Chemotherapy</SO>
<YR>2005</YR>
<VL>17</VL>
<NO>6</NO>
<PG>636-42</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Leophonte-1999" NAME="Leophonte 1999" YEAR="1999">
<REFERENCE NOTES="&lt;p&gt;Leophonte, P. and P. Veyssier (1999). &amp;quot;[Levofloxacin in the treatment of community-acquired pneumococcal pneumonia].&amp;quot; Presse Med 28(36): 1975-9.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Leophonte P, Veyssier P</AU>
<TI>Levofloxacin in the treatment of community-acquired pneumococcal pneumonia</TI>
<SO>La Presse Medicale</SO>
<YR>1999</YR>
<VL>28</VL>
<NO>36</NO>
<PG>1975-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Levine-1989" MODIFIED="2011-12-06 10:40:25 +1000" MODIFIED_BY="[Empty name]" NAME="Levine 1989" YEAR="1989">
<REFERENCE MODIFIED="2011-12-06 10:40:25 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Levine, D. P., P. McNeil, et al. (1989). &amp;quot;Randomized, double-blind comparative study of intravenous ciprofloxacin versus ceftazidime in the treatment of serious infections.&amp;quot; Am J Med 87(5A): 160S-163S.&lt;/p&gt;" NOTES_MODIFIED="2011-12-06 10:40:25 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Levine D, McNeil P, Lerner SA</AU>
<TI>Randomized, double-blind comparative study of intravenous ciprofloxacin versus ceftazidime in the treatment of serious infections</TI>
<SO>American Journal of Medicine</SO>
<YR>1989</YR>
<VL>87</VL>
<NO>5A</NO>
<PG>160-3</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lode-1987" MODIFIED="2012-07-23 14:56:49 +1000" MODIFIED_BY="[Empty name]" NAME="Lode 1987" YEAR="1987">
<REFERENCE MODIFIED="2012-07-23 14:56:49 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Antimicrob Agents Chemother. 1987 Oct;31(10):1491-6 Prospective randomized controlled study of ciprofloxacin versus imipenem-cilastatin in severe clinical infections Lode H, Wiley R, Hoffken G, Wagner J, Borner K.; presumed nosocomial infection? data extracted (once)&lt;/p&gt;" NOTES_MODIFIED="2012-07-23 14:56:49 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lode H, Wiley R, Hoffken G, Wagner J, Borner K, Lode H, et al</AU>
<TI>Prospective randomized controlled study of ciprofloxacin versus imipenem-cilastatin in severe clinical infections</TI>
<SO>Antimicrobial Agents and Chemotherapy</SO>
<YR>1987</YR>
<VL>31</VL>
<NO>10</NO>
<PG>1491-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lode-1990" MODIFIED="2012-07-23 14:57:00 +1000" MODIFIED_BY="[Empty name]" NAME="Lode 1990" YEAR="1990">
<REFERENCE MODIFIED="2012-07-23 14:57:00 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Lode, H., E. Wiley, et al. (1990). &amp;quot;Prospective randomized clinical trials of new quinolones versus beta-lactam antibiotics in lower respiratory tract infections.&amp;quot; Scand J Infect Dis Suppl 68: 50-5.; a report of 4 randomized trials: 1=lode 1987 (done), 2=irrelevant, 3+4 relevant but not tracked nor reported - letter sent to author. not responded.&lt;/p&gt;" NOTES_MODIFIED="2012-07-23 14:57:00 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lode H, Wiley E, Olschewski P, Sievers H, Wintermantel M, Baetz R, et al</AU>
<TI>Prospective randomized clinical trials of new quinolones versus beta-lactam antibiotics in lower respiratory tract infections</TI>
<SO>Scandinavian Journal of Infectious Diseases</SO>
<YR>1990</YR>
<VL>68</VL>
<NO>Suppl</NO>
<PG>50-5</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lode-1998" MODIFIED="2012-07-23 14:57:26 +1000" MODIFIED_BY="[Empty name]" NAME="Lode 1998" YEAR="1998">
<REFERENCE MODIFIED="2012-07-23 14:57:26 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Lode, H. Sparfloxacin as alternative treatment to standard therapy for community-acquired bacteremic pneumococcal pneumonia.&amp;quot; Clinical microbiology &amp;amp; infection 4(3): 135-143.&lt;/p&gt;" NOTES_MODIFIED="2012-07-23 14:57:26 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lode H, Aubier M, Portier H, Ortquist A; Sparfloxacin Study Group</AU>
<TI>Sparfloxacin as alternative treatment to standard therapy for community-acquired bacteremic pneumococcal pneumonia</TI>
<SO>Clinical Microbiology and Infection</SO>
<YR>1998</YR>
<VL>4</VL>
<NO>3</NO>
<PG>135-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Lode-2004" MODIFIED="2012-07-23 14:58:11 +1000" MODIFIED_BY="[Empty name]" NAME="Lode 2004" YEAR="2004">
<REFERENCE MODIFIED="2012-07-23 14:58:11 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Clin Microbiol Infect. 2004 Jun;10(6):512-20.&lt;br&gt;&lt;/p&gt;" NOTES_MODIFIED="2012-07-23 14:58:11 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Lode H, Magyar P, Muir JF, Loos U, Kleutgens K; International Gatifloxacin Study Group</AU>
<TI>Once-daily oral gatifloxacin vs three-times-daily co-amoxiclav in the treatment of patients with community-acquired pneumonia</TI>
<SO>Clinical Microbiology and Infection</SO>
<YR>2004</YR>
<VL>10</VL>
<NO>6</NO>
<PG>512-20</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mendoca-2004" NAME="Mendoca 2004" YEAR="2004">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mendonca JS, Yamaguti A, Correa JC, Badaro R</AU>
<TI>Gatifloxacin in the treatment of community-acquired pneumonias: a comparative trial of ceftriaxone, with or without macrolides, in hospitalized adult patients with mild to moderately severe pneumonia</TI>
<SO>Brazilian Journal of Infectious Diseases</SO>
<YR>2004</YR>
<VL>8</VL>
<NO>1</NO>
<PG>90-100</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Mouton-1991" MODIFIED="2012-07-23 14:58:32 +1000" MODIFIED_BY="[Empty name]" NAME="Mouton 1991" YEAR="1991">
<REFERENCE MODIFIED="2012-07-23 14:58:32 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Mouton, Y., C. Beuscart, et al. (1991). [Evaluation of ciprofloxacin versus amoxicillin + clavulanic acid or erythromycin for the empiric treatment of community-acquired pneumonia]. Pathol Biol (Paris) 39(1): 34-7.&lt;/p&gt;" NOTES_MODIFIED="2012-07-23 14:58:32 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Mouton Y, Beuscart C, Leroy O, Ajana F, Charrel J; Groupe Multicentrique</AU>
<TI>Evaluation of ciprofloxacin versus amoxicillin + clavulanic acid or erythromycin for the empiric treatment of community-acquired pneumonia</TI>
<SO>Pathologie-Biologie</SO>
<YR>1991</YR>
<VL>39</VL>
<NO>1</NO>
<PG>34-7</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-O_x0027_Doherty-1997" NAME="O'Doherty 1997" YEAR="1997">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>O'Doherty BO, Dutchman DA, Pettit R, Maroli A</AU>
<TI>Randomized, double blind, comparative study of grepafloxacin and amoxycillin in the treatment of patients with community-acquired pneumonia</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>1997</YR>
<VL>40</VL>
<NO>Supp A</NO>
<PG>73-81</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Ott--2008" MODIFIED="2012-01-12 11:12:41 +1000" MODIFIED_BY="[Empty name]" NAME="Ott  2008" YEAR="2008">
<REFERENCE MODIFIED="2012-01-12 11:12:41 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Ott SR, Allewelt M, Lorenz J, Reimnitz P, Lode H</AU>
<TI>Moxifloxacin vs ampicillin/sulbactam in aspiration pneumonia and primary lung abscess</TI>
<SO>Infection</SO>
<YR>2008</YR>
<VL>36</VL>
<NO>1</NO>
<PG>23-30</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Peacock-1987" MODIFIED="2012-07-23 15:01:36 +1000" MODIFIED_BY="[Empty name]" NAME="Peacock 1987" YEAR="1987">
<REFERENCE MODIFIED="2012-07-23 15:01:36 +1000" MODIFIED_BY="[Empty name]" NOTES="&lt;p&gt;Peacock, J. E., Jr., P. S. Pegram, et al. (1989). &amp;quot;Prospective, randomized comparison of sequential intravenous followed by oral ciprofloxacin with intravenous ceftazidime in the treatment of serious infections.&amp;quot; Am J Med 87(5A): 185S-190S.&lt;/p&gt;" NOTES_MODIFIED="2012-07-23 15:01:36 +1000" NOTES_MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Peacock J Jr, Pegram SP, Weber SF, Leone PA</AU>
<TI>Prospective, randomized comparison of sequential intravenous followed by oral ciprofloxacin with intravenous ceftazidime in the treatment of serious infections</TI>
<SO>American Journal of Medicine</SO>
<YR>1989</YR>
<VL>87</VL>
<NO>5A</NO>
<PG>185S-90S</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Plouffe-1996" MODIFIED="2012-07-23 15:02:00 +1000" MODIFIED_BY="[Empty name]" NAME="Plouffe 1996" YEAR="1996">
<REFERENCE MODIFIED="2012-07-23 15:02:00 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Plouffe JF, Herbert MT, File TM Jr, Baird I, Parsons JN, Kahn JB, et al</AU>
<TI>Ofloxacin versus standard therapy in treatment of community-acquired pneumonia requiring hospitalization</TI>
<SO>Antimicrobial Agents and Chemotherapy</SO>
<YR>1996</YR>
<VL>40</VL>
<NO>5</NO>
<PG>1175-9</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Rahav-2004" NAME="Rahav 2004" YEAR="2004">
<REFERENCE NOTES="&lt;p&gt;2004 Aug;24(2):181-4. &lt;br&gt;&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Rahav G, Fidel J, Gibor Y, Shapiro M</AU>
<TI>Azithromycin versus comparative therapy for the treatment of community acquired pneumonia</TI>
<SO>International Journal of Antimicrobial Agents</SO>
<YR>2004</YR>
<VL>24</VL>
<NO>2</NO>
<PG>181-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Siami-1995" NAME="Siami 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;Siami, G. A., W. T. Wilkins, et al. (1995). &amp;quot;Comparison of ciprofloxacin with imipenem in the treatment of severe pneumonia in hospitalised geriatric patients.&amp;quot; Drugs 49 Suppl 2: 436-8.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Siami GA, Wilkins WT, Bess DT, Christman JW</AU>
<TI>Comparison of ciprofloxacin with imipenem in the treatment of severe pneumonia in hospitalised geriatric patients</TI>
<SO>Drugs</SO>
<YR>1995</YR>
<VL>49</VL>
<NO>Supp 2</NO>
<PG>436-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sifuentes-1989" MODIFIED="2012-07-23 15:03:47 +1000" MODIFIED_BY="[Empty name]" NAME="Sifuentes 1989" YEAR="1989">
<REFERENCE MODIFIED="2012-07-23 15:03:47 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Sifuentes-Osornio J, Macias A, Amieva RI, Ramos A, Ruiz-Palacios GM</AU>
<TI>Intravenous ciprofloxacin and ceftazidime in serious infections. A prospective, controlled clinical trial with third-party blinding</TI>
<SO>American Journal of Medicine</SO>
<YR>1989</YR>
<VL>87</VL>
<NO>5A</NO>
<PG>202S-5S</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Snydman-1995" NAME="Snydman 1995" YEAR="1995">
<REFERENCE NOTES="&lt;p&gt;Snydman, D., M. Fink, et al. (1995). &amp;quot;Treatment of severe pneumonia in hospitalised patients. Results of a multicentre trial comparing i.v. ciprofloxacin with imipenem/cilastatin.&amp;quot; Drugs 49 Suppl 2: 439-41.&lt;/p&gt;" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Snydman D, Fink F, Niederman M, Reinhart H</AU>
<TI>Treatment of severe pneumonia in hospitalised patients. Results of a multicentre trial comparing i.v. ciprofloxacin with imipenem/cilastatin</TI>
<SO>Drugs</SO>
<YR>1995</YR>
<VL>49</VL>
<NO>Supp 2</NO>
<PG>439-41</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Stocks-1989" MODIFIED="2012-07-23 15:05:14 +1000" MODIFIED_BY="[Empty name]" NAME="Stocks 1989" YEAR="1989">
<REFERENCE MODIFIED="2012-07-23 15:05:14 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Stocks JM, Wallace RJ Jr, Griffith DE, Garcia JG, Kohler RB</AU>
<TI>Ofloxacin in community-acquired lower respiratory infections. A comparison with amoxicillin or erythromycin</TI>
<SO>American Journal of Medicine</SO>
<YR>1989</YR>
<VL>87</VL>
<NO>6C</NO>
<PG>52-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Sujata-2008" MODIFIED="2012-07-23 15:05:30 +1000" MODIFIED_BY="[Empty name]" NAME="Sujata 2008" YEAR="2008">
<REFERENCE MODIFIED="2012-07-23 15:05:30 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Bhavnani SM, Ambrose PG</AU>
<TI>Cost-effectiveness of oral gemifloxacin versus intravenous ceftriaxone followed by oral cefuroxime with/without a macrolide for the treatment of hospitalized patients with community-acquired pneumonia</TI>
<SO>Diagnostic Microbiology and Infectious Disease</SO>
<YR>2008</YR>
<VL>60</VL>
<NO>1</NO>
<PG>59-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Torres-2003" MODIFIED="2012-07-23 15:05:40 +1000" MODIFIED_BY="[Empty name]" NAME="Torres 2003" YEAR="2003">
<REFERENCE MODIFIED="2012-07-23 15:05:40 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Torres A, Muir JF, Corris P, Kubin R, Duprat-Lomon I, Sagnier PP, et al</AU>
<TI>Effectiveness of oral moxifloxacin in standard first-line therapy in community-acquired pneumonia</TI>
<SO>European Respiratory Journal</SO>
<YR>2003</YR>
<VL>21</VL>
<NO>1</NO>
<PG>135-43</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Trenholme-1989" MODIFIED="2012-07-23 15:07:09 +1000" MODIFIED_BY="Liz Dooley" NAME="Trenholme 1989" YEAR="1989">
<REFERENCE MODIFIED="2012-07-23 15:07:09 +1000" MODIFIED_BY="Liz Dooley" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Trenholme GM, Schmitt BA, Spear J, Gvazdinskas LC</AU>
<TI>Randomized study of intravenous/oral ciprofloxacin versus ceftazidime in the treatment of hospital and nursing home patients with lower respiratory tract infections</TI>
<SO>American Journal of Medicine</SO>
<YR>1989</YR>
<VL>87</VL>
<NO>Supp 5A</NO>
<PG>116S-8S</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Welte-2005" NAME="Welte 2005" YEAR="2005">
<REFERENCE PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Welte T, Petermann W, Schurmann D, Bauer TT, Reimnitz P</AU>
<TI>Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy</TI>
<SO>Clinical Infectious Diseases</SO>
<YR>2005</YR>
<VL>41</VL>
<NO>12</NO>
<PG>1697-705</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
<STUDY DATA_SOURCE="PUB" ID="STD-Wollschlager-1987" MODIFIED="2011-12-06 10:41:38 +1000" MODIFIED_BY="[Empty name]" NAME="Wollschlager 1987" YEAR="1987">
<REFERENCE MODIFIED="2011-12-06 10:41:38 +1000" MODIFIED_BY="[Empty name]" PRIMARY="NO" TYPE="JOURNAL_ARTICLE">
<AU>Wollschlager CM, Raoof S, Khan FA, Guarneri JJ, LaBombardi V, Afzal Q</AU>
<TI>Controlled, comparative study of ciprofloxacin versus ampicillin in treatment of bacterial respiratory tract infections</TI>
<SO>American Journal of Medicine</SO>
<YR>1987</YR>
<VL>82</VL>
<NO>4A</NO>
<PG>164-8</PG>
<IDENTIFIERS/>
</REFERENCE>
<IDENTIFIERS/>
</STUDY>
</EXCLUDED_STUDIES>
<AWAITING_STUDIES/>
<ONGOING_STUDIES/>
</STUDIES>
<OTHER_REFERENCES MODIFIED="2012-07-24 08:37:53 +1000" MODIFIED_BY="[Empty name]">
<ADDITIONAL_REFERENCES MODIFIED="2012-07-24 08:37:53 +1000" MODIFIED_BY="[Empty name]">
<REFERENCE ID="REF-BTS-2001" MODIFIED="2012-07-23 15:12:33 +1000" MODIFIED_BY="[Empty name]" NAME="BTS 2001" NOTES="&lt;p&gt;Thorax. 2001 Dec;56 Suppl 4:IV1-64&lt;/p&gt;" NOTES_MODIFIED="2012-07-23 15:12:33 +1000" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>British Thoracic Society</AU>
<TI>BTS guidelines for the management of community acquired pneumonia in adults</TI>
<SO>Thorax</SO>
<YR>2001</YR>
<VL>56</VL>
<NO>Suppl 4:IV</NO>
<PG>1-64</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Donowitz-2000" MODIFIED="2012-07-23 15:19:18 +1000" MODIFIED_BY="[Empty name]" NAME="Donowitz 2000" TYPE="BOOK_SECTION">
<AU>Donowitz G, Mandell G</AU>
<TI>Acute Pneumonia</TI>
<SO>Principles and Practice of Infectious Diseases</SO>
<YR>2000</YR>
<VL>1</VL>
<PG>717-43</PG>
<EN>5th</EN>
<ED>Mandell GL, Bennet JE, Dolin R</ED>
<PB>Churchill Livingstone</PB>
<CY>Philadelphia</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-FDA-2009" MODIFIED="2012-07-23 15:19:41 +1000" MODIFIED_BY="[Empty name]" NAME="FDA 2009" TYPE="OTHER">
<AU>FDA</AU>
<TI>Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims</TI>
<SO>www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf (accessed May 2010)</SO>
<YR>(accessed May 2010)</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Fine-1997" MODIFIED="2012-07-23 15:25:00 +1000" MODIFIED_BY="[Empty name]" NAME="Fine 1997" TYPE="JOURNAL_ARTICLE">
<AU>Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, et al</AU>
<TI>A prediction rule to identify low-risk patients with community-acquired pneumonia</TI>
<SO>New England Journal of Medicine</SO>
<YR>1997</YR>
<VL>336</VL>
<NO>4</NO>
<PG>243-50</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Hedlund-2005" NAME="Hedlund 2005" NOTES="&lt;p&gt;Hedlund J, Stralin K, Ortqvist A, Holmberg H. Swedish guidelines for the management of community-acquired pneumonia in immunocompetent adults. Scand J Infect Dis. 2005;37:791-805.&lt;/p&gt;" TYPE="JOURNAL_ARTICLE">
<AU>Hedlund J, Stralin K, Ortqvist A, Holmberg H</AU>
<TI>Swedish guidelines for the management of community-acquired pneumonia in immunocompetent adults</TI>
<SO>Scandinavian Journal of Infectious Diseases</SO>
<YR>2005</YR>
<VL>37</VL>
<PG>791-805</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Higgins-2011" MODIFIED="2012-07-24 08:37:51 +1000" MODIFIED_BY="[Empty name]" NAME="Higgins 2011" TYPE="OTHER">
<AU>Higgins JPT, Green S (editors)</AU>
<TI>Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<YR>2011</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Iezzoni-1988" NAME="Iezzoni 1988" TYPE="JOURNAL_ARTICLE">
<AU>Iezzoni LI, Moskowitz MA</AU>
<TI>A clinical assessment of MedisGroups</TI>
<SO>JAMA</SO>
<YR>1988</YR>
<VL>260</VL>
<NO>21</NO>
<PG>3159-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Johansen-2000" MODIFIED="2012-07-23 15:26:25 +1000" MODIFIED_BY="[Empty name]" NAME="Johansen 2000" NOTES="&lt;p&gt;2000; 46:973-80&lt;/p&gt;" NOTES_MODIFIED="2012-07-23 15:26:25 +1000" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Johansen HK, Jensen TG, Dessau RB, Lundgren B, Frimodt-Moller N</AU>
<TI>Antagonism between penicillin and erythromycin against Streptococcus pneumoniae in vitro and in vivo</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2000</YR>
<VL>46</VL>
<PG>973-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lefebvre-2011" MODIFIED="2012-07-23 15:31:22 +1000" MODIFIED_BY="[Empty name]" NAME="Lefebvre 2011" TYPE="OTHER">
<AU>Lefebvre C, Manheimer E, Glanville J</AU>
<TI>Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011</TI>
<SO>Available from www.cochrane-handbook.org</SO>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Levison-2001" NAME="Levison 2001" TYPE="BOOK_SECTION">
<AU>Levison M</AU>
<TI>Pneumonia, including necrotizing pulmonary infections (lung abscess)</TI>
<SO>Harrison's Principles of Internal Medicine</SO>
<YR>2001</YR>
<VL>2</VL>
<PG>1475-85</PG>
<EN>15th</EN>
<ED>Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL</ED>
<PB>McGraw-Hill</PB>
<CY>New York</CY>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lim-2003" MODIFIED="2012-07-23 15:34:31 +1000" MODIFIED_BY="[Empty name]" NAME="Lim 2003" TYPE="JOURNAL_ARTICLE">
<AU>Lim WS, van der Eerden MM, Laing R, Boersma WG, Karalus N, Town GI, et al</AU>
<TI>Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study</TI>
<SO>Thorax</SO>
<YR>2003</YR>
<VL>58</VL>
<NO>5</NO>
<PG>377-82</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Lim-2009" MODIFIED="2011-12-28 22:12:54 +1000" MODIFIED_BY="[Empty name]" NAME="Lim 2009" TYPE="JOURNAL_ARTICLE">
<AU>Lim WS, Baudouin SV, George RC, Hill AT, Jamieson C, Le Jeune I, et al</AU>
<TI>BTS guidelines for the management of community acquired pneumonia in adults</TI>
<SO>Thorax</SO>
<YR>2009</YR>
<VL>64</VL>
<NO>Suppl 3</NO>
<PG>1-55</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Malhotra_x002d_Kumar-2007" MODIFIED="2012-03-21 11:00:40 +1000" MODIFIED_BY="[Empty name]" NAME="Malhotra-Kumar 2007" TYPE="JOURNAL_ARTICLE">
<AU>Malhotra-Kumar S, Lammens C, Coenen S, Van Herck K, Goossens H</AU>
<TI>Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study</TI>
<SO>Lancet</SO>
<YR>2007</YR>
<VL>369</VL>
<NO>9560</NO>
<PG>482-90</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mandell-2000" MODIFIED="2012-07-23 15:35:25 +1000" MODIFIED_BY="[Empty name]" NAME="Mandell 2000" NOTES="&lt;p&gt;Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clin Infect Dis. 2000;31:383-421.&lt;/p&gt;" NOTES_MODIFIED="2012-07-23 15:35:25 +1000" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH; The Canadian Community-Acquired Pneumonia Working Group</AU>
<TI>Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society</TI>
<SO>Clinical Infectious Diseases</SO>
<YR>2000</YR>
<VL>31</VL>
<PG>383-421</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mandell-2007" MODIFIED="2012-07-23 15:37:45 +1000" MODIFIED_BY="[Empty name]" NAME="Mandell 2007" NOTES="&lt;p&gt;Mandell LA, Wunderink RG, Anzueto A et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clin Infect Dis. 2007;44 Suppl 2:S27-72.&lt;/p&gt;" NOTES_MODIFIED="2012-07-23 15:37:45 +1000" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al; Infectious Diseases Society of America/American Thoracic Society</AU>
<TI>Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults</TI>
<SO>Clinical Infectious Diseases</SO>
<YR>2007</YR>
<VL>44</VL>
<NO>Suppl 2</NO>
<PG>27-72</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Mills-2005" MODIFIED="2012-07-23 15:38:53 +1000" MODIFIED_BY="[Empty name]" NAME="Mills 2005" TYPE="JOURNAL_ARTICLE">
<AU>Mills DG, Oehley MR, Arrol B</AU>
<TI>Effectiveness of beta-lactam antibiotics compared with antibiotics active against atypical pathogens in non-severe community acquired pneumonia: meta-analysis</TI>
<SO>BMJ</SO>
<YR>2005</YR>
<VL>330</VL>
<NO>7489</NO>
<PG>456</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Niederman-2001" MODIFIED="2012-07-23 15:40:23 +1000" MODIFIED_BY="[Empty name]" NAME="Niederman 2001" NOTES="&lt;p&gt;Niederman MS, Mandell LA, Anzueto A et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med. 2001;163:1730-54.&lt;/p&gt;" NOTES_MODIFIED="2012-07-23 15:40:23 +1000" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, et al; American Thoracic Society</AU>
<TI>Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention</TI>
<SO>American Journal of Respiratory and Critical Care Medicine</SO>
<YR>2001</YR>
<VL>163</VL>
<NO>7</NO>
<PG>1730-54</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Oosterheert-2003" MODIFIED="2012-07-23 15:41:44 +1000" MODIFIED_BY="[Empty name]" NAME="Oosterheert 2003" TYPE="JOURNAL_ARTICLE">
<AU>Oosterheert JJ, Bonten MJM, Hak E, Schneider MM, Hoepelman IM</AU>
<TI>How good is the evidence for the recommended empirical antimicrobial treatment of patients hospitalized because of community-acquired pneumonia? A systematic review</TI>
<SO>Journal of Antimicrobial Chemotherapy</SO>
<YR>2003</YR>
<VL>52</VL>
<NO>4</NO>
<PG>555-63</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Paul-2007" MODIFIED="2012-07-23 15:50:01 +1000" MODIFIED_BY="[Empty name]" NAME="Paul 2007" NOTES="&lt;p&gt;Paul M, Nielsen AD, Gafter-Gvili A et al. The need for macrolides in hospitalised community-acquired pneumonia: propensity analysis. Eur Respir J. 2007;&lt;/p&gt;" NOTES_MODIFIED="2012-07-23 15:50:01 +1000" NOTES_MODIFIED_BY="[Empty name]" TYPE="OTHER">
<AU>Paul M, Nielsen AD, Gafter-Gvili A, Tacconelli E, Andreassen S, Almanasreh N, et al</AU>
<TI>The need for macrolides in hospitalised community-acquired pneumonia: propensity analysis</TI>
<SO>European Respiratory Journal</SO>
<YR>2007 May 30 [Epub ahead of print]</YR>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Ross-2007" NAME="Ross 2007" TYPE="JOURNAL_ARTICLE">
<AU>Ross DB</AU>
<TI>The FDA and the case of Ketek</TI>
<SO>New England Journal of Medicine</SO>
<YR>2007</YR>
<VL>356</VL>
<NO>16</NO>
<PG>1601-4</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Soreth-2007" MODIFIED="2012-07-23 15:53:27 +1000" MODIFIED_BY="[Empty name]" NAME="Soreth 2007" TYPE="JOURNAL_ARTICLE">
<AU>Soreth J, Cox E, Kweder S, Jenkins J, Galson S</AU>
<TI>Ketek - the FDA perspective</TI>
<SO>New England Journal of Medicine</SO>
<YR>2007</YR>
<VL>356</VL>
<NO>16</NO>
<PG>1675-6</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Woodhead-2005" MODIFIED="2011-12-06 10:49:47 +1000" MODIFIED_BY="[Empty name]" NAME="Woodhead 2005" NOTES="&lt;p&gt;Woodhead M, Blasi F, Ewig S et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J. 2005;26:1138-80.&lt;/p&gt;" NOTES_MODIFIED="2011-12-06 10:49:47 +1000" NOTES_MODIFIED_BY="[Empty name]" TYPE="JOURNAL_ARTICLE">
<AU>Woodhead M, Blasi F, Ewig S, Huchon G, Ieven M, Ortqvist A, et al</AU>
<TI>Guidelines for the management of adult lower respiratory tract infections</TI>
<SO>European Respiratory Journal</SO>
<YR>2005</YR>
<VL>26</VL>
<PG>1138-80</PG>
<IDENTIFIERS/>
</REFERENCE>
<REFERENCE ID="REF-Woodhead-2011" MODIFIED="2012-07-23 15:53:51 +1000" MODIFIED_BY="[Empty name]" NAME="Woodhead 2011" TYPE="JOURNAL_ARTICLE">
<AU>Woodhead M, Blasi F, Ewig S, Huchon G, Leven M, Ortqvist A, et al</AU>
<TI>Guidelines for the management of adult lower respiratory tract infections</TI>
<SO>Clinical Microbiology infections</SO>
<YR>2011</YR>
<VL>17</VL>
<NO>6</NO>
<PG>1-24</PG>
<IDENTIFIERS/>
</REFERENCE>
</ADDITIONAL_REFERENCES>
<OTHER_VERSIONS_REFERENCES MODIFIED="2012-07-23 15:54:46 +1000" MODIFIED_BY="Liz Dooley">
<REFERENCE ID="REF-Robenshtok-2008" MODIFIED="2012-07-23 15:54:31 +1000" MODIFIED_BY="[Empty name]" NAME="Robenshtok 2008" TYPE="COCHRANE_REVIEW">
<AU>Robenshtok E, Shefet D, Gafter-Gvili A, Paul M, Vidal L, Leibovici L</AU>
<TI>Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2008</YR>
<NO>1</NO>
<IDENTIFIERS MODIFIED="2011-12-06 15:33:29 +1000" MODIFIED_BY="[Empty name]">
<IDENTIFIER MODIFIED="2011-12-06 15:33:29 +1000" MODIFIED_BY="[Empty name]" TYPE="DOI" VALUE="10.1002/14651858.CD004418.pub3"/>
</IDENTIFIERS>
</REFERENCE>
<REFERENCE ID="REF-Shefet-2005" MODIFIED="2012-07-23 15:54:46 +1000" MODIFIED_BY="Liz Dooley" NAME="Shefet 2005" TYPE="COCHRANE_REVIEW">
<AU>Shefet D, Robenshtok E, Paul M, Leibovici L</AU>
<TI>Empiric antibiotic coverage of atypical pathogens for community-acquired pneumonia in hospitalized adults</TI>
<SO>Cochrane Database of Systematic Reviews</SO>
<YR>2005</YR>
<NO>2</NO>
<IDENTIFIERS MODIFIED="2008-06-23 10:24:18 +1000" MODIFIED_BY="Liz Dooley">
<IDENTIFIER MODIFIED="2008-06-23 10:24:18 +1000" MODIFIED_BY="Liz Dooley" TYPE="DOI" VALUE="10.1002/14651858.CD004418.pub3"/>
</IDENTIFIERS>
</REFERENCE>
</OTHER_VERSIONS_REFERENCES>
<PENDING_REFERENCES/>
</OTHER_REFERENCES>
</STUDIES_AND_REFERENCES>
<CHARACTERISTICS_OF_STUDIES MODIFIED="2012-07-24 08:43:52 +1000" MODIFIED_BY="[Empty name]">
<CHARACTERISTICS_OF_INCLUDED_STUDIES MODIFIED="2012-07-24 08:43:52 +1000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<INCLUDED_CHAR MODIFIED="2012-07-24 08:43:10 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Aubier-1998">
<CHAR_METHODS MODIFIED="2011-09-26 00:20:22 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized<BR/>Multicenter<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-07-23 12:44:57 +1000" MODIFIED_BY="[Empty name]">
<P>Adults (mean age: 42)<BR/>Hospitalized<BR/>CAP</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-24 08:43:10 +1000" MODIFIED_BY="[Empty name]">
<P>Atypical: PO sparfloxacin 400 mg X 1/d followed by 200 mg X 1/d<BR/>Non-atypical: PO amoxacillin 1 G X /d<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-23 12:36:09 +1000" MODIFIED_BY="[Empty name]">
<P>Success: resolution of signs and symptoms<BR/>Modification = failure</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-23 12:42:37 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Bohte-1995">
<CHAR_METHODS MODIFIED="2011-10-08 22:51:12 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized<BR/>Multicenter<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-07-23 12:42:37 +1000" MODIFIED_BY="[Empty name]">
<P>Adults (18 to 75, age ~ 53)<BR/>CAP - clinically suspected pneumococcal pneumonia (suspected <I>Legionella pneumophilae</I> (<I>L. pneumophilae</I>)<I> Staphylococcus aureus (S. aureus) </I>and <I>Klebsiella pneumonia</I> (<I>K. pneumonia</I>) excluded)<BR/>Hospitalized</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Atypical: PO azithromycin 500 mg X 2/d loading dose, followed by PO azithromycin 500 mg X 1/d <BR/>Non-atypical: IV benzylpenicillin 1,000,000 IU X 4/d</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Failure = clinical, radiological, change of antibiotics</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Study included a second comparison between erythromycin and azithromycin, which was excluded from analysis</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-23 12:45:09 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Carbon-1992">
<CHAR_METHODS MODIFIED="2011-10-08 23:03:06 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized<BR/>Multicenter<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-07-23 12:45:09 +1000" MODIFIED_BY="[Empty name]">
<P>Adults (mean age: 55)<BR/>Hospitalized<BR/>CAP (severe pneumonia excluded)<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Atypical: PO temafloxacin 600 mg X 2/d<BR/>Non-atypical: PO amoxicillin 500 mg X 3/d</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Failure = persistence of symptoms or signs, treatment modification<BR/>Modification = failure</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Severe pneumonia excluded<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-01-12 10:56:29 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chuard-1989">
<CHAR_METHODS MODIFIED="2011-10-09 00:36:31 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized<BR/>Multicenter<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-01-12 10:56:29 +1000" MODIFIED_BY="[Empty name]">
<P>Adults (mean ~ 66)<BR/>95% hospitalized<BR/>58% CAP (42% bronchitis or COPD exacerbation)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Atypical: PO ofloxacin 200 mg X 2/d (several 400 mg X 2/d)<BR/>Non-atypical: PO amoxicillin 750 mg X 3/d (several 375 mg X 4/d)<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Clinical</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-12-06 11:05:08 +1000" MODIFIED_BY="[Empty name]">
<P>Another trial reported in same study of non-randomized CAP suspected of atypical infection; relationship to this trial unclear<BR/>Results given are for all patients, including non-pneumonia<BR/>Study in German</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-23 12:46:37 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Feldman-2001">
<CHAR_METHODS MODIFIED="2012-07-23 12:46:10 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized<BR/>Multicentered</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-07-23 12:46:28 +1000" MODIFIED_BY="[Empty name]">
<P>Adults 18 to 70 (mean age: 43)<BR/>Hospitalized<BR/>~ 90% CAP; ~ 10% nosocomial<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-23 12:46:37 +1000" MODIFIED_BY="[Empty name]">
<P>Atypical: IV sitafloxacin 400 mg X 1/d<BR/>Non-atypical: IV imipenem/cilastatin 500 mg X 3/d</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Clinical success (as defined by investigator)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Phase II trial</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-23 12:47:53 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fourrier-1986">
<CHAR_METHODS MODIFIED="2011-10-09 00:56:05 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized<BR/>Allocation A/B<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-07-23 12:47:17 +1000" MODIFIED_BY="[Empty name]">
<P>Adults (no age mentioned)<BR/>Hospitalized<BR/>CAP; severe (per clinical)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-23 12:47:53 +1000" MODIFIED_BY="[Empty name]">
<P>Atypical: PO pefloxacine 1200 mg/d</P>
<P>Non-atypical: customary antibiotics:</P>
<UL>
<LI>beta lactam</LI>
<LI>cephalosporin - AG</LI>
<LI>anti-staphylococcal ABX</LI>
</UL>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Failure = opposite of complete recovery</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>A lot of data missing (letter), even after correspondence with author<BR/>Study in French</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-24 08:43:24 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Genne-1997">
<CHAR_METHODS MODIFIED="2011-10-09 01:01:33 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-07-23 12:48:26 +1000" MODIFIED_BY="[Empty name]">
<P>Adults (mean age: 70)<BR/>Hospitalized<BR/>CAP<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-24 08:43:24 +1000" MODIFIED_BY="[Empty name]">
<P>Atypical: IV clarythromycin 500 mg X 2/d 3 to 5/d , followed by PO clarythromycin 500 mg X 2/d<BR/>Non-atypical: IV amoxicillin-clavulanate 1.2 G X 4/d 3-5/d, followed by PO amoxicillin-clavulanate 625 mg X 3/d<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-23 13:05:22 +1000" MODIFIED_BY="[Empty name]">
<P>Failure = change of ABX, persistence or progression of sx/radiological finding, death, s/e enabling completion of trial</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-23 13:06:45 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Gleadhill-1986">
<CHAR_METHODS MODIFIED="2011-10-09 01:11:29 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-07-23 13:05:46 +1000" MODIFIED_BY="[Empty name]">
<P>Adults (mean 71)<BR/>46% CAP; 50% COPD exacerbation; 4% acute bronchitis<BR/>Hospitalized</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Atypical: PO ciprofloxacin 500 mg X 2/d<BR/>Non-atypical: PO amoxicillin 250 mg X 3/d</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-23 13:06:39 +1000" MODIFIED_BY="[Empty name]">
<P>Clinical and bacteriological:</P>
<UL>
<LI>complete success = clinical recovery, bacteriological eradication</LI>
<LI>partial success = clinical improvement, bacteriological reduction/indeterminate</LI>
<LI>unsuccessful = clinical failure, regardless of bacteriological response</LI>
<LI>undetermined (assessment impossible)</LI>
<LI>moderation = ?</LI>
</UL>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-07-23 13:06:45 +1000" MODIFIED_BY="[Empty name]">
<P>Less than 50% CAP<BR/>Data analyzed only for pneumonia patients (given separately)</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-23 13:07:21 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hatipoglu-2010">
<CHAR_METHODS MODIFIED="2011-10-09 01:12:41 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-10-09 06:32:31 +1000" MODIFIED_BY="[Empty name]">
<P>Adults (no age mentioned)<BR/>Hospitalized<BR/>CAP, moderately-severe </P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2011-12-06 11:13:46 +1000" MODIFIED_BY="[Empty name]">
<P>Atypical: ceftriaxone + clarithromycin<BR/>Non-atypical: ceftriaxone</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-23 13:07:21 +1000" MODIFIED_BY="[Empty name]">
<P>Success rate</P>
<P>Incremental cost-effectiveness analysis</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2011-12-06 11:13:50 +1000" MODIFIED_BY="[Empty name]">
<P>Data extracted from abstract, no correspondence</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-24 08:43:24 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hirata_x002d_Dulas-1991">
<CHAR_METHODS MODIFIED="2011-10-09 01:31:06 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-07-23 13:07:48 +1000" MODIFIED_BY="[Empty name]">
<P>Adults (mean age: 79)<BR/>Nursing home residents<BR/>Hospitalized<BR/>Nursing home-acquired lower respiratory tract infection (54 pneumonia, 6 acute bronchitis)<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-24 08:43:24 +1000" MODIFIED_BY="[Empty name]">
<P>Atypical: IV ciprofloxacin 200 mg/400 mg* X 2/d, followed by PO ciprofloxacin 750 mg X 2/d<BR/>(* protocol changed from 200 mg to 400 mg on 4/1989, 5/24 P in new protocol)<BR/>Non-atypical: IV ceftriaxone 2 G X 1/d, followed by IM ceftriaxone 1 G X 1/d</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-23 13:18:48 +1000" MODIFIED_BY="[Empty name]">
<P>Success = resolution or marked improvement in clinical signs and symptoms of lower RTI and completion of 14 d treatment course<BR/>Failure = all cause death, early termination due to lack of improvement, adverse event or superinfection<BR/>Indeterminate = withdrawal due to protocol specification or to other factors unrelated to study drug administration<BR/>Moderation = failure</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-24 08:43:24 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hong_x002d_yun-2007">
<CHAR_METHODS MODIFIED="2011-10-09 06:30:34 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2011-10-09 06:32:16 +1000" MODIFIED_BY="[Empty name]">
<P>Adults (no age mentioned)<BR/>Hospitalized<BR/>CAP</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-24 08:43:24 +1000" MODIFIED_BY="[Empty name]">
<P>Atypical: iv gatifloxacin (400 mg)<BR/>Non-atypical: iv cefuroxime (2 G)</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-24 08:28:41 +1000" MODIFIED_BY="[Empty name]">
<P>Success: clinical and bacteriological</P>
<P>Adverse reactions<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-07-23 13:10:56 +1000" MODIFIED_BY="[Empty name]">
<P>Data extracted from abstract, no correspondence</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-24 08:43:25 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kalbermatter-2000">
<CHAR_METHODS MODIFIED="2011-10-09 01:37:16 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-07-23 13:11:19 +1000" MODIFIED_BY="Liz Dooley">
<P>Adults (mean age: 69 years)<BR/>Hospitalized<BR/>CAP; severe pneumonia was excluded<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-24 08:43:25 +1000" MODIFIED_BY="[Empty name]">
<P>Atypical: PO levofloxacin 500 mg X 2/d<BR/>Non-atypical: IV amoxicillin/clavulanate 1 G X 3/d<BR/>IV ceftriaxone 1 G X 2/d</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Success = clinical and radiological<BR/>Modification = failure</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>3 arms, amoxicillin/clavulanate and ceftriaxone calculated together as non-atypical arm<BR/>Study in Spanish</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-24 08:43:25 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Khan-1989">
<CHAR_METHODS MODIFIED="2011-10-09 01:48:02 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-07-23 13:12:05 +1000" MODIFIED_BY="[Empty name]">
<P>Adults (mean age: 58)<BR/>Severe bacterial respiratory tract infection (34/122 presumed bacterial, no isolation)<BR/>CAP + nursing home-acquired + nosocomial<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-24 08:43:25 +1000" MODIFIED_BY="[Empty name]">
<P>Atypical: IV ciprofloxacin 200 mg X 2/d (5 patients received 300 mg X 2/d)<BR/>Non-atypical: IV ceftazidime 1 to 2 G X 2/d to 3/d</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-23 13:12:55 +1000" MODIFIED_BY="[Empty name]">
<P>Failure = continuation/worsening of signs and symptoms<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-07-23 13:13:10 +1000" MODIFIED_BY="[Empty name]">
<P>Distribution of nosocomial pneumonia versus CAP unclear; good results suggest low rate of nosocomial pneumonia</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-02 06:55:28 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kobayashi-1984">
<CHAR_METHODS MODIFIED="2011-10-09 04:54:29 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Adults<BR/>CAP + COPD (results given separately)<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS>
<P>Atypical: PO levofloxacin 200 mg X 3/d<BR/>Non-atypical: PO amoxicillin 250 mg X 4/d</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-02 06:55:28 +1000" MODIFIED_BY="[Empty name]"/>
<CHAR_NOTES>
<P>Study in Japanese</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-24 08:43:25 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kohno-2011">
<CHAR_METHODS MODIFIED="2012-07-23 13:14:24 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized, open-label, non-inferiority study</P>
<P>Multicenter</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-07-23 13:14:28 +1000" MODIFIED_BY="[Empty name]">
<P>Adults (mean age: 58.5)<BR/>CAP mild to severe (70% moderate)</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-24 08:43:25 +1000" MODIFIED_BY="[Empty name]">
<P>Atypical: IV levofloxacin 500 mg X 1/d for 7 to 14 days<BR/>Non-atypical: IV ceftriaxone 1 G X 2/d for 7 to 14 days</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-04 08:19:17 +1000" MODIFIED_BY="[Empty name]">
<P>Success: clinical, radiological and laboratory</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-07-02 06:44:38 +1000" MODIFIED_BY="[Empty name]">
<P>Study in Japanese</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-24 08:43:25 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lephonte-2004">
<CHAR_METHODS MODIFIED="2011-10-09 06:18:17 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized<BR/>Multicenter</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-07-23 13:15:23 +1000" MODIFIED_BY="[Empty name]">
<P>Adults (mean age: 54)<BR/>CAP<BR/>Suspected pneumococcal pneumonia<BR/>&gt; 90% hospitalized<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-24 08:43:25 +1000" MODIFIED_BY="[Empty name]">
<P>Atypical: PO gemifloxacin 320 mg X 1/d for 1 week<BR/>Non-atypical: amoxicillin/clavulanate 1 G/125 mg X 3/d for 10 days<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Failure = clinical, bacteriological and radiological</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Phase III <BR/>Suspected pneumococcal pneumonia<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-24 08:43:25 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lode-1995">
<CHAR_METHODS MODIFIED="2011-10-09 06:43:52 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized<BR/>Multicenter<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-07-23 13:16:46 +1000" MODIFIED_BY="[Empty name]">
<P>Adults (mean age: 54)<BR/>Hospitalized and outpatients<BR/>CAP<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-24 08:43:25 +1000" MODIFIED_BY="[Empty name]">
<P>Atypical: PO sparfloxacin 400 mg loading dose, followed by PO sparfloxacin 200 mg X 1/d<BR/>PO erythromycin 1 G X 2/d<BR/>Non-atypical: PO amoxicillin-clavulanic acid 500/125 mg X 3/d</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Failure = clinical, radiological, change of antibiotics<BR/>Modification = failure</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-07-23 13:17:32 +1000" MODIFIED_BY="[Empty name]">
<P>3 arms in 2:1:1 randomizations (sparfloxacin: amoxicillin-clavulanic acid: erythromycin); the two atypical arms were calculated as one, in comparison to the non-atypical arm<BR/>Note: also outpatients - no further data, short of stating the majority of patients were hospitalized</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-24 08:43:25 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Miki-1984">
<CHAR_METHODS MODIFIED="2011-10-09 06:45:28 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-07-23 13:18:18 +1000" MODIFIED_BY="[Empty name]">
<P>Adults<BR/>Hospitalized<BR/>Suspected bacterial pneumonia (CAP), small percentage of upper RTI</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-24 08:43:25 +1000" MODIFIED_BY="[Empty name]">
<P>Atypical: PO enoxacin 600 mg/d<BR/>Non-atypical: PO amoxicillin 1 G/d</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES/>
<CHAR_NOTES>
<P>Study in Japanese</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-24 08:43:26 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Norrby-1998">
<CHAR_METHODS MODIFIED="2012-07-23 13:21:19 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized</P>
<P>Multicenter<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-07-23 13:21:44 +1000" MODIFIED_BY="[Empty name]">
<P>Adults (mean 65)<BR/>Hospitalized<BR/>Pneumonia (CAP 94%; nosocomial 6%)<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-24 08:43:26 +1000" MODIFIED_BY="[Empty name]">
<P>Atypical: IV levofloxacin 500 mg X 2/d, followed by PO levofloxacin 500 mg X 2/d<BR/>Non-atypical: IV ceftriaxone 4 G X 1/d<BR/>
</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-23 13:22:16 +1000" MODIFIED_BY="[Empty name]">
<P>Cure = all infection related signs and symptoms disappeared or returned to pre-infection state and chest X-ray findings at least improved<BR/>Failure = all infection related signs and symptoms unchanged or worsened; patients developed new clinical findings consistent with active infection; patient died due to the infection; drug study discontinued; one or more antibiotics added to drug due to treatment failure</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>CAP and nosocomial infection<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-24 08:43:26 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Peterson-1988">
<CHAR_METHODS MODIFIED="2011-10-09 06:58:10 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-07-23 13:23:33 +1000" MODIFIED_BY="[Empty name]">
<P>Adults &gt; 60 years old (mean: 81 years)<BR/>Nursing home residents<BR/>Hospitalized<BR/>CAP/RTI<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-24 08:43:26 +1000" MODIFIED_BY="[Empty name]">
<P>Atypical: PO ciprofloxacin 750 mg X 2/d<BR/>Non-atypical: IM cefamandole 1 G X 4/d</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-23 13:24:03 +1000" MODIFIED_BY="[Empty name]">
<P>Success = improvement in signs and symptoms and patient not given another course of drug treatment for RTI within 6 weeks of discharge</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-07-23 13:24:16 +1000" MODIFIED_BY="[Empty name]">
<P>2/3 CAP, 1/3 RTI, most data combined</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-24 08:43:26 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Petitpretz-2001">
<CHAR_METHODS MODIFIED="2012-01-12 11:07:11 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized<BR/>Multinational, multicenter<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-07-23 13:24:43 +1000" MODIFIED_BY="[Empty name]">
<P>Adults (mean age: 51)<BR/>CAP: suspected pneumococcal pneumonia<BR/>79% hospitalized<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-24 08:43:26 +1000" MODIFIED_BY="[Empty name]">
<P>Atypical: PO moxifloxacin 400 mg X 1/d<BR/>Non-atypical: PO Amoxicillin 1 G X 3/d<BR/>Both for 10 days</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Clinical response<BR/>Failure = insufficient resolution of symptoms/death<BR/>
</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Presumed pneumococcal pneumonia</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-24 08:43:26 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rizzato-1997">
<CHAR_METHODS MODIFIED="2012-01-12 11:07:34 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized<BR/>Multicenter</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-07-23 13:25:46 +1000" MODIFIED_BY="[Empty name]">
<P>Age &gt; 65 or 18 to 65 years + comorbidities (mean age: 68.5)<BR/>Severe CAP: exclusion: "risk of death within 48h of study start"<BR/>Hospitalized</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-24 08:43:26 +1000" MODIFIED_BY="[Empty name]">
<P>Atypical: IV teicoplanin 400 mg LD, followed by 400/200 mg X 1/d (per investigator's discretion) + PO ciprofloxacin 500 mg X 2/d<BR/>Non-atypical: IV ceftriaxone 2 G X 1/d</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Clinical response: success (cure, improvement), failure and data could not be evaluated</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-07-23 13:26:31 +1000" MODIFIED_BY="[Empty name]">
<P>Severe CAP; elderly or comorbidities<BR/>Allegra 1995 is a double publication of this study</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-24 08:43:26 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Romanelli-2002">
<CHAR_METHODS MODIFIED="2011-10-09 07:07:51 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized<BR/>Multicenter<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-07-23 13:26:50 +1000" MODIFIED_BY="[Empty name]">
<P>Elderly &gt; 70 (mean age: 76)<BR/>CAP<BR/>Hospitalized<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-24 08:43:26 +1000" MODIFIED_BY="[Empty name]">
<P>Atypical: IV clarythromycin 500 mg + IV ceftriaxone 1 G X 2/d<BR/>IV clarythromycin 500 mg + IV amikacin 250 mg X 2/d<BR/>
<U>versus</U>
<BR/>Non-atypical: IV meropenem 500 mg X 3/d<BR/>IV imipenem/cilastatin 500 mg X 3/d</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-23 13:27:30 +1000" MODIFIED_BY="[Empty name]">
<P>Clinical response<BR/>Failure = no improvement or deterioration of signs and symptoms OR relapse</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Elderly<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-24 08:43:27 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tremolieres-1998">
<CHAR_METHODS MODIFIED="2011-10-09 07:08:56 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized<BR/>Multicenter<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-07-23 13:27:51 +1000" MODIFIED_BY="[Empty name]">
<P>Adults &gt; 16 years old (mean age: 52)<BR/>75% hospitalized<BR/>CAP: exclusion: high probability of atypical pneumonia</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-24 08:43:27 +1000" MODIFIED_BY="[Empty name]">
<P>Atypical: PO trovafloxacin 200 mg X 1/d<BR/>Non-atypical: PO amoxicillin 1 G X 3/d</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-23 13:28:21 +1000" MODIFIED_BY="[Empty name]">
<P>Primary = clinical response; Secondary = bacteriological response<BR/>Failure = lack of resolution of signs and symptoms/radiological failure/additional ABX given to patient</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-01-12 10:56:37 +1000" MODIFIED_BY="[Empty name]">
<P>Adult defined as age &gt; 16 years old (rather than 18 years old, as in other studies)<BR/>Only 75% hospitalized<BR/>
</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-24 08:43:27 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Tremolieres-2005">
<CHAR_METHODS MODIFIED="2011-10-11 18:59:16 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized<BR/>Multicenter</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-07-23 13:28:38 +1000" MODIFIED_BY="[Empty name]">
<P>Adults &gt; 18 years old (mean age: 48)<BR/>CAP</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-24 08:43:27 +1000" MODIFIED_BY="[Empty name]">
<P>Atypical: PO pristinamycin 1 G x 3<BR/>Non-atypical: amoxacillin 1 G x 3</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-23 13:30:49 +1000" MODIFIED_BY="[Empty name]">
<P>Clinical failure, bacteriological failure, pneumococcal treatment failure, mortality, s/e</P>
</CHAR_OUTCOMES>
<CHAR_NOTES MODIFIED="2012-07-23 13:30:54 +1000" MODIFIED_BY="[Empty name]">
<P>20% with COPD; 6.5% asthma</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-24 08:43:27 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vanderdonckt--1990">
<CHAR_METHODS MODIFIED="2011-10-09 07:12:42 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized<BR/>Multicentre<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS>
<P>Adults (mean 60)<BR/>Severe bronchopulmonary infections<BR/>Hospitalized</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-24 08:43:27 +1000" MODIFIED_BY="[Empty name]">
<P>Atypical: PO pefloxacin 400 mg X 2/d<BR/>Non-atypical: IV ceftazidime 2 G X 2/d</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Success not defined in study<BR/>Bacteriological outcome</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Severe infection = failure on previous treatment, multi-resistant pathogens, severe underlying disease, poor general condition</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-24 08:43:28 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Vogel-1991">
<CHAR_METHODS MODIFIED="2011-10-09 07:14:52 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized<BR/>Multicenter</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-07-23 13:31:24 +1000" MODIFIED_BY="[Empty name]">
<P>Adults (mean age: 62)<BR/>Hospitalized<BR/>CAP</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-24 08:43:28 +1000" MODIFIED_BY="[Empty name]">
<P>Atypical: PO temafloxacin 600 mg X 2/d<BR/>Non-atypical: IV cefotaxime 2 G X 3/d</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES MODIFIED="2012-07-23 13:31:47 +1000" MODIFIED_BY="[Empty name]">
<P>Cure: all signs and symptoms resolved<BR/>Improvement: reduction of severity or numbers of signs and symptoms<BR/>Failure: evidence of fever or worsening of signs, symptoms or chest X-ray after 3 treatment days<BR/>Modification = ?</P>
</CHAR_OUTCOMES>
<CHAR_NOTES/>
</INCLUDED_CHAR>
<INCLUDED_CHAR MODIFIED="2012-07-24 08:43:28 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Zeluff-1988">
<CHAR_METHODS MODIFIED="2011-10-09 07:16:39 +1000" MODIFIED_BY="[Empty name]">
<P>Randomized<BR/>
</P>
</CHAR_METHODS>
<CHAR_PARTICIPANTS MODIFIED="2012-07-24 08:43:28 +1000" MODIFIED_BY="[Empty name]">
<P>Adults (mean age: 31; all South-African black gold miners)<BR/>Hospitalized<BR/>Pneumococcal pneumonia per chest X-ray and sputum (analyzed only culture positive)<BR/>
</P>
</CHAR_PARTICIPANTS>
<CHAR_INTERVENTIONS MODIFIED="2012-07-24 08:43:28 +1000" MODIFIED_BY="[Empty name]">
<P>Atypical: PO roxithromycin 150 mg X 2/d<BR/>Non-atypical: PO cephradine 1 G X 2/d</P>
</CHAR_INTERVENTIONS>
<CHAR_OUTCOMES>
<P>Clinical response (= improvement of signs and symptoms and resolution of lung infiltrate)</P>
</CHAR_OUTCOMES>
<CHAR_NOTES>
<P>Pneumococcal pneumonia in a young homogenous group</P>
</CHAR_NOTES>
</INCLUDED_CHAR>
<FOOTNOTES>
<P>ABX: antibiotics<BR/>CAP: community-acquired pneumonia<BR/>COPD: chronic obstructive pulmonary disease<BR/>IM: intramuscular<BR/>ITT: intention-to-treat<BR/>IV: intravenous<BR/>LD: loading dose<BR/>PO: per oral<BR/>RTI: respiratory tract infection<BR/>s/e: side effects<BR/>1/d: once a day<BR/>2/d: two times a day<BR/>3/d: three times a day<BR/>4/d: four times a day<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_INCLUDED_STUDIES>
<CHARACTERISTICS_OF_EXCLUDED_STUDIES MODIFIED="2012-07-24 08:43:28 +1000" MODIFIED_BY="[Empty name]" SORT_BY="STUDY">
<EXCLUDED_CHAR STUDY_ID="STD-Ailani-1999">
<CHAR_REASON_FOR_EXCLUSION>
<P>Doxycycline versus standard therapy - latter arm not differentiated to regimens with atypical coverage and those without such coverage</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-06 10:54:40 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Aubier-1996">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-06 10:54:40 +1000" MODIFIED_BY="[Empty name]">
<P>Pooled analysis of 2 studies (1 = this paper)<BR/>Sparfloxacin versus comparator arm, including erythromycin<BR/>The results of studies are combined, thus no differentiation between atypical and non-atypical coverage<BR/>Note: very large study (N = 1137</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-06 10:55:02 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Chokshi-2007">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-06 10:55:02 +1000" MODIFIED_BY="[Empty name]">
<P>Retrospective observational cohort study</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-06 11:05:04 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Donowitz-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-06 11:05:04 +1000" MODIFIED_BY="[Empty name]">
<P>Outpatients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-03-21 11:05:13 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fass-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-03-21 11:05:13 +1000" MODIFIED_BY="[Empty name]">
<P>Study of general serious infections<BR/>Of 98 participants, 29 were non-randomized but included with randomized participants in the analysis<BR/>Only 21/98 participants with pneumonia, some may be nosocomial</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-File-1997">
<CHAR_REASON_FOR_EXCLUSION>
<P>Atypical coverage (macrolide or doxycycline) could be added to non-atypical arm at investigator's discretion (if atypical pathogens were suspected or proven)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-01-12 11:08:20 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fink-1994">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-01-12 11:08:20 +1000" MODIFIED_BY="[Empty name]">
<P>Of 402 participants randomized, 78% were diagnosed with nosocomial pneumonia</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-28 21:54:28 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Fong-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-28 21:54:28 +1000" MODIFIED_BY="[Empty name]">
<P>Outpatients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Geijo-Martinez-2002">
<CHAR_REASON_FOR_EXCLUSION>
<P>Non-atypical group were given a macrolide optionally</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-06 11:05:04 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hagberg-2002">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-06 11:05:04 +1000" MODIFIED_BY="[Empty name]">
<P>Outpatients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-23 13:54:31 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Hoepelman-1993">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-23 13:54:31 +1000" MODIFIED_BY="[Empty name]">
<OL>
<LI>Most probably outpatients. The data is consistent with outpatients (rather than hospitalized patients), both in antibiotic regimen, follow-up setting and results; however, not stated specifically in the text. Trial author did not reply to further enquires. After consulting with the third review author (MP), we had decided it was most probably outpatients and therefore excluded it</LI>
<LI>9 of 99 patients with pneumonia; data not given separately</LI>
</OL>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-06 11:05:04 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Katz-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-06 11:05:04 +1000" MODIFIED_BY="[Empty name]">
<P>In the typical arm, patients could receive azithromycin or/and flagyl</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-23 17:07:04 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Khajotia-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-23 17:07:04 +1000" MODIFIED_BY="[Empty name]">
<P>Over 80% lower respiratory tract infection without parenchymal involvement per chest X-ray. No separate information given for the (15 + 7) patients with CAP</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-06 11:05:04 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kinasewitz-1991">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-06 11:05:04 +1000" MODIFIED_BY="[Empty name]">
<P>Outpatients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-06 11:05:04 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Krumpe-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-06 11:05:04 +1000" MODIFIED_BY="[Empty name]">
<P>Study of treatment of severe infections: of 540 patients enrolled, 310 were diagnosed with pneumonia, of whom more than 50% (57% of original patients) were diagnosed with nosocomial pneumonia</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-06 16:52:53 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Kuzman-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-06 16:52:53 +1000" MODIFIED_BY="[Empty name]">
<P>In the typical arm 30% received doxycycline</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-23 13:55:11 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Leophonte-1999">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-23 13:55:11 +1000" MODIFIED_BY="[Empty name]">
<P>Meta-analysis of 5 trials, out of which 2 are included and 2 are excluded in this study; the fifth is yet to be located</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-23 13:55:22 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Levine-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-23 13:55:22 +1000" MODIFIED_BY="[Empty name]">
<P>&gt; 30% dropout rate (45/113 patients)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-06 11:05:04 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lode-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-06 11:05:04 +1000" MODIFIED_BY="[Empty name]">
<P>Study of general severe clinical infections. Pneumonia patients 25/66, some may be nosocomial (no response from trial author)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-23 13:55:48 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lode-1990">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-23 13:55:48 +1000" MODIFIED_BY="[Empty name]">
<P>Reports 4 trials. The first is included in our study and the second compares two quinolones. The third and the forth have insufficient data regarding the study populations and outcomes. Not published elsewhere</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-24 08:43:28 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lode-1998">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-24 08:43:28 +1000" MODIFIED_BY="[Empty name]">
<P>Retroactive analysis of 4 randomized clinical trials, concentrating on CAP patients with pneumococcal bacteraemia. Relevant studies were extracted and analyzed separately</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-03-21 11:05:14 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Lode-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-03-21 11:05:14 +1000" MODIFIED_BY="[Empty name]">
<P>Both ambulatory and hospitalized patients could be included in the study but that information was not recorded. Therefore, the proportion of hospitalized patients is unknown</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mendoca-2004">
<CHAR_REASON_FOR_EXCLUSION>
<P>In the typical arm 11% received a macrolide antibiotic</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Mouton-1991">
<CHAR_REASON_FOR_EXCLUSION>
<P>Non-atypical group were given amoxicillin and/or erythromycin</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-06 11:05:03 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-O_x0027_Doherty-1997">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-06 11:05:03 +1000" MODIFIED_BY="[Empty name]">
<P>Outpatients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-10-08 22:15:04 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Ott--2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-10-08 22:15:04 +1000" MODIFIED_BY="[Empty name]">
<P>Study of aspiration pneumonia and lung abscess</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-06 11:05:03 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Peacock-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-06 11:05:03 +1000" MODIFIED_BY="[Empty name]">
<P>Study of general serious infections. Small number of pneumonia patients (7 and 4)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR STUDY_ID="STD-Plouffe-1996">
<CHAR_REASON_FOR_EXCLUSION>
<P>Ofloxacin versus standard therapy - latter arm not differentiated to regimens with atypical coverage and those without such coverage</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-06 11:05:03 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Rahav-2004">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-06 11:05:03 +1000" MODIFIED_BY="[Empty name]">
<P>Outpatients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-01-12 11:08:33 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Siami-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-01-12 11:08:33 +1000" MODIFIED_BY="[Empty name]">
<P>Of 54 randomized patients, 89% were diagnosed with nosocomial pneumonia and only 11% diagnosed with CAP</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-06 11:05:03 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sifuentes-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-06 11:05:03 +1000" MODIFIED_BY="[Empty name]">
<P>Study of general severe infections. Small number of pneumonia patients. Data of mortality not given separately</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-23 13:57:04 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Snydman-1995">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-23 13:57:04 +1000" MODIFIED_BY="[Empty name]">
<P>Previously published (Fink 1994, excluded due to a high percentage of nosocomial pneumonia in enrolled patients)</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-06 11:05:03 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Stocks-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-06 11:05:03 +1000" MODIFIED_BY="[Empty name]">
<P>Outpatients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-06 11:05:03 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Sujata-2008">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-06 11:05:03 +1000" MODIFIED_BY="[Empty name]">
<P>In the typical arm, patients could receive macrolide</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-06 11:05:03 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Torres-2003">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-06 11:05:03 +1000" MODIFIED_BY="[Empty name]">
<P>Outpatients</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-23 13:57:36 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Trenholme-1989">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-23 13:57:36 +1000" MODIFIED_BY="[Empty name]">
<OL>
<LI>Over 50% of treated patients (27/44) were diagnosed with nosocomial pneumonia</LI>
<LI>Ciprofloxacin versus ceftazidime - when feasible, patients in latter group were switched to ANY alternative oral therapy</LI>
</OL>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2011-12-06 11:05:03 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Welte-2005">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2011-12-06 11:05:03 +1000" MODIFIED_BY="[Empty name]">
<P>In the typical arm, patients could receive erythromycin</P>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<EXCLUDED_CHAR MODIFIED="2012-07-23 13:58:02 +1000" MODIFIED_BY="[Empty name]" STUDY_ID="STD-Wollschlager-1987">
<CHAR_REASON_FOR_EXCLUSION MODIFIED="2012-07-23 13:58:02 +1000" MODIFIED_BY="[Empty name]">
<OL>
<LI>Outpatients</LI>
<LI>Bacterial bronchitis</LI>
</OL>
</CHAR_REASON_FOR_EXCLUSION>
</EXCLUDED_CHAR>
<FOOTNOTES>
<P>CAP: community-acquired pneumonia<BR/>
<BR/>
</P>
</FOOTNOTES>
</CHARACTERISTICS_OF_EXCLUDED_STUDIES>
<CHARACTERISTICS_OF_AWAITING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_AWAITING_STUDIES>
<CHARACTERISTICS_OF_ONGOING_STUDIES SORT_BY="STUDY" USER_DEF_1_ENABLED="NO" USER_DEF_2_ENABLED="NO" USER_DEF_3_ENABLED="NO">
<FOOTNOTES/>
</CHARACTERISTICS_OF_ONGOING_STUDIES>
</CHARACTERISTICS_OF_STUDIES>
<QUALITY_ITEMS MODIFIED="2012-07-24 08:43:52 +1000" MODIFIED_BY="[Empty name]">
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-01" LEVEL="STUDY" MODIFIED="2012-07-24 08:43:52 +1000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Random sequence generation (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate generation of a randomised sequence</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-26 00:22:24 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Aubier-1998">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-08 22:53:34 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bohte-1995">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-08 23:04:11 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Carbon-1992">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 00:32:43 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chuard-1989">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-24 08:43:21 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Feldman-2001">
<DESCRIPTION>
<P>Computer-generated randomization code designed to allocate equal numbers of patients to the 2 treatment groups using the method of random-permutated blocks of 4</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 00:53:07 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fourrier-1986">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-24 08:43:52 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Genne-1997">
<DESCRIPTION>
<P>Randomization was performed using sealed envelopes with random numbers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 01:10:06 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gleadhill-1986">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 01:23:44 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hatipoglu-2010">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 01:30:37 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hirata_x002d_Dulas-1991">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-11 19:15:24 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hong_x002d_yun-2007">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-11 18:41:52 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kalbermatter-2000">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-01-12 11:08:02 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Khan-1989">
<DESCRIPTION>
<P>Antibiotics were administered with a computer-generated, randomized code</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 04:54:54 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kobayashi-1984">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-01 23:24:51 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kohno-2011">
<DESCRIPTION>
<P>Central, registration control system </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 06:18:40 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lephonte-2004">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 06:43:07 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lode-1995">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 06:45:44 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Miki-1984">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 06:48:26 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Norrby-1998">
<DESCRIPTION>
<P>Central, computerized telephone system</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 07:00:26 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peterson-1988">
<DESCRIPTION>
<P>Computer-generated random assignment code</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-11 19:31:44 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Petitpretz-2001">
<DESCRIPTION>
<P>Author confirmed in correspondence adequate methods</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 07:05:37 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rizzato-1997">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 07:07:35 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Romanelli-2002">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 07:09:06 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tremolieres-1998">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-11 19:09:54 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tremolieres-2005">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 07:13:34 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Vanderdonckt--1990">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 07:14:11 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Vogel-1991">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 07:19:15 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zeluff-1988">
<DESCRIPTION>
<P>An allocation schedule of random numbers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-02" LEVEL="STUDY" MODIFIED="2012-07-23 13:22:55 +1000" MODIFIED_BY="[Empty name]" NO="2">
<NAME>Allocation concealment (selection bias)</NAME>
<DESCRIPTION>
<P>Selection bias (biased allocation to interventions) due to inadequate concealment of allocations prior to assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-09-26 00:22:39 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Aubier-1998">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-08 22:53:42 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bohte-1995">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-08 23:04:16 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Carbon-1992">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 00:34:26 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chuard-1989">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-23 12:47:01 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Feldman-2001">
<DESCRIPTION>
<P>Sealed, serially-numbered envelopes, each containing details of the treatment allocation for a single patient</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 00:53:12 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fourrier-1986">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-12-06 11:14:10 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Genne-1997">
<DESCRIPTION>
<P>Sealed opaque envelopes with numbers</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 01:10:07 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gleadhill-1986">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 01:23:45 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hatipoglu-2010">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 01:30:39 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hirata_x002d_Dulas-1991">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 06:33:00 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hong_x002d_yun-2007">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 04:51:38 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kalbermatter-2000">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 04:49:06 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Khan-1989">
<DESCRIPTION>
<P>Antibiotics were administered in a sequential manner</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 06:13:50 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kobayashi-1984">
<DESCRIPTION>
<P>Inadequate</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-23 13:15:01 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kohno-2011">
<DESCRIPTION>
<P>Evaluator center, randomly allocated patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 06:18:44 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lephonte-2004">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 06:43:11 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lode-1995">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 06:45:49 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Miki-1984">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-23 13:22:55 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Norrby-1998">
<DESCRIPTION>
<P>Evaluator-blinded for selected patients</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 07:00:07 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peterson-1988">
<DESCRIPTION>
<P>Sealed envelopes</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-11 19:31:56 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Petitpretz-2001">
<DESCRIPTION>
<P>Author confirmed in correspondence adequate methods</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 07:05:40 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rizzato-1997">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 07:07:39 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Romanelli-2002">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 07:09:10 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tremolieres-1998">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-12-06 16:52:45 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tremolieres-2005">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 07:13:05 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Vanderdonckt--1990">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 07:14:09 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Vogel-1991">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 07:17:28 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zeluff-1988">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-03" LEVEL="GROUP" MODIFIED="2011-09-26 00:29:39 +1000" MODIFIED_BY="[Empty name]" NO="3">
<NAME>Blinding (performance bias and detection bias)</NAME>
<DESCRIPTION>
<P>Performance bias or detection bias due to knowledge of the allocated interventions after assignment</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA/>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-04" LEVEL="GROUP" MODIFIED="2012-07-02 20:48:05 +1000" MODIFIED_BY="[Empty name]" NO="4">
<NAME>Incomplete outcome data (attrition bias)</NAME>
<DESCRIPTION>
<P>Attrition bias due to amount, nature or handling of incomplete outcome data</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.01" NO="1">
<NAME>Mortality</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-04.02" NO="2">
<NAME>Failure</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-12-06 11:05:09 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Aubier-1998">
<DESCRIPTION>
<P>All patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-12-06 11:05:09 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Aubier-1998">
<DESCRIPTION>
<P>266/329 patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-12-06 11:05:08 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bohte-1995">
<DESCRIPTION>
<P>All patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-12-06 11:05:08 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Bohte-1995">
<DESCRIPTION>
<P>64/66 patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-12-06 11:05:08 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Carbon-1992">
<DESCRIPTION>
<P>All patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-12-06 11:05:08 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Carbon-1992">
<DESCRIPTION>
<P>243/246 patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-12-06 11:05:07 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chuard-1989">
<DESCRIPTION>
<P>All patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-12-06 11:05:07 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chuard-1989">
<DESCRIPTION>
<P>All patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-12-06 11:05:07 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Feldman-2001">
<DESCRIPTION>
<P>All patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-12-06 11:05:07 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Feldman-2001">
<DESCRIPTION>
<P>All patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-12-06 11:05:07 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fourrier-1986">
<DESCRIPTION>
<P>All patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-12-06 11:05:07 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Fourrier-1986">
<DESCRIPTION>
<P>All patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-12-06 11:05:07 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Genne-1997">
<DESCRIPTION>
<P>112/127 patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-12-06 11:05:07 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Genne-1997">
<DESCRIPTION>
<P>112/127 patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-12-06 11:05:07 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Gleadhill-1986">
<DESCRIPTION>
<P>48/52 patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-12-06 11:05:07 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Gleadhill-1986">
<DESCRIPTION>
<P>48/52 patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-10-09 01:24:28 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hatipoglu-2010">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-12-06 11:13:36 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hatipoglu-2010">
<DESCRIPTION>
<P>All patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-12-06 11:13:23 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hirata_x002d_Dulas-1991">
<DESCRIPTION>
<P>All patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-12-06 11:13:26 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hirata_x002d_Dulas-1991">
<DESCRIPTION>
<P>All patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-10-09 06:33:00 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hong_x002d_yun-2007">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-10-09 06:42:04 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hong_x002d_yun-2007">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-12-06 11:05:07 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kalbermatter-2000">
<DESCRIPTION>
<P>All patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-12-06 11:05:07 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kalbermatter-2000">
<DESCRIPTION>
<P>All patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-12-06 11:05:07 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Khan-1989">
<DESCRIPTION>
<P>122/140 patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-12-06 11:05:07 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Khan-1989">
<DESCRIPTION>
<P>122/140 patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-12-06 11:05:07 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kobayashi-1984">
<DESCRIPTION>
<P>All patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-12-06 11:05:07 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kobayashi-1984">
<DESCRIPTION>
<P>74/76 patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2012-07-02 20:48:03 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kohno-2011">
<DESCRIPTION>
<P>200/260 patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2012-07-02 20:48:05 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kohno-2011">
<DESCRIPTION>
<P>200/260 patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-12-06 11:05:06 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lephonte-2004">
<DESCRIPTION>
<P>249/324 patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-12-06 11:05:06 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Lephonte-2004">
<DESCRIPTION>
<P>249/324 patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-12-06 11:05:06 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lode-1995">
<DESCRIPTION>
<P>All patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-12-06 11:05:06 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lode-1995">
<DESCRIPTION>
<P>All patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-12-06 11:05:06 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Miki-1984">
<DESCRIPTION>
<P>145\147 patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-12-06 11:05:06 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Miki-1984">
<DESCRIPTION>
<P>139/147 patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-12-06 11:05:06 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Norrby-1998">
<DESCRIPTION>
<P>619/625 patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-12-06 11:05:05 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Norrby-1998">
<DESCRIPTION>
<P>619/625 patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-12-06 11:05:05 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peterson-1988">
<DESCRIPTION>
<P>All patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-12-06 11:05:05 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peterson-1988">
<DESCRIPTION>
<P>All patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-12-06 11:05:05 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Petitpretz-2001">
<DESCRIPTION>
<P>408/411 patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-12-06 11:05:05 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Petitpretz-2001">
<DESCRIPTION>
<P>408/411 patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-12-06 11:05:05 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Rizzato-1997">
<DESCRIPTION>
<P>225/240 patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-12-06 11:05:05 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Rizzato-1997">
<DESCRIPTION>
<P>225/240 patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-12-06 11:05:05 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Romanelli-2002">
<DESCRIPTION>
<P>204/226 patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-12-06 11:05:05 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Romanelli-2002">
<DESCRIPTION>
<P>204/226 patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-12-06 11:05:05 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Tremolieres-1998">
<DESCRIPTION>
<P>335/344 patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-12-06 11:05:05 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Tremolieres-1998">
<DESCRIPTION>
<P>285/344 patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-12-06 11:05:05 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Tremolieres-2005">
<DESCRIPTION>
<P>285/342 patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-12-06 11:05:04 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Tremolieres-2005">
<DESCRIPTION>
<P>285/342 patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-12-06 11:05:04 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Vanderdonckt--1990">
<DESCRIPTION>
<P>All patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-12-06 11:05:04 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Vanderdonckt--1990">
<DESCRIPTION>
<P>156/170 patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-12-06 11:05:04 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Vogel-1991">
<DESCRIPTION>
<P>All patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-12-06 11:05:04 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Vogel-1991">
<DESCRIPTION>
<P>75/100 patients evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.01" MODIFIED="2011-12-06 11:03:22 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zeluff-1988">
<DESCRIPTION>
<P>158/160 participants evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-04.02" MODIFIED="2011-12-06 11:03:04 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Zeluff-1988">
<DESCRIPTION>
<P>90/160 participants evaluated</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-05" LEVEL="STUDY" MODIFIED="2012-07-02 20:51:56 +1000" MODIFIED_BY="[Empty name]" NO="5">
<NAME>Selective reporting (reporting bias)</NAME>
<DESCRIPTION>
<P>Reporting bias due to selective outcome reporting</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-08 22:44:18 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Aubier-1998">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-08 23:01:05 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Bohte-1995">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-08 23:08:50 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Carbon-1992">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 00:37:58 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Chuard-1989">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 00:52:21 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Feldman-2001">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-12-06 16:54:05 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fourrier-1986">
<DESCRIPTION>
<P>Number of patients with bacteriologically documented pathogen and pneumococcal pneumonia was lost (correspondence with author)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 01:12:02 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Genne-1997">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 01:11:58 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Gleadhill-1986">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 01:24:59 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hatipoglu-2010">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 01:33:44 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Hirata_x002d_Dulas-1991">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 06:33:00 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hong_x002d_yun-2007">
<DESCRIPTION>
<P>Not described</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 04:53:51 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kalbermatter-2000">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 04:54:03 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Khan-1989">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 04:54:09 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kobayashi-1984">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-02 20:51:56 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kohno-2011">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 06:18:52 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lephonte-2004">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 06:43:59 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lode-1995">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 06:46:47 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Miki-1984">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 06:50:50 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Norrby-1998">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 06:58:56 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Peterson-1988">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 07:01:14 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Petitpretz-2001">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 07:05:10 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Rizzato-1997">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 07:07:55 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Romanelli-2002">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 07:10:32 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tremolieres-1998">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-11 19:13:12 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tremolieres-2005">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 07:12:29 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Vanderdonckt--1990">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 07:14:25 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Vogel-1991">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 07:16:21 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zeluff-1988">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="YES" ID="QIT-06" LEVEL="STUDY" MODIFIED="2012-07-23 13:23:00 +1000" MODIFIED_BY="[Empty name]" NO="6">
<NAME>Other bias</NAME>
<DESCRIPTION>
<P>Bias due to problems not covered elsewhere in the table</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-08 22:47:42 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Aubier-1998">
<DESCRIPTION/>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-23 12:44:06 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bohte-1995">
<DESCRIPTION>
<P>Not ITT (4/108 lost)<BR/>Sponsored: grant from Pfizer Inc.</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-08 23:05:43 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Carbon-1992">
<DESCRIPTION>
<P>Not ITT</P>
<P>Sponsored</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-08 23:19:00 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Chuard-1989">
<DESCRIPTION>
<P>Sponsored</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 01:02:37 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Feldman-2001">
<DESCRIPTION>
<P>Sponsored</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 00:56:10 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Fourrier-1986">
<DESCRIPTION>
<P>Sponsored</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 01:00:46 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Genne-1997">
<DESCRIPTION>
<P>Sponsored</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 01:11:34 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Gleadhill-1986">
<DESCRIPTION>
<P>Sponsor?</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 01:25:15 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hatipoglu-2010">
<DESCRIPTION>
<P>Not enough data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 01:31:21 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hirata_x002d_Dulas-1991">
<DESCRIPTION>
<P>Sponsored</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 06:33:00 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hong_x002d_yun-2007">
<DESCRIPTION>
<P>Not enough data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 04:52:54 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kalbermatter-2000">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-23 13:13:56 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Khan-1989">
<DESCRIPTION>
<P>Manufacturer/Pharmaceutical company sponsored</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 04:54:32 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Kobayashi-1984">
<DESCRIPTION>
<P>Sponsored</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-02 20:52:03 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kohno-2011">
<DESCRIPTION>
<P>Not identified</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-23 13:16:32 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lephonte-2004">
<DESCRIPTION>
<P>Manufacturer/Pharmaceutical company sponsored</P>
<P>No ITT analysis</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 06:43:56 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Lode-1995">
<DESCRIPTION>
<P>Sponsored</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 06:45:21 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Miki-1984">
<DESCRIPTION>
<P>Sponsored</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2012-07-23 13:23:00 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Norrby-1998">
<DESCRIPTION>
<P>Sponsored</P>
<P>No ITT</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 06:58:07 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Peterson-1988">
<DESCRIPTION>
<P>Sponsored</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 07:02:14 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Petitpretz-2001">
<DESCRIPTION>
<P>Sponsored</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 07:05:19 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Rizzato-1997">
<DESCRIPTION>
<P>Sponsored</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 07:07:47 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Romanelli-2002">
<DESCRIPTION>
<P>Sponsored</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 07:08:53 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tremolieres-1998">
<DESCRIPTION>
<P>Sponsored</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-12-06 16:52:49 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Tremolieres-2005">
<DESCRIPTION>
<P>sponsored by Pfizer Center Research</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 07:12:45 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Vanderdonckt--1990">
<DESCRIPTION>
<P>Unknown sponsorship</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 07:14:55 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Vogel-1991">
<DESCRIPTION>
<P>Sponsored</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY MODIFIED="2011-10-09 07:16:31 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Zeluff-1988">
<DESCRIPTION>
<P>? sponsored</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-07" LEVEL="GROUP" MODIFIED="2012-07-24 08:27:58 +1000" MODIFIED_BY="[Empty name]" NO="7">
<NAME>Blinding of participants and personnel (performance bias)</NAME>
<DESCRIPTION>
<P>Performance bias due to knowledge of the allocated interventions by participants and personnel during the study</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-07.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-12-06 11:02:40 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Aubier-1998">
<DESCRIPTION>
<P>Double-blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-10-08 23:01:51 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bohte-1995">
<DESCRIPTION>
<P>None (open label)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-12-06 11:02:41 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Carbon-1992">
<DESCRIPTION>
<P>Double-blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-10-09 00:38:23 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Chuard-1989">
<DESCRIPTION>
<P>None (open label)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-10-09 00:40:08 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Feldman-2001">
<DESCRIPTION>
<P>None (open label)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-24 08:27:58 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fourrier-1986">
<DESCRIPTION>
<P>Maybe single-blinded - simple randomization</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-10-09 01:01:35 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Genne-1997">
<DESCRIPTION>
<P>None</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-10-09 01:11:17 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Gleadhill-1986">
<DESCRIPTION>
<P>None</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-10-09 01:25:56 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hatipoglu-2010">
<DESCRIPTION>
<P>Not enough data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-10-09 01:32:33 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hirata_x002d_Dulas-1991">
<DESCRIPTION>
<P>None (unknown)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-10-09 06:33:00 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hong_x002d_yun-2007">
<DESCRIPTION>
<P>Not enough data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-10-09 01:37:24 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kalbermatter-2000">
<DESCRIPTION>
<P>None</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-10-09 04:50:38 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Khan-1989">
<DESCRIPTION>
<P>None</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-12-06 11:02:42 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kobayashi-1984">
<DESCRIPTION>
<P>Double-blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2012-07-04 08:12:09 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kohno-2011">
<DESCRIPTION>
<P>Open label trial</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-12-06 11:02:43 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lephonte-2004">
<DESCRIPTION>
<P>Double-blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-12-06 11:02:44 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lode-1995">
<DESCRIPTION>
<P>Double-blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-12-06 11:02:45 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Miki-1984">
<DESCRIPTION>
<P>Double-blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-10-09 06:50:40 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Norrby-1998">
<DESCRIPTION>
<P>None </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-10-09 06:57:38 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Peterson-1988">
<DESCRIPTION>
<P>None</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-12-06 11:02:45 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Petitpretz-2001">
<DESCRIPTION>
<P>Double-blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-10-09 07:05:07 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Rizzato-1997">
<DESCRIPTION>
<P>None</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-10-09 07:08:13 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Romanelli-2002">
<DESCRIPTION>
<P>None</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-10-09 07:08:42 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tremolieres-1998">
<DESCRIPTION>
<P>Double-blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-12-06 11:02:46 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tremolieres-2005">
<DESCRIPTION>
<P>Double-blind, double dummy</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-10-09 07:12:21 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Vanderdonckt--1990">
<DESCRIPTION>
<P>None</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-10-09 07:14:17 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Vogel-1991">
<DESCRIPTION>
<P>None</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-07.01" MODIFIED="2011-12-06 11:02:47 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zeluff-1988">
<DESCRIPTION>
<P>Double-blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
<QUALITY_ITEM CORE_ITEM="NO" ID="QIT-08" LEVEL="GROUP" MODIFIED="2012-07-23 13:15:16 +1000" MODIFIED_BY="[Empty name]" NO="8">
<NAME>Blinding of outcome assessment (detection bias)</NAME>
<DESCRIPTION>
<P>Detection bias due to knowledge of the allocated interventions by outcome assessors</P>
</DESCRIPTION>
<QUALITY_ITEM_DATA_ENTRY_GROUP ID="QIG-08.01" NO="1">
<NAME>All outcomes</NAME>
</QUALITY_ITEM_DATA_ENTRY_GROUP>
<QUALITY_ITEM_DATA>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-12-06 11:02:40 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Aubier-1998">
<DESCRIPTION>
<P>Double-blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-10-08 22:57:26 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Bohte-1995">
<DESCRIPTION>
<P>None</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-12-06 11:02:41 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Carbon-1992">
<DESCRIPTION>
<P>Double-blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-10-09 00:38:29 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Chuard-1989">
<DESCRIPTION>
<P>None</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-10-09 00:40:14 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Feldman-2001">
<DESCRIPTION>
<P>None (open label)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-10-09 00:54:17 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Fourrier-1986">
<DESCRIPTION>
<P>None </P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-10-09 01:01:36 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Genne-1997">
<DESCRIPTION>
<P>None</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-10-09 01:11:18 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Gleadhill-1986">
<DESCRIPTION>
<P>None</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-10-09 01:25:57 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hatipoglu-2010">
<DESCRIPTION>
<P>Not enough data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-10-09 01:32:26 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Hirata_x002d_Dulas-1991">
<DESCRIPTION>
<P>None (unknown)</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-10-09 06:33:00 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Hong_x002d_yun-2007">
<DESCRIPTION>
<P>Not enough data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-10-09 01:37:25 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Kalbermatter-2000">
<DESCRIPTION>
<P>None</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-10-09 04:50:40 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Khan-1989">
<DESCRIPTION>
<P>None</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-12-06 11:02:42 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kobayashi-1984">
<DESCRIPTION>
<P>Double-blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2012-07-23 13:15:16 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Kohno-2011">
<DESCRIPTION>
<P>A separate party committee evaluated the effects of the drugs, not knowing which drug had been used</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-12-06 11:02:43 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lephonte-2004">
<DESCRIPTION>
<P>Double-blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-12-06 11:02:44 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Lode-1995">
<DESCRIPTION>
<P>Double-blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-12-06 11:02:45 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Miki-1984">
<DESCRIPTION>
<P>Double-blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-12-06 11:05:05 +1000" MODIFIED_BY="[Empty name]" RESULT="UNKNOWN" STUDY_ID="STD-Norrby-1998">
<DESCRIPTION>
<P>Three types of assessments were performed according to the study protocol: protocol, conducted by computer; investigator, conducted by the investigator and evaluator-blinded, conducted by an external evaluator for selected patients using blinded data</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-10-09 06:57:39 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Peterson-1988">
<DESCRIPTION>
<P>None</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-12-06 11:02:45 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Petitpretz-2001">
<DESCRIPTION>
<P>Double-blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-10-09 07:05:09 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Rizzato-1997">
<DESCRIPTION>
<P>None</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-10-09 07:08:14 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Romanelli-2002">
<DESCRIPTION>
<P>None</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-10-09 07:08:43 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tremolieres-1998">
<DESCRIPTION>
<P>Double-blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-12-06 11:02:47 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Tremolieres-2005">
<DESCRIPTION>
<P>Double-blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-10-09 07:12:22 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Vanderdonckt--1990">
<DESCRIPTION>
<P>None</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-10-09 07:14:21 +1000" MODIFIED_BY="[Empty name]" RESULT="NO" STUDY_ID="STD-Vogel-1991">
<DESCRIPTION>
<P>None</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
<QUALITY_ITEM_DATA_ENTRY GROUP_ID="QIG-08.01" MODIFIED="2011-12-06 11:02:26 +1000" MODIFIED_BY="[Empty name]" RESULT="YES" STUDY_ID="STD-Zeluff-1988">
<DESCRIPTION>
<P>Double-blind</P>
</DESCRIPTION>
</QUALITY_ITEM_DATA_ENTRY>
</QUALITY_ITEM_DATA>
</QUALITY_ITEM>
</QUALITY_ITEMS>
<SOF_TABLES/>
<ADDITIONAL_TABLES MODIFIED="2011-10-08 21:48:44 +1000" MODIFIED_BY="[Empty name]"/>
<ANALYSES_AND_DATA CALCULATED_DATA="YES" MODIFIED="2012-07-23 16:44:10 +1000" MODIFIED_BY="[Empty name]">
<COMPARISON ID="CMP-001" MODIFIED="2012-07-23 16:44:10 +1000" MODIFIED_BY="[Empty name]" NO="1">
<NAME>Atypical versus non-aytpical</NAME>
<DICH_OUTCOME CHI2="8.421193888768842" CI_END="1.5465174949505158" CI_START="0.8420663528669545" CI_STUDY="95" CI_TOTAL="95" DF="18" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1411706036425577" ESTIMABLE="YES" EVENTS_1="99" EVENTS_2="71" I2="0.0" I2_Q="0.0" ID="CMP-001.01" LOG_CI_END="0.189354837315269" LOG_CI_START="-0.07465368575854146" LOG_EFFECT_SIZE="0.05735057577836377" METHOD="MH" MODIFIED="2012-07-02 21:59:16 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9716843735535586" P_Q="0.4101514667048102" P_Z="0.3944772260076007" Q="2.88216964351445" RANDOM="NO" SCALE="706.0255711154135" SORT_BY="EFFECT_SIZE" STUDIES="25" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2930" TOTAL_2="2514" WEIGHT="100.0" Z="0.85152601673244">
<NAME>Mortality per antibiotic (ABX) treatment</NAME>
<GROUP_LABEL_1>Atypical ABX</GROUP_LABEL_1>
<GROUP_LABEL_2>Non-atypical ABX</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favors atypical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favors non-atypical</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="5.185890501199601" CI_END="1.391535687424283" CI_START="0.6898926212015818" DF="13" EFFECT_SIZE="0.9798011037413071" ESTIMABLE="YES" EVENTS_1="57" EVENTS_2="57" I2="0.0" ID="CMP-001.01.01" LOG_CI_END="0.14349434876039266" LOG_CI_START="-0.16121850005786026" LOG_EFFECT_SIZE="-0.008862075648733779" MODIFIED="2012-07-02 21:59:16 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9708696847244995" P_Z="0.9092340643523568" STUDIES="19" TAU2="0.0" TOTAL_1="1848" TOTAL_2="1850" WEIGHT="78.16474296752769" Z="0.11400470421349154">
<NAME>Quinolone (atypical arm)</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="245" O_E="0.0" SE="0.0" STUDY_ID="STD-Vanderdonckt--1990" TOTAL_1="82" TOTAL_2="88" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="234" O_E="0.0" SE="0.0" STUDY_ID="STD-Gleadhill-1986" TOTAL_1="26" TOTAL_2="22" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="239" O_E="0.0" SE="0.0" STUDY_ID="STD-Miki-1984" TOTAL_1="73" TOTAL_2="72" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="236" O_E="0.0" SE="0.0" STUDY_ID="STD-Kalbermatter-2000" TOTAL_1="28" TOTAL_2="56" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="231" O_E="0.0" SE="0.0" STUDY_ID="STD-Chuard-1989" TOTAL_1="59" TOTAL_2="62" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.8037512393518735" CI_START="0.00787283446475005" EFFECT_SIZE="0.14857142857142858" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.44773947856376095" LOG_CI_START="-2.103868879994714" LOG_EFFECT_SIZE="-0.8280647007154764" ORDER="246" O_E="0.0" SE="1.4988273804823278" STUDY_ID="STD-Vogel-1991" TOTAL_1="49" TOTAL_2="51" VAR="2.2464835164835164" WEIGHT="4.547138004573629"/>
<DICH_DATA CI_END="7.846269290500529" CI_START="0.013276171449257431" EFFECT_SIZE="0.32275132275132273" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8946632093978316" LOG_CI_START="-1.8769271477227858" LOG_EFFECT_SIZE="-0.49113196916247714" ORDER="230" O_E="0.0" SE="1.6280458953661852" STUDY_ID="STD-Carbon-1992" TOTAL_1="125" TOTAL_2="121" VAR="2.6505334374186833" WEIGHT="2.0198093652573834"/>
<DICH_DATA CI_END="3.3909149191699557" CI_START="0.03745796603903159" EFFECT_SIZE="0.35639412997903563" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.5303168931108628" LOG_CI_START="-1.426455808434543" LOG_EFFECT_SIZE="-0.44806945766184" ORDER="229" O_E="0.0" SE="1.1494179710688606" STUDY_ID="STD-Aubier-1998" TOTAL_1="159" TOTAL_2="170" VAR="1.3211616722160562" WEIGHT="3.8425784190104277"/>
<DICH_DATA CI_END="3.4412964975231937" CI_START="0.17679383349789363" EFFECT_SIZE="0.78" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.5367220924671535" LOG_CI_START="-0.7525328870861927" LOG_EFFECT_SIZE="-0.10790539730951958" ORDER="242" O_E="0.0" SE="0.7573147569047106" STUDY_ID="STD-Petitpretz-2001" TOTAL_1="200" TOTAL_2="208" VAR="0.573525641025641" WEIGHT="5.196729148084148"/>
<DICH_DATA CI_END="5.9286419449592" CI_START="0.12239760542807132" EFFECT_SIZE="0.8518518518518519" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.7729552223092031" LOG_CI_START="-0.9122270785919919" LOG_EFFECT_SIZE="-0.06963592814139442" MODIFIED="2012-07-02 21:59:16 +1000" MODIFIED_BY="[Empty name]" ORDER="977" O_E="0.0" SE="0.9898844253362861" STUDY_ID="STD-Kohno-2011" TOTAL_1="108" TOTAL_2="92" VAR="0.9798711755233493" WEIGHT="2.862358414764749"/>
<DICH_DATA CI_END="1.650714989229768" CI_START="0.520788655723" EFFECT_SIZE="0.9271858714533874" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="22" LOG_CI_END="0.21767209489215533" LOG_CI_START="-0.2833384845215875" LOG_EFFECT_SIZE="-0.03283319481471606" ORDER="240" O_E="0.0" SE="0.2942960943899982" STUDY_ID="STD-Norrby-1998" TOTAL_1="314" TOTAL_2="305" VAR="0.08661019117320673" WEIGHT="29.57753235384863"/>
<DICH_DATA CI_END="2.925649438310225" CI_START="0.3418044509726267" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.4662222862019852" LOG_CI_START="-0.46622228620198514" LOG_EFFECT_SIZE="0.0" ORDER="233" O_E="0.0" SE="0.5477225575051662" STUDY_ID="STD-Fourrier-1986" TOTAL_1="20" TOTAL_2="20" VAR="0.30000000000000004" WEIGHT="6.625829663807289"/>
<DICH_DATA CI_END="7.098213466980093" CI_START="0.1653389429002928" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8511490558931599" LOG_CI_START="-0.781624843374736" LOG_EFFECT_SIZE="0.03476210625921191" ORDER="235" O_E="0.0" SE="0.959099470791114" STUDY_ID="STD-Hirata_x002d_Dulas-1991" TOTAL_1="24" TOTAL_2="26" VAR="0.9198717948717949" WEIGHT="2.544318590901999"/>
<DICH_DATA CI_END="4.842137134309385" CI_START="0.26431911480013565" EFFECT_SIZE="1.1313131313131313" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.6850370849467889" LOG_CI_START="-0.5778714288015255" LOG_EFFECT_SIZE="0.05358282807263168" ORDER="237" O_E="0.0" SE="0.7418387124737258" STUDY_ID="STD-Khan-1989" TOTAL_1="66" TOTAL_2="56" VAR="0.5503246753246752" WEIGHT="4.301358273553585"/>
<DICH_DATA CI_END="5.370477008077758" CI_START="0.2778526421480827" EFFECT_SIZE="1.221556886227545" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.730012861635424" LOG_CI_START="-0.5561854690787931" LOG_EFFECT_SIZE="0.08691369627831551" ORDER="238" O_E="0.0" SE="0.7555192662459503" STUDY_ID="STD-Lephonte-2004" TOTAL_1="167" TOTAL_2="153" VAR="0.5708093616688191" WEIGHT="4.149425826959315"/>
<DICH_DATA CI_END="5.732497858664328" CI_START="0.295947567713187" EFFECT_SIZE="1.302504816955684" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7583439011742503" LOG_CI_START="-0.528785224987894" LOG_EFFECT_SIZE="0.11477933809317811" ORDER="244" O_E="0.0" SE="0.7560660200995746" STUDY_ID="STD-Tremolieres-1998" TOTAL_1="173" TOTAL_2="169" VAR="0.5716358267492103" WEIGHT="4.021994848556705"/>
<DICH_DATA CI_END="4.474509367366996" CI_START="0.47876341942251066" EFFECT_SIZE="1.4636363636363636" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.650745421612411" LOG_CI_START="-0.31987903986516164" LOG_EFFECT_SIZE="0.16543319087362465" ORDER="243" O_E="0.0" SE="0.5701496133404992" STUDY_ID="STD-Rizzato-1997" TOTAL_1="110" TOTAL_2="115" VAR="0.3250705815923207" WEIGHT="6.478589004611572"/>
<DICH_DATA CI_END="69.20358703801709" CI_START="0.1229263511986906" EFFECT_SIZE="2.9166666666666665" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.840128605879343" LOG_CI_START="-0.9103550092740413" LOG_EFFECT_SIZE="0.4648867983026508" ORDER="232" O_E="0.0" SE="1.6156476906545747" STUDY_ID="STD-Feldman-2001" TOTAL_1="35" TOTAL_2="34" VAR="2.6103174603174604" WEIGHT="0.6719151208367955"/>
<DICH_DATA CI_END="27.234348125670902" CI_START="0.33046504210308847" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4351169845729048" LOG_CI_START="-0.4808744751335797" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="241" O_E="0.0" SE="1.1254628677422753" STUDY_ID="STD-Peterson-1988" TOTAL_1="30" TOTAL_2="30" VAR="1.2666666666666664" WEIGHT="1.3251659327614578"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.5804076085962756" CI_END="3.0146353397276053" CI_START="0.5185848874480404" DF="2" EFFECT_SIZE="1.25033768572715" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="8" I2="0.0" ID="CMP-001.01.02" LOG_CI_END="0.47923478595472385" LOG_CI_START="-0.2851801435511565" LOG_EFFECT_SIZE="0.09702732120178365" NO="2" P_CHI2="0.7481111104817422" P_Z="0.6187962173693675" STUDIES="4" TAU2="0.0" TOTAL_1="273" TOTAL_2="267" WEIGHT="11.181249955460679" Z="0.49755714529234">
<NAME>Macrolide (atypical arm)</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="247" O_E="0.0" SE="0.0" STUDY_ID="STD-Bohte-1995" TOTAL_1="36" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.802921395811218" CI_START="0.3710400442802314" EFFECT_SIZE="1.0198019801980198" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.44761091872207476" LOG_CI_START="-0.4305792168770155" LOG_EFFECT_SIZE="0.008515850922529638" ORDER="249" O_E="0.0" SE="0.5158532327621861" STUDY_ID="STD-Romanelli-2002" TOTAL_1="101" TOTAL_2="103" VAR="0.2661045577511981" WEIGHT="9.185218769238732"/>
<DICH_DATA CI_END="21.43133294583097" CI_START="0.18664261388268522" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3310491833151046" LOG_CI_START="-0.7289891919871422" LOG_EFFECT_SIZE="0.3010299956639812" ORDER="248" O_E="0.0" SE="1.2100767390069584" STUDY_ID="STD-Genne-1997" TOTAL_1="56" TOTAL_2="56" VAR="1.4642857142857144" WEIGHT="1.3251659327614578"/>
<DICH_DATA CI_END="70.75181835719732" CI_START="0.12100102474800362" EFFECT_SIZE="2.925925925925926" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8497376059256418" LOG_CI_START="-0.9172109516627335" LOG_EFFECT_SIZE="0.46626332713145413" ORDER="250" O_E="0.0" SE="1.6253192793436677" STUDY_ID="STD-Zeluff-1988" TOTAL_1="80" TOTAL_2="78" VAR="2.6416627598062195" WEIGHT="0.670865253460488"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="6.441400205989379" CI_START="0.8122455950171147" DF="0" EFFECT_SIZE="2.2873563218390807" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="4" I2="0.0" ID="CMP-001.01.03" LOG_CI_END="0.808980282831327" LOG_CI_START="-0.09031263524915063" LOG_EFFECT_SIZE="0.3593338237910882" NO="3" P_CHI2="1.0" P_Z="0.11727834675038146" STUDIES="1" TAU2="0.0" TOTAL_1="609" TOTAL_2="199" WEIGHT="7.990356960908196" Z="1.5663002318774377">
<NAME>Combined quinolone and macrolide (atypical arm)</NAME>
<DICH_DATA CI_END="6.441400205989379" CI_START="0.8122455950171147" EFFECT_SIZE="2.2873563218390807" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="4" LOG_CI_END="0.808980282831327" LOG_CI_START="-0.09031263524915063" LOG_EFFECT_SIZE="0.3593338237910882" ORDER="251" O_E="0.0" SE="0.5282491116522111" STUDY_ID="STD-Lode-1995" TOTAL_1="609" TOTAL_2="199" VAR="0.27904712396135023" WEIGHT="7.990356960908196"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="10.687385050990041" CI_START="0.3668249980042432" DF="0" EFFECT_SIZE="1.98" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" I2="0.0" ID="CMP-001.01.04" LOG_CI_END="1.0288714566729127" LOG_CI_START="-0.4355410761498505" LOG_EFFECT_SIZE="0.2966651902615311" NO="4" P_CHI2="1.0" P_Z="0.4271307912897301" STUDIES="1" TAU2="0.0" TOTAL_1="200" TOTAL_2="198" WEIGHT="2.6636501161034323" Z="0.794111051833912">
<NAME>Pristinamycine (atypical arm)</NAME>
<DICH_DATA CI_END="10.687385050990036" CI_START="0.36682499800424323" EFFECT_SIZE="1.98" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0288714566729125" LOG_CI_START="-0.43554107614985044" LOG_EFFECT_SIZE="0.2966651902615311" ORDER="252" O_E="0.0" SE="0.8602031707390382" STUDY_ID="STD-Tremolieres-2005" TOTAL_1="200" TOTAL_2="198" VAR="0.7399494949494949" WEIGHT="2.6636501161034323"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="8.421193888768844" CI_END="1.5465174949505158" CI_START="0.8420663528669545" CI_STUDY="95" CI_TOTAL="95" DF="18" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1411706036425577" ESTIMABLE="YES" EVENTS_1="99" EVENTS_2="71" I2="0.0" I2_Q="0.0" ID="CMP-001.02" LOG_CI_END="0.189354837315269" LOG_CI_START="-0.07465368575854146" LOG_EFFECT_SIZE="0.05735057577836377" METHOD="MH" MODIFIED="2012-07-02 22:13:35 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.9716843735535585" P_Q="0.9344621332274099" P_Z="0.3944772260076007" Q="0.13556837171912084" RANDOM="NO" SCALE="33.80962394237473" SORT_BY="STUDY" STUDIES="25" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2930" TOTAL_2="2514" WEIGHT="100.0" Z="0.85152601673244">
<NAME>Mortality per age</NAME>
<GROUP_LABEL_1>Atypical ABx</GROUP_LABEL_1>
<GROUP_LABEL_2>Non-atypical ABx</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours atypical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-atypical</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="6.600929283052489" CI_END="1.9382874580813227" CI_START="0.7518892607634075" DF="11" EFFECT_SIZE="1.2072189213244422" ESTIMABLE="YES" EVENTS_1="52" EVENTS_2="28" I2="0.0" ID="CMP-001.02.01" LOG_CI_END="0.2874181856150156" LOG_CI_START="-0.12384611815947595" LOG_EFFECT_SIZE="0.08178603372776981" MODIFIED="2012-07-02 22:13:35 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8304196148885561" P_Z="0.435664002290019" STUDIES="15" TAU2="0.0" TOTAL_1="2117" TOTAL_2="1703" WEIGHT="42.93817975206886" Z="0.7795360748483681">
<NAME>Mean age under 65 years old</NAME>
<DICH_DATA CI_END="3.3909149191699557" CI_START="0.03745796603903159" EFFECT_SIZE="0.35639412997903563" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.5303168931108628" LOG_CI_START="-1.426455808434543" LOG_EFFECT_SIZE="-0.44806945766184" ORDER="253" O_E="0.0" SE="1.1494179710688606" STUDY_ID="STD-Aubier-1998" TOTAL_1="159" TOTAL_2="170" VAR="1.3211616722160562" WEIGHT="3.8425784190104277"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="254" O_E="0.0" SE="0.0" STUDY_ID="STD-Bohte-1995" TOTAL_1="36" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="7.846269290500529" CI_START="0.013276171449257431" EFFECT_SIZE="0.32275132275132273" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8946632093978316" LOG_CI_START="-1.8769271477227858" LOG_EFFECT_SIZE="-0.49113196916247714" ORDER="255" O_E="0.0" SE="1.6280458953661852" STUDY_ID="STD-Carbon-1992" TOTAL_1="125" TOTAL_2="121" VAR="2.6505334374186833" WEIGHT="2.0198093652573834"/>
<DICH_DATA CI_END="69.20358703801709" CI_START="0.1229263511986906" EFFECT_SIZE="2.9166666666666665" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.840128605879343" LOG_CI_START="-0.9103550092740413" LOG_EFFECT_SIZE="0.4648867983026508" ORDER="256" O_E="0.0" SE="1.6156476906545747" STUDY_ID="STD-Feldman-2001" TOTAL_1="35" TOTAL_2="34" VAR="2.6103174603174604" WEIGHT="0.6719151208367955"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="257" O_E="0.0" SE="0.0" STUDY_ID="STD-Kalbermatter-2000" TOTAL_1="28" TOTAL_2="56" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.842137134309385" CI_START="0.26431911480013565" EFFECT_SIZE="1.1313131313131313" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.6850370849467889" LOG_CI_START="-0.5778714288015255" LOG_EFFECT_SIZE="0.05358282807263168" ORDER="258" O_E="0.0" SE="0.7418387124737258" STUDY_ID="STD-Khan-1989" TOTAL_1="66" TOTAL_2="56" VAR="0.5503246753246752" WEIGHT="4.301358273553585"/>
<DICH_DATA CI_END="5.9286419449592" CI_START="0.12239760542807132" EFFECT_SIZE="0.8518518518518519" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.7729552223092031" LOG_CI_START="-0.9122270785919919" LOG_EFFECT_SIZE="-0.06963592814139442" MODIFIED="2012-07-02 22:13:35 +1000" MODIFIED_BY="[Empty name]" ORDER="983" O_E="0.0" SE="0.9898844253362861" STUDY_ID="STD-Kohno-2011" TOTAL_1="108" TOTAL_2="92" VAR="0.9798711755233493" WEIGHT="2.862358414764749"/>
<DICH_DATA CI_END="5.370477008077758" CI_START="0.2778526421480827" EFFECT_SIZE="1.221556886227545" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.730012861635424" LOG_CI_START="-0.5561854690787931" LOG_EFFECT_SIZE="0.08691369627831551" ORDER="259" O_E="0.0" SE="0.7555192662459503" STUDY_ID="STD-Lephonte-2004" TOTAL_1="167" TOTAL_2="153" VAR="0.5708093616688191" WEIGHT="4.149425826959315"/>
<DICH_DATA CI_END="6.441400205989379" CI_START="0.8122455950171147" EFFECT_SIZE="2.2873563218390807" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="4" LOG_CI_END="0.808980282831327" LOG_CI_START="-0.09031263524915063" LOG_EFFECT_SIZE="0.3593338237910882" ORDER="260" O_E="0.0" SE="0.5282491116522111" STUDY_ID="STD-Lode-1995" TOTAL_1="609" TOTAL_2="199" VAR="0.27904712396135023" WEIGHT="7.990356960908196"/>
<DICH_DATA CI_END="3.4412964975231937" CI_START="0.17679383349789363" EFFECT_SIZE="0.78" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.5367220924671535" LOG_CI_START="-0.7525328870861927" LOG_EFFECT_SIZE="-0.10790539730951958" ORDER="261" O_E="0.0" SE="0.7573147569047106" STUDY_ID="STD-Petitpretz-2001" TOTAL_1="200" TOTAL_2="208" VAR="0.573525641025641" WEIGHT="5.196729148084148"/>
<DICH_DATA CI_END="5.732497858664328" CI_START="0.295947567713187" EFFECT_SIZE="1.302504816955684" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7583439011742503" LOG_CI_START="-0.528785224987894" LOG_EFFECT_SIZE="0.11477933809317811" ORDER="262" O_E="0.0" SE="0.7560660200995746" STUDY_ID="STD-Tremolieres-1998" TOTAL_1="173" TOTAL_2="169" VAR="0.5716358267492103" WEIGHT="4.021994848556705"/>
<DICH_DATA CI_END="10.687385050990036" CI_START="0.36682499800424323" EFFECT_SIZE="1.98" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0288714566729125" LOG_CI_START="-0.43554107614985044" LOG_EFFECT_SIZE="0.2966651902615311" ORDER="263" O_E="0.0" SE="0.8602031707390382" STUDY_ID="STD-Tremolieres-2005" TOTAL_1="200" TOTAL_2="198" VAR="0.7399494949494949" WEIGHT="2.6636501161034323"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="264" O_E="0.0" SE="0.0" STUDY_ID="STD-Vanderdonckt--1990" TOTAL_1="82" TOTAL_2="88" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.8037512393518735" CI_START="0.00787283446475005" EFFECT_SIZE="0.14857142857142858" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.44773947856376095" LOG_CI_START="-2.103868879994714" LOG_EFFECT_SIZE="-0.8280647007154764" ORDER="265" O_E="0.0" SE="1.4988273804823278" STUDY_ID="STD-Vogel-1991" TOTAL_1="49" TOTAL_2="51" VAR="2.2464835164835164" WEIGHT="4.547138004573629"/>
<DICH_DATA CI_END="70.75181835719732" CI_START="0.12100102474800362" EFFECT_SIZE="2.925925925925926" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8497376059256418" LOG_CI_START="-0.9172109516627335" LOG_EFFECT_SIZE="0.46626332713145413" ORDER="266" O_E="0.0" SE="1.6253192793436677" STUDY_ID="STD-Zeluff-1988" TOTAL_1="80" TOTAL_2="78" VAR="2.6416627598062195" WEIGHT="0.670865253460488"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.6502289539374817" CI_END="1.6862443291557963" CI_START="0.7221272745241336" DF="5" EFFECT_SIZE="1.1034867564203257" ESTIMABLE="YES" EVENTS_1="42" EVENTS_2="38" I2="0.0" ID="CMP-001.02.02" LOG_CI_END="0.22692050214890855" LOG_CI_START="-0.1413862515270765" LOG_EFFECT_SIZE="0.042767125310916004" NO="2" P_CHI2="0.8951095021332787" P_Z="0.6489832990082938" STUDIES="8" TAU2="0.0" TOTAL_1="720" TOTAL_2="719" WEIGHT="50.43599058412384" Z="0.45517506532312196">
<NAME>Mean age over 65 years old</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="267" O_E="0.0" SE="0.0" STUDY_ID="STD-Chuard-1989" TOTAL_1="59" TOTAL_2="62" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="21.43133294583097" CI_START="0.18664261388268522" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3310491833151046" LOG_CI_START="-0.7289891919871422" LOG_EFFECT_SIZE="0.3010299956639812" ORDER="268" O_E="0.0" SE="1.2100767390069584" STUDY_ID="STD-Genne-1997" TOTAL_1="56" TOTAL_2="56" VAR="1.4642857142857144" WEIGHT="1.3251659327614578"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="269" O_E="0.0" SE="0.0" STUDY_ID="STD-Gleadhill-1986" TOTAL_1="26" TOTAL_2="22" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="7.098213466980093" CI_START="0.1653389429002928" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8511490558931599" LOG_CI_START="-0.781624843374736" LOG_EFFECT_SIZE="0.03476210625921191" ORDER="270" O_E="0.0" SE="0.959099470791114" STUDY_ID="STD-Hirata_x002d_Dulas-1991" TOTAL_1="24" TOTAL_2="26" VAR="0.9198717948717949" WEIGHT="2.544318590901999"/>
<DICH_DATA CI_END="1.650714989229768" CI_START="0.520788655723" EFFECT_SIZE="0.9271858714533874" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="22" LOG_CI_END="0.21767209489215533" LOG_CI_START="-0.2833384845215875" LOG_EFFECT_SIZE="-0.03283319481471606" ORDER="271" O_E="0.0" SE="0.2942960943899982" STUDY_ID="STD-Norrby-1998" TOTAL_1="314" TOTAL_2="305" VAR="0.08661019117320673" WEIGHT="29.57753235384863"/>
<DICH_DATA CI_END="27.234348125670902" CI_START="0.33046504210308847" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4351169845729048" LOG_CI_START="-0.4808744751335797" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="272" O_E="0.0" SE="1.1254628677422753" STUDY_ID="STD-Peterson-1988" TOTAL_1="30" TOTAL_2="30" VAR="1.2666666666666664" WEIGHT="1.3251659327614578"/>
<DICH_DATA CI_END="4.474509367366996" CI_START="0.47876341942251066" EFFECT_SIZE="1.4636363636363636" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.650745421612411" LOG_CI_START="-0.31987903986516164" LOG_EFFECT_SIZE="0.16543319087362465" ORDER="273" O_E="0.0" SE="0.5701496133404992" STUDY_ID="STD-Rizzato-1997" TOTAL_1="110" TOTAL_2="115" VAR="0.3250705815923207" WEIGHT="6.478589004611572"/>
<DICH_DATA CI_END="2.802921395811218" CI_START="0.3710400442802314" EFFECT_SIZE="1.0198019801980198" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.44761091872207476" LOG_CI_START="-0.4305792168770155" LOG_EFFECT_SIZE="0.008515850922529638" ORDER="274" O_E="0.0" SE="0.5158532327621861" STUDY_ID="STD-Romanelli-2002" TOTAL_1="101" TOTAL_2="103" VAR="0.2661045577511981" WEIGHT="9.185218769238732"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="2.9256494383102245" CI_START="0.34180445097262674" DF="0" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" I2="0.0" ID="CMP-001.02.03" LOG_CI_END="0.46622228620198514" LOG_CI_START="-0.4662222862019851" LOG_EFFECT_SIZE="0.0" MODIFIED="2012-07-02 22:13:08 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="1.0" P_Z="1.0" STUDIES="2" TAU2="0.0" TOTAL_1="93" TOTAL_2="92" WEIGHT="6.625829663807289" Z="0.0">
<NAME>Data unavailable</NAME>
<DICH_DATA CI_END="2.925649438310225" CI_START="0.3418044509726267" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.4662222862019852" LOG_CI_START="-0.46622228620198514" LOG_EFFECT_SIZE="0.0" ORDER="275" O_E="0.0" SE="0.5477225575051662" STUDY_ID="STD-Fourrier-1986" TOTAL_1="20" TOTAL_2="20" VAR="0.30000000000000004" WEIGHT="6.625829663807289"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="276" O_E="0.0" SE="0.0" STUDY_ID="STD-Miki-1984" TOTAL_1="73" TOTAL_2="72" VAR="0.0" WEIGHT="0.0"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="8.421193888768842" CI_END="1.5465174949505156" CI_START="0.8420663528669543" CI_STUDY="95" CI_TOTAL="95" DF="18" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1411706036425575" ESTIMABLE="YES" EVENTS_1="99" EVENTS_2="71" I2="0.0" I2_Q="0.0" ID="CMP-001.03" LOG_CI_END="0.18935483731526895" LOG_CI_START="-0.07465368575854157" LOG_EFFECT_SIZE="0.05735057577836369" METHOD="MH" MODIFIED="2012-07-23 16:42:34 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9716843735535586" P_Q="0.7386002895841056" P_Z="0.3944772260076015" Q="0.6059968656732131" RANDOM="NO" SCALE="43.51181780055523" SORT_BY="STUDY" STUDIES="25" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2930" TOTAL_2="2514" WEIGHT="99.99999999999997" Z="0.8515260167324386">
<NAME>Mortality - per geographical area</NAME>
<GROUP_LABEL_1>Atypical ABx</GROUP_LABEL_1>
<GROUP_LABEL_2>Non-atypical ABx</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours atypical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-atypical</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="6.047083907992463" CI_END="1.8874038780629794" CI_START="0.793850379497703" DF="9" EFFECT_SIZE="1.2240573045677774" ESTIMABLE="YES" EVENTS_1="58" EVENTS_2="34" I2="0.0" ID="CMP-001.03.01" LOG_CI_END="0.2758648430615846" LOG_CI_START="-0.10026134326763482" LOG_EFFECT_SIZE="0.08780174989697488" NO="1" P_CHI2="0.7351968943164429" P_Z="0.36016222657310404" STUDIES="14" TAU2="0.0" TOTAL_1="1805" TOTAL_2="1404" WEIGHT="48.700331084828825" Z="0.9150560308344874">
<NAME>Europe</NAME>
<DICH_DATA CI_END="3.3909149191699557" CI_START="0.03745796603903159" EFFECT_SIZE="0.35639412997903563" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.5303168931108628" LOG_CI_START="-1.426455808434543" LOG_EFFECT_SIZE="-0.44806945766184" ORDER="277" O_E="0.0" SE="1.1494179710688606" STUDY_ID="STD-Aubier-1998" TOTAL_1="159" TOTAL_2="170" VAR="1.3211616722160562" WEIGHT="3.842578419010427"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="278" O_E="0.0" SE="0.0" STUDY_ID="STD-Bohte-1995" TOTAL_1="36" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="7.846269290500529" CI_START="0.013276171449257431" EFFECT_SIZE="0.32275132275132273" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8946632093978316" LOG_CI_START="-1.8769271477227858" LOG_EFFECT_SIZE="-0.49113196916247714" ORDER="279" O_E="0.0" SE="1.6280458953661852" STUDY_ID="STD-Carbon-1992" TOTAL_1="125" TOTAL_2="121" VAR="2.6505334374186833" WEIGHT="2.019809365257383"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="280" O_E="0.0" SE="0.0" STUDY_ID="STD-Chuard-1989" TOTAL_1="59" TOTAL_2="62" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.925649438310225" CI_START="0.3418044509726267" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.4662222862019852" LOG_CI_START="-0.46622228620198514" LOG_EFFECT_SIZE="0.0" ORDER="281" O_E="0.0" SE="0.5477225575051662" STUDY_ID="STD-Fourrier-1986" TOTAL_1="20" TOTAL_2="20" VAR="0.30000000000000004" WEIGHT="6.625829663807288"/>
<DICH_DATA CI_END="21.43133294583097" CI_START="0.18664261388268522" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3310491833151046" LOG_CI_START="-0.7289891919871422" LOG_EFFECT_SIZE="0.3010299956639812" ORDER="282" O_E="0.0" SE="1.2100767390069584" STUDY_ID="STD-Genne-1997" TOTAL_1="56" TOTAL_2="56" VAR="1.4642857142857144" WEIGHT="1.3251659327614576"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="283" O_E="0.0" SE="0.0" STUDY_ID="STD-Gleadhill-1986" TOTAL_1="26" TOTAL_2="22" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="6.441400205989379" CI_START="0.8122455950171147" EFFECT_SIZE="2.2873563218390807" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="4" LOG_CI_END="0.808980282831327" LOG_CI_START="-0.09031263524915063" LOG_EFFECT_SIZE="0.3593338237910882" ORDER="284" O_E="0.0" SE="0.5282491116522111" STUDY_ID="STD-Lode-1995" TOTAL_1="609" TOTAL_2="199" VAR="0.27904712396135023" WEIGHT="7.990356960908195"/>
<DICH_DATA CI_END="4.474509367366996" CI_START="0.47876341942251066" EFFECT_SIZE="1.4636363636363636" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.650745421612411" LOG_CI_START="-0.31987903986516164" LOG_EFFECT_SIZE="0.16543319087362465" ORDER="285" O_E="0.0" SE="0.5701496133404992" STUDY_ID="STD-Rizzato-1997" TOTAL_1="110" TOTAL_2="115" VAR="0.3250705815923207" WEIGHT="6.478589004611571"/>
<DICH_DATA CI_END="2.802921395811218" CI_START="0.3710400442802314" EFFECT_SIZE="1.0198019801980198" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.44761091872207476" LOG_CI_START="-0.4305792168770155" LOG_EFFECT_SIZE="0.008515850922529638" ORDER="286" O_E="0.0" SE="0.5158532327621861" STUDY_ID="STD-Romanelli-2002" TOTAL_1="101" TOTAL_2="103" VAR="0.2661045577511981" WEIGHT="9.18521876923873"/>
<DICH_DATA CI_END="5.732497858664328" CI_START="0.295947567713187" EFFECT_SIZE="1.302504816955684" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7583439011742503" LOG_CI_START="-0.528785224987894" LOG_EFFECT_SIZE="0.11477933809317811" ORDER="287" O_E="0.0" SE="0.7560660200995746" STUDY_ID="STD-Tremolieres-1998" TOTAL_1="173" TOTAL_2="169" VAR="0.5716358267492103" WEIGHT="4.021994848556704"/>
<DICH_DATA CI_END="10.687385050990036" CI_START="0.36682499800424323" EFFECT_SIZE="1.98" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0288714566729125" LOG_CI_START="-0.43554107614985044" LOG_EFFECT_SIZE="0.2966651902615311" ORDER="288" O_E="0.0" SE="0.8602031707390382" STUDY_ID="STD-Tremolieres-2005" TOTAL_1="200" TOTAL_2="198" VAR="0.7399494949494949" WEIGHT="2.663650116103432"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="289" O_E="0.0" SE="0.0" STUDY_ID="STD-Vanderdonckt--1990" TOTAL_1="82" TOTAL_2="88" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.8037512393518735" CI_START="0.00787283446475005" EFFECT_SIZE="0.14857142857142858" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.44773947856376095" LOG_CI_START="-2.103868879994714" LOG_EFFECT_SIZE="-0.8280647007154764" ORDER="290" O_E="0.0" SE="1.4988273804823278" STUDY_ID="STD-Vogel-1991" TOTAL_1="49" TOTAL_2="51" VAR="2.2464835164835164" WEIGHT="4.547138004573629"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.6150439498842546" CI_END="3.8563982885030956" CI_START="0.5224594239832734" DF="2" EFFECT_SIZE="1.4194406040625331" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="6" I2="0.0" ID="CMP-001.03.02" LOG_CI_END="0.5861818814461449" LOG_CI_START="-0.2819474327277885" LOG_EFFECT_SIZE="0.15211722435917824" NO="2" P_CHI2="0.735266749381257" P_Z="0.49216714054657007" STUDIES="3" TAU2="0.0" TOTAL_1="120" TOTAL_2="112" WEIGHT="8.17084279721704" Z="0.6868660608607299">
<NAME>North America</NAME>
<DICH_DATA CI_END="7.098213466980093" CI_START="0.1653389429002928" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8511490558931599" LOG_CI_START="-0.781624843374736" LOG_EFFECT_SIZE="0.03476210625921191" ORDER="291" O_E="0.0" SE="0.959099470791114" STUDY_ID="STD-Hirata_x002d_Dulas-1991" TOTAL_1="24" TOTAL_2="26" VAR="0.9198717948717949" WEIGHT="2.5443185909019985"/>
<DICH_DATA CI_END="4.842137134309385" CI_START="0.26431911480013565" EFFECT_SIZE="1.1313131313131313" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.6850370849467889" LOG_CI_START="-0.5778714288015255" LOG_EFFECT_SIZE="0.05358282807263168" ORDER="292" O_E="0.0" SE="0.7418387124737258" STUDY_ID="STD-Khan-1989" TOTAL_1="66" TOTAL_2="56" VAR="0.5503246753246752" WEIGHT="4.301358273553584"/>
<DICH_DATA CI_END="27.234348125670902" CI_START="0.33046504210308847" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4351169845729048" LOG_CI_START="-0.4808744751335797" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="293" O_E="0.0" SE="1.1254628677422753" STUDY_ID="STD-Peterson-1988" TOTAL_1="30" TOTAL_2="30" VAR="1.2666666666666664" WEIGHT="1.3251659327614576"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="1.142657230281842" CI_END="1.597660530762462" CI_START="0.619494271608324" DF="5" EFFECT_SIZE="0.994857551000172" ESTIMABLE="YES" EVENTS_1="32" EVENTS_2="31" I2="0.0" ID="CMP-001.03.03" LOG_CI_END="0.2034845063431949" LOG_CI_START="-0.20796270514005213" LOG_EFFECT_SIZE="-0.0022390993984285905" MODIFIED="2012-07-02 22:05:23 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.9502589415484226" P_Z="0.9829805915773886" STUDIES="8" TAU2="0.0" TOTAL_1="1005" TOTAL_2="998" WEIGHT="43.12882611795412" Z="0.021332283006147087">
<NAME>Other</NAME>
<DICH_DATA CI_END="69.20358703801709" CI_START="0.1229263511986906" EFFECT_SIZE="2.9166666666666665" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.840128605879343" LOG_CI_START="-0.9103550092740413" LOG_EFFECT_SIZE="0.4648867983026508" ORDER="294" O_E="0.0" SE="1.6156476906545747" STUDY_ID="STD-Feldman-2001" TOTAL_1="35" TOTAL_2="34" VAR="2.6103174603174604" WEIGHT="0.6719151208367954"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="295" O_E="0.0" SE="0.0" STUDY_ID="STD-Kalbermatter-2000" TOTAL_1="28" TOTAL_2="56" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="5.9286419449592" CI_START="0.12239760542807132" EFFECT_SIZE="0.8518518518518519" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.7729552223092031" LOG_CI_START="-0.9122270785919919" LOG_EFFECT_SIZE="-0.06963592814139442" MODIFIED="2012-07-02 22:05:23 +1000" MODIFIED_BY="[Empty name]" ORDER="980" O_E="0.0" SE="0.9898844253362861" STUDY_ID="STD-Kohno-2011" TOTAL_1="108" TOTAL_2="92" VAR="0.9798711755233493" WEIGHT="2.8623584147647487"/>
<DICH_DATA CI_END="5.370477008077758" CI_START="0.2778526421480827" EFFECT_SIZE="1.221556886227545" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.730012861635424" LOG_CI_START="-0.5561854690787931" LOG_EFFECT_SIZE="0.08691369627831551" ORDER="296" O_E="0.0" SE="0.7555192662459503" STUDY_ID="STD-Lephonte-2004" TOTAL_1="167" TOTAL_2="153" VAR="0.5708093616688191" WEIGHT="4.149425826959314"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="297" O_E="0.0" SE="0.0" STUDY_ID="STD-Miki-1984" TOTAL_1="73" TOTAL_2="72" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.650714989229768" CI_START="0.520788655723" EFFECT_SIZE="0.9271858714533874" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="22" LOG_CI_END="0.21767209489215533" LOG_CI_START="-0.2833384845215875" LOG_EFFECT_SIZE="-0.03283319481471606" ORDER="298" O_E="0.0" SE="0.2942960943899982" STUDY_ID="STD-Norrby-1998" TOTAL_1="314" TOTAL_2="305" VAR="0.08661019117320673" WEIGHT="29.577532353848625"/>
<DICH_DATA CI_END="3.4412964975231937" CI_START="0.17679383349789363" EFFECT_SIZE="0.78" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.5367220924671535" LOG_CI_START="-0.7525328870861927" LOG_EFFECT_SIZE="-0.10790539730951958" ORDER="299" O_E="0.0" SE="0.7573147569047106" STUDY_ID="STD-Petitpretz-2001" TOTAL_1="200" TOTAL_2="208" VAR="0.573525641025641" WEIGHT="5.196729148084147"/>
<DICH_DATA CI_END="70.75181835719732" CI_START="0.12100102474800362" EFFECT_SIZE="2.925925925925926" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8497376059256418" LOG_CI_START="-0.9172109516627335" LOG_EFFECT_SIZE="0.46626332713145413" ORDER="300" O_E="0.0" SE="1.6253192793436677" STUDY_ID="STD-Zeluff-1988" TOTAL_1="80" TOTAL_2="78" VAR="2.6416627598062195" WEIGHT="0.6708652534604879"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="8.421193888768842" CI_END="1.5465174949505163" CI_START="0.8420663528669545" CI_STUDY="95" CI_TOTAL="95" DF="18" EFFECT_MEASURE="RR" EFFECT_SIZE="1.141170603642558" ESTIMABLE="YES" EVENTS_1="99" EVENTS_2="71" I2="0.0" I2_Q="0.0" ID="CMP-001.04" LOG_CI_END="0.18935483731526914" LOG_CI_START="-0.07465368575854146" LOG_EFFECT_SIZE="0.05735057577836385" METHOD="MH" MODIFIED="2012-07-02 22:26:32 +1000" MODIFIED_BY="[Empty name]" NO="4" P_CHI2="0.9716843735535586" P_Q="0.7252302753281399" P_Z="0.39447722600760005" Q="0.12353637665140596" RANDOM="NO" SCALE="32.20246805757867" SORT_BY="STUDY" STUDIES="25" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2930" TOTAL_2="2514" WEIGHT="100.00000000000003" Z="0.851526016732441">
<NAME>Mortality per allocation generation</NAME>
<GROUP_LABEL_1>Atypical ABx</GROUP_LABEL_1>
<GROUP_LABEL_2>Non-atypical ABx</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours atypical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-atypical</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.347215776121175" CI_END="1.6843232770380312" CI_START="0.6848388657763114" DF="7" EFFECT_SIZE="1.074006537525431" ESTIMABLE="YES" EVENTS_1="37" EVENTS_2="33" I2="0.0" ID="CMP-001.04.01" LOG_CI_END="0.22642545055997162" LOG_CI_START="-0.16441160067725782" LOG_EFFECT_SIZE="0.03100692494135691" MODIFIED="2012-07-02 22:26:32 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9381560085091856" P_Z="0.7558111463064422" STUDIES="10" TAU2="0.0" TOTAL_1="976" TOTAL_2="977" WEIGHT="45.93109043007132" Z="0.3109861563227727">
<NAME>A</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="301" O_E="0.0" SE="0.0" STUDY_ID="STD-Chuard-1989" TOTAL_1="59" TOTAL_2="62" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="69.20358703801709" CI_START="0.1229263511986906" EFFECT_SIZE="2.9166666666666665" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.840128605879343" LOG_CI_START="-0.9103550092740413" LOG_EFFECT_SIZE="0.4648867983026508" ORDER="302" O_E="0.0" SE="1.6156476906545747" STUDY_ID="STD-Feldman-2001" TOTAL_1="35" TOTAL_2="34" VAR="2.6103174603174604" WEIGHT="0.6719151208367957"/>
<DICH_DATA CI_END="21.43133294583097" CI_START="0.18664261388268522" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3310491833151046" LOG_CI_START="-0.7289891919871422" LOG_EFFECT_SIZE="0.3010299956639812" ORDER="303" O_E="0.0" SE="1.2100767390069584" STUDY_ID="STD-Genne-1997" TOTAL_1="56" TOTAL_2="56" VAR="1.4642857142857144" WEIGHT="1.3251659327614582"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="304" O_E="0.0" SE="0.0" STUDY_ID="STD-Kalbermatter-2000" TOTAL_1="28" TOTAL_2="56" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.842137134309385" CI_START="0.26431911480013565" EFFECT_SIZE="1.1313131313131313" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.6850370849467889" LOG_CI_START="-0.5778714288015255" LOG_EFFECT_SIZE="0.05358282807263168" ORDER="305" O_E="0.0" SE="0.7418387124737258" STUDY_ID="STD-Khan-1989" TOTAL_1="66" TOTAL_2="56" VAR="0.5503246753246752" WEIGHT="4.301358273553586"/>
<DICH_DATA CI_END="5.9286419449592" CI_START="0.12239760542807132" EFFECT_SIZE="0.8518518518518519" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.7729552223092031" LOG_CI_START="-0.9122270785919919" LOG_EFFECT_SIZE="-0.06963592814139442" MODIFIED="2012-07-02 22:26:32 +1000" MODIFIED_BY="[Empty name]" ORDER="993" O_E="0.0" SE="0.9898844253362861" STUDY_ID="STD-Kohno-2011" TOTAL_1="108" TOTAL_2="92" VAR="0.9798711755233493" WEIGHT="2.86235841476475"/>
<DICH_DATA CI_END="1.650714989229768" CI_START="0.520788655723" EFFECT_SIZE="0.9271858714533874" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="22" LOG_CI_END="0.21767209489215533" LOG_CI_START="-0.2833384845215875" LOG_EFFECT_SIZE="-0.03283319481471606" ORDER="306" O_E="0.0" SE="0.2942960943899982" STUDY_ID="STD-Norrby-1998" TOTAL_1="314" TOTAL_2="305" VAR="0.08661019117320673" WEIGHT="29.57753235384864"/>
<DICH_DATA CI_END="27.234348125670902" CI_START="0.33046504210308847" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4351169845729048" LOG_CI_START="-0.4808744751335797" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="307" O_E="0.0" SE="1.1254628677422753" STUDY_ID="STD-Peterson-1988" TOTAL_1="30" TOTAL_2="30" VAR="1.2666666666666664" WEIGHT="1.3251659327614582"/>
<DICH_DATA CI_END="3.4412964975231937" CI_START="0.17679383349789363" EFFECT_SIZE="0.78" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.5367220924671535" LOG_CI_START="-0.7525328870861927" LOG_EFFECT_SIZE="-0.10790539730951958" ORDER="308" O_E="0.0" SE="0.7573147569047106" STUDY_ID="STD-Petitpretz-2001" TOTAL_1="200" TOTAL_2="208" VAR="0.573525641025641" WEIGHT="5.19672914808415"/>
<DICH_DATA CI_END="70.75181835719732" CI_START="0.12100102474800362" EFFECT_SIZE="2.925925925925926" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8497376059256418" LOG_CI_START="-0.9172109516627335" LOG_EFFECT_SIZE="0.46626332713145413" ORDER="309" O_E="0.0" SE="1.6253192793436677" STUDY_ID="STD-Zeluff-1988" TOTAL_1="80" TOTAL_2="78" VAR="2.6416627598062195" WEIGHT="0.6708652534604882"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="5.89458543585883" CI_END="1.8097006581834059" CI_START="0.7933606871693237" DF="10" EFFECT_SIZE="1.1982259209961885" ESTIMABLE="YES" EVENTS_1="62" EVENTS_2="38" I2="0.0" ID="CMP-001.04.02" LOG_CI_END="0.25760674434410935" LOG_CI_START="-0.10052932361033728" LOG_EFFECT_SIZE="0.07853871036688602" NO="2" P_CHI2="0.8240406579542694" P_Z="0.3899906096436878" STUDIES="15" TAU2="0.0" TOTAL_1="1954" TOTAL_2="1537" WEIGHT="54.0689095699287" Z="0.8596344098517259">
<NAME>B</NAME>
<DICH_DATA CI_END="3.3909149191699557" CI_START="0.03745796603903159" EFFECT_SIZE="0.35639412997903563" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.5303168931108628" LOG_CI_START="-1.426455808434543" LOG_EFFECT_SIZE="-0.44806945766184" ORDER="310" O_E="0.0" SE="1.1494179710688606" STUDY_ID="STD-Aubier-1998" TOTAL_1="159" TOTAL_2="170" VAR="1.3211616722160562" WEIGHT="3.842578419010429"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="311" O_E="0.0" SE="0.0" STUDY_ID="STD-Bohte-1995" TOTAL_1="36" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="7.846269290500529" CI_START="0.013276171449257431" EFFECT_SIZE="0.32275132275132273" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8946632093978316" LOG_CI_START="-1.8769271477227858" LOG_EFFECT_SIZE="-0.49113196916247714" ORDER="312" O_E="0.0" SE="1.6280458953661852" STUDY_ID="STD-Carbon-1992" TOTAL_1="125" TOTAL_2="121" VAR="2.6505334374186833" WEIGHT="2.019809365257384"/>
<DICH_DATA CI_END="2.925649438310225" CI_START="0.3418044509726267" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.4662222862019852" LOG_CI_START="-0.46622228620198514" LOG_EFFECT_SIZE="0.0" ORDER="313" O_E="0.0" SE="0.5477225575051662" STUDY_ID="STD-Fourrier-1986" TOTAL_1="20" TOTAL_2="20" VAR="0.30000000000000004" WEIGHT="6.625829663807291"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="314" O_E="0.0" SE="0.0" STUDY_ID="STD-Gleadhill-1986" TOTAL_1="26" TOTAL_2="22" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="7.098213466980093" CI_START="0.1653389429002928" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8511490558931599" LOG_CI_START="-0.781624843374736" LOG_EFFECT_SIZE="0.03476210625921191" ORDER="315" O_E="0.0" SE="0.959099470791114" STUDY_ID="STD-Hirata_x002d_Dulas-1991" TOTAL_1="24" TOTAL_2="26" VAR="0.9198717948717949" WEIGHT="2.544318590902"/>
<DICH_DATA CI_END="5.370477008077758" CI_START="0.2778526421480827" EFFECT_SIZE="1.221556886227545" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.730012861635424" LOG_CI_START="-0.5561854690787931" LOG_EFFECT_SIZE="0.08691369627831551" ORDER="316" O_E="0.0" SE="0.7555192662459503" STUDY_ID="STD-Lephonte-2004" TOTAL_1="167" TOTAL_2="153" VAR="0.5708093616688191" WEIGHT="4.149425826959316"/>
<DICH_DATA CI_END="6.441400205989379" CI_START="0.8122455950171147" EFFECT_SIZE="2.2873563218390807" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="4" LOG_CI_END="0.808980282831327" LOG_CI_START="-0.09031263524915063" LOG_EFFECT_SIZE="0.3593338237910882" ORDER="317" O_E="0.0" SE="0.5282491116522111" STUDY_ID="STD-Lode-1995" TOTAL_1="609" TOTAL_2="199" VAR="0.27904712396135023" WEIGHT="7.990356960908199"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="318" O_E="0.0" SE="0.0" STUDY_ID="STD-Miki-1984" TOTAL_1="73" TOTAL_2="72" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.474509367366996" CI_START="0.47876341942251066" EFFECT_SIZE="1.4636363636363636" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.650745421612411" LOG_CI_START="-0.31987903986516164" LOG_EFFECT_SIZE="0.16543319087362465" ORDER="319" O_E="0.0" SE="0.5701496133404992" STUDY_ID="STD-Rizzato-1997" TOTAL_1="110" TOTAL_2="115" VAR="0.3250705815923207" WEIGHT="6.478589004611574"/>
<DICH_DATA CI_END="2.802921395811218" CI_START="0.3710400442802314" EFFECT_SIZE="1.0198019801980198" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.44761091872207476" LOG_CI_START="-0.4305792168770155" LOG_EFFECT_SIZE="0.008515850922529638" ORDER="320" O_E="0.0" SE="0.5158532327621861" STUDY_ID="STD-Romanelli-2002" TOTAL_1="101" TOTAL_2="103" VAR="0.2661045577511981" WEIGHT="9.185218769238736"/>
<DICH_DATA CI_END="5.732497858664328" CI_START="0.295947567713187" EFFECT_SIZE="1.302504816955684" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7583439011742503" LOG_CI_START="-0.528785224987894" LOG_EFFECT_SIZE="0.11477933809317811" ORDER="321" O_E="0.0" SE="0.7560660200995746" STUDY_ID="STD-Tremolieres-1998" TOTAL_1="173" TOTAL_2="169" VAR="0.5716358267492103" WEIGHT="4.021994848556707"/>
<DICH_DATA CI_END="10.687385050990036" CI_START="0.36682499800424323" EFFECT_SIZE="1.98" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0288714566729125" LOG_CI_START="-0.43554107614985044" LOG_EFFECT_SIZE="0.2966651902615311" ORDER="322" O_E="0.0" SE="0.8602031707390382" STUDY_ID="STD-Tremolieres-2005" TOTAL_1="200" TOTAL_2="198" VAR="0.7399494949494949" WEIGHT="2.663650116103433"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="323" O_E="0.0" SE="0.0" STUDY_ID="STD-Vanderdonckt--1990" TOTAL_1="82" TOTAL_2="88" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.8037512393518735" CI_START="0.00787283446475005" EFFECT_SIZE="0.14857142857142858" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.44773947856376095" LOG_CI_START="-2.103868879994714" LOG_EFFECT_SIZE="-0.8280647007154764" ORDER="324" O_E="0.0" SE="1.4988273804823278" STUDY_ID="STD-Vogel-1991" TOTAL_1="49" TOTAL_2="51" VAR="2.2464835164835164" WEIGHT="4.547138004573631"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.04.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>C</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="8.42119388876884" CI_END="1.5465174949505158" CI_START="0.8420663528669545" CI_STUDY="95" CI_TOTAL="95" DF="18" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1411706036425577" ESTIMABLE="YES" EVENTS_1="99" EVENTS_2="71" I2="0.0" I2_Q="0.0" ID="CMP-001.05" LOG_CI_END="0.189354837315269" LOG_CI_START="-0.07465368575854146" LOG_EFFECT_SIZE="0.05735057577836377" METHOD="MH" MODIFIED="2012-07-02 22:27:38 +1000" MODIFIED_BY="[Empty name]" NO="5" P_CHI2="0.9716843735535586" P_Q="0.6244043635419251" P_Z="0.3944772260076007" Q="0.23972564773950866" RANDOM="NO" SCALE="17.77976552424021" SORT_BY="STUDY" STUDIES="25" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2930" TOTAL_2="2514" WEIGHT="100.0" Z="0.85152601673244">
<NAME>Mortality per allocation concealment</NAME>
<GROUP_LABEL_1>Atypical ABx</GROUP_LABEL_1>
<GROUP_LABEL_2>Non-atypical ABx</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours atypical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-atypical</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.938721123772528" CI_END="1.650874938836673" CI_START="0.6634547432824929" DF="6" EFFECT_SIZE="1.0465566438264993" ESTIMABLE="YES" EVENTS_1="36" EVENTS_2="33" I2="0.0" ID="CMP-001.05.01" LOG_CI_END="0.21771417475866167" LOG_CI_START="-0.17818869663229434" LOG_EFFECT_SIZE="0.019762739063183665" MODIFIED="2012-07-02 22:27:38 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9252472061008807" P_Z="0.8448641198745703" STUDIES="7" TAU2="0.0" TOTAL_1="809" TOTAL_2="781" WEIGHT="45.26022517661082" Z="0.19567555377214008">
<NAME>A</NAME>
<DICH_DATA CI_END="69.20358703801709" CI_START="0.1229263511986906" EFFECT_SIZE="2.9166666666666665" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.840128605879343" LOG_CI_START="-0.9103550092740413" LOG_EFFECT_SIZE="0.4648867983026508" ORDER="325" O_E="0.0" SE="1.6156476906545747" STUDY_ID="STD-Feldman-2001" TOTAL_1="35" TOTAL_2="34" VAR="2.6103174603174604" WEIGHT="0.6719151208367955"/>
<DICH_DATA CI_END="21.43133294583097" CI_START="0.18664261388268522" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3310491833151046" LOG_CI_START="-0.7289891919871422" LOG_EFFECT_SIZE="0.3010299956639812" ORDER="326" O_E="0.0" SE="1.2100767390069584" STUDY_ID="STD-Genne-1997" TOTAL_1="56" TOTAL_2="56" VAR="1.4642857142857144" WEIGHT="1.3251659327614578"/>
<DICH_DATA CI_END="4.842137134309385" CI_START="0.26431911480013565" EFFECT_SIZE="1.1313131313131313" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.6850370849467889" LOG_CI_START="-0.5778714288015255" LOG_EFFECT_SIZE="0.05358282807263168" ORDER="327" O_E="0.0" SE="0.7418387124737258" STUDY_ID="STD-Khan-1989" TOTAL_1="66" TOTAL_2="56" VAR="0.5503246753246752" WEIGHT="4.301358273553585"/>
<DICH_DATA CI_END="5.9286419449592" CI_START="0.12239760542807132" EFFECT_SIZE="0.8518518518518519" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.7729552223092031" LOG_CI_START="-0.9122270785919919" LOG_EFFECT_SIZE="-0.06963592814139442" MODIFIED="2012-07-02 22:27:38 +1000" MODIFIED_BY="[Empty name]" ORDER="995" O_E="0.0" SE="0.9898844253362861" STUDY_ID="STD-Kohno-2011" TOTAL_1="108" TOTAL_2="92" VAR="0.9798711755233493" WEIGHT="2.862358414764749"/>
<DICH_DATA CI_END="1.650714989229768" CI_START="0.520788655723" EFFECT_SIZE="0.9271858714533874" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="22" LOG_CI_END="0.21767209489215533" LOG_CI_START="-0.2833384845215875" LOG_EFFECT_SIZE="-0.03283319481471606" ORDER="328" O_E="0.0" SE="0.2942960943899982" STUDY_ID="STD-Norrby-1998" TOTAL_1="314" TOTAL_2="305" VAR="0.08661019117320673" WEIGHT="29.57753235384863"/>
<DICH_DATA CI_END="27.234348125670902" CI_START="0.33046504210308847" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4351169845729048" LOG_CI_START="-0.4808744751335797" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="329" O_E="0.0" SE="1.1254628677422753" STUDY_ID="STD-Peterson-1988" TOTAL_1="30" TOTAL_2="30" VAR="1.2666666666666664" WEIGHT="1.3251659327614578"/>
<DICH_DATA CI_END="3.4412964975231937" CI_START="0.17679383349789363" EFFECT_SIZE="0.78" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.5367220924671535" LOG_CI_START="-0.7525328870861927" LOG_EFFECT_SIZE="-0.10790539730951958" ORDER="330" O_E="0.0" SE="0.7573147569047106" STUDY_ID="STD-Petitpretz-2001" TOTAL_1="200" TOTAL_2="208" VAR="0.573525641025641" WEIGHT="5.196729148084148"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="6.186522703519599" CI_END="1.834144091403327" CI_START="0.8106974271823171" DF="11" EFFECT_SIZE="1.2193998097352343" ESTIMABLE="YES" EVENTS_1="63" EVENTS_2="38" I2="0.0" ID="CMP-001.05.02" LOG_CI_END="0.2634334510958368" LOG_CI_START="-0.0911412052512515" LOG_EFFECT_SIZE="0.08614612292229266" NO="2" P_CHI2="0.8606334440568421" P_Z="0.3409089066353065" STUDIES="18" TAU2="0.0" TOTAL_1="2121" TOTAL_2="1733" WEIGHT="54.739774823389176" Z="0.9523709340927944">
<NAME>B</NAME>
<DICH_DATA CI_END="3.3909149191699557" CI_START="0.03745796603903159" EFFECT_SIZE="0.35639412997903563" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.5303168931108628" LOG_CI_START="-1.426455808434543" LOG_EFFECT_SIZE="-0.44806945766184" ORDER="331" O_E="0.0" SE="1.1494179710688606" STUDY_ID="STD-Aubier-1998" TOTAL_1="159" TOTAL_2="170" VAR="1.3211616722160562" WEIGHT="3.8425784190104277"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="332" O_E="0.0" SE="0.0" STUDY_ID="STD-Bohte-1995" TOTAL_1="36" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="7.846269290500529" CI_START="0.013276171449257431" EFFECT_SIZE="0.32275132275132273" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8946632093978316" LOG_CI_START="-1.8769271477227858" LOG_EFFECT_SIZE="-0.49113196916247714" ORDER="333" O_E="0.0" SE="1.6280458953661852" STUDY_ID="STD-Carbon-1992" TOTAL_1="125" TOTAL_2="121" VAR="2.6505334374186833" WEIGHT="2.0198093652573834"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="334" O_E="0.0" SE="0.0" STUDY_ID="STD-Chuard-1989" TOTAL_1="59" TOTAL_2="62" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.925649438310225" CI_START="0.3418044509726267" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.4662222862019852" LOG_CI_START="-0.46622228620198514" LOG_EFFECT_SIZE="0.0" ORDER="335" O_E="0.0" SE="0.5477225575051662" STUDY_ID="STD-Fourrier-1986" TOTAL_1="20" TOTAL_2="20" VAR="0.30000000000000004" WEIGHT="6.625829663807289"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="336" O_E="0.0" SE="0.0" STUDY_ID="STD-Gleadhill-1986" TOTAL_1="26" TOTAL_2="22" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="7.098213466980093" CI_START="0.1653389429002928" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8511490558931599" LOG_CI_START="-0.781624843374736" LOG_EFFECT_SIZE="0.03476210625921191" ORDER="337" O_E="0.0" SE="0.959099470791114" STUDY_ID="STD-Hirata_x002d_Dulas-1991" TOTAL_1="24" TOTAL_2="26" VAR="0.9198717948717949" WEIGHT="2.544318590901999"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="338" O_E="0.0" SE="0.0" STUDY_ID="STD-Kalbermatter-2000" TOTAL_1="28" TOTAL_2="56" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="5.370477008077758" CI_START="0.2778526421480827" EFFECT_SIZE="1.221556886227545" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.730012861635424" LOG_CI_START="-0.5561854690787931" LOG_EFFECT_SIZE="0.08691369627831551" ORDER="339" O_E="0.0" SE="0.7555192662459503" STUDY_ID="STD-Lephonte-2004" TOTAL_1="167" TOTAL_2="153" VAR="0.5708093616688191" WEIGHT="4.149425826959315"/>
<DICH_DATA CI_END="6.441400205989379" CI_START="0.8122455950171147" EFFECT_SIZE="2.2873563218390807" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="4" LOG_CI_END="0.808980282831327" LOG_CI_START="-0.09031263524915063" LOG_EFFECT_SIZE="0.3593338237910882" ORDER="340" O_E="0.0" SE="0.5282491116522111" STUDY_ID="STD-Lode-1995" TOTAL_1="609" TOTAL_2="199" VAR="0.27904712396135023" WEIGHT="7.990356960908196"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="341" O_E="0.0" SE="0.0" STUDY_ID="STD-Miki-1984" TOTAL_1="73" TOTAL_2="72" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.474509367366996" CI_START="0.47876341942251066" EFFECT_SIZE="1.4636363636363636" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.650745421612411" LOG_CI_START="-0.31987903986516164" LOG_EFFECT_SIZE="0.16543319087362465" ORDER="342" O_E="0.0" SE="0.5701496133404992" STUDY_ID="STD-Rizzato-1997" TOTAL_1="110" TOTAL_2="115" VAR="0.3250705815923207" WEIGHT="6.478589004611572"/>
<DICH_DATA CI_END="2.802921395811218" CI_START="0.3710400442802314" EFFECT_SIZE="1.0198019801980198" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.44761091872207476" LOG_CI_START="-0.4305792168770155" LOG_EFFECT_SIZE="0.008515850922529638" ORDER="343" O_E="0.0" SE="0.5158532327621861" STUDY_ID="STD-Romanelli-2002" TOTAL_1="101" TOTAL_2="103" VAR="0.2661045577511981" WEIGHT="9.185218769238732"/>
<DICH_DATA CI_END="5.732497858664328" CI_START="0.295947567713187" EFFECT_SIZE="1.302504816955684" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7583439011742503" LOG_CI_START="-0.528785224987894" LOG_EFFECT_SIZE="0.11477933809317811" ORDER="344" O_E="0.0" SE="0.7560660200995746" STUDY_ID="STD-Tremolieres-1998" TOTAL_1="173" TOTAL_2="169" VAR="0.5716358267492103" WEIGHT="4.021994848556705"/>
<DICH_DATA CI_END="10.687385050990036" CI_START="0.36682499800424323" EFFECT_SIZE="1.98" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0288714566729125" LOG_CI_START="-0.43554107614985044" LOG_EFFECT_SIZE="0.2966651902615311" ORDER="345" O_E="0.0" SE="0.8602031707390382" STUDY_ID="STD-Tremolieres-2005" TOTAL_1="200" TOTAL_2="198" VAR="0.7399494949494949" WEIGHT="2.6636501161034323"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="346" O_E="0.0" SE="0.0" STUDY_ID="STD-Vanderdonckt--1990" TOTAL_1="82" TOTAL_2="88" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.8037512393518735" CI_START="0.00787283446475005" EFFECT_SIZE="0.14857142857142858" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.44773947856376095" LOG_CI_START="-2.103868879994714" LOG_EFFECT_SIZE="-0.8280647007154764" ORDER="347" O_E="0.0" SE="1.4988273804823278" STUDY_ID="STD-Vogel-1991" TOTAL_1="49" TOTAL_2="51" VAR="2.2464835164835164" WEIGHT="4.547138004573629"/>
<DICH_DATA CI_END="70.75181835719732" CI_START="0.12100102474800362" EFFECT_SIZE="2.925925925925926" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8497376059256418" LOG_CI_START="-0.9172109516627335" LOG_EFFECT_SIZE="0.46626332713145413" ORDER="348" O_E="0.0" SE="1.6253192793436677" STUDY_ID="STD-Zeluff-1988" TOTAL_1="80" TOTAL_2="78" VAR="2.6416627598062195" WEIGHT="0.670865253460488"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.05.03" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="3" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>C</NAME>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="8.421193888768842" CI_END="1.5465174949505158" CI_START="0.8420663528669544" CI_STUDY="95" CI_TOTAL="95" DF="18" EFFECT_MEASURE="RR" EFFECT_SIZE="1.1411706036425577" ESTIMABLE="YES" EVENTS_1="99" EVENTS_2="71" I2="0.0" I2_Q="0.0" ID="CMP-001.06" LOG_CI_END="0.189354837315269" LOG_CI_START="-0.07465368575854152" LOG_EFFECT_SIZE="0.05735057577836377" METHOD="MH" MODIFIED="2012-07-02 22:10:30 +1000" MODIFIED_BY="[Empty name]" NO="6" P_CHI2="0.9716843735535586" P_Q="0.4120947683294395" P_Z="0.3944772260076007" Q="0.6727501126901715" RANDOM="NO" SCALE="20.02759406554014" SORT_BY="STUDY" STUDIES="25" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2930" TOTAL_2="2514" WEIGHT="100.0" Z="0.8515260167324398">
<NAME>Mortality per blinding</NAME>
<GROUP_LABEL_1>Atypical ABx</GROUP_LABEL_1>
<GROUP_LABEL_2>Non-atypical ABx</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours atypical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-atypical</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="3.8443298290811576" CI_END="1.4970284234125253" CI_START="0.7224723484373013" DF="10" EFFECT_SIZE="1.039981557884676" ESTIMABLE="YES" EVENTS_1="54" EVENTS_2="51" I2="0.0" ID="CMP-001.06.01" LOG_CI_END="0.17523004617740745" LOG_CI_START="-0.14117877023356673" LOG_EFFECT_SIZE="0.017025637971920353" MODIFIED="2012-07-02 22:10:30 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9540963946831924" P_Z="0.8329439588938884" STUDIES="16" TAU2="0.0" TOTAL_1="1144" TOTAL_2="1146" WEIGHT="69.4445900616599" Z="0.2109273541571523">
<NAME>Non-blinded</NAME>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="349" O_E="0.0" SE="0.0" STUDY_ID="STD-Bohte-1995" TOTAL_1="36" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="350" O_E="0.0" SE="0.0" STUDY_ID="STD-Chuard-1989" TOTAL_1="59" TOTAL_2="62" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="69.20358703801709" CI_START="0.1229263511986906" EFFECT_SIZE="2.9166666666666665" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.840128605879343" LOG_CI_START="-0.9103550092740413" LOG_EFFECT_SIZE="0.4648867983026508" ORDER="351" O_E="0.0" SE="1.6156476906545747" STUDY_ID="STD-Feldman-2001" TOTAL_1="35" TOTAL_2="34" VAR="2.6103174603174604" WEIGHT="0.6719151208367955"/>
<DICH_DATA CI_END="2.925649438310225" CI_START="0.3418044509726267" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.4662222862019852" LOG_CI_START="-0.46622228620198514" LOG_EFFECT_SIZE="0.0" ORDER="352" O_E="0.0" SE="0.5477225575051662" STUDY_ID="STD-Fourrier-1986" TOTAL_1="20" TOTAL_2="20" VAR="0.30000000000000004" WEIGHT="6.625829663807289"/>
<DICH_DATA CI_END="21.43133294583097" CI_START="0.18664261388268522" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3310491833151046" LOG_CI_START="-0.7289891919871422" LOG_EFFECT_SIZE="0.3010299956639812" ORDER="353" O_E="0.0" SE="1.2100767390069584" STUDY_ID="STD-Genne-1997" TOTAL_1="56" TOTAL_2="56" VAR="1.4642857142857144" WEIGHT="1.3251659327614578"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="354" O_E="0.0" SE="0.0" STUDY_ID="STD-Gleadhill-1986" TOTAL_1="26" TOTAL_2="22" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="7.098213466980093" CI_START="0.1653389429002928" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8511490558931599" LOG_CI_START="-0.781624843374736" LOG_EFFECT_SIZE="0.03476210625921191" ORDER="355" O_E="0.0" SE="0.959099470791114" STUDY_ID="STD-Hirata_x002d_Dulas-1991" TOTAL_1="24" TOTAL_2="26" VAR="0.9198717948717949" WEIGHT="2.544318590901999"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="356" O_E="0.0" SE="0.0" STUDY_ID="STD-Kalbermatter-2000" TOTAL_1="28" TOTAL_2="56" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="4.842137134309385" CI_START="0.26431911480013565" EFFECT_SIZE="1.1313131313131313" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.6850370849467889" LOG_CI_START="-0.5778714288015255" LOG_EFFECT_SIZE="0.05358282807263168" ORDER="357" O_E="0.0" SE="0.7418387124737258" STUDY_ID="STD-Khan-1989" TOTAL_1="66" TOTAL_2="56" VAR="0.5503246753246752" WEIGHT="4.301358273553585"/>
<DICH_DATA CI_END="5.9286419449592" CI_START="0.12239760542807132" EFFECT_SIZE="0.8518518518518519" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.7729552223092031" LOG_CI_START="-0.9122270785919919" LOG_EFFECT_SIZE="-0.06963592814139442" MODIFIED="2012-07-02 22:10:30 +1000" MODIFIED_BY="[Empty name]" ORDER="981" O_E="0.0" SE="0.9898844253362861" STUDY_ID="STD-Kohno-2011" TOTAL_1="108" TOTAL_2="92" VAR="0.9798711755233493" WEIGHT="2.862358414764749"/>
<DICH_DATA CI_END="1.650714989229768" CI_START="0.520788655723" EFFECT_SIZE="0.9271858714533874" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="22" LOG_CI_END="0.21767209489215533" LOG_CI_START="-0.2833384845215875" LOG_EFFECT_SIZE="-0.03283319481471606" ORDER="358" O_E="0.0" SE="0.2942960943899982" STUDY_ID="STD-Norrby-1998" TOTAL_1="314" TOTAL_2="305" VAR="0.08661019117320673" WEIGHT="29.57753235384863"/>
<DICH_DATA CI_END="27.234348125670902" CI_START="0.33046504210308847" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4351169845729048" LOG_CI_START="-0.4808744751335797" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="359" O_E="0.0" SE="1.1254628677422753" STUDY_ID="STD-Peterson-1988" TOTAL_1="30" TOTAL_2="30" VAR="1.2666666666666664" WEIGHT="1.3251659327614578"/>
<DICH_DATA CI_END="4.474509367366996" CI_START="0.47876341942251066" EFFECT_SIZE="1.4636363636363636" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="5" LOG_CI_END="0.650745421612411" LOG_CI_START="-0.31987903986516164" LOG_EFFECT_SIZE="0.16543319087362465" ORDER="360" O_E="0.0" SE="0.5701496133404992" STUDY_ID="STD-Rizzato-1997" TOTAL_1="110" TOTAL_2="115" VAR="0.3250705815923207" WEIGHT="6.478589004611572"/>
<DICH_DATA CI_END="2.802921395811218" CI_START="0.3710400442802314" EFFECT_SIZE="1.0198019801980198" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="7" LOG_CI_END="0.44761091872207476" LOG_CI_START="-0.4305792168770155" LOG_EFFECT_SIZE="0.008515850922529638" ORDER="361" O_E="0.0" SE="0.5158532327621861" STUDY_ID="STD-Romanelli-2002" TOTAL_1="101" TOTAL_2="103" VAR="0.2661045577511981" WEIGHT="9.185218769238732"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="362" O_E="0.0" SE="0.0" STUDY_ID="STD-Vanderdonckt--1990" TOTAL_1="82" TOTAL_2="88" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.8037512393518735" CI_START="0.00787283446475005" EFFECT_SIZE="0.14857142857142858" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.44773947856376095" LOG_CI_START="-2.103868879994714" LOG_EFFECT_SIZE="-0.8280647007154764" ORDER="363" O_E="0.0" SE="1.4988273804823278" STUDY_ID="STD-Vogel-1991" TOTAL_1="49" TOTAL_2="51" VAR="2.2464835164835164" WEIGHT="4.547138004573629"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.06.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Single-blind</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="4.084819931571123" CI_END="2.3790832001121753" CI_START="0.7902392314107402" DF="7" EFFECT_SIZE="1.3711472858591267" ESTIMABLE="YES" EVENTS_1="45" EVENTS_2="20" I2="0.0" ID="CMP-001.06.03" LOG_CI_END="0.3764096302330566" LOG_CI_START="-0.10224141357855444" LOG_EFFECT_SIZE="0.13708410832725113" NO="3" P_CHI2="0.7699577380272775" P_Z="0.26158420461490384" STUDIES="9" TAU2="0.0" TOTAL_1="1786" TOTAL_2="1368" WEIGHT="30.555409938340098" Z="1.1226546714894343">
<NAME>Double or triple-blind</NAME>
<DICH_DATA CI_END="3.3909149191699557" CI_START="0.03745796603903159" EFFECT_SIZE="0.35639412997903563" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.5303168931108628" LOG_CI_START="-1.426455808434543" LOG_EFFECT_SIZE="-0.44806945766184" ORDER="364" O_E="0.0" SE="1.1494179710688606" STUDY_ID="STD-Aubier-1998" TOTAL_1="159" TOTAL_2="170" VAR="1.3211616722160562" WEIGHT="3.8425784190104277"/>
<DICH_DATA CI_END="7.846269290500529" CI_START="0.013276171449257431" EFFECT_SIZE="0.32275132275132273" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8946632093978316" LOG_CI_START="-1.8769271477227858" LOG_EFFECT_SIZE="-0.49113196916247714" ORDER="365" O_E="0.0" SE="1.6280458953661852" STUDY_ID="STD-Carbon-1992" TOTAL_1="125" TOTAL_2="121" VAR="2.6505334374186833" WEIGHT="2.0198093652573834"/>
<DICH_DATA CI_END="5.370477008077758" CI_START="0.2778526421480827" EFFECT_SIZE="1.221556886227545" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.730012861635424" LOG_CI_START="-0.5561854690787931" LOG_EFFECT_SIZE="0.08691369627831551" ORDER="366" O_E="0.0" SE="0.7555192662459503" STUDY_ID="STD-Lephonte-2004" TOTAL_1="167" TOTAL_2="153" VAR="0.5708093616688191" WEIGHT="4.149425826959315"/>
<DICH_DATA CI_END="6.441400205989379" CI_START="0.8122455950171147" EFFECT_SIZE="2.2873563218390807" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="4" LOG_CI_END="0.808980282831327" LOG_CI_START="-0.09031263524915063" LOG_EFFECT_SIZE="0.3593338237910882" ORDER="367" O_E="0.0" SE="0.5282491116522111" STUDY_ID="STD-Lode-1995" TOTAL_1="609" TOTAL_2="199" VAR="0.27904712396135023" WEIGHT="7.990356960908196"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="368" O_E="0.0" SE="0.0" STUDY_ID="STD-Miki-1984" TOTAL_1="73" TOTAL_2="72" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="3.4412964975231937" CI_START="0.17679383349789363" EFFECT_SIZE="0.78" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="4" LOG_CI_END="0.5367220924671535" LOG_CI_START="-0.7525328870861927" LOG_EFFECT_SIZE="-0.10790539730951958" ORDER="369" O_E="0.0" SE="0.7573147569047106" STUDY_ID="STD-Petitpretz-2001" TOTAL_1="200" TOTAL_2="208" VAR="0.573525641025641" WEIGHT="5.196729148084148"/>
<DICH_DATA CI_END="5.732497858664328" CI_START="0.295947567713187" EFFECT_SIZE="1.302504816955684" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7583439011742503" LOG_CI_START="-0.528785224987894" LOG_EFFECT_SIZE="0.11477933809317811" ORDER="370" O_E="0.0" SE="0.7560660200995746" STUDY_ID="STD-Tremolieres-1998" TOTAL_1="173" TOTAL_2="169" VAR="0.5716358267492103" WEIGHT="4.021994848556705"/>
<DICH_DATA CI_END="10.687385050990036" CI_START="0.36682499800424323" EFFECT_SIZE="1.98" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0288714566729125" LOG_CI_START="-0.43554107614985044" LOG_EFFECT_SIZE="0.2966651902615311" ORDER="371" O_E="0.0" SE="0.8602031707390382" STUDY_ID="STD-Tremolieres-2005" TOTAL_1="200" TOTAL_2="198" VAR="0.7399494949494949" WEIGHT="2.6636501161034323"/>
<DICH_DATA CI_END="70.75181835719732" CI_START="0.12100102474800362" EFFECT_SIZE="2.925925925925926" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8497376059256418" LOG_CI_START="-0.9172109516627335" LOG_EFFECT_SIZE="0.46626332713145413" ORDER="372" O_E="0.0" SE="1.6253192793436677" STUDY_ID="STD-Zeluff-1988" TOTAL_1="80" TOTAL_2="78" VAR="2.6416627598062195" WEIGHT="0.670865253460488"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="6.278585771397347" CI_END="2.150381231071005" CI_START="0.7005973167670198" CI_STUDY="95" CI_TOTAL="95" DF="7" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2274165228293559" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="19" I2="0.0" I2_Q="0.0" ID="CMP-001.07" LOG_CI_END="0.33251546078692573" LOG_CI_START="-0.15453153032907221" LOG_EFFECT_SIZE="0.08899196522892677" METHOD="MH" MODIFIED="2008-06-22 17:05:19 +1000" MODIFIED_BY="[Empty name]" NO="7" P_CHI2="0.5076230499222503" P_Q="1.0" P_Z="0.47384373534095403" Q="0.0" RANDOM="NO" SCALE="25.06377384549593" SORT_BY="STUDY" STUDIES="12" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1256" TOTAL_2="887" WEIGHT="100.0" Z="0.7162390896306601">
<NAME>Mortality - ITT analysis</NAME>
<GROUP_LABEL_1>Atypical ABx</GROUP_LABEL_1>
<GROUP_LABEL_2>Non-atypical ABx</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours atypical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-atypical</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="6.278585771397347" CI_END="2.150381231071005" CI_START="0.7005973167670198" DF="7" EFFECT_SIZE="1.2274165228293559" ESTIMABLE="YES" EVENTS_1="40" EVENTS_2="19" I2="0.0" ID="CMP-001.07.01" LOG_CI_END="0.33251546078692573" LOG_CI_START="-0.15453153032907221" LOG_EFFECT_SIZE="0.08899196522892677" NO="1" P_CHI2="0.5076230499222503" P_Z="0.47384373534095403" STUDIES="12" TAU2="0.0" TOTAL_1="1256" TOTAL_2="887" WEIGHT="100.0" Z="0.7162390896306601">
<NAME>ITT (type 1)</NAME>
<DICH_DATA CI_END="3.3909149191699557" CI_START="0.03745796603903159" EFFECT_SIZE="0.35639412997903563" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.5303168931108628" LOG_CI_START="-1.426455808434543" LOG_EFFECT_SIZE="-0.44806945766184" ORDER="373" O_E="0.0" SE="1.1494179710688606" STUDY_ID="STD-Aubier-1998" TOTAL_1="159" TOTAL_2="170" VAR="1.3211616722160562" WEIGHT="12.996123569543233"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="374" O_E="0.0" SE="0.0" STUDY_ID="STD-Bohte-1995" TOTAL_1="36" TOTAL_2="30" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="7.846269290500529" CI_START="0.013276171449257431" EFFECT_SIZE="0.32275132275132273" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.8946632093978316" LOG_CI_START="-1.8769271477227858" LOG_EFFECT_SIZE="-0.49113196916247714" ORDER="375" O_E="0.0" SE="1.6280458953661852" STUDY_ID="STD-Carbon-1992" TOTAL_1="125" TOTAL_2="121" VAR="2.6505334374186833" WEIGHT="6.831270369900654"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="376" O_E="0.0" SE="0.0" STUDY_ID="STD-Chuard-1989" TOTAL_1="59" TOTAL_2="62" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="69.20358703801709" CI_START="0.1229263511986906" EFFECT_SIZE="2.9166666666666665" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.840128605879343" LOG_CI_START="-0.9103550092740413" LOG_EFFECT_SIZE="0.4648867983026508" ORDER="377" O_E="0.0" SE="1.6156476906545747" STUDY_ID="STD-Feldman-2001" TOTAL_1="35" TOTAL_2="34" VAR="2.6103174603174604" WEIGHT="2.2725084530320085"/>
<DICH_DATA CI_END="2.925649438310225" CI_START="0.3418044509726267" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="5" LOG_CI_END="0.4662222862019852" LOG_CI_START="-0.46622228620198514" LOG_EFFECT_SIZE="0.0" ORDER="378" O_E="0.0" SE="0.5477225575051662" STUDY_ID="STD-Fourrier-1986" TOTAL_1="20" TOTAL_2="20" VAR="0.30000000000000004" WEIGHT="22.40945835628786"/>
<DICH_DATA CI_END="7.098213466980093" CI_START="0.1653389429002928" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8511490558931599" LOG_CI_START="-0.781624843374736" LOG_EFFECT_SIZE="0.03476210625921191" ORDER="379" O_E="0.0" SE="0.959099470791114" STUDY_ID="STD-Hirata_x002d_Dulas-1991" TOTAL_1="24" TOTAL_2="26" VAR="0.9198717948717949" WEIGHT="8.60523200881454"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="380" O_E="0.0" SE="0.0" STUDY_ID="STD-Kalbermatter-2000" TOTAL_1="28" TOTAL_2="56" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="6.441400205989379" CI_START="0.8122455950171147" EFFECT_SIZE="2.2873563218390807" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="4" LOG_CI_END="0.808980282831327" LOG_CI_START="-0.09031263524915063" LOG_EFFECT_SIZE="0.3593338237910882" ORDER="381" O_E="0.0" SE="0.5282491116522111" STUDY_ID="STD-Lode-1995" TOTAL_1="609" TOTAL_2="199" VAR="0.27904712396135023" WEIGHT="27.0244755227313"/>
<DICH_DATA CI_END="27.234348125670902" CI_START="0.33046504210308847" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="1" LOG_CI_END="1.4351169845729048" LOG_CI_START="-0.4808744751335797" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="382" O_E="0.0" SE="1.1254628677422753" STUDY_ID="STD-Peterson-1988" TOTAL_1="30" TOTAL_2="30" VAR="1.2666666666666664" WEIGHT="4.481891671257572"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="383" O_E="0.0" SE="0.0" STUDY_ID="STD-Vanderdonckt--1990" TOTAL_1="82" TOTAL_2="88" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.8037512393518735" CI_START="0.00787283446475005" EFFECT_SIZE="0.14857142857142858" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.44773947856376095" LOG_CI_START="-2.103868879994714" LOG_EFFECT_SIZE="-0.8280647007154764" ORDER="384" O_E="0.0" SE="1.4988273804823278" STUDY_ID="STD-Vogel-1991" TOTAL_1="49" TOTAL_2="51" VAR="2.2464835164835164" WEIGHT="15.379040048432845"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="29.66774389686158" CI_END="1.0364513535765298" CI_START="0.8416421031698167" CI_STUDY="95" CI_TOTAL="95" DF="27" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9339813151542989" ESTIMABLE="YES" EVENTS_1="621" EVENTS_2="519" I2="8.992068645785327" I2_Q="0.0" ID="CMP-001.08" LOG_CI_END="0.01554892305402778" LOG_CI_START="-0.0748725470532684" LOG_EFFECT_SIZE="-0.029661811999620313" METHOD="MH" MODIFIED="2012-07-23 15:56:45 +1000" MODIFIED_BY="[Empty name]" NO="8" P_CHI2="0.32928766608466997" P_Q="0.5075012639502329" P_Z="0.19848105935655277" Q="2.3263007152952397" RANDOM="NO" SCALE="19.094182003450054" SORT_BY="STUDY" STUDIES="28" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2919" TOTAL_2="2500" WEIGHT="99.99999999999999" Z="1.2858911310879642">
<NAME>Clinical failure per antibiotic (ABx) treatment</NAME>
<GROUP_LABEL_1>Atypical ABx</GROUP_LABEL_1>
<GROUP_LABEL_2>Non-atypical ABx</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours atypical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-atypical</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="21.219772338710168" CI_END="1.018070677711628" CI_START="0.7865589905979087" DF="20" EFFECT_SIZE="0.8948590082343625" ESTIMABLE="YES" EVENTS_1="340" EVENTS_2="379" I2="5.748281928948873" ID="CMP-001.08.01" LOG_CI_END="0.007777929154628567" LOG_CI_START="-0.10426870046544949" LOG_EFFECT_SIZE="-0.04824538565541048" MODIFIED="2012-07-02 22:11:59 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.38430003281409075" P_Z="0.09143911368397073" STUDIES="21" TAU2="0.0" TOTAL_1="1849" TOTAL_2="1855" WEIGHT="68.10763445979323" Z="1.6878547552117624">
<NAME>Quinolone (atypical arm)</NAME>
<DICH_DATA CI_END="1.3214574081413286" CI_START="0.37833151618610517" EFFECT_SIZE="0.7070707070707071" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="22" LOG_CI_END="0.12105316995937764" LOG_CI_START="-0.4221274791259638" LOG_EFFECT_SIZE="-0.1505371545832931" ORDER="385" O_E="0.0" SE="0.31906700206030675" STUDY_ID="STD-Aubier-1998" TOTAL_1="126" TOTAL_2="140" VAR="0.1018037518037518" WEIGHT="3.752834781854974"/>
<DICH_DATA CI_END="1.3344254423156148" CI_START="0.4470361807057921" EFFECT_SIZE="0.7723577235772358" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="24" LOG_CI_END="0.12529431368330868" LOG_CI_START="-0.349657325984409" LOG_EFFECT_SIZE="-0.11218150615055017" ORDER="386" O_E="0.0" SE="0.2789889441893509" STUDY_ID="STD-Carbon-1992" TOTAL_1="123" TOTAL_2="120" VAR="0.07783483097988873" WEIGHT="4.374797299012384"/>
<DICH_DATA CI_END="2.7163637226662987" CI_START="0.28231174199774495" EFFECT_SIZE="0.8757062146892656" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.4339879217832775" LOG_CI_START="-0.5492710581663077" LOG_EFFECT_SIZE="-0.05764156819151513" ORDER="387" O_E="0.0" SE="0.5775711920328345" STUDY_ID="STD-Chuard-1989" TOTAL_1="59" TOTAL_2="62" VAR="0.3335884818662293" WEIGHT="1.0535757050987795"/>
<DICH_DATA CI_END="4.482318710854454" CI_START="0.2105324342739262" EFFECT_SIZE="0.9714285714285714" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6515027333780666" LOG_CI_START="-0.6766809879941078" LOG_EFFECT_SIZE="-0.012589127308020516" ORDER="388" O_E="0.0" SE="0.78018169254947" STUDY_ID="STD-Feldman-2001" TOTAL_1="35" TOTAL_2="34" VAR="0.6086834733893557" WEIGHT="0.5480094707803158"/>
<DICH_DATA CI_END="2.102230118933325" CI_START="0.3494830898549799" EFFECT_SIZE="0.8571428571428571" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.32268025399138267" LOG_CI_START="-0.45657383325260914" LOG_EFFECT_SIZE="-0.06694678963061322" ORDER="389" O_E="0.0" SE="0.4577377082170635" STUDY_ID="STD-Fourrier-1986" TOTAL_1="20" TOTAL_2="20" VAR="0.20952380952380956" WEIGHT="1.2604217827947264"/>
<DICH_DATA CI_END="3.4624038633203176" CI_START="0.32310298333559356" EFFECT_SIZE="1.0576923076923077" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.5393777236727578" LOG_CI_START="-0.4906590319538684" LOG_EFFECT_SIZE="0.024359345859444693" ORDER="390" O_E="0.0" SE="0.6050486890192525" STUDY_ID="STD-Gleadhill-1986" TOTAL_1="26" TOTAL_2="22" VAR="0.36608391608391605" WEIGHT="0.7802611036348305"/>
<DICH_DATA CI_END="1.9282513388396094" CI_START="0.6086401121429384" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.2851636415776451" LOG_CI_START="-0.21563942905922126" LOG_EFFECT_SIZE="0.03476210625921191" ORDER="391" O_E="0.0" SE="0.29417420270727607" STUDY_ID="STD-Hirata_x002d_Dulas-1991" TOTAL_1="24" TOTAL_2="26" VAR="0.08653846153846154" WEIGHT="2.0742941339707492"/>
<DICH_DATA CI_END="1.443503564398061" CI_START="0.6128857834811439" EFFECT_SIZE="0.9405864197530864" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="24" LOG_CI_END="0.15941786060780128" LOG_CI_START="-0.21262045244018643" LOG_EFFECT_SIZE="-0.026601295916192598" MODIFIED="2011-10-11 19:40:33 +1000" MODIFIED_BY="[Empty name]" ORDER="471" O_E="0.0" SE="0.21853714670373883" STUDY_ID="STD-Hong_x002d_yun-2007" TOTAL_1="54" TOTAL_2="53" VAR="0.047758484489411474" WEIGHT="4.361833459284286"/>
<DICH_DATA CI_END="4.2660503456694485" CI_START="0.05860221510366839" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.6300259764573879" LOG_CI_START="-1.2320859677853504" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="392" O_E="0.0" SE="1.093813773650968" STUDY_ID="STD-Kalbermatter-2000" TOTAL_1="28" TOTAL_2="56" VAR="1.1964285714285714" WEIGHT="0.4801606791598957"/>
<DICH_DATA CI_END="2.48381127526022" CI_START="0.28984751993000446" EFFECT_SIZE="0.8484848484848485" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.39511859423126344" LOG_CI_START="-0.5378304113025999" LOG_EFFECT_SIZE="-0.07135590853566824" ORDER="393" O_E="0.0" SE="0.5480188640226497" STUDY_ID="STD-Khan-1989" TOTAL_1="66" TOTAL_2="56" VAR="0.3003246753246753" WEIGHT="1.16891575172532"/>
<DICH_DATA CI_END="130.6416413078046" CI_START="0.40631480224590605" EFFECT_SIZE="7.285714285714286" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.1160816279934997" LOG_CI_START="-0.39113735582614056" LOG_EFFECT_SIZE="0.8624721360836796" ORDER="394" O_E="0.0" SE="1.4727528420297875" STUDY_ID="STD-Kobayashi-1984" TOTAL_1="41" TOTAL_2="33" VAR="2.1690009337068163" WEIGHT="0.09950698285221524"/>
<DICH_DATA CI_END="2.2628158592596277" CI_START="0.46604366926357205" EFFECT_SIZE="1.0269230769230768" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="10" LOG_CI_END="0.35464921389230963" LOG_CI_START="-0.3315733871047952" LOG_EFFECT_SIZE="0.011537913393757216" MODIFIED="2012-07-02 22:11:59 +1000" MODIFIED_BY="[Empty name]" ORDER="982" O_E="0.0" SE="0.40309055268235816" STUDY_ID="STD-Kohno-2011" TOTAL_1="104" TOTAL_2="89" VAR="0.16248199366176896" WEIGHT="1.9405457499726355"/>
<DICH_DATA CI_END="1.649147772920286" CI_START="0.7177241891450693" EFFECT_SIZE="1.0879491017964071" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="32" LOG_CI_END="0.21725957261750875" LOG_CI_START="-0.14404241668366938" LOG_EFFECT_SIZE="0.036608577966919686" ORDER="395" O_E="0.0" SE="0.2122305769892032" STUDY_ID="STD-Lephonte-2004" TOTAL_1="167" TOTAL_2="153" VAR="0.045041817809170104" WEIGHT="6.014012506477694"/>
<DICH_DATA CI_END="3.655277831125175" CI_START="0.6196836329905102" EFFECT_SIZE="1.5050301810865192" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.5629203924946599" LOG_CI_START="-0.20782997423240124" LOG_EFFECT_SIZE="0.17754520913112926" ORDER="396" O_E="0.0" SE="0.45274258069132295" STUDY_ID="STD-Miki-1984" TOTAL_1="71" TOTAL_2="68" VAR="0.20497584437103905" WEIGHT="1.2876251306248283"/>
<DICH_DATA CI_END="1.2547827956845181" CI_START="0.7519203298154321" EFFECT_SIZE="0.9713375796178344" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="85" LOG_CI_END="0.09856855545884344" LOG_CI_START="-0.12382817291170159" LOG_EFFECT_SIZE="-0.01262980872642909" ORDER="397" O_E="0.0" SE="0.13063693912641838" STUDY_ID="STD-Norrby-1998" TOTAL_1="314" TOTAL_2="305" VAR="0.01706600986431954" WEIGHT="15.527651688341217"/>
<DICH_DATA CI_END="1.8165256832791987" CI_START="0.33301938815029664" EFFECT_SIZE="0.7777777777777778" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" LOG_CI_END="0.25924154259376825" LOG_CI_START="-0.4775304814439043" LOG_EFFECT_SIZE="-0.10914446942506803" ORDER="398" O_E="0.0" SE="0.4327835340000672" STUDY_ID="STD-Peterson-1988" TOTAL_1="30" TOTAL_2="30" VAR="0.1873015873015873" WEIGHT="1.620542292164648"/>
<DICH_DATA CI_END="1.5660492289920993" CI_START="0.7548689795862338" EFFECT_SIZE="1.0872727272727272" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="44" LOG_CI_END="0.19480541004860086" LOG_CI_START="-0.12212842106026693" LOG_EFFECT_SIZE="0.036338494494166956" ORDER="399" O_E="0.0" SE="0.186168501241115" STUDY_ID="STD-Petitpretz-2001" TOTAL_1="200" TOTAL_2="208" VAR="0.034658710854363034" WEIGHT="7.7673051040571375"/>
<DICH_DATA CI_END="0.5735349127990342" CI_START="0.11910513011290594" EFFECT_SIZE="0.26136363636363635" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="28" LOG_CI_END="-0.24144014014376425" LOG_CI_START="-0.9240695321213873" LOG_EFFECT_SIZE="-0.5827548361325757" ORDER="400" O_E="0.0" SE="0.40097988391764294" STUDY_ID="STD-Rizzato-1997" TOTAL_1="110" TOTAL_2="115" VAR="0.1607848673066064" WEIGHT="4.929649639374929"/>
<DICH_DATA CI_END="0.9151459649634782" CI_START="0.2672740345449367" EFFECT_SIZE="0.4945652173913043" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="28" LOG_CI_END="-0.038509630827043506" LOG_CI_START="-0.5730432305498423" LOG_EFFECT_SIZE="-0.3057764306884429" ORDER="401" O_E="0.0" SE="0.3139876824611645" STUDY_ID="STD-Tremolieres-1998" TOTAL_1="138" TOTAL_2="147" VAR="0.09858826473733306" WEIGHT="4.882475958615361"/>
<DICH_DATA CI_END="1.8110069918099756" CI_START="0.6440615664516371" EFFECT_SIZE="1.08" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="21" LOG_CI_END="0.2579201270112585" LOG_CI_START="-0.19107261603735906" LOG_EFFECT_SIZE="0.03342375548694973" ORDER="402" O_E="0.0" SE="0.2637405598166809" STUDY_ID="STD-Vanderdonckt--1990" TOTAL_1="75" TOTAL_2="81" VAR="0.06955908289241622" WEIGHT="3.6358320657540184"/>
<DICH_DATA CI_END="3.6650773639034675" CI_START="0.11496630950828501" EFFECT_SIZE="0.6491228070175439" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5640831463336992" LOG_CI_START="-0.939429409544692" LOG_EFFECT_SIZE="-0.1876731316054964" ORDER="403" O_E="0.0" SE="0.8831707178301498" STUDY_ID="STD-Vogel-1991" TOTAL_1="38" TOTAL_2="37" VAR="0.779990516832622" WEIGHT="0.5473831742422811"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="7.0352085615543025" CI_END="1.616313806893246" CI_START="0.7561597028154459" DF="4" EFFECT_SIZE="1.1055276422943476" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="40" I2="43.14312127348969" ID="CMP-001.08.02" LOG_CI_END="0.208525682782289" LOG_CI_START="-0.12138647073334358" LOG_EFFECT_SIZE="0.04356960602447274" MODIFIED="2011-10-11 21:36:16 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.13403947093651558" P_Z="0.6046798780729388" STUDIES="5" TAU2="0.0" TOTAL_1="272" TOTAL_2="264" WEIGHT="7.476684427064235" Z="0.5176824055650899">
<NAME>Macrolide (atypical arm)</NAME>
<DICH_DATA CI_END="1.203850666497277" CI_START="0.20530039753790533" EFFECT_SIZE="0.49714285714285716" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="10" LOG_CI_END="0.08057261753764383" LOG_CI_START="-0.6876102096729957" LOG_EFFECT_SIZE="-0.3035187960676759" ORDER="404" O_E="0.0" SE="0.4512343952698513" STUDY_ID="STD-Bohte-1995" TOTAL_1="35" TOTAL_2="29" VAR="0.2036124794745484" WEIGHT="1.9694090356167597"/>
<DICH_DATA CI_END="2.137439548505052" CI_START="0.36965885530785847" EFFECT_SIZE="0.8888888888888888" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="9" LOG_CI_END="0.32989384077006656" LOG_CI_START="-0.43219888566482917" LOG_EFFECT_SIZE="-0.05115252244738131" ORDER="405" O_E="0.0" SE="0.44765703992769446" STUDY_ID="STD-Genne-1997" TOTAL_1="56" TOTAL_2="56" VAR="0.2003968253968254" WEIGHT="1.620542292164648"/>
<DICH_DATA CI_END="2.144644481217491" CI_START="0.3034542567633229" EFFECT_SIZE="0.8067226890756303" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.33135530927495327" LOG_CI_START="-0.517906765980878" LOG_EFFECT_SIZE="-0.09327572835296233" MODIFIED="2011-10-11 21:36:16 +1000" MODIFIED_BY="[Empty name]" ORDER="489" O_E="0.0" SE="0.49886074692034765" STUDY_ID="STD-Hatipoglu-2010" TOTAL_1="34" TOTAL_2="32" VAR="0.24886204481792717" WEIGHT="1.2986163822733543"/>
<DICH_DATA CI_END="3.068198954218383" CI_START="0.9148455606032033" EFFECT_SIZE="1.6753889674681754" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="14" LOG_CI_END="0.4868835175708553" LOG_CI_START="-0.038652215047086325" LOG_EFFECT_SIZE="0.2241156512618845" ORDER="406" O_E="0.0" SE="0.30870229078361094" STUDY_ID="STD-Romanelli-2002" TOTAL_1="101" TOTAL_2="103" VAR="0.09529710433504908" WEIGHT="2.4961294129856344"/>
<DICH_DATA CI_END="126.12592421227448" CI_START="0.3561402260936749" EFFECT_SIZE="6.702127659574468" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1008043616340277" LOG_CI_START="-0.4483789699262618" LOG_EFFECT_SIZE="0.826212695853883" ORDER="407" O_E="0.0" SE="1.4974029076195166" STUDY_ID="STD-Zeluff-1988" TOTAL_1="46" TOTAL_2="44" VAR="2.2422154677473825" WEIGHT="0.09198730402383873"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.1655672270079651" CI_START="0.7467384445333052" DF="0" EFFECT_SIZE="0.9329382927583827" ESTIMABLE="YES" EVENTS_1="197" EVENTS_2="69" I2="0.0" ID="CMP-001.08.03" LOG_CI_END="0.06653732760056165" LOG_CI_START="-0.1268314891982239" LOG_EFFECT_SIZE="-0.030147080798831105" NO="3" P_CHI2="1.0" P_Z="0.541110442103365" STUDIES="1" TAU2="0.0" TOTAL_1="609" TOTAL_2="199" WEIGHT="18.72849495573451" Z="0.6111346553484116">
<NAME>Combined quinolone and macrolide (atypical arm)</NAME>
<DICH_DATA CI_END="1.1655672270079651" CI_START="0.7467384445333052" EFFECT_SIZE="0.9329382927583827" ESTIMABLE="YES" EVENTS_1="197" EVENTS_2="69" LOG_CI_END="0.06653732760056165" LOG_CI_START="-0.1268314891982239" LOG_EFFECT_SIZE="-0.030147080798831105" ORDER="408" O_E="0.0" SE="0.11358580017868716" STUDY_ID="STD-Lode-1995" TOTAL_1="609" TOTAL_2="199" VAR="0.01290173400223265" WEIGHT="18.72849495573451"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="1.8117938612293694" CI_START="0.7690493144462788" DF="0" EFFECT_SIZE="1.1804062126642771" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="31" I2="0.0" ID="CMP-001.08.04" LOG_CI_END="0.25810878383566455" LOG_CI_START="-0.11404581064692823" LOG_EFFECT_SIZE="0.07203148659436812" NO="4" P_CHI2="1.0" P_Z="0.4480247308645088" STUDIES="1" TAU2="0.0" TOTAL_1="189" TOTAL_2="182" WEIGHT="5.687186157408011" Z="0.7587122210549239">
<NAME>Pristinamycine (atypical arm)</NAME>
<DICH_DATA CI_END="1.8117938612293691" CI_START="0.7690493144462788" EFFECT_SIZE="1.1804062126642771" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="31" LOG_CI_END="0.2581087838356645" LOG_CI_START="-0.11404581064692823" LOG_EFFECT_SIZE="0.07203148659436812" ORDER="409" O_E="0.0" SE="0.21860545099402817" STUDY_ID="STD-Tremolieres-2005" TOTAL_1="189" TOTAL_2="182" VAR="0.047788343204302454" WEIGHT="5.687186157408011"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="29.667743896861573" CI_END="1.0364513535765296" CI_START="0.8416421031698165" CI_STUDY="95" CI_TOTAL="95" DF="27" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9339813151542987" ESTIMABLE="YES" EVENTS_1="621" EVENTS_2="519" I2="8.992068645785304" I2_Q="0.0" ID="CMP-001.09" LOG_CI_END="0.015548923054027688" LOG_CI_START="-0.07487254705326853" LOG_EFFECT_SIZE="-0.029661811999620417" METHOD="MH" MODIFIED="2012-07-02 22:14:15 +1000" MODIFIED_BY="[Empty name]" NO="9" P_CHI2="0.3292876660846702" P_Q="0.6881912214994106" P_Z="0.19848105935655125" Q="0.7473775063597636" RANDOM="NO" SCALE="22.943158213464002" SORT_BY="STUDY" STUDIES="28" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2919" TOTAL_2="2500" WEIGHT="99.99999999999999" Z="1.2858911310879686">
<NAME>Clinical failure per age</NAME>
<GROUP_LABEL_1>Atypical ABx</GROUP_LABEL_1>
<GROUP_LABEL_2>Non-atypical ABx</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours atypical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-atypical</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="12.23482626441557" CI_END="1.062472489668428" CI_START="0.8134054853612421" DF="14" EFFECT_SIZE="0.9296348482827627" ESTIMABLE="YES" EVENTS_1="419" EVENTS_2="307" I2="0.0" ID="CMP-001.09.01" LOG_CI_END="0.026317693790703436" LOG_CI_START="-0.08969290317056812" LOG_EFFECT_SIZE="-0.03168760468993233" MODIFIED="2012-07-02 22:14:15 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.587450806505917" P_Z="0.2843021035058626" STUDIES="15" TAU2="0.0" TOTAL_1="1979" TOTAL_2="1575" WEIGHT="61.58934999443514" Z="1.0707050144624843">
<NAME>Mean age under 65 years old</NAME>
<DICH_DATA CI_END="1.3214574081413286" CI_START="0.37833151618610517" EFFECT_SIZE="0.7070707070707071" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="22" LOG_CI_END="0.12105316995937764" LOG_CI_START="-0.4221274791259638" LOG_EFFECT_SIZE="-0.1505371545832931" ORDER="410" O_E="0.0" SE="0.31906700206030675" STUDY_ID="STD-Aubier-1998" TOTAL_1="126" TOTAL_2="140" VAR="0.1018037518037518" WEIGHT="3.752834781854975"/>
<DICH_DATA CI_END="1.203850666497277" CI_START="0.20530039753790533" EFFECT_SIZE="0.49714285714285716" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="10" LOG_CI_END="0.08057261753764383" LOG_CI_START="-0.6876102096729957" LOG_EFFECT_SIZE="-0.3035187960676759" ORDER="411" O_E="0.0" SE="0.4512343952698513" STUDY_ID="STD-Bohte-1995" TOTAL_1="35" TOTAL_2="29" VAR="0.2036124794745484" WEIGHT="1.9694090356167602"/>
<DICH_DATA CI_END="1.3344254423156148" CI_START="0.4470361807057921" EFFECT_SIZE="0.7723577235772358" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="24" LOG_CI_END="0.12529431368330868" LOG_CI_START="-0.349657325984409" LOG_EFFECT_SIZE="-0.11218150615055017" ORDER="412" O_E="0.0" SE="0.2789889441893509" STUDY_ID="STD-Carbon-1992" TOTAL_1="123" TOTAL_2="120" VAR="0.07783483097988873" WEIGHT="4.374797299012384"/>
<DICH_DATA CI_END="4.482318710854454" CI_START="0.2105324342739262" EFFECT_SIZE="0.9714285714285714" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6515027333780666" LOG_CI_START="-0.6766809879941078" LOG_EFFECT_SIZE="-0.012589127308020516" ORDER="413" O_E="0.0" SE="0.78018169254947" STUDY_ID="STD-Feldman-2001" TOTAL_1="35" TOTAL_2="34" VAR="0.6086834733893557" WEIGHT="0.5480094707803159"/>
<DICH_DATA CI_END="4.2660503456694485" CI_START="0.05860221510366839" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.6300259764573879" LOG_CI_START="-1.2320859677853504" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="414" O_E="0.0" SE="1.093813773650968" STUDY_ID="STD-Kalbermatter-2000" TOTAL_1="28" TOTAL_2="56" VAR="1.1964285714285714" WEIGHT="0.4801606791598958"/>
<DICH_DATA CI_END="2.48381127526022" CI_START="0.28984751993000446" EFFECT_SIZE="0.8484848484848485" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.39511859423126344" LOG_CI_START="-0.5378304113025999" LOG_EFFECT_SIZE="-0.07135590853566824" ORDER="415" O_E="0.0" SE="0.5480188640226497" STUDY_ID="STD-Khan-1989" TOTAL_1="66" TOTAL_2="56" VAR="0.3003246753246753" WEIGHT="1.1689157517253201"/>
<DICH_DATA CI_END="2.2628158592596277" CI_START="0.46604366926357205" EFFECT_SIZE="1.0269230769230768" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="10" LOG_CI_END="0.35464921389230963" LOG_CI_START="-0.3315733871047952" LOG_EFFECT_SIZE="0.011537913393757216" MODIFIED="2012-07-02 22:14:15 +1000" MODIFIED_BY="[Empty name]" ORDER="984" O_E="0.0" SE="0.40309055268235816" STUDY_ID="STD-Kohno-2011" TOTAL_1="104" TOTAL_2="89" VAR="0.16248199366176896" WEIGHT="1.9405457499726357"/>
<DICH_DATA CI_END="1.649147772920286" CI_START="0.7177241891450693" EFFECT_SIZE="1.0879491017964071" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="32" LOG_CI_END="0.21725957261750875" LOG_CI_START="-0.14404241668366938" LOG_EFFECT_SIZE="0.036608577966919686" ORDER="416" O_E="0.0" SE="0.2122305769892032" STUDY_ID="STD-Lephonte-2004" TOTAL_1="167" TOTAL_2="153" VAR="0.045041817809170104" WEIGHT="6.014012506477695"/>
<DICH_DATA CI_END="1.1655672270079651" CI_START="0.7467384445333052" EFFECT_SIZE="0.9329382927583827" ESTIMABLE="YES" EVENTS_1="197" EVENTS_2="69" LOG_CI_END="0.06653732760056165" LOG_CI_START="-0.1268314891982239" LOG_EFFECT_SIZE="-0.030147080798831105" ORDER="417" O_E="0.0" SE="0.11358580017868716" STUDY_ID="STD-Lode-1995" TOTAL_1="609" TOTAL_2="199" VAR="0.01290173400223265" WEIGHT="18.728494955734515"/>
<DICH_DATA CI_END="1.5660492289920993" CI_START="0.7548689795862338" EFFECT_SIZE="1.0872727272727272" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="44" LOG_CI_END="0.19480541004860086" LOG_CI_START="-0.12212842106026693" LOG_EFFECT_SIZE="0.036338494494166956" ORDER="418" O_E="0.0" SE="0.186168501241115" STUDY_ID="STD-Petitpretz-2001" TOTAL_1="200" TOTAL_2="208" VAR="0.034658710854363034" WEIGHT="7.767305104057138"/>
<DICH_DATA CI_END="0.9151459649634782" CI_START="0.2672740345449367" EFFECT_SIZE="0.4945652173913043" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="28" LOG_CI_END="-0.038509630827043506" LOG_CI_START="-0.5730432305498423" LOG_EFFECT_SIZE="-0.3057764306884429" ORDER="419" O_E="0.0" SE="0.3139876824611645" STUDY_ID="STD-Tremolieres-1998" TOTAL_1="138" TOTAL_2="147" VAR="0.09858826473733306" WEIGHT="4.882475958615362"/>
<DICH_DATA CI_END="1.8117938612293691" CI_START="0.7690493144462788" EFFECT_SIZE="1.1804062126642771" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="31" LOG_CI_END="0.2581087838356645" LOG_CI_START="-0.11404581064692823" LOG_EFFECT_SIZE="0.07203148659436812" ORDER="420" O_E="0.0" SE="0.21860545099402817" STUDY_ID="STD-Tremolieres-2005" TOTAL_1="189" TOTAL_2="182" VAR="0.047788343204302454" WEIGHT="5.687186157408012"/>
<DICH_DATA CI_END="1.8110069918099756" CI_START="0.6440615664516371" EFFECT_SIZE="1.08" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="21" LOG_CI_END="0.2579201270112585" LOG_CI_START="-0.19107261603735906" LOG_EFFECT_SIZE="0.03342375548694973" ORDER="421" O_E="0.0" SE="0.2637405598166809" STUDY_ID="STD-Vanderdonckt--1990" TOTAL_1="75" TOTAL_2="81" VAR="0.06955908289241622" WEIGHT="3.635832065754019"/>
<DICH_DATA CI_END="3.6650773639034675" CI_START="0.11496630950828501" EFFECT_SIZE="0.6491228070175439" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5640831463336992" LOG_CI_START="-0.939429409544692" LOG_EFFECT_SIZE="-0.1876731316054964" ORDER="422" O_E="0.0" SE="0.8831707178301498" STUDY_ID="STD-Vogel-1991" TOTAL_1="38" TOTAL_2="37" VAR="0.779990516832622" WEIGHT="0.5473831742422812"/>
<DICH_DATA CI_END="126.12592421227448" CI_START="0.3561402260936749" EFFECT_SIZE="6.702127659574468" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1008043616340277" LOG_CI_START="-0.4483789699262618" LOG_EFFECT_SIZE="0.826212695853883" ORDER="423" O_E="0.0" SE="1.4974029076195166" STUDY_ID="STD-Zeluff-1988" TOTAL_1="46" TOTAL_2="44" VAR="2.2422154677473825" WEIGHT="0.09198730402383874"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="14.43327399993642" CI_END="1.0962037004580842" CI_START="0.7474797199889003" DF="7" EFFECT_SIZE="0.9052016543672493" ESTIMABLE="YES" EVENTS_1="152" EVENTS_2="167" I2="51.50095536168138" ID="CMP-001.09.02" LOG_CI_END="0.039891263787827085" LOG_CI_START="-0.12640058576793592" LOG_EFFECT_SIZE="-0.043254660990054435" NO="2" P_CHI2="0.04399045201918472" P_Z="0.3079068477106953" STUDIES="8" TAU2="0.0" TOTAL_1="720" TOTAL_2="719" WEIGHT="30.102646267735437" Z="1.0196239675062087">
<NAME>Mean age over 65 years old</NAME>
<DICH_DATA CI_END="2.7163637226662987" CI_START="0.28231174199774495" EFFECT_SIZE="0.8757062146892656" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.4339879217832775" LOG_CI_START="-0.5492710581663077" LOG_EFFECT_SIZE="-0.05764156819151513" ORDER="424" O_E="0.0" SE="0.5775711920328345" STUDY_ID="STD-Chuard-1989" TOTAL_1="59" TOTAL_2="62" VAR="0.3335884818662293" WEIGHT="1.0535757050987797"/>
<DICH_DATA CI_END="2.137439548505052" CI_START="0.36965885530785847" EFFECT_SIZE="0.8888888888888888" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="9" LOG_CI_END="0.32989384077006656" LOG_CI_START="-0.43219888566482917" LOG_EFFECT_SIZE="-0.05115252244738131" ORDER="425" O_E="0.0" SE="0.44765703992769446" STUDY_ID="STD-Genne-1997" TOTAL_1="56" TOTAL_2="56" VAR="0.2003968253968254" WEIGHT="1.6205422921646484"/>
<DICH_DATA CI_END="3.4624038633203176" CI_START="0.32310298333559356" EFFECT_SIZE="1.0576923076923077" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.5393777236727578" LOG_CI_START="-0.4906590319538684" LOG_EFFECT_SIZE="0.024359345859444693" ORDER="426" O_E="0.0" SE="0.6050486890192525" STUDY_ID="STD-Gleadhill-1986" TOTAL_1="26" TOTAL_2="22" VAR="0.36608391608391605" WEIGHT="0.7802611036348306"/>
<DICH_DATA CI_END="1.9282513388396094" CI_START="0.6086401121429384" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.2851636415776451" LOG_CI_START="-0.21563942905922126" LOG_EFFECT_SIZE="0.03476210625921191" ORDER="427" O_E="0.0" SE="0.29417420270727607" STUDY_ID="STD-Hirata_x002d_Dulas-1991" TOTAL_1="24" TOTAL_2="26" VAR="0.08653846153846154" WEIGHT="2.0742941339707497"/>
<DICH_DATA CI_END="1.2547827956845181" CI_START="0.7519203298154321" EFFECT_SIZE="0.9713375796178344" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="85" LOG_CI_END="0.09856855545884344" LOG_CI_START="-0.12382817291170159" LOG_EFFECT_SIZE="-0.01262980872642909" ORDER="428" O_E="0.0" SE="0.13063693912641838" STUDY_ID="STD-Norrby-1998" TOTAL_1="314" TOTAL_2="305" VAR="0.01706600986431954" WEIGHT="15.52765168834122"/>
<DICH_DATA CI_END="1.8165256832791987" CI_START="0.33301938815029664" EFFECT_SIZE="0.7777777777777778" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" LOG_CI_END="0.25924154259376825" LOG_CI_START="-0.4775304814439043" LOG_EFFECT_SIZE="-0.10914446942506803" ORDER="429" O_E="0.0" SE="0.4327835340000672" STUDY_ID="STD-Peterson-1988" TOTAL_1="30" TOTAL_2="30" VAR="0.1873015873015873" WEIGHT="1.6205422921646484"/>
<DICH_DATA CI_END="0.5735349127990342" CI_START="0.11910513011290594" EFFECT_SIZE="0.26136363636363635" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="28" LOG_CI_END="-0.24144014014376425" LOG_CI_START="-0.9240695321213873" LOG_EFFECT_SIZE="-0.5827548361325757" ORDER="430" O_E="0.0" SE="0.40097988391764294" STUDY_ID="STD-Rizzato-1997" TOTAL_1="110" TOTAL_2="115" VAR="0.1607848673066064" WEIGHT="4.92964963937493"/>
<DICH_DATA CI_END="3.068198954218383" CI_START="0.9148455606032033" EFFECT_SIZE="1.6753889674681754" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="14" LOG_CI_END="0.4868835175708553" LOG_CI_START="-0.038652215047086325" LOG_EFFECT_SIZE="0.2241156512618845" ORDER="431" O_E="0.0" SE="0.30870229078361094" STUDY_ID="STD-Romanelli-2002" TOTAL_1="101" TOTAL_2="103" VAR="0.09529710433504908" WEIGHT="2.496129412985635"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.16972525462547" CI_END="1.4950632560613561" CI_START="0.7664756652592875" DF="4" EFFECT_SIZE="1.0704810151489583" ESTIMABLE="YES" EVENTS_1="50" EVENTS_2="45" I2="0.0" ID="CMP-001.09.03" LOG_CI_END="0.1746595680298272" LOG_CI_START="-0.11550162895230183" LOG_EFFECT_SIZE="0.02957896953876269" MODIFIED="2011-10-11 21:36:40 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.5298347930140868" P_Z="0.689453656411209" STUDIES="5" TAU2="0.0" TOTAL_1="220" TOTAL_2="206" WEIGHT="8.308003737829411" Z="0.3995966076701345">
<NAME>Data unavailable</NAME>
<DICH_DATA CI_END="2.102230118933325" CI_START="0.3494830898549799" EFFECT_SIZE="0.8571428571428571" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.32268025399138267" LOG_CI_START="-0.45657383325260914" LOG_EFFECT_SIZE="-0.06694678963061322" ORDER="432" O_E="0.0" SE="0.4577377082170635" STUDY_ID="STD-Fourrier-1986" TOTAL_1="20" TOTAL_2="20" VAR="0.20952380952380956" WEIGHT="1.2604217827947264"/>
<DICH_DATA CI_END="2.144644481217491" CI_START="0.3034542567633229" EFFECT_SIZE="0.8067226890756303" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.33135530927495327" LOG_CI_START="-0.517906765980878" LOG_EFFECT_SIZE="-0.09327572835296233" MODIFIED="2011-10-11 21:36:40 +1000" MODIFIED_BY="[Empty name]" ORDER="490" O_E="0.0" SE="0.49886074692034765" STUDY_ID="STD-Hatipoglu-2010" TOTAL_1="34" TOTAL_2="32" VAR="0.24886204481792717" WEIGHT="1.2986163822733545"/>
<DICH_DATA CI_END="1.443503564398061" CI_START="0.6128857834811439" EFFECT_SIZE="0.9405864197530864" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="24" LOG_CI_END="0.15941786060780128" LOG_CI_START="-0.21262045244018643" LOG_EFFECT_SIZE="-0.026601295916192598" MODIFIED="2011-10-11 19:41:38 +1000" MODIFIED_BY="[Empty name]" ORDER="472" O_E="0.0" SE="0.21853714670373883" STUDY_ID="STD-Hong_x002d_yun-2007" TOTAL_1="54" TOTAL_2="53" VAR="0.047758484489411474" WEIGHT="4.361833459284287"/>
<DICH_DATA CI_END="130.6416413078046" CI_START="0.40631480224590605" EFFECT_SIZE="7.285714285714286" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.1160816279934997" LOG_CI_START="-0.39113735582614056" LOG_EFFECT_SIZE="0.8624721360836796" ORDER="433" O_E="0.0" SE="1.4727528420297875" STUDY_ID="STD-Kobayashi-1984" TOTAL_1="41" TOTAL_2="33" VAR="2.1690009337068163" WEIGHT="0.09950698285221525"/>
<DICH_DATA CI_END="3.655277831125175" CI_START="0.6196836329905102" EFFECT_SIZE="1.5050301810865192" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.5629203924946599" LOG_CI_START="-0.20782997423240124" LOG_EFFECT_SIZE="0.17754520913112926" ORDER="434" O_E="0.0" SE="0.45274258069132295" STUDY_ID="STD-Miki-1984" TOTAL_1="71" TOTAL_2="68" VAR="0.20497584437103905" WEIGHT="1.2876251306248285"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="29.667743896861573" CI_END="1.03645135357653" CI_START="0.8416421031698168" CI_STUDY="95" CI_TOTAL="95" DF="27" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9339813151542992" ESTIMABLE="YES" EVENTS_1="621" EVENTS_2="519" I2="8.992068645785304" I2_Q="45.62734427694219" ID="CMP-001.10" LOG_CI_END="0.015548923054027873" LOG_CI_START="-0.07487254705326835" LOG_EFFECT_SIZE="-0.02966181199962021" METHOD="MH" MODIFIED="2012-07-02 22:14:51 +1000" MODIFIED_BY="[Empty name]" NO="10" P_CHI2="0.3292876660846702" P_Q="0.15895100908391813" P_Z="0.19848105935655455" Q="3.6783195034408815" RANDOM="NO" SCALE="27.168403769202474" SORT_BY="STUDY" STUDIES="28" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2919" TOTAL_2="2500" WEIGHT="100.00000000000003" Z="1.285891131087959">
<NAME>Clinical failure per geographical area</NAME>
<GROUP_LABEL_1>Atypical ABx</GROUP_LABEL_1>
<GROUP_LABEL_2>Non-atypical ABx</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours atypical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-atypical</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="22.266430628838343" CI_END="0.9840928643836498" CI_START="0.7407302457910572" DF="14" EFFECT_SIZE="0.8537841350810674" ESTIMABLE="YES" EVENTS_1="370" EVENTS_2="283" I2="37.125081997345745" ID="CMP-001.10.01" LOG_CI_END="-0.006963917232863905" LOG_CI_START="-0.13033992170188893" LOG_EFFECT_SIZE="-0.06865191946737642" MODIFIED="2011-10-11 20:48:18 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.07330324561372836" P_Z="0.029166926047046043" STUDIES="15" TAU2="0.0" TOTAL_1="1739" TOTAL_2="1345" WEIGHT="57.01760974656523" Z="2.181223005311113">
<NAME>Europe</NAME>
<DICH_DATA CI_END="1.3214574081413286" CI_START="0.37833151618610517" EFFECT_SIZE="0.7070707070707071" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="22" LOG_CI_END="0.12105316995937764" LOG_CI_START="-0.4221274791259638" LOG_EFFECT_SIZE="-0.1505371545832931" ORDER="435" O_E="0.0" SE="0.31906700206030675" STUDY_ID="STD-Aubier-1998" TOTAL_1="126" TOTAL_2="140" VAR="0.1018037518037518" WEIGHT="3.752834781854976"/>
<DICH_DATA CI_END="1.203850666497277" CI_START="0.20530039753790533" EFFECT_SIZE="0.49714285714285716" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="10" LOG_CI_END="0.08057261753764383" LOG_CI_START="-0.6876102096729957" LOG_EFFECT_SIZE="-0.3035187960676759" ORDER="436" O_E="0.0" SE="0.4512343952698513" STUDY_ID="STD-Bohte-1995" TOTAL_1="35" TOTAL_2="29" VAR="0.2036124794745484" WEIGHT="1.9694090356167606"/>
<DICH_DATA CI_END="1.3344254423156148" CI_START="0.4470361807057921" EFFECT_SIZE="0.7723577235772358" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="24" LOG_CI_END="0.12529431368330868" LOG_CI_START="-0.349657325984409" LOG_EFFECT_SIZE="-0.11218150615055017" ORDER="437" O_E="0.0" SE="0.2789889441893509" STUDY_ID="STD-Carbon-1992" TOTAL_1="123" TOTAL_2="120" VAR="0.07783483097988873" WEIGHT="4.374797299012386"/>
<DICH_DATA CI_END="2.7163637226662987" CI_START="0.28231174199774495" EFFECT_SIZE="0.8757062146892656" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.4339879217832775" LOG_CI_START="-0.5492710581663077" LOG_EFFECT_SIZE="-0.05764156819151513" ORDER="438" O_E="0.0" SE="0.5775711920328345" STUDY_ID="STD-Chuard-1989" TOTAL_1="59" TOTAL_2="62" VAR="0.3335884818662293" WEIGHT="1.05357570509878"/>
<DICH_DATA CI_END="2.102230118933325" CI_START="0.3494830898549799" EFFECT_SIZE="0.8571428571428571" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.32268025399138267" LOG_CI_START="-0.45657383325260914" LOG_EFFECT_SIZE="-0.06694678963061322" ORDER="439" O_E="0.0" SE="0.4577377082170635" STUDY_ID="STD-Fourrier-1986" TOTAL_1="20" TOTAL_2="20" VAR="0.20952380952380956" WEIGHT="1.2604217827947268"/>
<DICH_DATA CI_END="2.137439548505052" CI_START="0.36965885530785847" EFFECT_SIZE="0.8888888888888888" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="9" LOG_CI_END="0.32989384077006656" LOG_CI_START="-0.43219888566482917" LOG_EFFECT_SIZE="-0.05115252244738131" ORDER="440" O_E="0.0" SE="0.44765703992769446" STUDY_ID="STD-Genne-1997" TOTAL_1="56" TOTAL_2="56" VAR="0.2003968253968254" WEIGHT="1.6205422921646488"/>
<DICH_DATA CI_END="3.4624038633203176" CI_START="0.32310298333559356" EFFECT_SIZE="1.0576923076923077" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.5393777236727578" LOG_CI_START="-0.4906590319538684" LOG_EFFECT_SIZE="0.024359345859444693" ORDER="441" O_E="0.0" SE="0.6050486890192525" STUDY_ID="STD-Gleadhill-1986" TOTAL_1="26" TOTAL_2="22" VAR="0.36608391608391605" WEIGHT="0.7802611036348308"/>
<DICH_DATA CI_END="2.144644481217491" CI_START="0.3034542567633229" EFFECT_SIZE="0.8067226890756303" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.33135530927495327" LOG_CI_START="-0.517906765980878" LOG_EFFECT_SIZE="-0.09327572835296233" MODIFIED="2011-10-11 20:48:18 +1000" MODIFIED_BY="[Empty name]" ORDER="481" O_E="0.0" SE="0.49886074692034765" STUDY_ID="STD-Hatipoglu-2010" TOTAL_1="34" TOTAL_2="32" VAR="0.24886204481792717" WEIGHT="1.298616382273355"/>
<DICH_DATA CI_END="1.1655672270079651" CI_START="0.7467384445333052" EFFECT_SIZE="0.9329382927583827" ESTIMABLE="YES" EVENTS_1="197" EVENTS_2="69" LOG_CI_END="0.06653732760056165" LOG_CI_START="-0.1268314891982239" LOG_EFFECT_SIZE="-0.030147080798831105" ORDER="442" O_E="0.0" SE="0.11358580017868716" STUDY_ID="STD-Lode-1995" TOTAL_1="609" TOTAL_2="199" VAR="0.01290173400223265" WEIGHT="18.72849495573452"/>
<DICH_DATA CI_END="0.5735349127990342" CI_START="0.11910513011290594" EFFECT_SIZE="0.26136363636363635" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="28" LOG_CI_END="-0.24144014014376425" LOG_CI_START="-0.9240695321213873" LOG_EFFECT_SIZE="-0.5827548361325757" ORDER="443" O_E="0.0" SE="0.40097988391764294" STUDY_ID="STD-Rizzato-1997" TOTAL_1="110" TOTAL_2="115" VAR="0.1607848673066064" WEIGHT="4.929649639374931"/>
<DICH_DATA CI_END="3.068198954218383" CI_START="0.9148455606032033" EFFECT_SIZE="1.6753889674681754" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="14" LOG_CI_END="0.4868835175708553" LOG_CI_START="-0.038652215047086325" LOG_EFFECT_SIZE="0.2241156512618845" ORDER="444" O_E="0.0" SE="0.30870229078361094" STUDY_ID="STD-Romanelli-2002" TOTAL_1="101" TOTAL_2="103" VAR="0.09529710433504908" WEIGHT="2.4961294129856357"/>
<DICH_DATA CI_END="0.9151459649634782" CI_START="0.2672740345449367" EFFECT_SIZE="0.4945652173913043" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="28" LOG_CI_END="-0.038509630827043506" LOG_CI_START="-0.5730432305498423" LOG_EFFECT_SIZE="-0.3057764306884429" ORDER="445" O_E="0.0" SE="0.3139876824611645" STUDY_ID="STD-Tremolieres-1998" TOTAL_1="138" TOTAL_2="147" VAR="0.09858826473733306" WEIGHT="4.8824759586153625"/>
<DICH_DATA CI_END="1.8117938612293691" CI_START="0.7690493144462788" EFFECT_SIZE="1.1804062126642771" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="31" LOG_CI_END="0.2581087838356645" LOG_CI_START="-0.11404581064692823" LOG_EFFECT_SIZE="0.07203148659436812" ORDER="446" O_E="0.0" SE="0.21860545099402817" STUDY_ID="STD-Tremolieres-2005" TOTAL_1="189" TOTAL_2="182" VAR="0.047788343204302454" WEIGHT="5.687186157408013"/>
<DICH_DATA CI_END="1.8110069918099756" CI_START="0.6440615664516371" EFFECT_SIZE="1.08" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="21" LOG_CI_END="0.2579201270112585" LOG_CI_START="-0.19107261603735906" LOG_EFFECT_SIZE="0.03342375548694973" ORDER="447" O_E="0.0" SE="0.2637405598166809" STUDY_ID="STD-Vanderdonckt--1990" TOTAL_1="75" TOTAL_2="81" VAR="0.06955908289241622" WEIGHT="3.63583206575402"/>
<DICH_DATA CI_END="3.6650773639034675" CI_START="0.11496630950828501" EFFECT_SIZE="0.6491228070175439" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5640831463336992" LOG_CI_START="-0.939429409544692" LOG_EFFECT_SIZE="-0.1876731316054964" ORDER="448" O_E="0.0" SE="0.8831707178301498" STUDY_ID="STD-Vogel-1991" TOTAL_1="38" TOTAL_2="37" VAR="0.779990516832622" WEIGHT="0.5473831742422813"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.473642433019708" CI_END="1.4453009028312125" CI_START="0.5921127355398127" DF="2" EFFECT_SIZE="0.9250843589930328" ESTIMABLE="YES" EVENTS_1="25" EVENTS_2="27" I2="0.0" ID="CMP-001.10.02" LOG_CI_END="0.1599582739678645" LOG_CI_START="-0.22759559773377006" LOG_EFFECT_SIZE="-0.033818661882952766" NO="2" P_CHI2="0.7891323659841545" P_Z="0.7323056596041415" STUDIES="3" TAU2="0.0" TOTAL_1="120" TOTAL_2="112" WEIGHT="4.86375217786072" Z="0.3420601064047912">
<NAME>North America</NAME>
<DICH_DATA CI_END="1.9282513388396094" CI_START="0.6086401121429384" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.2851636415776451" LOG_CI_START="-0.21563942905922126" LOG_EFFECT_SIZE="0.03476210625921191" ORDER="449" O_E="0.0" SE="0.29417420270727607" STUDY_ID="STD-Hirata_x002d_Dulas-1991" TOTAL_1="24" TOTAL_2="26" VAR="0.08653846153846154" WEIGHT="2.0742941339707506"/>
<DICH_DATA CI_END="2.48381127526022" CI_START="0.28984751993000446" EFFECT_SIZE="0.8484848484848485" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.39511859423126344" LOG_CI_START="-0.5378304113025999" LOG_EFFECT_SIZE="-0.07135590853566824" ORDER="450" O_E="0.0" SE="0.5480188640226497" STUDY_ID="STD-Khan-1989" TOTAL_1="66" TOTAL_2="56" VAR="0.3003246753246753" WEIGHT="1.1689157517253206"/>
<DICH_DATA CI_END="1.8165256832791987" CI_START="0.33301938815029664" EFFECT_SIZE="0.7777777777777778" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" LOG_CI_END="0.25924154259376825" LOG_CI_START="-0.4775304814439043" LOG_EFFECT_SIZE="-0.10914446942506803" ORDER="451" O_E="0.0" SE="0.4327835340000672" STUDY_ID="STD-Peterson-1988" TOTAL_1="30" TOTAL_2="30" VAR="0.1873015873015873" WEIGHT="1.6205422921646488"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="5.067119907367792" CI_END="1.2421771191546456" CI_START="0.8961549158097455" DF="9" EFFECT_SIZE="1.0550749412420066" ESTIMABLE="YES" EVENTS_1="226" EVENTS_2="209" I2="0.0" ID="CMP-001.10.03" LOG_CI_END="0.0941835252988429" LOG_CI_START="-0.047616908567983035" LOG_EFFECT_SIZE="0.023283308365429956" MODIFIED="2012-07-02 22:14:51 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.8284184505270658" P_Z="0.5198068035001521" STUDIES="10" TAU2="0.0" TOTAL_1="1060" TOTAL_2="1043" WEIGHT="38.11863807557408" Z="0.6436432469598953">
<NAME>Other</NAME>
<DICH_DATA CI_END="4.482318710854454" CI_START="0.2105324342739262" EFFECT_SIZE="0.9714285714285714" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6515027333780666" LOG_CI_START="-0.6766809879941078" LOG_EFFECT_SIZE="-0.012589127308020516" ORDER="452" O_E="0.0" SE="0.78018169254947" STUDY_ID="STD-Feldman-2001" TOTAL_1="35" TOTAL_2="34" VAR="0.6086834733893557" WEIGHT="0.548009470780316"/>
<DICH_DATA CI_END="1.443503564398061" CI_START="0.6128857834811439" EFFECT_SIZE="0.9405864197530864" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="24" LOG_CI_END="0.15941786060780128" LOG_CI_START="-0.21262045244018643" LOG_EFFECT_SIZE="-0.026601295916192598" MODIFIED="2011-10-11 19:41:47 +1000" MODIFIED_BY="[Empty name]" ORDER="473" O_E="0.0" SE="0.21853714670373883" STUDY_ID="STD-Hong_x002d_yun-2007" TOTAL_1="54" TOTAL_2="53" VAR="0.047758484489411474" WEIGHT="4.361833459284289"/>
<DICH_DATA CI_END="4.2660503456694485" CI_START="0.05860221510366839" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.6300259764573879" LOG_CI_START="-1.2320859677853504" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="453" O_E="0.0" SE="1.093813773650968" STUDY_ID="STD-Kalbermatter-2000" TOTAL_1="28" TOTAL_2="56" VAR="1.1964285714285714" WEIGHT="0.4801606791598959"/>
<DICH_DATA CI_END="130.6416413078046" CI_START="0.40631480224590605" EFFECT_SIZE="7.285714285714286" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.1160816279934997" LOG_CI_START="-0.39113735582614056" LOG_EFFECT_SIZE="0.8624721360836796" ORDER="454" O_E="0.0" SE="1.4727528420297875" STUDY_ID="STD-Kobayashi-1984" TOTAL_1="41" TOTAL_2="33" VAR="2.1690009337068163" WEIGHT="0.09950698285221529"/>
<DICH_DATA CI_END="2.2628158592596277" CI_START="0.46604366926357205" EFFECT_SIZE="1.0269230769230768" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="10" LOG_CI_END="0.35464921389230963" LOG_CI_START="-0.3315733871047952" LOG_EFFECT_SIZE="0.011537913393757216" MODIFIED="2012-07-02 22:14:51 +1000" MODIFIED_BY="[Empty name]" ORDER="985" O_E="0.0" SE="0.40309055268235816" STUDY_ID="STD-Kohno-2011" TOTAL_1="104" TOTAL_2="89" VAR="0.16248199366176896" WEIGHT="1.9405457499726364"/>
<DICH_DATA CI_END="1.649147772920286" CI_START="0.7177241891450693" EFFECT_SIZE="1.0879491017964071" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="32" LOG_CI_END="0.21725957261750875" LOG_CI_START="-0.14404241668366938" LOG_EFFECT_SIZE="0.036608577966919686" ORDER="455" O_E="0.0" SE="0.2122305769892032" STUDY_ID="STD-Lephonte-2004" TOTAL_1="167" TOTAL_2="153" VAR="0.045041817809170104" WEIGHT="6.014012506477696"/>
<DICH_DATA CI_END="3.655277831125175" CI_START="0.6196836329905102" EFFECT_SIZE="1.5050301810865192" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.5629203924946599" LOG_CI_START="-0.20782997423240124" LOG_EFFECT_SIZE="0.17754520913112926" ORDER="456" O_E="0.0" SE="0.45274258069132295" STUDY_ID="STD-Miki-1984" TOTAL_1="71" TOTAL_2="68" VAR="0.20497584437103905" WEIGHT="1.287625130624829"/>
<DICH_DATA CI_END="1.2547827956845181" CI_START="0.7519203298154321" EFFECT_SIZE="0.9713375796178344" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="85" LOG_CI_END="0.09856855545884344" LOG_CI_START="-0.12382817291170159" LOG_EFFECT_SIZE="-0.01262980872642909" ORDER="457" O_E="0.0" SE="0.13063693912641838" STUDY_ID="STD-Norrby-1998" TOTAL_1="314" TOTAL_2="305" VAR="0.01706600986431954" WEIGHT="15.527651688341225"/>
<DICH_DATA CI_END="1.5660492289920993" CI_START="0.7548689795862338" EFFECT_SIZE="1.0872727272727272" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="44" LOG_CI_END="0.19480541004860086" LOG_CI_START="-0.12212842106026693" LOG_EFFECT_SIZE="0.036338494494166956" ORDER="458" O_E="0.0" SE="0.186168501241115" STUDY_ID="STD-Petitpretz-2001" TOTAL_1="200" TOTAL_2="208" VAR="0.034658710854363034" WEIGHT="7.767305104057141"/>
<DICH_DATA CI_END="126.12592421227448" CI_START="0.3561402260936749" EFFECT_SIZE="6.702127659574468" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1008043616340277" LOG_CI_START="-0.4483789699262618" LOG_EFFECT_SIZE="0.826212695853883" ORDER="459" O_E="0.0" SE="1.4974029076195166" STUDY_ID="STD-Zeluff-1988" TOTAL_1="46" TOTAL_2="44" VAR="2.2422154677473825" WEIGHT="0.09198730402383877"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="29.667743896861573" CI_END="1.0364513535765296" CI_START="0.8416421031698165" CI_STUDY="95" CI_TOTAL="95" DF="27" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9339813151542987" ESTIMABLE="YES" EVENTS_1="621" EVENTS_2="519" I2="8.992068645785304" I2_Q="25.869243935129756" ID="CMP-001.11" LOG_CI_END="0.015548923054027688" LOG_CI_START="-0.07487254705326853" LOG_EFFECT_SIZE="-0.029661811999620417" METHOD="MH" MODIFIED="2012-07-02 22:28:19 +1000" MODIFIED_BY="[Empty name]" NO="11" P_CHI2="0.3292876660846702" P_Q="0.25950819373670075" P_Z="0.19848105935655125" Q="2.6979355211888607" RANDOM="NO" SCALE="50.80576121091236" SORT_BY="STUDY" STUDIES="28" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2919" TOTAL_2="2500" WEIGHT="99.99999999999997" Z="1.2858911310879686">
<NAME>Clinical failure per allocation generation</NAME>
<GROUP_LABEL_1>Atypical ABx</GROUP_LABEL_1>
<GROUP_LABEL_2>Non-atypical ABx</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours atypical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-atypical</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="2.798807395841009" CI_END="1.1911855636828075" CI_START="0.8240372249349761" DF="9" EFFECT_SIZE="0.9907478217386027" ESTIMABLE="YES" EVENTS_1="176" EVENTS_2="176" I2="0.0" ID="CMP-001.11.01" LOG_CI_END="0.07597942143746494" LOG_CI_START="-0.0840531691054444" LOG_EFFECT_SIZE="-0.004036873833989713" MODIFIED="2012-07-02 22:28:19 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9717401942551589" P_Z="0.9212323972345569" STUDIES="10" TAU2="0.0" TOTAL_1="938" TOTAL_2="940" WEIGHT="31.81923603748843" Z="0.09888145030846694">
<NAME>A</NAME>
<DICH_DATA CI_END="2.7163637226662987" CI_START="0.28231174199774495" EFFECT_SIZE="0.8757062146892656" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.4339879217832775" LOG_CI_START="-0.5492710581663077" LOG_EFFECT_SIZE="-0.05764156819151513" ORDER="460" O_E="0.0" SE="0.5775711920328345" STUDY_ID="STD-Chuard-1989" TOTAL_1="59" TOTAL_2="62" VAR="0.3335884818662293" WEIGHT="1.0535757050987795"/>
<DICH_DATA CI_END="4.482318710854454" CI_START="0.2105324342739262" EFFECT_SIZE="0.9714285714285714" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6515027333780666" LOG_CI_START="-0.6766809879941078" LOG_EFFECT_SIZE="-0.012589127308020516" ORDER="461" O_E="0.0" SE="0.78018169254947" STUDY_ID="STD-Feldman-2001" TOTAL_1="35" TOTAL_2="34" VAR="0.6086834733893557" WEIGHT="0.5480094707803158"/>
<DICH_DATA CI_END="2.137439548505052" CI_START="0.36965885530785847" EFFECT_SIZE="0.8888888888888888" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="9" LOG_CI_END="0.32989384077006656" LOG_CI_START="-0.43219888566482917" LOG_EFFECT_SIZE="-0.05115252244738131" ORDER="462" O_E="0.0" SE="0.44765703992769446" STUDY_ID="STD-Genne-1997" TOTAL_1="56" TOTAL_2="56" VAR="0.2003968253968254" WEIGHT="1.620542292164648"/>
<DICH_DATA CI_END="4.2660503456694485" CI_START="0.05860221510366839" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.6300259764573879" LOG_CI_START="-1.2320859677853504" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="463" O_E="0.0" SE="1.093813773650968" STUDY_ID="STD-Kalbermatter-2000" TOTAL_1="28" TOTAL_2="56" VAR="1.1964285714285714" WEIGHT="0.4801606791598957"/>
<DICH_DATA CI_END="2.48381127526022" CI_START="0.28984751993000446" EFFECT_SIZE="0.8484848484848485" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.39511859423126344" LOG_CI_START="-0.5378304113025999" LOG_EFFECT_SIZE="-0.07135590853566824" ORDER="464" O_E="0.0" SE="0.5480188640226497" STUDY_ID="STD-Khan-1989" TOTAL_1="66" TOTAL_2="56" VAR="0.3003246753246753" WEIGHT="1.16891575172532"/>
<DICH_DATA CI_END="2.2628158592596277" CI_START="0.46604366926357205" EFFECT_SIZE="1.0269230769230768" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="10" LOG_CI_END="0.35464921389230963" LOG_CI_START="-0.3315733871047952" LOG_EFFECT_SIZE="0.011537913393757216" MODIFIED="2012-07-02 22:28:19 +1000" MODIFIED_BY="[Empty name]" ORDER="996" O_E="0.0" SE="0.40309055268235816" STUDY_ID="STD-Kohno-2011" TOTAL_1="104" TOTAL_2="89" VAR="0.16248199366176896" WEIGHT="1.9405457499726355"/>
<DICH_DATA CI_END="1.2547827956845181" CI_START="0.7519203298154321" EFFECT_SIZE="0.9713375796178344" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="85" LOG_CI_END="0.09856855545884344" LOG_CI_START="-0.12382817291170159" LOG_EFFECT_SIZE="-0.01262980872642909" ORDER="465" O_E="0.0" SE="0.13063693912641838" STUDY_ID="STD-Norrby-1998" TOTAL_1="314" TOTAL_2="305" VAR="0.01706600986431954" WEIGHT="15.527651688341217"/>
<DICH_DATA CI_END="1.8165256832791987" CI_START="0.33301938815029664" EFFECT_SIZE="0.7777777777777778" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" LOG_CI_END="0.25924154259376825" LOG_CI_START="-0.4775304814439043" LOG_EFFECT_SIZE="-0.10914446942506803" ORDER="466" O_E="0.0" SE="0.4327835340000672" STUDY_ID="STD-Peterson-1988" TOTAL_1="30" TOTAL_2="30" VAR="0.1873015873015873" WEIGHT="1.620542292164648"/>
<DICH_DATA CI_END="1.5660492289920993" CI_START="0.7548689795862338" EFFECT_SIZE="1.0872727272727272" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="44" LOG_CI_END="0.19480541004860086" LOG_CI_START="-0.12212842106026693" LOG_EFFECT_SIZE="0.036338494494166956" ORDER="467" O_E="0.0" SE="0.186168501241115" STUDY_ID="STD-Petitpretz-2001" TOTAL_1="200" TOTAL_2="208" VAR="0.034658710854363034" WEIGHT="7.7673051040571375"/>
<DICH_DATA CI_END="126.12592421227448" CI_START="0.3561402260936749" EFFECT_SIZE="6.702127659574468" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1008043616340277" LOG_CI_START="-0.4483789699262618" LOG_EFFECT_SIZE="0.826212695853883" ORDER="468" O_E="0.0" SE="1.4974029076195166" STUDY_ID="STD-Zeluff-1988" TOTAL_1="46" TOTAL_2="44" VAR="2.2422154677473825" WEIGHT="0.09198730402383873"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="24.73475912019164" CI_END="1.019232056399223" CI_START="0.7914814821151896" DF="16" EFFECT_SIZE="0.8981666318774983" ESTIMABLE="YES" EVENTS_1="441" EVENTS_2="343" I2="35.31370197602298" ID="CMP-001.11.02" LOG_CI_END="0.008273074428438863" LOG_CI_START="-0.10155924164719535" LOG_EFFECT_SIZE="-0.04664308360937823" MODIFIED="2011-10-11 21:37:18 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.07463991517592683" P_Z="0.09597322012854395" STUDIES="17" TAU2="0.0" TOTAL_1="1940" TOTAL_2="1527" WEIGHT="68.08125697965933" Z="1.6646970084709471">
<NAME>B</NAME>
<DICH_DATA CI_END="1.3214574081413286" CI_START="0.37833151618610517" EFFECT_SIZE="0.7070707070707071" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="22" LOG_CI_END="0.12105316995937764" LOG_CI_START="-0.4221274791259638" LOG_EFFECT_SIZE="-0.1505371545832931" ORDER="469" O_E="0.0" SE="0.31906700206030675" STUDY_ID="STD-Aubier-1998" TOTAL_1="126" TOTAL_2="140" VAR="0.1018037518037518" WEIGHT="3.752834781854974"/>
<DICH_DATA CI_END="1.203850666497277" CI_START="0.20530039753790533" EFFECT_SIZE="0.49714285714285716" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="10" LOG_CI_END="0.08057261753764383" LOG_CI_START="-0.6876102096729957" LOG_EFFECT_SIZE="-0.3035187960676759" ORDER="470" O_E="0.0" SE="0.4512343952698513" STUDY_ID="STD-Bohte-1995" TOTAL_1="35" TOTAL_2="29" VAR="0.2036124794745484" WEIGHT="1.9694090356167597"/>
<DICH_DATA CI_END="1.3344254423156148" CI_START="0.4470361807057921" EFFECT_SIZE="0.7723577235772358" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="24" LOG_CI_END="0.12529431368330868" LOG_CI_START="-0.349657325984409" LOG_EFFECT_SIZE="-0.11218150615055017" ORDER="471" O_E="0.0" SE="0.2789889441893509" STUDY_ID="STD-Carbon-1992" TOTAL_1="123" TOTAL_2="120" VAR="0.07783483097988873" WEIGHT="4.374797299012384"/>
<DICH_DATA CI_END="2.102230118933325" CI_START="0.3494830898549799" EFFECT_SIZE="0.8571428571428571" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.32268025399138267" LOG_CI_START="-0.45657383325260914" LOG_EFFECT_SIZE="-0.06694678963061322" ORDER="472" O_E="0.0" SE="0.4577377082170635" STUDY_ID="STD-Fourrier-1986" TOTAL_1="20" TOTAL_2="20" VAR="0.20952380952380956" WEIGHT="1.2604217827947264"/>
<DICH_DATA CI_END="3.4624038633203176" CI_START="0.32310298333559356" EFFECT_SIZE="1.0576923076923077" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.5393777236727578" LOG_CI_START="-0.4906590319538684" LOG_EFFECT_SIZE="0.024359345859444693" ORDER="473" O_E="0.0" SE="0.6050486890192525" STUDY_ID="STD-Gleadhill-1986" TOTAL_1="26" TOTAL_2="22" VAR="0.36608391608391605" WEIGHT="0.7802611036348305"/>
<DICH_DATA CI_END="2.144644481217491" CI_START="0.3034542567633229" EFFECT_SIZE="0.8067226890756303" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.33135530927495327" LOG_CI_START="-0.517906765980878" LOG_EFFECT_SIZE="-0.09327572835296233" MODIFIED="2011-10-11 21:37:18 +1000" MODIFIED_BY="[Empty name]" ORDER="491" O_E="0.0" SE="0.49886074692034765" STUDY_ID="STD-Hatipoglu-2010" TOTAL_1="34" TOTAL_2="32" VAR="0.24886204481792717" WEIGHT="1.2986163822733543"/>
<DICH_DATA CI_END="1.9282513388396094" CI_START="0.6086401121429384" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.2851636415776451" LOG_CI_START="-0.21563942905922126" LOG_EFFECT_SIZE="0.03476210625921191" ORDER="474" O_E="0.0" SE="0.29417420270727607" STUDY_ID="STD-Hirata_x002d_Dulas-1991" TOTAL_1="24" TOTAL_2="26" VAR="0.08653846153846154" WEIGHT="2.0742941339707492"/>
<DICH_DATA CI_END="1.443503564398061" CI_START="0.6128857834811439" EFFECT_SIZE="0.9405864197530864" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="24" LOG_CI_END="0.15941786060780128" LOG_CI_START="-0.21262045244018643" LOG_EFFECT_SIZE="-0.026601295916192598" MODIFIED="2011-10-11 19:42:39 +1000" MODIFIED_BY="[Empty name]" ORDER="474" O_E="0.0" SE="0.21853714670373883" STUDY_ID="STD-Hong_x002d_yun-2007" TOTAL_1="54" TOTAL_2="53" VAR="0.047758484489411474" WEIGHT="4.361833459284286"/>
<DICH_DATA CI_END="1.649147772920286" CI_START="0.7177241891450693" EFFECT_SIZE="1.0879491017964071" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="32" LOG_CI_END="0.21725957261750875" LOG_CI_START="-0.14404241668366938" LOG_EFFECT_SIZE="0.036608577966919686" ORDER="475" O_E="0.0" SE="0.2122305769892032" STUDY_ID="STD-Lephonte-2004" TOTAL_1="167" TOTAL_2="153" VAR="0.045041817809170104" WEIGHT="6.014012506477694"/>
<DICH_DATA CI_END="1.1655672270079651" CI_START="0.7467384445333052" EFFECT_SIZE="0.9329382927583827" ESTIMABLE="YES" EVENTS_1="197" EVENTS_2="69" LOG_CI_END="0.06653732760056165" LOG_CI_START="-0.1268314891982239" LOG_EFFECT_SIZE="-0.030147080798831105" ORDER="476" O_E="0.0" SE="0.11358580017868716" STUDY_ID="STD-Lode-1995" TOTAL_1="609" TOTAL_2="199" VAR="0.01290173400223265" WEIGHT="18.72849495573451"/>
<DICH_DATA CI_END="3.655277831125175" CI_START="0.6196836329905102" EFFECT_SIZE="1.5050301810865192" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.5629203924946599" LOG_CI_START="-0.20782997423240124" LOG_EFFECT_SIZE="0.17754520913112926" ORDER="477" O_E="0.0" SE="0.45274258069132295" STUDY_ID="STD-Miki-1984" TOTAL_1="71" TOTAL_2="68" VAR="0.20497584437103905" WEIGHT="1.2876251306248283"/>
<DICH_DATA CI_END="0.5735349127990342" CI_START="0.11910513011290594" EFFECT_SIZE="0.26136363636363635" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="28" LOG_CI_END="-0.24144014014376425" LOG_CI_START="-0.9240695321213873" LOG_EFFECT_SIZE="-0.5827548361325757" ORDER="478" O_E="0.0" SE="0.40097988391764294" STUDY_ID="STD-Rizzato-1997" TOTAL_1="110" TOTAL_2="115" VAR="0.1607848673066064" WEIGHT="4.929649639374929"/>
<DICH_DATA CI_END="3.068198954218383" CI_START="0.9148455606032033" EFFECT_SIZE="1.6753889674681754" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="14" LOG_CI_END="0.4868835175708553" LOG_CI_START="-0.038652215047086325" LOG_EFFECT_SIZE="0.2241156512618845" ORDER="479" O_E="0.0" SE="0.30870229078361094" STUDY_ID="STD-Romanelli-2002" TOTAL_1="101" TOTAL_2="103" VAR="0.09529710433504908" WEIGHT="2.4961294129856344"/>
<DICH_DATA CI_END="0.9151459649634782" CI_START="0.2672740345449367" EFFECT_SIZE="0.4945652173913043" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="28" LOG_CI_END="-0.038509630827043506" LOG_CI_START="-0.5730432305498423" LOG_EFFECT_SIZE="-0.3057764306884429" ORDER="480" O_E="0.0" SE="0.3139876824611645" STUDY_ID="STD-Tremolieres-1998" TOTAL_1="138" TOTAL_2="147" VAR="0.09858826473733306" WEIGHT="4.882475958615361"/>
<DICH_DATA CI_END="1.8117938612293691" CI_START="0.7690493144462788" EFFECT_SIZE="1.1804062126642771" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="31" LOG_CI_END="0.2581087838356645" LOG_CI_START="-0.11404581064692823" LOG_EFFECT_SIZE="0.07203148659436812" ORDER="481" O_E="0.0" SE="0.21860545099402817" STUDY_ID="STD-Tremolieres-2005" TOTAL_1="189" TOTAL_2="182" VAR="0.047788343204302454" WEIGHT="5.687186157408011"/>
<DICH_DATA CI_END="1.8110069918099756" CI_START="0.6440615664516371" EFFECT_SIZE="1.08" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="21" LOG_CI_END="0.2579201270112585" LOG_CI_START="-0.19107261603735906" LOG_EFFECT_SIZE="0.03342375548694973" ORDER="482" O_E="0.0" SE="0.2637405598166809" STUDY_ID="STD-Vanderdonckt--1990" TOTAL_1="75" TOTAL_2="81" VAR="0.06955908289241622" WEIGHT="3.6358320657540184"/>
<DICH_DATA CI_END="3.6650773639034675" CI_START="0.11496630950828501" EFFECT_SIZE="0.6491228070175439" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5640831463336992" LOG_CI_START="-0.939429409544692" LOG_EFFECT_SIZE="-0.1876731316054964" ORDER="483" O_E="0.0" SE="0.8831707178301498" STUDY_ID="STD-Vogel-1991" TOTAL_1="38" TOTAL_2="37" VAR="0.779990516832622" WEIGHT="0.5473831742422811"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="130.6416413078046" CI_START="0.4063148022459062" DF="0" EFFECT_SIZE="7.2857142857142865" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" I2="0.0" ID="CMP-001.11.03" LOG_CI_END="2.1160816279934997" LOG_CI_START="-0.3911373558261404" LOG_EFFECT_SIZE="0.8624721360836796" NO="3" P_CHI2="1.0" P_Z="0.17751763900298193" STUDIES="1" TAU2="0.0" TOTAL_1="41" TOTAL_2="33" WEIGHT="0.09950698285221524" Z="1.348437719483176">
<NAME>C</NAME>
<DICH_DATA CI_END="130.6416413078046" CI_START="0.40631480224590605" EFFECT_SIZE="7.285714285714286" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.1160816279934997" LOG_CI_START="-0.39113735582614056" LOG_EFFECT_SIZE="0.8624721360836796" ORDER="484" O_E="0.0" SE="1.4727528420297875" STUDY_ID="STD-Kobayashi-1984" TOTAL_1="41" TOTAL_2="33" VAR="2.1690009337068163" WEIGHT="0.09950698285221524"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="29.66774389686158" CI_END="1.0364513535765294" CI_START="0.8416421031698164" CI_STUDY="95" CI_TOTAL="95" DF="27" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9339813151542986" ESTIMABLE="YES" EVENTS_1="621" EVENTS_2="519" I2="8.992068645785327" I2_Q="20.968333621057266" ID="CMP-001.12" LOG_CI_END="0.015548923054027594" LOG_CI_START="-0.07487254705326858" LOG_EFFECT_SIZE="-0.02966181199962047" METHOD="MH" MODIFIED="2012-07-02 22:28:46 +1000" MODIFIED_BY="[Empty name]" NO="12" P_CHI2="0.32928766608466997" P_Q="0.28215034183455245" P_Z="0.19848105935655047" Q="2.5306311908069317" RANDOM="NO" SCALE="34.64367880868763" SORT_BY="STUDY" STUDIES="28" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2919" TOTAL_2="2500" WEIGHT="99.99999999999997" Z="1.2858911310879708">
<NAME>Clinical failure per allocation concealment</NAME>
<GROUP_LABEL_1>Atypical ABx</GROUP_LABEL_1>
<GROUP_LABEL_2>Non-atypical ABx</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours atypical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-atypical</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.7285884200101216" CI_END="1.1890856671823105" CI_START="0.8162172705044041" DF="6" EFFECT_SIZE="0.9851661066355529" ESTIMABLE="YES" EVENTS_1="167" EVENTS_2="166" I2="0.0" ID="CMP-001.12.01" LOG_CI_END="0.07521314431114223" LOG_CI_START="-0.08819422014176077" LOG_EFFECT_SIZE="-0.006490537915309274" MODIFIED="2012-07-02 22:28:46 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.993853194109305" P_Z="0.8762699098468455" STUDIES="7" TAU2="0.0" TOTAL_1="805" TOTAL_2="778" WEIGHT="30.19351234920592" Z="0.15569947654304586">
<NAME>A</NAME>
<DICH_DATA CI_END="4.482318710854454" CI_START="0.2105324342739262" EFFECT_SIZE="0.9714285714285714" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6515027333780666" LOG_CI_START="-0.6766809879941078" LOG_EFFECT_SIZE="-0.012589127308020516" ORDER="485" O_E="0.0" SE="0.78018169254947" STUDY_ID="STD-Feldman-2001" TOTAL_1="35" TOTAL_2="34" VAR="0.6086834733893557" WEIGHT="0.5480094707803158"/>
<DICH_DATA CI_END="2.137439548505052" CI_START="0.36965885530785847" EFFECT_SIZE="0.8888888888888888" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="9" LOG_CI_END="0.32989384077006656" LOG_CI_START="-0.43219888566482917" LOG_EFFECT_SIZE="-0.05115252244738131" ORDER="486" O_E="0.0" SE="0.44765703992769446" STUDY_ID="STD-Genne-1997" TOTAL_1="56" TOTAL_2="56" VAR="0.2003968253968254" WEIGHT="1.620542292164648"/>
<DICH_DATA CI_END="2.48381127526022" CI_START="0.28984751993000446" EFFECT_SIZE="0.8484848484848485" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.39511859423126344" LOG_CI_START="-0.5378304113025999" LOG_EFFECT_SIZE="-0.07135590853566824" ORDER="487" O_E="0.0" SE="0.5480188640226497" STUDY_ID="STD-Khan-1989" TOTAL_1="66" TOTAL_2="56" VAR="0.3003246753246753" WEIGHT="1.16891575172532"/>
<DICH_DATA CI_END="2.2628158592596277" CI_START="0.46604366926357205" EFFECT_SIZE="1.0269230769230768" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="10" LOG_CI_END="0.35464921389230963" LOG_CI_START="-0.3315733871047952" LOG_EFFECT_SIZE="0.011537913393757216" MODIFIED="2012-07-02 22:28:46 +1000" MODIFIED_BY="[Empty name]" ORDER="997" O_E="0.0" SE="0.40309055268235816" STUDY_ID="STD-Kohno-2011" TOTAL_1="104" TOTAL_2="89" VAR="0.16248199366176896" WEIGHT="1.9405457499726355"/>
<DICH_DATA CI_END="1.2547827956845181" CI_START="0.7519203298154321" EFFECT_SIZE="0.9713375796178344" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="85" LOG_CI_END="0.09856855545884344" LOG_CI_START="-0.12382817291170159" LOG_EFFECT_SIZE="-0.01262980872642909" ORDER="488" O_E="0.0" SE="0.13063693912641838" STUDY_ID="STD-Norrby-1998" TOTAL_1="314" TOTAL_2="305" VAR="0.01706600986431954" WEIGHT="15.527651688341217"/>
<DICH_DATA CI_END="1.8165256832791987" CI_START="0.33301938815029664" EFFECT_SIZE="0.7777777777777778" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" LOG_CI_END="0.25924154259376825" LOG_CI_START="-0.4775304814439043" LOG_EFFECT_SIZE="-0.10914446942506803" ORDER="489" O_E="0.0" SE="0.4327835340000672" STUDY_ID="STD-Peterson-1988" TOTAL_1="30" TOTAL_2="30" VAR="0.1873015873015873" WEIGHT="1.620542292164648"/>
<DICH_DATA CI_END="1.5660492289920993" CI_START="0.7548689795862338" EFFECT_SIZE="1.0872727272727272" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="44" LOG_CI_END="0.19480541004860086" LOG_CI_START="-0.12212842106026693" LOG_EFFECT_SIZE="0.036338494494166956" ORDER="490" O_E="0.0" SE="0.186168501241115" STUDY_ID="STD-Petitpretz-2001" TOTAL_1="200" TOTAL_2="208" VAR="0.034658710854363034" WEIGHT="7.7673051040571375"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="26.76474423319894" CI_END="1.0232124707601709" CI_START="0.7964581522391514" DF="19" EFFECT_SIZE="0.90274354819611" ESTIMABLE="YES" EVENTS_1="450" EVENTS_2="353" I2="29.011090730198593" ID="CMP-001.12.02" LOG_CI_END="0.009965824618879971" LOG_CI_START="-0.09883703810398828" LOG_EFFECT_SIZE="-0.04443560674255415" MODIFIED="2011-10-11 21:37:40 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.11025335006424819" P_Z="0.10939525264956397" STUDIES="20" TAU2="0.0" TOTAL_1="2073" TOTAL_2="1689" WEIGHT="69.70698066794183" Z="1.600917230797941">
<NAME>B</NAME>
<DICH_DATA CI_END="1.3214574081413286" CI_START="0.37833151618610517" EFFECT_SIZE="0.7070707070707071" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="22" LOG_CI_END="0.12105316995937764" LOG_CI_START="-0.4221274791259638" LOG_EFFECT_SIZE="-0.1505371545832931" ORDER="491" O_E="0.0" SE="0.31906700206030675" STUDY_ID="STD-Aubier-1998" TOTAL_1="126" TOTAL_2="140" VAR="0.1018037518037518" WEIGHT="3.752834781854974"/>
<DICH_DATA CI_END="1.203850666497277" CI_START="0.20530039753790533" EFFECT_SIZE="0.49714285714285716" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="10" LOG_CI_END="0.08057261753764383" LOG_CI_START="-0.6876102096729957" LOG_EFFECT_SIZE="-0.3035187960676759" ORDER="492" O_E="0.0" SE="0.4512343952698513" STUDY_ID="STD-Bohte-1995" TOTAL_1="35" TOTAL_2="29" VAR="0.2036124794745484" WEIGHT="1.9694090356167597"/>
<DICH_DATA CI_END="1.3344254423156148" CI_START="0.4470361807057921" EFFECT_SIZE="0.7723577235772358" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="24" LOG_CI_END="0.12529431368330868" LOG_CI_START="-0.349657325984409" LOG_EFFECT_SIZE="-0.11218150615055017" ORDER="493" O_E="0.0" SE="0.2789889441893509" STUDY_ID="STD-Carbon-1992" TOTAL_1="123" TOTAL_2="120" VAR="0.07783483097988873" WEIGHT="4.374797299012384"/>
<DICH_DATA CI_END="2.7163637226662987" CI_START="0.28231174199774495" EFFECT_SIZE="0.8757062146892656" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.4339879217832775" LOG_CI_START="-0.5492710581663077" LOG_EFFECT_SIZE="-0.05764156819151513" ORDER="494" O_E="0.0" SE="0.5775711920328345" STUDY_ID="STD-Chuard-1989" TOTAL_1="59" TOTAL_2="62" VAR="0.3335884818662293" WEIGHT="1.0535757050987795"/>
<DICH_DATA CI_END="2.102230118933325" CI_START="0.3494830898549799" EFFECT_SIZE="0.8571428571428571" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.32268025399138267" LOG_CI_START="-0.45657383325260914" LOG_EFFECT_SIZE="-0.06694678963061322" ORDER="495" O_E="0.0" SE="0.4577377082170635" STUDY_ID="STD-Fourrier-1986" TOTAL_1="20" TOTAL_2="20" VAR="0.20952380952380956" WEIGHT="1.2604217827947264"/>
<DICH_DATA CI_END="3.4624038633203176" CI_START="0.32310298333559356" EFFECT_SIZE="1.0576923076923077" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.5393777236727578" LOG_CI_START="-0.4906590319538684" LOG_EFFECT_SIZE="0.024359345859444693" ORDER="496" O_E="0.0" SE="0.6050486890192525" STUDY_ID="STD-Gleadhill-1986" TOTAL_1="26" TOTAL_2="22" VAR="0.36608391608391605" WEIGHT="0.7802611036348305"/>
<DICH_DATA CI_END="2.144644481217491" CI_START="0.3034542567633229" EFFECT_SIZE="0.8067226890756303" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.33135530927495327" LOG_CI_START="-0.517906765980878" LOG_EFFECT_SIZE="-0.09327572835296233" MODIFIED="2011-10-11 21:37:40 +1000" MODIFIED_BY="[Empty name]" ORDER="492" O_E="0.0" SE="0.49886074692034765" STUDY_ID="STD-Hatipoglu-2010" TOTAL_1="34" TOTAL_2="32" VAR="0.24886204481792717" WEIGHT="1.2986163822733543"/>
<DICH_DATA CI_END="1.9282513388396094" CI_START="0.6086401121429384" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.2851636415776451" LOG_CI_START="-0.21563942905922126" LOG_EFFECT_SIZE="0.03476210625921191" ORDER="497" O_E="0.0" SE="0.29417420270727607" STUDY_ID="STD-Hirata_x002d_Dulas-1991" TOTAL_1="24" TOTAL_2="26" VAR="0.08653846153846154" WEIGHT="2.0742941339707492"/>
<DICH_DATA CI_END="1.443503564398061" CI_START="0.6128857834811439" EFFECT_SIZE="0.9405864197530864" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="24" LOG_CI_END="0.15941786060780128" LOG_CI_START="-0.21262045244018643" LOG_EFFECT_SIZE="-0.026601295916192598" MODIFIED="2011-10-11 19:42:47 +1000" MODIFIED_BY="[Empty name]" ORDER="475" O_E="0.0" SE="0.21853714670373883" STUDY_ID="STD-Hong_x002d_yun-2007" TOTAL_1="54" TOTAL_2="53" VAR="0.047758484489411474" WEIGHT="4.361833459284286"/>
<DICH_DATA CI_END="4.2660503456694485" CI_START="0.05860221510366839" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.6300259764573879" LOG_CI_START="-1.2320859677853504" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="498" O_E="0.0" SE="1.093813773650968" STUDY_ID="STD-Kalbermatter-2000" TOTAL_1="28" TOTAL_2="56" VAR="1.1964285714285714" WEIGHT="0.4801606791598957"/>
<DICH_DATA CI_END="1.649147772920286" CI_START="0.7177241891450693" EFFECT_SIZE="1.0879491017964071" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="32" LOG_CI_END="0.21725957261750875" LOG_CI_START="-0.14404241668366938" LOG_EFFECT_SIZE="0.036608577966919686" ORDER="499" O_E="0.0" SE="0.2122305769892032" STUDY_ID="STD-Lephonte-2004" TOTAL_1="167" TOTAL_2="153" VAR="0.045041817809170104" WEIGHT="6.014012506477694"/>
<DICH_DATA CI_END="1.1655672270079651" CI_START="0.7467384445333052" EFFECT_SIZE="0.9329382927583827" ESTIMABLE="YES" EVENTS_1="197" EVENTS_2="69" LOG_CI_END="0.06653732760056165" LOG_CI_START="-0.1268314891982239" LOG_EFFECT_SIZE="-0.030147080798831105" ORDER="500" O_E="0.0" SE="0.11358580017868716" STUDY_ID="STD-Lode-1995" TOTAL_1="609" TOTAL_2="199" VAR="0.01290173400223265" WEIGHT="18.72849495573451"/>
<DICH_DATA CI_END="3.655277831125175" CI_START="0.6196836329905102" EFFECT_SIZE="1.5050301810865192" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.5629203924946599" LOG_CI_START="-0.20782997423240124" LOG_EFFECT_SIZE="0.17754520913112926" ORDER="501" O_E="0.0" SE="0.45274258069132295" STUDY_ID="STD-Miki-1984" TOTAL_1="71" TOTAL_2="68" VAR="0.20497584437103905" WEIGHT="1.2876251306248283"/>
<DICH_DATA CI_END="0.5735349127990342" CI_START="0.11910513011290594" EFFECT_SIZE="0.26136363636363635" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="28" LOG_CI_END="-0.24144014014376425" LOG_CI_START="-0.9240695321213873" LOG_EFFECT_SIZE="-0.5827548361325757" ORDER="502" O_E="0.0" SE="0.40097988391764294" STUDY_ID="STD-Rizzato-1997" TOTAL_1="110" TOTAL_2="115" VAR="0.1607848673066064" WEIGHT="4.929649639374929"/>
<DICH_DATA CI_END="3.068198954218383" CI_START="0.9148455606032033" EFFECT_SIZE="1.6753889674681754" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="14" LOG_CI_END="0.4868835175708553" LOG_CI_START="-0.038652215047086325" LOG_EFFECT_SIZE="0.2241156512618845" ORDER="503" O_E="0.0" SE="0.30870229078361094" STUDY_ID="STD-Romanelli-2002" TOTAL_1="101" TOTAL_2="103" VAR="0.09529710433504908" WEIGHT="2.4961294129856344"/>
<DICH_DATA CI_END="0.9151459649634782" CI_START="0.2672740345449367" EFFECT_SIZE="0.4945652173913043" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="28" LOG_CI_END="-0.038509630827043506" LOG_CI_START="-0.5730432305498423" LOG_EFFECT_SIZE="-0.3057764306884429" ORDER="504" O_E="0.0" SE="0.3139876824611645" STUDY_ID="STD-Tremolieres-1998" TOTAL_1="138" TOTAL_2="147" VAR="0.09858826473733306" WEIGHT="4.882475958615361"/>
<DICH_DATA CI_END="1.8117938612293691" CI_START="0.7690493144462788" EFFECT_SIZE="1.1804062126642771" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="31" LOG_CI_END="0.2581087838356645" LOG_CI_START="-0.11404581064692823" LOG_EFFECT_SIZE="0.07203148659436812" ORDER="505" O_E="0.0" SE="0.21860545099402817" STUDY_ID="STD-Tremolieres-2005" TOTAL_1="189" TOTAL_2="182" VAR="0.047788343204302454" WEIGHT="5.687186157408011"/>
<DICH_DATA CI_END="1.8110069918099756" CI_START="0.6440615664516371" EFFECT_SIZE="1.08" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="21" LOG_CI_END="0.2579201270112585" LOG_CI_START="-0.19107261603735906" LOG_EFFECT_SIZE="0.03342375548694973" ORDER="506" O_E="0.0" SE="0.2637405598166809" STUDY_ID="STD-Vanderdonckt--1990" TOTAL_1="75" TOTAL_2="81" VAR="0.06955908289241622" WEIGHT="3.6358320657540184"/>
<DICH_DATA CI_END="3.6650773639034675" CI_START="0.11496630950828501" EFFECT_SIZE="0.6491228070175439" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5640831463336992" LOG_CI_START="-0.939429409544692" LOG_EFFECT_SIZE="-0.1876731316054964" ORDER="507" O_E="0.0" SE="0.8831707178301498" STUDY_ID="STD-Vogel-1991" TOTAL_1="38" TOTAL_2="37" VAR="0.779990516832622" WEIGHT="0.5473831742422811"/>
<DICH_DATA CI_END="126.12592421227448" CI_START="0.3561402260936749" EFFECT_SIZE="6.702127659574468" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1008043616340277" LOG_CI_START="-0.4483789699262618" LOG_EFFECT_SIZE="0.826212695853883" ORDER="508" O_E="0.0" SE="1.4974029076195166" STUDY_ID="STD-Zeluff-1988" TOTAL_1="46" TOTAL_2="44" VAR="2.2422154677473825" WEIGHT="0.09198730402383873"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="130.6416413078046" CI_START="0.4063148022459062" DF="0" EFFECT_SIZE="7.2857142857142865" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" I2="0.0" ID="CMP-001.12.03" LOG_CI_END="2.1160816279934997" LOG_CI_START="-0.3911373558261404" LOG_EFFECT_SIZE="0.8624721360836796" NO="3" P_CHI2="1.0" P_Z="0.17751763900298193" STUDIES="1" TAU2="0.0" TOTAL_1="41" TOTAL_2="33" WEIGHT="0.09950698285221524" Z="1.348437719483176">
<NAME>C</NAME>
<DICH_DATA CI_END="130.6416413078046" CI_START="0.40631480224590605" EFFECT_SIZE="7.285714285714286" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.1160816279934997" LOG_CI_START="-0.39113735582614056" LOG_EFFECT_SIZE="0.8624721360836796" ORDER="509" O_E="0.0" SE="1.4727528420297875" STUDY_ID="STD-Kobayashi-1984" TOTAL_1="41" TOTAL_2="33" VAR="2.1690009337068163" WEIGHT="0.09950698285221524"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="29.66774389686158" CI_END="1.0364513535765298" CI_START="0.8416421031698167" CI_STUDY="95" CI_TOTAL="95" DF="27" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9339813151542989" ESTIMABLE="YES" EVENTS_1="621" EVENTS_2="519" I2="8.992068645785327" I2_Q="0.0" ID="CMP-001.13" LOG_CI_END="0.01554892305402778" LOG_CI_START="-0.0748725470532684" LOG_EFFECT_SIZE="-0.029661811999620313" METHOD="MH" MODIFIED="2012-07-02 22:16:20 +1000" MODIFIED_BY="[Empty name]" NO="13" P_CHI2="0.32928766608466997" P_Q="0.4937194673922274" P_Z="0.19848105935655277" Q="0.46841026266529207" RANDOM="NO" SCALE="36.67229211464778" SORT_BY="STUDY" STUDIES="28" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2919" TOTAL_2="2500" WEIGHT="100.0" Z="1.2858911310879642">
<NAME>Clinical failure per blinding</NAME>
<GROUP_LABEL_1>Atypical ABx</GROUP_LABEL_1>
<GROUP_LABEL_2>Non-atypical ABx</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours atypical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-atypical</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="17.36867025288499" CI_END="1.045932271790529" CI_START="0.7713531982854074" DF="17" EFFECT_SIZE="0.8982111127321608" ESTIMABLE="YES" EVENTS_1="238" EVENTS_2="262" I2="2.122616455475352" ID="CMP-001.13.01" LOG_CI_END="0.019503563173743684" LOG_CI_START="-0.11274671540905987" LOG_EFFECT_SIZE="-0.04662157611765811" MODIFIED="2012-07-02 22:16:20 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.4296716495016083" P_Z="0.16701039541671206" STUDIES="18" TAU2="0.0" TOTAL_1="1209" TOTAL_2="1206" WEIGHT="47.31377381933904" Z="1.3818739903204147">
<NAME>Non-blinded</NAME>
<DICH_DATA CI_END="1.203850666497277" CI_START="0.20530039753790533" EFFECT_SIZE="0.49714285714285716" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="10" LOG_CI_END="0.08057261753764383" LOG_CI_START="-0.6876102096729957" LOG_EFFECT_SIZE="-0.3035187960676759" ORDER="510" O_E="0.0" SE="0.4512343952698513" STUDY_ID="STD-Bohte-1995" TOTAL_1="35" TOTAL_2="29" VAR="0.2036124794745484" WEIGHT="1.9694090356167602"/>
<DICH_DATA CI_END="2.7163637226662987" CI_START="0.28231174199774495" EFFECT_SIZE="0.8757062146892656" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.4339879217832775" LOG_CI_START="-0.5492710581663077" LOG_EFFECT_SIZE="-0.05764156819151513" ORDER="511" O_E="0.0" SE="0.5775711920328345" STUDY_ID="STD-Chuard-1989" TOTAL_1="59" TOTAL_2="62" VAR="0.3335884818662293" WEIGHT="1.0535757050987797"/>
<DICH_DATA CI_END="4.482318710854454" CI_START="0.2105324342739262" EFFECT_SIZE="0.9714285714285714" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6515027333780666" LOG_CI_START="-0.6766809879941078" LOG_EFFECT_SIZE="-0.012589127308020516" ORDER="512" O_E="0.0" SE="0.78018169254947" STUDY_ID="STD-Feldman-2001" TOTAL_1="35" TOTAL_2="34" VAR="0.6086834733893557" WEIGHT="0.5480094707803159"/>
<DICH_DATA CI_END="2.102230118933325" CI_START="0.3494830898549799" EFFECT_SIZE="0.8571428571428571" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.32268025399138267" LOG_CI_START="-0.45657383325260914" LOG_EFFECT_SIZE="-0.06694678963061322" ORDER="513" O_E="0.0" SE="0.4577377082170635" STUDY_ID="STD-Fourrier-1986" TOTAL_1="20" TOTAL_2="20" VAR="0.20952380952380956" WEIGHT="1.2604217827947264"/>
<DICH_DATA CI_END="2.137439548505052" CI_START="0.36965885530785847" EFFECT_SIZE="0.8888888888888888" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="9" LOG_CI_END="0.32989384077006656" LOG_CI_START="-0.43219888566482917" LOG_EFFECT_SIZE="-0.05115252244738131" ORDER="514" O_E="0.0" SE="0.44765703992769446" STUDY_ID="STD-Genne-1997" TOTAL_1="56" TOTAL_2="56" VAR="0.2003968253968254" WEIGHT="1.6205422921646484"/>
<DICH_DATA CI_END="3.4624038633203176" CI_START="0.32310298333559356" EFFECT_SIZE="1.0576923076923077" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.5393777236727578" LOG_CI_START="-0.4906590319538684" LOG_EFFECT_SIZE="0.024359345859444693" ORDER="515" O_E="0.0" SE="0.6050486890192525" STUDY_ID="STD-Gleadhill-1986" TOTAL_1="26" TOTAL_2="22" VAR="0.36608391608391605" WEIGHT="0.7802611036348306"/>
<DICH_DATA CI_END="2.144644481217491" CI_START="0.3034542567633229" EFFECT_SIZE="0.8067226890756303" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.33135530927495327" LOG_CI_START="-0.517906765980878" LOG_EFFECT_SIZE="-0.09327572835296233" MODIFIED="2011-10-11 21:38:08 +1000" MODIFIED_BY="[Empty name]" ORDER="493" O_E="0.0" SE="0.49886074692034765" STUDY_ID="STD-Hatipoglu-2010" TOTAL_1="34" TOTAL_2="32" VAR="0.24886204481792717" WEIGHT="1.2986163822733545"/>
<DICH_DATA CI_END="1.9282513388396094" CI_START="0.6086401121429384" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.2851636415776451" LOG_CI_START="-0.21563942905922126" LOG_EFFECT_SIZE="0.03476210625921191" ORDER="516" O_E="0.0" SE="0.29417420270727607" STUDY_ID="STD-Hirata_x002d_Dulas-1991" TOTAL_1="24" TOTAL_2="26" VAR="0.08653846153846154" WEIGHT="2.0742941339707497"/>
<DICH_DATA CI_END="1.443503564398061" CI_START="0.6128857834811439" EFFECT_SIZE="0.9405864197530864" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="24" LOG_CI_END="0.15941786060780128" LOG_CI_START="-0.21262045244018643" LOG_EFFECT_SIZE="-0.026601295916192598" MODIFIED="2011-10-11 19:43:15 +1000" MODIFIED_BY="[Empty name]" ORDER="476" O_E="0.0" SE="0.21853714670373883" STUDY_ID="STD-Hong_x002d_yun-2007" TOTAL_1="54" TOTAL_2="53" VAR="0.047758484489411474" WEIGHT="4.361833459284287"/>
<DICH_DATA CI_END="4.2660503456694485" CI_START="0.05860221510366839" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.6300259764573879" LOG_CI_START="-1.2320859677853504" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="517" O_E="0.0" SE="1.093813773650968" STUDY_ID="STD-Kalbermatter-2000" TOTAL_1="28" TOTAL_2="56" VAR="1.1964285714285714" WEIGHT="0.4801606791598958"/>
<DICH_DATA CI_END="2.48381127526022" CI_START="0.28984751993000446" EFFECT_SIZE="0.8484848484848485" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.39511859423126344" LOG_CI_START="-0.5378304113025999" LOG_EFFECT_SIZE="-0.07135590853566824" ORDER="518" O_E="0.0" SE="0.5480188640226497" STUDY_ID="STD-Khan-1989" TOTAL_1="66" TOTAL_2="56" VAR="0.3003246753246753" WEIGHT="1.1689157517253201"/>
<DICH_DATA CI_END="2.2628158592596277" CI_START="0.46604366926357205" EFFECT_SIZE="1.0269230769230768" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="10" LOG_CI_END="0.35464921389230963" LOG_CI_START="-0.3315733871047952" LOG_EFFECT_SIZE="0.011537913393757216" MODIFIED="2012-07-02 22:16:20 +1000" MODIFIED_BY="[Empty name]" ORDER="988" O_E="0.0" SE="0.40309055268235816" STUDY_ID="STD-Kohno-2011" TOTAL_1="104" TOTAL_2="89" VAR="0.16248199366176896" WEIGHT="1.9405457499726357"/>
<DICH_DATA CI_END="1.2547827956845181" CI_START="0.7519203298154321" EFFECT_SIZE="0.9713375796178344" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="85" LOG_CI_END="0.09856855545884344" LOG_CI_START="-0.12382817291170159" LOG_EFFECT_SIZE="-0.01262980872642909" ORDER="519" O_E="0.0" SE="0.13063693912641838" STUDY_ID="STD-Norrby-1998" TOTAL_1="314" TOTAL_2="305" VAR="0.01706600986431954" WEIGHT="15.52765168834122"/>
<DICH_DATA CI_END="1.8165256832791987" CI_START="0.33301938815029664" EFFECT_SIZE="0.7777777777777778" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" LOG_CI_END="0.25924154259376825" LOG_CI_START="-0.4775304814439043" LOG_EFFECT_SIZE="-0.10914446942506803" ORDER="520" O_E="0.0" SE="0.4327835340000672" STUDY_ID="STD-Peterson-1988" TOTAL_1="30" TOTAL_2="30" VAR="0.1873015873015873" WEIGHT="1.6205422921646484"/>
<DICH_DATA CI_END="0.5735349127990342" CI_START="0.11910513011290594" EFFECT_SIZE="0.26136363636363635" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="28" LOG_CI_END="-0.24144014014376425" LOG_CI_START="-0.9240695321213873" LOG_EFFECT_SIZE="-0.5827548361325757" ORDER="521" O_E="0.0" SE="0.40097988391764294" STUDY_ID="STD-Rizzato-1997" TOTAL_1="110" TOTAL_2="115" VAR="0.1607848673066064" WEIGHT="4.92964963937493"/>
<DICH_DATA CI_END="3.068198954218383" CI_START="0.9148455606032033" EFFECT_SIZE="1.6753889674681754" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="14" LOG_CI_END="0.4868835175708553" LOG_CI_START="-0.038652215047086325" LOG_EFFECT_SIZE="0.2241156512618845" ORDER="522" O_E="0.0" SE="0.30870229078361094" STUDY_ID="STD-Romanelli-2002" TOTAL_1="101" TOTAL_2="103" VAR="0.09529710433504908" WEIGHT="2.496129412985635"/>
<DICH_DATA CI_END="1.8110069918099756" CI_START="0.6440615664516371" EFFECT_SIZE="1.08" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="21" LOG_CI_END="0.2579201270112585" LOG_CI_START="-0.19107261603735906" LOG_EFFECT_SIZE="0.03342375548694973" ORDER="523" O_E="0.0" SE="0.2637405598166809" STUDY_ID="STD-Vanderdonckt--1990" TOTAL_1="75" TOTAL_2="81" VAR="0.06955908289241622" WEIGHT="3.635832065754019"/>
<DICH_DATA CI_END="3.6650773639034675" CI_START="0.11496630950828501" EFFECT_SIZE="0.6491228070175439" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5640831463336992" LOG_CI_START="-0.939429409544692" LOG_EFFECT_SIZE="-0.1876731316054964" ORDER="524" O_E="0.0" SE="0.8831707178301498" STUDY_ID="STD-Vogel-1991" TOTAL_1="38" TOTAL_2="37" VAR="0.779990516832622" WEIGHT="0.5473831742422812"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.0" CI_END="0.0" CI_START="0.0" DF="0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" I2="0.0" ID="CMP-001.13.02" LOG_CI_END="-Infinity" LOG_CI_START="-Infinity" LOG_EFFECT_SIZE="-Infinity" NO="2" P_CHI2="0.0" P_Z="0.0" STUDIES="0" TAU2="0.0" TOTAL_1="0" TOTAL_2="0" WEIGHT="0.0" Z="0.0">
<NAME>Single-blind</NAME>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="12.312803023501992" CI_END="1.1142790413507446" CI_START="0.8376330456957743" DF="9" EFFECT_SIZE="0.9661040043191995" ESTIMABLE="YES" EVENTS_1="383" EVENTS_2="257" I2="26.905352235219702" ID="CMP-001.13.03" LOG_CI_END="0.04699396188230174" LOG_CI_START="-0.07694619751805368" LOG_EFFECT_SIZE="-0.014976117817875972" NO="3" P_CHI2="0.19624392523494605" P_Z="0.6357434928541781" STUDIES="10" TAU2="0.0" TOTAL_1="1710" TOTAL_2="1294" WEIGHT="52.68622618066095" Z="0.47365844441832006">
<NAME>Double or triple-blind</NAME>
<DICH_DATA CI_END="1.3214574081413286" CI_START="0.37833151618610517" EFFECT_SIZE="0.7070707070707071" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="22" LOG_CI_END="0.12105316995937764" LOG_CI_START="-0.4221274791259638" LOG_EFFECT_SIZE="-0.1505371545832931" ORDER="525" O_E="0.0" SE="0.31906700206030675" STUDY_ID="STD-Aubier-1998" TOTAL_1="126" TOTAL_2="140" VAR="0.1018037518037518" WEIGHT="3.752834781854975"/>
<DICH_DATA CI_END="1.3344254423156148" CI_START="0.4470361807057921" EFFECT_SIZE="0.7723577235772358" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="24" LOG_CI_END="0.12529431368330868" LOG_CI_START="-0.349657325984409" LOG_EFFECT_SIZE="-0.11218150615055017" ORDER="526" O_E="0.0" SE="0.2789889441893509" STUDY_ID="STD-Carbon-1992" TOTAL_1="123" TOTAL_2="120" VAR="0.07783483097988873" WEIGHT="4.374797299012384"/>
<DICH_DATA CI_END="130.6416413078046" CI_START="0.40631480224590605" EFFECT_SIZE="7.285714285714286" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.1160816279934997" LOG_CI_START="-0.39113735582614056" LOG_EFFECT_SIZE="0.8624721360836796" ORDER="527" O_E="0.0" SE="1.4727528420297875" STUDY_ID="STD-Kobayashi-1984" TOTAL_1="41" TOTAL_2="33" VAR="2.1690009337068163" WEIGHT="0.09950698285221525"/>
<DICH_DATA CI_END="1.649147772920286" CI_START="0.7177241891450693" EFFECT_SIZE="1.0879491017964071" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="32" LOG_CI_END="0.21725957261750875" LOG_CI_START="-0.14404241668366938" LOG_EFFECT_SIZE="0.036608577966919686" ORDER="528" O_E="0.0" SE="0.2122305769892032" STUDY_ID="STD-Lephonte-2004" TOTAL_1="167" TOTAL_2="153" VAR="0.045041817809170104" WEIGHT="6.014012506477695"/>
<DICH_DATA CI_END="1.1655672270079651" CI_START="0.7467384445333052" EFFECT_SIZE="0.9329382927583827" ESTIMABLE="YES" EVENTS_1="197" EVENTS_2="69" LOG_CI_END="0.06653732760056165" LOG_CI_START="-0.1268314891982239" LOG_EFFECT_SIZE="-0.030147080798831105" ORDER="529" O_E="0.0" SE="0.11358580017868716" STUDY_ID="STD-Lode-1995" TOTAL_1="609" TOTAL_2="199" VAR="0.01290173400223265" WEIGHT="18.728494955734515"/>
<DICH_DATA CI_END="3.655277831125175" CI_START="0.6196836329905102" EFFECT_SIZE="1.5050301810865192" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.5629203924946599" LOG_CI_START="-0.20782997423240124" LOG_EFFECT_SIZE="0.17754520913112926" ORDER="530" O_E="0.0" SE="0.45274258069132295" STUDY_ID="STD-Miki-1984" TOTAL_1="71" TOTAL_2="68" VAR="0.20497584437103905" WEIGHT="1.2876251306248285"/>
<DICH_DATA CI_END="1.5660492289920993" CI_START="0.7548689795862338" EFFECT_SIZE="1.0872727272727272" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="44" LOG_CI_END="0.19480541004860086" LOG_CI_START="-0.12212842106026693" LOG_EFFECT_SIZE="0.036338494494166956" ORDER="531" O_E="0.0" SE="0.186168501241115" STUDY_ID="STD-Petitpretz-2001" TOTAL_1="200" TOTAL_2="208" VAR="0.034658710854363034" WEIGHT="7.767305104057138"/>
<DICH_DATA CI_END="0.9151459649634782" CI_START="0.2672740345449367" EFFECT_SIZE="0.4945652173913043" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="28" LOG_CI_END="-0.038509630827043506" LOG_CI_START="-0.5730432305498423" LOG_EFFECT_SIZE="-0.3057764306884429" ORDER="532" O_E="0.0" SE="0.3139876824611645" STUDY_ID="STD-Tremolieres-1998" TOTAL_1="138" TOTAL_2="147" VAR="0.09858826473733306" WEIGHT="4.882475958615362"/>
<DICH_DATA CI_END="1.8117938612293691" CI_START="0.7690493144462788" EFFECT_SIZE="1.1804062126642771" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="31" LOG_CI_END="0.2581087838356645" LOG_CI_START="-0.11404581064692823" LOG_EFFECT_SIZE="0.07203148659436812" ORDER="533" O_E="0.0" SE="0.21860545099402817" STUDY_ID="STD-Tremolieres-2005" TOTAL_1="189" TOTAL_2="182" VAR="0.047788343204302454" WEIGHT="5.687186157408012"/>
<DICH_DATA CI_END="126.12592421227448" CI_START="0.3561402260936749" EFFECT_SIZE="6.702127659574468" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1008043616340277" LOG_CI_START="-0.4483789699262618" LOG_EFFECT_SIZE="0.826212695853883" ORDER="534" O_E="0.0" SE="1.4974029076195166" STUDY_ID="STD-Zeluff-1988" TOTAL_1="46" TOTAL_2="44" VAR="2.2422154677473825" WEIGHT="0.09198730402383874"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="16.518050732318198" CI_END="1.0157351484920263" CI_START="0.8471162792518776" CI_STUDY="95" CI_TOTAL="95" DF="27" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9276021667158387" ESTIMABLE="YES" EVENTS_1="757" EVENTS_2="664" I2="0.0" I2_Q="0.0" ID="CMP-001.14" LOG_CI_END="0.006780481035255223" LOG_CI_START="-0.07205697222963083" LOG_EFFECT_SIZE="-0.03263824559718781" METHOD="MH" MODIFIED="2012-07-23 16:44:10 +1000" MODIFIED_BY="[Empty name]" NO="14" P_CHI2="0.9423417166300094" P_Q="0.8282068569914389" P_Z="0.10462632710204608" Q="0.3769847850472666" RANDOM="NO" SCALE="35.49871572093805" SORT_BY="STUDY" STUDIES="28" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="3060" TOTAL_2="2622" WEIGHT="100.00000000000001" Z="1.6228273045332642">
<NAME>Clinical failure - ITT analysis</NAME>
<GROUP_LABEL_1>Atypical ABx</GROUP_LABEL_1>
<GROUP_LABEL_2>Non-atypical ABx</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours atypical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-atypical</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="0.8165768955074998" CI_END="1.1182271017286924" CI_START="0.7601896882475974" DF="6" EFFECT_SIZE="0.9219895399911807" ESTIMABLE="YES" EVENTS_1="231" EVENTS_2="110" I2="0.0" ID="CMP-001.14.01" LOG_CI_END="0.04853001375755621" LOG_CI_START="-0.11907802577151112" LOG_EFFECT_SIZE="-0.035274006006977464" NO="1" P_CHI2="0.9916218101727283" P_Z="0.40938877182166244" STUDIES="7" TAU2="0.0" TOTAL_1="805" TOTAL_2="427" WEIGHT="20.33963110718456" Z="0.8249697515510348">
<NAME>ITT studies (type 1)</NAME>
<DICH_DATA CI_END="2.7163637226662987" CI_START="0.28231174199774495" EFFECT_SIZE="0.8757062146892656" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.4339879217832775" LOG_CI_START="-0.5492710581663077" LOG_EFFECT_SIZE="-0.05764156819151513" ORDER="535" O_E="0.0" SE="0.5775711920328345" STUDY_ID="STD-Chuard-1989" TOTAL_1="59" TOTAL_2="62" VAR="0.3335884818662293" WEIGHT="0.8317068172758231"/>
<DICH_DATA CI_END="4.482318710854454" CI_START="0.2105324342739262" EFFECT_SIZE="0.9714285714285714" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6515027333780666" LOG_CI_START="-0.6766809879941078" LOG_EFFECT_SIZE="-0.012589127308020516" ORDER="536" O_E="0.0" SE="0.78018169254947" STUDY_ID="STD-Feldman-2001" TOTAL_1="35" TOTAL_2="34" VAR="0.6086834733893557" WEIGHT="0.43260603919959606"/>
<DICH_DATA CI_END="2.102230118933325" CI_START="0.3494830898549799" EFFECT_SIZE="0.8571428571428571" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.32268025399138267" LOG_CI_START="-0.45657383325260914" LOG_EFFECT_SIZE="-0.06694678963061322" ORDER="537" O_E="0.0" SE="0.4577377082170635" STUDY_ID="STD-Fourrier-1986" TOTAL_1="20" TOTAL_2="20" VAR="0.20952380952380956" WEIGHT="0.9949938901590708"/>
<DICH_DATA CI_END="1.9282513388396094" CI_START="0.6086401121429384" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.2851636415776451" LOG_CI_START="-0.21563942905922126" LOG_EFFECT_SIZE="0.03476210625921191" ORDER="538" O_E="0.0" SE="0.29417420270727607" STUDY_ID="STD-Hirata_x002d_Dulas-1991" TOTAL_1="24" TOTAL_2="26" VAR="0.08653846153846154" WEIGHT="1.6374756592332136"/>
<DICH_DATA CI_END="4.2660503456694485" CI_START="0.05860221510366839" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.6300259764573879" LOG_CI_START="-1.2320859677853504" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="539" O_E="0.0" SE="1.093813773650968" STUDY_ID="STD-Kalbermatter-2000" TOTAL_1="28" TOTAL_2="56" VAR="1.1964285714285714" WEIGHT="0.3790452914891698"/>
<DICH_DATA CI_END="1.1655672270079651" CI_START="0.7467384445333052" EFFECT_SIZE="0.9329382927583827" ESTIMABLE="YES" EVENTS_1="197" EVENTS_2="69" LOG_CI_END="0.06653732760056165" LOG_CI_START="-0.1268314891982239" LOG_EFFECT_SIZE="-0.030147080798831105" ORDER="540" O_E="0.0" SE="0.11358580017868716" STUDY_ID="STD-Lode-1995" TOTAL_1="609" TOTAL_2="199" VAR="0.01290173400223265" WEIGHT="14.78452555105174"/>
<DICH_DATA CI_END="1.8165256832791987" CI_START="0.33301938815029664" EFFECT_SIZE="0.7777777777777778" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" LOG_CI_END="0.25924154259376825" LOG_CI_START="-0.4775304814439043" LOG_EFFECT_SIZE="-0.10914446942506803" ORDER="541" O_E="0.0" SE="0.4327835340000672" STUDY_ID="STD-Peterson-1988" TOTAL_1="30" TOTAL_2="30" VAR="0.1873015873015873" WEIGHT="1.2792778587759481"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="11.688979318800715" CI_END="1.0480017386783171" CI_START="0.8424567055260799" DF="14" EFFECT_SIZE="0.9396255063335279" ESTIMABLE="YES" EVENTS_1="470" EVENTS_2="489" I2="0.0" ID="CMP-001.14.02" LOG_CI_END="0.02036200316084961" LOG_CI_START="-0.07445240859816757" LOG_EFFECT_SIZE="-0.027045202718658977" MODIFIED="2012-07-03 01:12:36 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.6312644153333078" P_Z="0.26350965427978357" STUDIES="15" TAU2="0.0" TOTAL_1="1952" TOTAL_2="1897" WEIGHT="70.28028262803622" Z="1.1181343067946656">
<NAME>Dropouts assumed as failure (type 2)</NAME>
<DICH_DATA CI_END="1.3440978140808661" CI_START="0.694803100722693" EFFECT_SIZE="0.9663763909046927" ESTIMABLE="YES" EVENTS_1="47" EVENTS_2="52" LOG_CI_END="0.1284308747965502" LOG_CI_START="-0.1581382520790687" LOG_EFFECT_SIZE="-0.014853688641259273" ORDER="542" O_E="0.0" SE="0.16833212366679448" STUDY_ID="STD-Aubier-1998" TOTAL_1="159" TOTAL_2="170" VAR="0.028335703858172988" WEIGHT="7.144254870894657"/>
<DICH_DATA CI_END="1.1973292271727956" CI_START="0.23487383216445235" EFFECT_SIZE="0.5303030303030303" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="11" LOG_CI_END="0.07821358389426702" LOG_CI_START="-0.6291653662774532" LOG_EFFECT_SIZE="-0.27547589119159305" ORDER="543" O_E="0.0" SE="0.4155178969131446" STUDY_ID="STD-Bohte-1995" TOTAL_1="36" TOTAL_2="30" VAR="0.17265512265512267" WEIGHT="1.7057038117012642"/>
<DICH_DATA CI_END="1.3725556891196866" CI_START="0.48170295722139295" EFFECT_SIZE="0.81312" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="25" LOG_CI_END="0.13752997424178923" LOG_CI_START="-0.3172206875012386" LOG_EFFECT_SIZE="-0.0898453566297247" ORDER="544" O_E="0.0" SE="0.2671227897599347" STUDY_ID="STD-Carbon-1992" TOTAL_1="125" TOTAL_2="121" VAR="0.07135458480913026" WEIGHT="3.611330902145292"/>
<DICH_DATA CI_END="1.436717070877362" CI_START="0.4018884643449093" EFFECT_SIZE="0.7598684210526315" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="16" LOG_CI_END="0.15737125202105387" LOG_CI_START="-0.3958944594542728" LOG_EFFECT_SIZE="-0.11926160371660946" ORDER="545" O_E="0.0" SE="0.324991017630048" STUDY_ID="STD-Khan-1989" TOTAL_1="76" TOTAL_2="66" VAR="0.10561916154021417" WEIGHT="2.4344317312543864"/>
<DICH_DATA CI_END="33.01659237457657" CI_START="0.4962117158784664" EFFECT_SIZE="4.0476190476190474" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="1" LOG_CI_END="1.5187322479308425" LOG_CI_START="-0.3043329859700955" LOG_EFFECT_SIZE="0.6071996309803734" ORDER="546" O_E="0.0" SE="1.070877542711861" STUDY_ID="STD-Kobayashi-1984" TOTAL_1="42" TOTAL_2="34" VAR="1.146778711484594" WEIGHT="0.1571042984461691"/>
<DICH_DATA CI_END="1.2449359366980368" CI_START="0.5112515715791635" EFFECT_SIZE="0.7977941176470589" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="32" LOG_CI_END="0.09514700359691233" LOG_CI_START="-0.29136534396825065" LOG_EFFECT_SIZE="-0.09810917018566917" MODIFIED="2012-07-03 01:12:36 +1000" MODIFIED_BY="[Empty name]" ORDER="996" O_E="0.0" SE="0.22703926622675397" STUDY_ID="STD-Kohno-2011" TOTAL_1="136" TOTAL_2="124" VAR="0.051546828408782865" WEIGHT="4.758476274694809"/>
<DICH_DATA CI_END="1.5450556192809795" CI_START="0.6929144859780424" EFFECT_SIZE="1.0346938775510204" ESTIMABLE="YES" EVENTS_1="39" EVENTS_2="35" LOG_CI_END="0.18894411787867882" LOG_CI_START="-0.15932035926903426" LOG_EFFECT_SIZE="0.014811879304822303" ORDER="547" O_E="0.0" SE="0.20457227781353185" STUDY_ID="STD-Lephonte-2004" TOTAL_1="168" TOTAL_2="156" VAR="0.041849816849816854" WEIGHT="5.159227578602589"/>
<DICH_DATA CI_END="2.3175919861676086" CI_START="0.5715297997232166" EFFECT_SIZE="1.1509009009009008" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="12" LOG_CI_END="0.36503698048307004" LOG_CI_START="-0.2429611204428843" LOG_EFFECT_SIZE="0.06103793002009287" ORDER="548" O_E="0.0" SE="0.35714109412304396" STUDY_ID="STD-Miki-1984" TOTAL_1="74" TOTAL_2="73" VAR="0.12754976111140495" WEIGHT="1.717307238991749"/>
<DICH_DATA CI_END="1.289643601001091" CI_START="0.7814116749391238" EFFECT_SIZE="1.0038638186192317" ESTIMABLE="YES" EVENTS_1="90" EVENTS_2="86" LOG_CI_END="0.11046970758297701" LOG_CI_START="-0.10712010434266496" LOG_EFFECT_SIZE="0.0016748016201560555" ORDER="549" O_E="0.0" SE="0.12781333261206218" STUDY_ID="STD-Norrby-1998" TOTAL_1="319" TOTAL_2="306" VAR="0.016336247993401637" WEIGHT="12.478474232056662"/>
<DICH_DATA CI_END="1.6325905088100303" CI_START="0.7975246842443322" EFFECT_SIZE="1.141065830721003" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="44" LOG_CI_END="0.21287726736650545" LOG_CI_START="-0.0982558661827557" LOG_EFFECT_SIZE="0.05731070059187485" ORDER="550" O_E="0.0" SE="0.18276114278068603" STUDY_ID="STD-Petitpretz-2001" TOTAL_1="203" TOTAL_2="208" VAR="0.0334016353105023" WEIGHT="6.178161575878221"/>
<DICH_DATA CI_END="0.929634700613738" CI_START="0.3291970307741333" EFFECT_SIZE="0.5532024793388429" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="32" LOG_CI_END="-0.03168767367599473" LOG_CI_START="-0.48254409060504383" LOG_EFFECT_SIZE="-0.2571158821405193" ORDER="551" O_E="0.0" SE="0.26483529107938086" STUDY_ID="STD-Rizzato-1997" TOTAL_1="121" TOTAL_2="119" VAR="0.07013773140110038" WEIGHT="4.586448027018955"/>
<DICH_DATA CI_END="1.3104042640247497" CI_START="0.671148109883223" EFFECT_SIZE="0.9378034682080925" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="50" LOG_CI_END="0.11740529760270359" LOG_CI_START="-0.1731816285538105" LOG_EFFECT_SIZE="-0.027888165475553475" ORDER="552" O_E="0.0" SE="0.1706921988528195" STUDY_ID="STD-Tremolieres-1998" TOTAL_1="173" TOTAL_2="169" VAR="0.02913582674921048" WEIGHT="7.19022318285377"/>
<DICH_DATA CI_END="1.3839266884272692" CI_START="0.6982577559203741" EFFECT_SIZE="0.9830246913580247" ESTIMABLE="YES" EVENTS_1="49" EVENTS_2="48" LOG_CI_END="0.14111308458982144" LOG_CI_START="-0.15598423166030723" LOG_EFFECT_SIZE="-0.007435573535242888" ORDER="553" O_E="0.0" SE="0.17451643422075946" STUDY_ID="STD-Tremolieres-2005" TOTAL_1="189" TOTAL_2="182" VAR="0.030455985813128666" WEIGHT="6.951547609952323"/>
<DICH_DATA CI_END="1.6478006218556365" CI_START="0.6989288656149799" EFFECT_SIZE="1.0731707317073171" ESTIMABLE="YES" EVENTS_1="28" EVENTS_2="28" LOG_CI_END="0.2169046624180318" LOG_CI_START="-0.15556702288512786" LOG_EFFECT_SIZE="0.030668819766451964" ORDER="554" O_E="0.0" SE="0.21879171171165407" STUDY_ID="STD-Vanderdonckt--1990" TOTAL_1="82" TOTAL_2="88" VAR="0.04786981311371555" WEIGHT="3.8395058349667672"/>
<DICH_DATA CI_END="1.4595983563334198" CI_START="0.4340139496125246" EFFECT_SIZE="0.7959183673469388" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="17" LOG_CI_END="0.16423336563004026" LOG_CI_START="-0.36249631163406915" LOG_EFFECT_SIZE="-0.09913147300201446" ORDER="555" O_E="0.0" SE="0.30940361977889114" STUDY_ID="STD-Vogel-1991" TOTAL_1="49" TOTAL_2="51" VAR="0.09573059993228063" WEIGHT="2.3680854585785887"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="3.5943062657509497" CI_END="1.1516687918277346" CI_START="0.6268895159664114" DF="5" EFFECT_SIZE="0.8496876434681808" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="65" I2="0.0" ID="CMP-001.14.03" LOG_CI_END="0.06132759838986599" LOG_CI_START="-0.20280899319503165" LOG_EFFECT_SIZE="-0.07074069740258283" MODIFIED="2012-07-23 16:44:10 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.6091685531542536" P_Z="0.29379643359648566" STUDIES="6" TAU2="0.0" TOTAL_1="303" TOTAL_2="298" WEIGHT="9.38008626477923" Z="1.0498296984781414">
<NAME>Non-ITT, dropouts cannot be calculated (type 3)</NAME>
<DICH_DATA CI_END="2.137439548505052" CI_START="0.36965885530785847" EFFECT_SIZE="0.8888888888888888" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="9" LOG_CI_END="0.32989384077006656" LOG_CI_START="-0.43219888566482917" LOG_EFFECT_SIZE="-0.05115252244738131" ORDER="556" O_E="0.0" SE="0.44765703992769446" STUDY_ID="STD-Genne-1997" TOTAL_1="56" TOTAL_2="56" VAR="0.2003968253968254" WEIGHT="1.2792778587759481"/>
<DICH_DATA CI_END="7.053566626941115" CI_START="0.20415203770811727" EFFECT_SIZE="1.2" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8484087729796358" LOG_CI_START="-0.690046280884386" LOG_EFFECT_SIZE="0.07918124604762482" ORDER="557" O_E="0.0" SE="0.9036961141150639" STUDY_ID="STD-Gleadhill-1986" TOTAL_1="10" TOTAL_2="12" VAR="0.8166666666666667" WEIGHT="0.2584399714698885"/>
<DICH_DATA CI_END="2.144644481217491" CI_START="0.3034542567633229" EFFECT_SIZE="0.8067226890756303" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.33135530927495327" LOG_CI_START="-0.517906765980878" LOG_EFFECT_SIZE="-0.09327572835296233" MODIFIED="2011-10-11 21:38:54 +1000" MODIFIED_BY="[Empty name]" ORDER="494" O_E="0.0" SE="0.49886074692034765" STUDY_ID="STD-Hatipoglu-2010" TOTAL_1="34" TOTAL_2="32" VAR="0.24886204481792717" WEIGHT="1.025145220163891"/>
<DICH_DATA CI_END="1.443503564398061" CI_START="0.6128857834811439" EFFECT_SIZE="0.9405864197530864" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="24" LOG_CI_END="0.15941786060780128" LOG_CI_START="-0.21262045244018643" LOG_EFFECT_SIZE="-0.026601295916192598" MODIFIED="2011-10-11 19:43:43 +1000" MODIFIED_BY="[Empty name]" ORDER="477" O_E="0.0" SE="0.21853714670373883" STUDY_ID="STD-Hong_x002d_yun-2007" TOTAL_1="54" TOTAL_2="53" VAR="0.047758484489411474" WEIGHT="3.443289937639935"/>
<DICH_DATA CI_END="1.0930806718247068" CI_START="0.32592410561418356" EFFECT_SIZE="0.5968763191219923" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="23" LOG_CI_END="0.03865221504708633" LOG_CI_START="-0.48688351757085535" LOG_EFFECT_SIZE="-0.2241156512618845" ORDER="558" O_E="0.0" SE="0.30870229078361094" STUDY_ID="STD-Romanelli-2002" TOTAL_1="103" TOTAL_2="101" VAR="0.09529710433504908" WEIGHT="3.3013172630067773"/>
<DICH_DATA CI_END="126.12592421227448" CI_START="0.3561402260936749" EFFECT_SIZE="6.702127659574468" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1008043616340277" LOG_CI_START="-0.4483789699262618" LOG_EFFECT_SIZE="0.826212695853883" ORDER="559" O_E="0.0" SE="1.4974029076195166" STUDY_ID="STD-Zeluff-1988" TOTAL_1="46" TOTAL_2="44" VAR="2.2422154677473825" WEIGHT="0.07261601372278934"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="10.790109952062023" CI_END="1.6971204994892273" CI_START="0.8780189471366533" CI_STUDY="95" CI_TOTAL="95" DF="16" EFFECT_MEASURE="RR" EFFECT_SIZE="1.2206981420996603" ESTIMABLE="YES" EVENTS_1="67" EVENTS_2="48" I2="0.0" I2_Q="0.0" ID="CMP-001.15" LOG_CI_END="0.22971267932730668" LOG_CI_START="-0.056496112171219574" LOG_EFFECT_SIZE="0.08660828357804355" METHOD="MH" MODIFIED="2012-07-03 00:23:23 +1000" MODIFIED_BY="[Empty name]" NO="15" P_CHI2="0.8222516590121092" P_Q="1.0" P_Z="0.23554698282789466" Q="0.0" RANDOM="NO" SCALE="35.78847901832285" SORT_BY="STUDY" STUDIES="18" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="549" TOTAL_2="472" WEIGHT="100.0" Z="1.1861907923025579">
<NAME>Clinical failure - pneumococcal pneumonia</NAME>
<GROUP_LABEL_1>Atypical ABx</GROUP_LABEL_1>
<GROUP_LABEL_2>Non-atypical ABx</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours atypical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-atypical</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.2465676006111113" CI_START="0.45751444147363746" EFFECT_SIZE="1.21875" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="6" LOG_CI_END="0.5114244502602832" LOG_CI_START="-0.33959519284709677" LOG_EFFECT_SIZE="0.08591462870659324" ORDER="560" O_E="0.0" SE="0.49989315097644854" STUDY_ID="STD-Aubier-1998" TOTAL_1="80" TOTAL_2="65" VAR="0.2498931623931624" WEIGHT="12.409742501722462"/>
<DICH_DATA CI_END="1.9664269800517977" CI_START="0.46335665348193483" EFFECT_SIZE="0.9545454545454546" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="11" LOG_CI_END="0.293677824252323" LOG_CI_START="-0.334084596428897" LOG_EFFECT_SIZE="-0.02020338608828695" ORDER="561" O_E="0.0" SE="0.3687507533822477" STUDY_ID="STD-Carbon-1992" TOTAL_1="56" TOTAL_2="49" VAR="0.1359771181199753" WEIGHT="21.99282143360814"/>
<DICH_DATA CI_END="64.26151584089634" CI_START="0.14005271867976013" EFFECT_SIZE="3.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8079509657466573" LOG_CI_START="-0.8537084563073322" LOG_EFFECT_SIZE="0.47712125471966244" ORDER="562" O_E="0.0" SE="1.563471919941143" STUDY_ID="STD-Chuard-1989" TOTAL_1="8" TOTAL_2="8" VAR="2.444444444444444" WEIGHT="0.9371940951821651"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="563" O_E="0.0" SE="0.0" STUDY_ID="STD-Gleadhill-1986" TOTAL_1="5" TOTAL_2="7" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="2.426496348204678" CI_START="0.08140579496181002" EFFECT_SIZE="0.4444444444444444" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.3849796420532204" LOG_CI_START="-1.0893446782759455" LOG_EFFECT_SIZE="-0.35218251811136253" ORDER="564" O_E="0.0" SE="0.8660254037844386" STUDY_ID="STD-Hirata_x002d_Dulas-1991" TOTAL_1="3" TOTAL_2="4" VAR="0.75" WEIGHT="4.819855346651135"/>
<DICH_DATA CI_END="18.573610852180913" CI_START="0.0538398272666825" EFFECT_SIZE="1.0" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.2688963421207617" LOG_CI_START="-1.2688963421207617" LOG_EFFECT_SIZE="0.0" ORDER="565" O_E="0.0" SE="1.4907119849998596" STUDY_ID="STD-Kobayashi-1984" TOTAL_1="8" TOTAL_2="2" VAR="2.222222222222222" WEIGHT="1.4057911427732477"/>
<DICH_DATA CI_END="67.95810673223356" CI_START="0.12314384333797562" EFFECT_SIZE="2.892857142857143" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.832241271209411" LOG_CI_START="-0.9095872961365497" LOG_EFFECT_SIZE="0.46132698753643053" MODIFIED="2012-07-03 00:23:23 +1000" MODIFIED_BY="[Empty name]" ORDER="506" O_E="0.0" SE="1.6105636727293162" STUDY_ID="STD-Kohno-2011" TOTAL_1="27" TOTAL_2="26" VAR="2.5939153439153437" WEIGHT="0.9542339878218408"/>
<DICH_DATA CI_END="18.70139102320895" CI_START="0.17830724830257294" EFFECT_SIZE="1.826086956521739" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.2718739108806743" LOG_CI_START="-0.7488310021200593" LOG_EFFECT_SIZE="0.26152145438030755" ORDER="566" O_E="0.0" SE="1.1869720685472709" STUDY_ID="STD-Lephonte-2004" TOTAL_1="23" TOTAL_2="21" VAR="1.4089026915113871" WEIGHT="1.9595876535627088"/>
<DICH_DATA CI_END="1.8052962947469926" CI_START="0.1994132492530557" EFFECT_SIZE="0.6" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="4" LOG_CI_END="0.25654849079198466" LOG_CI_START="-0.7002459900246975" LOG_EFFECT_SIZE="-0.2218487496163564" ORDER="567" O_E="0.0" SE="0.5620258142407837" STUDY_ID="STD-Lode-1995" TOTAL_1="105" TOTAL_2="28" VAR="0.31587301587301586" WEIGHT="11.838241202301033"/>
<DICH_DATA CI_END="7.22923756456156" CI_START="0.4236269693242174" EFFECT_SIZE="1.75" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="2" LOG_CI_END="0.8590924966079385" LOG_CI_START="-0.3730163992353497" LOG_EFFECT_SIZE="0.24303804868629444" ORDER="568" O_E="0.0" SE="0.7237468644557459" STUDY_ID="STD-Miki-1984" TOTAL_1="6" TOTAL_2="7" VAR="0.5238095238095237" WEIGHT="3.460408966826456"/>
<DICH_DATA CI_END="4.964349091600333" CI_START="0.3938597133175314" EFFECT_SIZE="1.3983050847457628" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6958623133635664" LOG_CI_START="-0.4046584395480046" LOG_EFFECT_SIZE="0.14560193690778092" ORDER="569" O_E="0.0" SE="0.6464513379258426" STUDY_ID="STD-Norrby-1998" TOTAL_1="59" TOTAL_2="66" VAR="0.417899332306112" WEIGHT="7.077689806815711"/>
<DICH_DATA CI_END="3.2224349190196233" CI_START="0.4223859116835813" EFFECT_SIZE="1.1666666666666667" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.508184155010369" LOG_CI_START="-0.37429057574914254" LOG_EFFECT_SIZE="0.06694678963061322" ORDER="570" O_E="0.0" SE="0.5183700251685057" STUDY_ID="STD-Petitpretz-2001" TOTAL_1="49" TOTAL_2="49" VAR="0.26870748299319724" WEIGHT="11.246329142185981"/>
<DICH_DATA CI_END="6.653147663128051" CI_START="0.5215304809028924" EFFECT_SIZE="1.8627450980392157" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="3" LOG_CI_END="0.8230271624915971" LOG_CI_START="-0.2827203041097743" LOG_EFFECT_SIZE="0.2701534291909114" ORDER="571" O_E="0.0" SE="0.6495215354198813" STUDY_ID="STD-Romanelli-2002" TOTAL_1="17" TOTAL_2="19" VAR="0.4218782249742002" WEIGHT="5.310766539365603"/>
<DICH_DATA CI_END="2.317968858579606" CI_START="0.007548294082399919" EFFECT_SIZE="0.13227513227513227" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.3651075970124413" LOG_CI_START="-2.1221511880148545" LOG_EFFECT_SIZE="-0.8785217955012066" ORDER="572" O_E="0.0" SE="1.4610281224545867" STUDY_ID="STD-Tremolieres-1998" TOTAL_1="20" TOTAL_2="24" VAR="2.134603174603175" WEIGHT="7.701290608236053"/>
<DICH_DATA CI_END="6.210604234391976" CI_START="0.6087755804167764" EFFECT_SIZE="1.9444444444444444" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.7931338550713448" LOG_CI_START="-0.21554277657740564" LOG_EFFECT_SIZE="0.28879553924696955" ORDER="573" O_E="0.0" SE="0.5925016464603292" STUDY_ID="STD-Tremolieres-2005" TOTAL_1="27" TOTAL_2="35" VAR="0.351058201058201" WEIGHT="6.530126598688635"/>
<DICH_DATA CI_END="100.2534754225905" CI_START="0.2216829860734229" EFFECT_SIZE="4.714285714285714" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.0010994369599615" LOG_CI_START="-0.6542676372327" LOG_EFFECT_SIZE="0.6734158998636307" ORDER="574" O_E="0.0" SE="1.5597757636597747" STUDY_ID="STD-Vanderdonckt--1990" TOTAL_1="6" TOTAL_2="10" VAR="2.432900432900433" WEIGHT="0.7289287406972396"/>
<DICH_DATA CI_END="109.34589972004233" CI_START="0.26667666620017927" EFFECT_SIZE="5.4" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="2.0388025023956353" LOG_CI_START="-0.5740149827496981" LOG_EFFECT_SIZE="0.7323937598229685" ORDER="575" O_E="0.0" SE="1.5347819244295116" STUDY_ID="STD-Vogel-1991" TOTAL_1="4" TOTAL_2="8" VAR="2.355555555555555" WEIGHT="0.6694243537015465"/>
<DICH_DATA CI_END="126.12592421227448" CI_START="0.3561402260936749" EFFECT_SIZE="6.702127659574468" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1008043616340277" LOG_CI_START="-0.4483789699262618" LOG_EFFECT_SIZE="0.826212695853883" ORDER="576" O_E="0.0" SE="1.4974029076195166" STUDY_ID="STD-Zeluff-1988" TOTAL_1="46" TOTAL_2="44" VAR="2.2422154677473825" WEIGHT="0.9575678798600383"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="2.0451687453213947" CI_END="1.0992243360998157" CI_START="0.2444875370031068" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.5184078033237146" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="17" I2="0.0" I2_Q="0.0" ID="CMP-001.16" LOG_CI_END="0.04108633481451492" LOG_CI_START="-0.6117432745719886" LOG_EFFECT_SIZE="-0.2853284698787369" METHOD="MH" MODIFIED="2008-06-22 17:06:48 +1000" MODIFIED_BY="[Empty name]" NO="16" P_CHI2="0.5630849277906035" P_Q="1.0" P_Z="0.08666466339168613" Q="0.0" RANDOM="NO" SCALE="20.18780305814245" SORT_BY="STUDY" STUDIES="4" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="80" TOTAL_2="78" WEIGHT="100.0" Z="1.713260295444582">
<NAME>Clinical failure - atypical pathogens</NAME>
<GROUP_LABEL_1>Atypical ABx</GROUP_LABEL_1>
<GROUP_LABEL_2>Non-atypical ABx</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours atypical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-atypical</GRAPH_LABEL_2>
<DICH_DATA CI_END="3.189166839918678" CI_START="0.015484519477394905" EFFECT_SIZE="0.2222222222222222" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="4" LOG_CI_END="0.503677239769994" LOG_CI_START="-1.8101022673206812" LOG_EFFECT_SIZE="-0.6532125137753437" ORDER="577" O_E="0.0" SE="1.359125535858341" STUDY_ID="STD-Aubier-1998" TOTAL_1="3" TOTAL_2="7" VAR="1.8472222222222223" WEIGHT="17.42118572516186"/>
<DICH_DATA CI_END="5.125422685194599" CI_START="0.012194116239532551" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.7097296867576527" LOG_CI_START="-1.9138496694135776" LOG_EFFECT_SIZE="-0.6020599913279624" ORDER="578" O_E="0.0" SE="1.541103500742244" STUDY_ID="STD-Carbon-1992" TOTAL_1="7" TOTAL_2="5" VAR="2.375" WEIGHT="9.954963271521061"/>
<DICH_DATA CI_END="1.4556790847585406" CI_START="0.06888728348694469" EFFECT_SIZE="0.31666666666666665" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.1630656420922933" LOG_CI_START="-1.1618609409539227" LOG_EFFECT_SIZE="-0.4993976494308147" ORDER="579" O_E="0.0" SE="0.7782684333737074" STUDY_ID="STD-Lode-1995" TOTAL_1="24" TOTAL_2="19" VAR="0.6057017543859649" WEIGHT="32.41150832588253"/>
<DICH_DATA CI_END="2.408912937092698" CI_START="0.31839436230142243" EFFECT_SIZE="0.8757763975155279" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.38182110401515834" LOG_CI_START="-0.4970346307680979" LOG_EFFECT_SIZE="-0.05760676337646981" ORDER="580" O_E="0.0" SE="0.5162442090177343" STUDY_ID="STD-Tremolieres-1998" TOTAL_1="46" TOTAL_2="47" VAR="0.2665080833443461" WEIGHT="40.21234267743454"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="0.8799394509138679" CI_END="0.6334108978485098" CI_START="0.04705323172085188" CI_STUDY="95" CI_TOTAL="95" DF="3" EFFECT_MEASURE="RR" EFFECT_SIZE="0.17263843648208466" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="9" I2="0.0" I2_Q="0.0" ID="CMP-001.17" LOG_CI_END="-0.19831446885365916" LOG_CI_START="-1.327410542899136" LOG_EFFECT_SIZE="-0.7628625058763975" METHOD="MH" MODIFIED="2008-06-22 17:07:00 +1000" MODIFIED_BY="[Empty name]" NO="17" P_CHI2="0.8302660851808303" P_Q="1.0" P_Z="0.008085935708322323" Q="0.0" RANDOM="NO" SCALE="98.38293388024195" SORT_BY="STUDY" STUDIES="5" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="23" TOTAL_2="20" WEIGHT="100.0" Z="2.648460252485995">
<NAME>Clinical failure - Legionella pneumophilae</NAME>
<GROUP_LABEL_1>Atypical ABx</GROUP_LABEL_1>
<GROUP_LABEL_2>Non-atypical ABx</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours atypical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-atypical</GRAPH_LABEL_2>
<DICH_DATA CI_END="4.214235200320645" CI_START="0.03026670661344635" EFFECT_SIZE="0.35714285714285715" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.624718770320707" LOG_CI_START="-1.5190348330051455" LOG_EFFECT_SIZE="-0.4471580313422192" ORDER="581" O_E="0.0" SE="1.2592514783450863" STUDY_ID="STD-Aubier-1998" TOTAL_1="1" TOTAL_2="4" VAR="1.5857142857142856" WEIGHT="18.24104234527687"/>
<DICH_DATA CI_END="4.231980022952686" CI_START="0.014768500716218706" EFFECT_SIZE="0.25" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.6265436089463424" LOG_CI_START="-1.830663591602267" LOG_EFFECT_SIZE="-0.6020599913279624" ORDER="582" O_E="0.0" SE="1.4433756729740643" STUDY_ID="STD-Carbon-1992" TOTAL_1="3" TOTAL_2="2" VAR="2.083333333333333" WEIGHT="15.635179153094459"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="583" O_E="0.0" SE="0.0" STUDY_ID="STD-Lephonte-2004" TOTAL_1="5" TOTAL_2="6" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="1.0333299593491778" CI_START="0.004301089312501584" EFFECT_SIZE="0.06666666666666667" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.01423902107742348" LOG_CI_START="-2.366421539188786" LOG_EFFECT_SIZE="-1.1760912590556813" ORDER="584" O_E="0.0" SE="1.398411797560202" STUDY_ID="STD-Lode-1995" TOTAL_1="8" TOTAL_2="2" VAR="1.9555555555555555" WEIGHT="34.20195439739413"/>
<DICH_DATA CI_END="2.28392967181282" CI_START="0.00893554802373033" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.35868272671310053" LOG_CI_START="-2.0488788067416146" LOG_EFFECT_SIZE="-0.8450980400142568" ORDER="585" O_E="0.0" SE="1.4142135623730951" STUDY_ID="STD-Tremolieres-1998" TOTAL_1="6" TOTAL_2="6" VAR="2.0" WEIGHT="31.921824104234524"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="29.667743896861587" CI_END="1.0364513535765298" CI_START="0.8416421031698167" CI_STUDY="95" CI_TOTAL="95" DF="27" EFFECT_MEASURE="RR" EFFECT_SIZE="0.9339813151542989" ESTIMABLE="YES" EVENTS_1="621" EVENTS_2="519" I2="8.99206864578535" I2_Q="55.81920978362659" ID="CMP-001.18" LOG_CI_END="0.01554892305402778" LOG_CI_START="-0.0748725470532684" LOG_EFFECT_SIZE="-0.029661811999620313" METHOD="MH" MODIFIED="2012-07-02 22:17:22 +1000" MODIFIED_BY="[Empty name]" NO="18" P_CHI2="0.32928766608466953" P_Q="0.10399360218806819" P_Z="0.19848105935655277" Q="4.526854296188663" RANDOM="NO" SCALE="49.983307980198845" SORT_BY="STUDY" STUDIES="28" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2919" TOTAL_2="2500" WEIGHT="100.0" Z="1.2858911310879642">
<NAME>Clinical failure per sponsorship</NAME>
<GROUP_LABEL_1>Atypical ABx</GROUP_LABEL_1>
<GROUP_LABEL_2>Non-atypical ABx</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours atypical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-atypical</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="18.4604196903921" CI_END="1.0849217077319584" CI_START="0.8646254529083192" DF="20" EFFECT_SIZE="0.9685302901395555" ESTIMABLE="YES" EVENTS_1="546" EVENTS_2="421" I2="0.0" ID="CMP-001.18.01" LOG_CI_END="0.035398398897163195" LOG_CI_START="-0.0631719838209598" LOG_EFFECT_SIZE="-0.013886792461898317" NO="1" P_CHI2="0.5571063221332819" P_Z="0.5807789448416798" STUDIES="21" TAU2="0.0" TOTAL_1="2488" TOTAL_2="2052" WEIGHT="82.57310092054605" Z="0.5522472843376479">
<NAME>Sponsored trials</NAME>
<DICH_DATA CI_END="1.3214574081413286" CI_START="0.37833151618610517" EFFECT_SIZE="0.7070707070707071" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="22" LOG_CI_END="0.12105316995937764" LOG_CI_START="-0.4221274791259638" LOG_EFFECT_SIZE="-0.1505371545832931" ORDER="586" O_E="0.0" SE="0.31906700206030675" STUDY_ID="STD-Aubier-1998" TOTAL_1="126" TOTAL_2="140" VAR="0.1018037518037518" WEIGHT="3.752834781854975"/>
<DICH_DATA CI_END="1.203850666497277" CI_START="0.20530039753790533" EFFECT_SIZE="0.49714285714285716" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="10" LOG_CI_END="0.08057261753764383" LOG_CI_START="-0.6876102096729957" LOG_EFFECT_SIZE="-0.3035187960676759" ORDER="587" O_E="0.0" SE="0.4512343952698513" STUDY_ID="STD-Bohte-1995" TOTAL_1="35" TOTAL_2="29" VAR="0.2036124794745484" WEIGHT="1.9694090356167602"/>
<DICH_DATA CI_END="1.3344254423156148" CI_START="0.4470361807057921" EFFECT_SIZE="0.7723577235772358" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="24" LOG_CI_END="0.12529431368330868" LOG_CI_START="-0.349657325984409" LOG_EFFECT_SIZE="-0.11218150615055017" ORDER="588" O_E="0.0" SE="0.2789889441893509" STUDY_ID="STD-Carbon-1992" TOTAL_1="123" TOTAL_2="120" VAR="0.07783483097988873" WEIGHT="4.374797299012384"/>
<DICH_DATA CI_END="2.7163637226662987" CI_START="0.28231174199774495" EFFECT_SIZE="0.8757062146892656" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="6" LOG_CI_END="0.4339879217832775" LOG_CI_START="-0.5492710581663077" LOG_EFFECT_SIZE="-0.05764156819151513" ORDER="589" O_E="0.0" SE="0.5775711920328345" STUDY_ID="STD-Chuard-1989" TOTAL_1="59" TOTAL_2="62" VAR="0.3335884818662293" WEIGHT="1.0535757050987797"/>
<DICH_DATA CI_END="4.482318710854454" CI_START="0.2105324342739262" EFFECT_SIZE="0.9714285714285714" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6515027333780666" LOG_CI_START="-0.6766809879941078" LOG_EFFECT_SIZE="-0.012589127308020516" ORDER="590" O_E="0.0" SE="0.78018169254947" STUDY_ID="STD-Feldman-2001" TOTAL_1="35" TOTAL_2="34" VAR="0.6086834733893557" WEIGHT="0.5480094707803159"/>
<DICH_DATA CI_END="2.102230118933325" CI_START="0.3494830898549799" EFFECT_SIZE="0.8571428571428571" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.32268025399138267" LOG_CI_START="-0.45657383325260914" LOG_EFFECT_SIZE="-0.06694678963061322" ORDER="591" O_E="0.0" SE="0.4577377082170635" STUDY_ID="STD-Fourrier-1986" TOTAL_1="20" TOTAL_2="20" VAR="0.20952380952380956" WEIGHT="1.2604217827947264"/>
<DICH_DATA CI_END="2.137439548505052" CI_START="0.36965885530785847" EFFECT_SIZE="0.8888888888888888" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="9" LOG_CI_END="0.32989384077006656" LOG_CI_START="-0.43219888566482917" LOG_EFFECT_SIZE="-0.05115252244738131" ORDER="592" O_E="0.0" SE="0.44765703992769446" STUDY_ID="STD-Genne-1997" TOTAL_1="56" TOTAL_2="56" VAR="0.2003968253968254" WEIGHT="1.6205422921646484"/>
<DICH_DATA CI_END="1.9282513388396094" CI_START="0.6086401121429384" EFFECT_SIZE="1.0833333333333333" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="12" LOG_CI_END="0.2851636415776451" LOG_CI_START="-0.21563942905922126" LOG_EFFECT_SIZE="0.03476210625921191" ORDER="593" O_E="0.0" SE="0.29417420270727607" STUDY_ID="STD-Hirata_x002d_Dulas-1991" TOTAL_1="24" TOTAL_2="26" VAR="0.08653846153846154" WEIGHT="2.0742941339707497"/>
<DICH_DATA CI_END="2.48381127526022" CI_START="0.28984751993000446" EFFECT_SIZE="0.8484848484848485" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="6" LOG_CI_END="0.39511859423126344" LOG_CI_START="-0.5378304113025999" LOG_EFFECT_SIZE="-0.07135590853566824" ORDER="594" O_E="0.0" SE="0.5480188640226497" STUDY_ID="STD-Khan-1989" TOTAL_1="66" TOTAL_2="56" VAR="0.3003246753246753" WEIGHT="1.1689157517253201"/>
<DICH_DATA CI_END="130.6416413078046" CI_START="0.40631480224590605" EFFECT_SIZE="7.285714285714286" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.1160816279934997" LOG_CI_START="-0.39113735582614056" LOG_EFFECT_SIZE="0.8624721360836796" ORDER="595" O_E="0.0" SE="1.4727528420297875" STUDY_ID="STD-Kobayashi-1984" TOTAL_1="41" TOTAL_2="33" VAR="2.1690009337068163" WEIGHT="0.09950698285221525"/>
<DICH_DATA CI_END="1.649147772920286" CI_START="0.7177241891450693" EFFECT_SIZE="1.0879491017964071" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="32" LOG_CI_END="0.21725957261750875" LOG_CI_START="-0.14404241668366938" LOG_EFFECT_SIZE="0.036608577966919686" ORDER="596" O_E="0.0" SE="0.2122305769892032" STUDY_ID="STD-Lephonte-2004" TOTAL_1="167" TOTAL_2="153" VAR="0.045041817809170104" WEIGHT="6.014012506477695"/>
<DICH_DATA CI_END="1.1655672270079651" CI_START="0.7467384445333052" EFFECT_SIZE="0.9329382927583827" ESTIMABLE="YES" EVENTS_1="197" EVENTS_2="69" LOG_CI_END="0.06653732760056165" LOG_CI_START="-0.1268314891982239" LOG_EFFECT_SIZE="-0.030147080798831105" ORDER="597" O_E="0.0" SE="0.11358580017868716" STUDY_ID="STD-Lode-1995" TOTAL_1="609" TOTAL_2="199" VAR="0.01290173400223265" WEIGHT="18.728494955734515"/>
<DICH_DATA CI_END="3.655277831125175" CI_START="0.6196836329905102" EFFECT_SIZE="1.5050301810865192" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="7" LOG_CI_END="0.5629203924946599" LOG_CI_START="-0.20782997423240124" LOG_EFFECT_SIZE="0.17754520913112926" ORDER="598" O_E="0.0" SE="0.45274258069132295" STUDY_ID="STD-Miki-1984" TOTAL_1="71" TOTAL_2="68" VAR="0.20497584437103905" WEIGHT="1.2876251306248285"/>
<DICH_DATA CI_END="1.2547827956845181" CI_START="0.7519203298154321" EFFECT_SIZE="0.9713375796178344" ESTIMABLE="YES" EVENTS_1="85" EVENTS_2="85" LOG_CI_END="0.09856855545884344" LOG_CI_START="-0.12382817291170159" LOG_EFFECT_SIZE="-0.01262980872642909" ORDER="599" O_E="0.0" SE="0.13063693912641838" STUDY_ID="STD-Norrby-1998" TOTAL_1="314" TOTAL_2="305" VAR="0.01706600986431954" WEIGHT="15.52765168834122"/>
<DICH_DATA CI_END="1.8165256832791987" CI_START="0.33301938815029664" EFFECT_SIZE="0.7777777777777778" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="9" LOG_CI_END="0.25924154259376825" LOG_CI_START="-0.4775304814439043" LOG_EFFECT_SIZE="-0.10914446942506803" ORDER="600" O_E="0.0" SE="0.4327835340000672" STUDY_ID="STD-Peterson-1988" TOTAL_1="30" TOTAL_2="30" VAR="0.1873015873015873" WEIGHT="1.6205422921646484"/>
<DICH_DATA CI_END="1.5660492289920993" CI_START="0.7548689795862338" EFFECT_SIZE="1.0872727272727272" ESTIMABLE="YES" EVENTS_1="46" EVENTS_2="44" LOG_CI_END="0.19480541004860086" LOG_CI_START="-0.12212842106026693" LOG_EFFECT_SIZE="0.036338494494166956" ORDER="601" O_E="0.0" SE="0.186168501241115" STUDY_ID="STD-Petitpretz-2001" TOTAL_1="200" TOTAL_2="208" VAR="0.034658710854363034" WEIGHT="7.767305104057138"/>
<DICH_DATA CI_END="3.068198954218383" CI_START="0.9148455606032033" EFFECT_SIZE="1.6753889674681754" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="14" LOG_CI_END="0.4868835175708553" LOG_CI_START="-0.038652215047086325" LOG_EFFECT_SIZE="0.2241156512618845" ORDER="602" O_E="0.0" SE="0.30870229078361094" STUDY_ID="STD-Romanelli-2002" TOTAL_1="101" TOTAL_2="103" VAR="0.09529710433504908" WEIGHT="2.496129412985635"/>
<DICH_DATA CI_END="0.9151459649634782" CI_START="0.2672740345449367" EFFECT_SIZE="0.4945652173913043" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="28" LOG_CI_END="-0.038509630827043506" LOG_CI_START="-0.5730432305498423" LOG_EFFECT_SIZE="-0.3057764306884429" ORDER="603" O_E="0.0" SE="0.3139876824611645" STUDY_ID="STD-Tremolieres-1998" TOTAL_1="138" TOTAL_2="147" VAR="0.09858826473733306" WEIGHT="4.882475958615362"/>
<DICH_DATA CI_END="1.8117938612293691" CI_START="0.7690493144462788" EFFECT_SIZE="1.1804062126642771" ESTIMABLE="YES" EVENTS_1="38" EVENTS_2="31" LOG_CI_END="0.2581087838356645" LOG_CI_START="-0.11404581064692823" LOG_EFFECT_SIZE="0.07203148659436812" ORDER="604" O_E="0.0" SE="0.21860545099402817" STUDY_ID="STD-Tremolieres-2005" TOTAL_1="189" TOTAL_2="182" VAR="0.047788343204302454" WEIGHT="5.687186157408012"/>
<DICH_DATA CI_END="3.6650773639034675" CI_START="0.11496630950828501" EFFECT_SIZE="0.6491228070175439" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.5640831463336992" LOG_CI_START="-0.939429409544692" LOG_EFFECT_SIZE="-0.1876731316054964" ORDER="605" O_E="0.0" SE="0.8831707178301498" STUDY_ID="STD-Vogel-1991" TOTAL_1="38" TOTAL_2="37" VAR="0.779990516832622" WEIGHT="0.5473831742422812"/>
<DICH_DATA CI_END="126.12592421227448" CI_START="0.3561402260936749" EFFECT_SIZE="6.702127659574468" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="0" LOG_CI_END="2.1008043616340277" LOG_CI_START="-0.4483789699262618" LOG_EFFECT_SIZE="0.826212695853883" ORDER="606" O_E="0.0" SE="1.4974029076195166" STUDY_ID="STD-Zeluff-1988" TOTAL_1="46" TOTAL_2="44" VAR="2.2422154677473825" WEIGHT="0.09198730402383874"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="0.47569057633781436" CI_END="1.6206773885714043" CI_START="0.6414079259985244" DF="2" EFFECT_SIZE="1.0195662423385197" ESTIMABLE="YES" EVENTS_1="27" EVENTS_2="29" I2="0.0" ID="CMP-001.18.02" LOG_CI_END="0.20969657295630534" LOG_CI_START="-0.1928656777157253" LOG_EFFECT_SIZE="0.00841544762029003" NO="2" P_CHI2="0.7883246517496175" P_Z="0.934690479811685" STUDIES="3" TAU2="0.0" TOTAL_1="129" TOTAL_2="159" WEIGHT="4.896253848548746" Z="0.08194496241024589">
<NAME>Non-sponsored trials</NAME>
<DICH_DATA CI_END="3.4624038633203176" CI_START="0.32310298333559356" EFFECT_SIZE="1.0576923076923077" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.5393777236727578" LOG_CI_START="-0.4906590319538684" LOG_EFFECT_SIZE="0.024359345859444693" ORDER="607" O_E="0.0" SE="0.6050486890192525" STUDY_ID="STD-Gleadhill-1986" TOTAL_1="26" TOTAL_2="22" VAR="0.36608391608391605" WEIGHT="0.7802611036348306"/>
<DICH_DATA CI_END="4.2660503456694485" CI_START="0.05860221510366839" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="4" LOG_CI_END="0.6300259764573879" LOG_CI_START="-1.2320859677853504" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="608" O_E="0.0" SE="1.093813773650968" STUDY_ID="STD-Kalbermatter-2000" TOTAL_1="28" TOTAL_2="56" VAR="1.1964285714285714" WEIGHT="0.4801606791598958"/>
<DICH_DATA CI_END="1.8110069918099756" CI_START="0.6440615664516371" EFFECT_SIZE="1.08" ESTIMABLE="YES" EVENTS_1="21" EVENTS_2="21" LOG_CI_END="0.2579201270112585" LOG_CI_START="-0.19107261603735906" LOG_EFFECT_SIZE="0.03342375548694973" ORDER="609" O_E="0.0" SE="0.2637405598166809" STUDY_ID="STD-Vanderdonckt--1990" TOTAL_1="75" TOTAL_2="81" VAR="0.06955908289241622" WEIGHT="3.635832065754019"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="9.143102269727503" CI_END="0.9280215357071009" CI_START="0.4878738553142688" DF="3" EFFECT_SIZE="0.6728725320891704" ESTIMABLE="YES" EVENTS_1="48" EVENTS_2="69" I2="67.18837970419628" ID="CMP-001.18.03" LOG_CI_END="-0.03244194540803904" LOG_CI_START="-0.3116924546833411" LOG_EFFECT_SIZE="-0.1720672000456901" MODIFIED="2012-07-02 22:17:22 +1000" MODIFIED_BY="[Empty name]" NO="3" P_CHI2="0.027447583696428968" P_Z="0.015719583912783757" STUDIES="4" TAU2="0.0" TOTAL_1="302" TOTAL_2="289" WEIGHT="12.530645230905208" Z="2.415361861902456">
<NAME>Unclear sponsorship</NAME>
<DICH_DATA CI_END="2.144644481217491" CI_START="0.3034542567633229" EFFECT_SIZE="0.8067226890756303" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="7" LOG_CI_END="0.33135530927495327" LOG_CI_START="-0.517906765980878" LOG_EFFECT_SIZE="-0.09327572835296233" MODIFIED="2011-10-11 21:39:19 +1000" MODIFIED_BY="[Empty name]" ORDER="495" O_E="0.0" SE="0.49886074692034765" STUDY_ID="STD-Hatipoglu-2010" TOTAL_1="34" TOTAL_2="32" VAR="0.24886204481792717" WEIGHT="1.2986163822733545"/>
<DICH_DATA CI_END="1.443503564398061" CI_START="0.6128857834811439" EFFECT_SIZE="0.9405864197530864" ESTIMABLE="YES" EVENTS_1="23" EVENTS_2="24" LOG_CI_END="0.15941786060780128" LOG_CI_START="-0.21262045244018643" LOG_EFFECT_SIZE="-0.026601295916192598" MODIFIED="2011-10-11 19:45:38 +1000" MODIFIED_BY="[Empty name]" ORDER="478" O_E="0.0" SE="0.21853714670373883" STUDY_ID="STD-Hong_x002d_yun-2007" TOTAL_1="54" TOTAL_2="53" VAR="0.047758484489411474" WEIGHT="4.361833459284287"/>
<DICH_DATA CI_END="2.2628158592596277" CI_START="0.46604366926357205" EFFECT_SIZE="1.0269230769230768" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="10" LOG_CI_END="0.35464921389230963" LOG_CI_START="-0.3315733871047952" LOG_EFFECT_SIZE="0.011537913393757216" MODIFIED="2012-07-02 22:17:22 +1000" MODIFIED_BY="[Empty name]" ORDER="989" O_E="0.0" SE="0.40309055268235816" STUDY_ID="STD-Kohno-2011" TOTAL_1="104" TOTAL_2="89" VAR="0.16248199366176896" WEIGHT="1.9405457499726357"/>
<DICH_DATA CI_END="0.5735349127990342" CI_START="0.11910513011290594" EFFECT_SIZE="0.26136363636363635" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="28" LOG_CI_END="-0.24144014014376425" LOG_CI_START="-0.9240695321213873" LOG_EFFECT_SIZE="-0.5827548361325757" ORDER="610" O_E="0.0" SE="0.40097988391764294" STUDY_ID="STD-Rizzato-1997" TOTAL_1="110" TOTAL_2="115" VAR="0.1607848673066064" WEIGHT="4.92964963937493"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="14.450192683277715" CI_END="0.9763533548186392" CI_START="0.6495821191159405" CI_STUDY="95" CI_TOTAL="95" DF="20" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7963803621568336" ESTIMABLE="YES" EVENTS_1="149" EVENTS_2="156" I2="0.0" I2_Q="0.0" ID="CMP-001.19" LOG_CI_END="-0.010392977133557035" LOG_CI_START="-0.187365938317617" LOG_EFFECT_SIZE="-0.098879457725587" METHOD="MH" MODIFIED="2012-07-02 22:18:38 +1000" MODIFIED_BY="[Empty name]" NO="19" P_CHI2="0.8069566954078708" P_Q="1.0" P_Z="0.028512122480625977" Q="0.0" RANDOM="NO" SCALE="50.80576121091236" SORT_BY="STUDY" STUDIES="21" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1251" TOTAL_2="1059" WEIGHT="99.99999999999997" Z="2.1901670702276417">
<NAME>Bacteriological failure</NAME>
<GROUP_LABEL_1>Atypical ABx</GROUP_LABEL_1>
<GROUP_LABEL_2>Non-atypical ABx</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours atypical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-atypical</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="14.450192683277715" CI_END="0.9763533548186392" CI_START="0.6495821191159405" DF="20" EFFECT_SIZE="0.7963803621568336" ESTIMABLE="YES" EVENTS_1="149" EVENTS_2="156" I2="0.0" ID="CMP-001.19.01" LOG_CI_END="-0.010392977133557035" LOG_CI_START="-0.187365938317617" LOG_EFFECT_SIZE="-0.098879457725587" MODIFIED="2012-07-02 22:18:38 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.8069566954078708" P_Z="0.028512122480625977" STUDIES="21" TAU2="0.0" TOTAL_1="1251" TOTAL_2="1059" WEIGHT="99.99999999999997" Z="2.1901670702276417">
<NAME>Overall</NAME>
<DICH_DATA CI_END="2.5353315664125016" CI_START="0.0069775135542235805" EFFECT_SIZE="0.1330049261083744" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4040347636879149" LOG_CI_START="-2.156299311196366" LOG_EFFECT_SIZE="-0.8761322737542256" ORDER="611" O_E="0.0" SE="1.5039529094450985" STUDY_ID="STD-Aubier-1998" TOTAL_1="86" TOTAL_2="80" VAR="2.2618743538283765" WEIGHT="2.15980948077062"/>
<DICH_DATA CI_END="3.017938598806537" CI_START="0.08881720359201564" EFFECT_SIZE="0.5177304964539007" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.47971039963083384" LOG_CI_START="-1.0515029047006816" LOG_EFFECT_SIZE="-0.285896252534924" ORDER="612" O_E="0.0" SE="0.8994422745924313" STUDY_ID="STD-Carbon-1992" TOTAL_1="94" TOTAL_2="73" VAR="0.8089964053240066" WEIGHT="2.0121949983970757"/>
<DICH_DATA CI_END="2.8142498704764805" CI_START="0.11748246076814135" EFFECT_SIZE="0.575" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4493626547730287" LOG_CI_START="-0.9300269653937677" LOG_EFFECT_SIZE="-0.24033215531036956" ORDER="613" O_E="0.0" SE="0.8102602909747181" STUDY_ID="STD-Chuard-1989" TOTAL_1="20" TOTAL_2="23" VAR="0.6565217391304348" WEIGHT="2.2169656258110613"/>
<DICH_DATA CI_END="76.32862590851101" CI_START="0.14143996749380947" EFFECT_SIZE="3.2857142857142856" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8826874441486245" LOG_CI_START="-0.8494278521419524" LOG_EFFECT_SIZE="0.516629796003336" ORDER="614" O_E="0.0" SE="1.6048580492299167" STUDY_ID="STD-Feldman-2001" TOTAL_1="20" TOTAL_2="22" VAR="2.5755693581780537" WEIGHT="0.2843636306970722"/>
<DICH_DATA CI_END="2.917136140497918" CI_START="0.21939325735094428" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.4649566977838263" LOG_CI_START="-0.6587767237999391" LOG_EFFECT_SIZE="-0.09691001300805639" ORDER="615" O_E="0.0" SE="0.6600865744084526" STUDY_ID="STD-Genne-1997" TOTAL_1="35" TOTAL_2="28" VAR="0.4357142857142857" WEIGHT="2.648042275274323"/>
<DICH_DATA CI_END="1.4988013401293931" CI_START="0.12528530149403705" EFFECT_SIZE="0.43333333333333335" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.17574407273944134" LOG_CI_START="-0.9020998775650927" LOG_EFFECT_SIZE="-0.36317790241282566" ORDER="616" O_E="0.0" SE="0.6331308718224857" STUDY_ID="STD-Gleadhill-1986" TOTAL_1="18" TOTAL_2="13" VAR="0.4008547008547008" WEIGHT="3.4595391015680677"/>
<DICH_DATA CI_END="7.444967413103108" CI_START="0.5175608407879234" EFFECT_SIZE="1.962962962962963" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.8718628011693937" LOG_CI_START="-0.28603859028579015" LOG_EFFECT_SIZE="0.29291210544180174" MODIFIED="2011-10-11 20:23:12 +1000" MODIFIED_BY="[Empty name]" ORDER="479" O_E="0.0" SE="0.6801570090451025" STUDY_ID="STD-Hong_x002d_yun-2007" TOTAL_1="54" TOTAL_2="53" VAR="0.4626135569531796" WEIGHT="1.804133475397179"/>
<DICH_DATA CI_END="4.174006694548" CI_START="0.1903263455450001" EFFECT_SIZE="0.8913043478260869" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6205531412802076" LOG_CI_START="-0.7205010912038846" LOG_EFFECT_SIZE="-0.0499739749618386" ORDER="617" O_E="0.0" SE="0.7877418944866681" STUDY_ID="STD-Khan-1989" TOTAL_1="46" TOTAL_2="41" VAR="0.620537292329445" WEIGHT="1.8901543137302927"/>
<DICH_DATA CI_END="1.585802058877472" CI_START="0.07971975592963187" EFFECT_SIZE="0.35555555555555557" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.20024897736864225" LOG_CI_START="-1.0984340396074799" LOG_EFFECT_SIZE="-0.4490925311194189" ORDER="618" O_E="0.0" SE="0.7628528327563872" STUDY_ID="STD-Kobayashi-1984" TOTAL_1="18" TOTAL_2="16" VAR="0.5819444444444444" WEIGHT="3.154285651429708"/>
<DICH_DATA CI_END="15.772876425842368" CI_START="0.13801123685927735" EFFECT_SIZE="1.4754098360655739" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.1979109008087498" LOG_CI_START="-0.8600855519516342" LOG_EFFECT_SIZE="0.16891267442855787" MODIFIED="2012-07-02 22:18:38 +1000" MODIFIED_BY="[Empty name]" ORDER="990" O_E="0.0" SE="1.2088773035981886" STUDY_ID="STD-Kohno-2011" TOTAL_1="61" TOTAL_2="45" VAR="1.461384335154827" WEIGHT="0.6857430231724544"/>
<DICH_DATA CI_END="1.9055335749897033" CI_START="0.5785781024645328" EFFECT_SIZE="1.05" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="15" LOG_CI_END="0.28001660532770684" LOG_CI_START="-0.23763800718783065" LOG_EFFECT_SIZE="0.021189299069938092" ORDER="619" O_E="0.0" SE="0.304072881823285" STUDY_ID="STD-Lephonte-2004" TOTAL_1="72" TOTAL_2="63" VAR="0.09246031746031746" WEIGHT="9.532952190987563"/>
<DICH_DATA CI_END="0.9612615559614982" CI_START="0.31440603045500926" EFFECT_SIZE="0.5497512437810945" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="16" LOG_CI_END="-0.01715842621766975" LOG_CI_START="-0.502509132581049" LOG_EFFECT_SIZE="-0.25983377939935937" ORDER="620" O_E="0.0" SE="0.2850974074425929" STUDY_ID="STD-Lode-1995" TOTAL_1="201" TOTAL_2="68" VAR="0.08128053173048783" WEIGHT="14.246270560509295"/>
<DICH_DATA CI_END="1.884262844457118" CI_START="0.41230131050481167" EFFECT_SIZE="0.8814102564102564" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="8" LOG_CI_END="0.27514148440970854" LOG_CI_START="-0.3847852847860689" LOG_EFFECT_SIZE="-0.05482190018818015" ORDER="621" O_E="0.0" SE="0.3876442509157917" STUDY_ID="STD-Miki-1984" TOTAL_1="39" TOTAL_2="25" VAR="0.15026806526806527" WEIGHT="5.809142741383046"/>
<DICH_DATA CI_END="2.131854990902494" CI_START="0.5229840333583919" EFFECT_SIZE="1.0559006211180124" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="14" LOG_CI_END="0.32875766058311595" LOG_CI_START="-0.28151156989026754" LOG_EFFECT_SIZE="0.023623045346424218" ORDER="622" O_E="0.0" SE="0.35847516686147646" STUDY_ID="STD-Norrby-1998" TOTAL_1="69" TOTAL_2="85" VAR="0.1285044452563634" WEIGHT="7.474701149751612"/>
<DICH_DATA CI_END="1.8490838749459557" CI_START="0.3820644604758853" EFFECT_SIZE="0.8405172413793104" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="12" LOG_CI_END="0.266956611321439" LOG_CI_START="-0.4178633583782022" LOG_EFFECT_SIZE="-0.07545337352838163" ORDER="623" O_E="0.0" SE="0.40226664011509106" STUDY_ID="STD-Petitpretz-2001" TOTAL_1="58" TOTAL_2="65" VAR="0.1618184497494842" WEIGHT="6.742819842405837"/>
<DICH_DATA CI_END="1.5940435798834631" CI_START="0.4525391402183927" EFFECT_SIZE="0.8493333333333334" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="15" LOG_CI_END="0.20250019048806714" LOG_CI_START="-0.34434385260076633" LOG_EFFECT_SIZE="-0.0709218310563496" ORDER="624" O_E="0.0" SE="0.32121889783205076" STUDY_ID="STD-Romanelli-2002" TOTAL_1="50" TOTAL_2="49" VAR="0.10318158032443746" WEIGHT="9.027416847526101"/>
<DICH_DATA CI_END="1.1003415865017987" CI_START="0.202547849995716" EFFECT_SIZE="0.4720930232558139" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="15" LOG_CI_END="0.041527527070885896" LOG_CI_START="-0.6934723624036331" LOG_EFFECT_SIZE="-0.32597241766637364" ORDER="625" O_E="0.0" SE="0.43174257338546324" STUDY_ID="STD-Tremolieres-1998" TOTAL_1="86" TOTAL_2="87" VAR="0.1864016496735021" WEIGHT="8.885482894778871"/>
<DICH_DATA CI_END="3.451100616756805" CI_START="0.6397554605159247" EFFECT_SIZE="1.4858870967741935" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="8" LOG_CI_END="0.5379576213214099" LOG_CI_START="-0.19398599858370186" LOG_EFFECT_SIZE="0.171985811368854" ORDER="626" O_E="0.0" SE="0.42994730551161503" STUDY_ID="STD-Tremolieres-2005" TOTAL_1="62" TOTAL_2="67" VAR="0.18485468551669804" WEIGHT="4.581728960009527"/>
<DICH_DATA CI_END="1.500822730106864" CI_START="0.24711290567245311" EFFECT_SIZE="0.6089931573802542" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="11" LOG_CI_END="0.17632939851715265" LOG_CI_START="-0.6071045726231337" LOG_EFFECT_SIZE="-0.21538758705299052" ORDER="627" O_E="0.0" SE="0.46019299270850594" STUDY_ID="STD-Vanderdonckt--1990" TOTAL_1="93" TOTAL_2="89" VAR="0.21177759053801098" WEIGHT="6.697946491332607"/>
<DICH_DATA CI_END="20.552567517689006" CI_START="0.19462288575660025" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3128660835898294" LOG_CI_START="-0.710806092261867" LOG_EFFECT_SIZE="0.3010299956639812" ORDER="628" O_E="0.0" SE="1.1887150534341144" STUDY_ID="STD-Vogel-1991" TOTAL_1="23" TOTAL_2="23" VAR="1.4130434782608696" WEIGHT="0.5958095119367227"/>
<DICH_DATA CI_END="1.759762033744506" CI_START="0.33274820386291315" EFFECT_SIZE="0.7652173913043478" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="10" LOG_CI_END="0.24545394371245946" LOG_CI_START="-0.4778842801193455" LOG_EFFECT_SIZE="-0.11621516820344305" ORDER="629" O_E="0.0" SE="0.4248924532607571" STUDY_ID="STD-Zeluff-1988" TOTAL_1="46" TOTAL_2="44" VAR="0.18053359683794465" WEIGHT="6.090497233130943"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="14.450192683277713" CI_END="0.9763533548186392" CI_START="0.6495821191159405" CI_STUDY="95" CI_TOTAL="95" DF="20" EFFECT_MEASURE="RR" EFFECT_SIZE="0.7963803621568336" ESTIMABLE="YES" EVENTS_1="149" EVENTS_2="156" I2="0.0" I2_Q="0.0" ID="CMP-001.20" LOG_CI_END="-0.010392977133557035" LOG_CI_START="-0.187365938317617" LOG_EFFECT_SIZE="-0.098879457725587" METHOD="MH" MODIFIED="2012-07-02 22:29:56 +1000" MODIFIED_BY="[Empty name]" NO="20" P_CHI2="0.8069566954078708" P_Q="0.44705822250087723" P_Z="0.028512122480625977" Q="0.5780998305418283" RANDOM="NO" SCALE="49.983307980198845" SORT_BY="STUDY" STUDIES="21" SUBGROUPS="YES" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="1251" TOTAL_2="1059" WEIGHT="99.99999999999997" Z="2.1901670702276417">
<NAME>Bacteriological failure per allocation generation</NAME>
<GROUP_LABEL_1>Atypical ABx</GROUP_LABEL_1>
<GROUP_LABEL_2>Non-atypical ABx</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours atypical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-atypical</GRAPH_LABEL_2>
<DICH_SUBGROUP CHI2="1.5295293077354315" CI_END="1.3192702220135366" CI_START="0.6146854026245947" DF="7" EFFECT_SIZE="0.9005199318110784" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="48" I2="0.0" ID="CMP-001.20.01" LOG_CI_END="0.12033375984486581" LOG_CI_START="-0.21134710025943088" LOG_EFFECT_SIZE="-0.045506670207282524" MODIFIED="2012-07-02 22:29:56 +1000" MODIFIED_BY="[Empty name]" NO="1" P_CHI2="0.9812697141204567" P_Z="0.5907049283412087" STUDIES="8" TAU2="0.0" TOTAL_1="355" TOTAL_2="353" WEIGHT="28.03328709397359" Z="0.5378147815618273">
<NAME>A</NAME>
<DICH_DATA CI_END="2.8142498704764805" CI_START="0.11748246076814135" EFFECT_SIZE="0.575" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="4" LOG_CI_END="0.4493626547730287" LOG_CI_START="-0.9300269653937677" LOG_EFFECT_SIZE="-0.24033215531036956" ORDER="630" O_E="0.0" SE="0.8102602909747181" STUDY_ID="STD-Chuard-1989" TOTAL_1="20" TOTAL_2="23" VAR="0.6565217391304348" WEIGHT="2.2169656258110613"/>
<DICH_DATA CI_END="76.32862590851101" CI_START="0.14143996749380947" EFFECT_SIZE="3.2857142857142856" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8826874441486245" LOG_CI_START="-0.8494278521419524" LOG_EFFECT_SIZE="0.516629796003336" ORDER="631" O_E="0.0" SE="1.6048580492299167" STUDY_ID="STD-Feldman-2001" TOTAL_1="20" TOTAL_2="22" VAR="2.5755693581780537" WEIGHT="0.2843636306970722"/>
<DICH_DATA CI_END="2.917136140497918" CI_START="0.21939325735094428" EFFECT_SIZE="0.8" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="4" LOG_CI_END="0.4649566977838263" LOG_CI_START="-0.6587767237999391" LOG_EFFECT_SIZE="-0.09691001300805639" ORDER="632" O_E="0.0" SE="0.6600865744084526" STUDY_ID="STD-Genne-1997" TOTAL_1="35" TOTAL_2="28" VAR="0.4357142857142857" WEIGHT="2.648042275274323"/>
<DICH_DATA CI_END="4.174006694548" CI_START="0.1903263455450001" EFFECT_SIZE="0.8913043478260869" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6205531412802076" LOG_CI_START="-0.7205010912038846" LOG_EFFECT_SIZE="-0.0499739749618386" ORDER="633" O_E="0.0" SE="0.7877418944866681" STUDY_ID="STD-Khan-1989" TOTAL_1="46" TOTAL_2="41" VAR="0.620537292329445" WEIGHT="1.8901543137302927"/>
<DICH_DATA CI_END="15.772876425842368" CI_START="0.13801123685927735" EFFECT_SIZE="1.4754098360655739" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.1979109008087498" LOG_CI_START="-0.8600855519516342" LOG_EFFECT_SIZE="0.16891267442855787" MODIFIED="2012-07-02 22:29:56 +1000" MODIFIED_BY="[Empty name]" ORDER="998" O_E="0.0" SE="1.2088773035981886" STUDY_ID="STD-Kohno-2011" TOTAL_1="61" TOTAL_2="45" VAR="1.461384335154827" WEIGHT="0.6857430231724544"/>
<DICH_DATA CI_END="2.131854990902494" CI_START="0.5229840333583919" EFFECT_SIZE="1.0559006211180124" ESTIMABLE="YES" EVENTS_1="12" EVENTS_2="14" LOG_CI_END="0.32875766058311595" LOG_CI_START="-0.28151156989026754" LOG_EFFECT_SIZE="0.023623045346424218" ORDER="634" O_E="0.0" SE="0.35847516686147646" STUDY_ID="STD-Norrby-1998" TOTAL_1="69" TOTAL_2="85" VAR="0.1285044452563634" WEIGHT="7.474701149751612"/>
<DICH_DATA CI_END="1.8490838749459557" CI_START="0.3820644604758853" EFFECT_SIZE="0.8405172413793104" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="12" LOG_CI_END="0.266956611321439" LOG_CI_START="-0.4178633583782022" LOG_EFFECT_SIZE="-0.07545337352838163" ORDER="635" O_E="0.0" SE="0.40226664011509106" STUDY_ID="STD-Petitpretz-2001" TOTAL_1="58" TOTAL_2="65" VAR="0.1618184497494842" WEIGHT="6.742819842405837"/>
<DICH_DATA CI_END="1.759762033744506" CI_START="0.33274820386291315" EFFECT_SIZE="0.7652173913043478" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="10" LOG_CI_END="0.24545394371245946" LOG_CI_START="-0.4778842801193455" LOG_EFFECT_SIZE="-0.11621516820344305" ORDER="636" O_E="0.0" SE="0.4248924532607571" STUDY_ID="STD-Zeluff-1988" TOTAL_1="46" TOTAL_2="44" VAR="0.18053359683794465" WEIGHT="6.090497233130943"/>
</DICH_SUBGROUP>
<DICH_SUBGROUP CHI2="12.485017957749411" CI_END="0.9618151811969913" CI_START="0.5939352310006384" DF="12" EFFECT_SIZE="0.7558147404120641" ESTIMABLE="YES" EVENTS_1="108" EVENTS_2="108" I2="3.8847998408233146" ID="CMP-001.20.02" LOG_CI_END="-0.01690837234637746" LOG_CI_START="-0.22626091251493075" LOG_EFFECT_SIZE="-0.12158464243065413" MODIFIED="2011-10-11 21:58:39 +1000" MODIFIED_BY="[Empty name]" NO="2" P_CHI2="0.4075543556399315" P_Z="0.022812678951794146" STUDIES="13" TAU2="0.0" TOTAL_1="896" TOTAL_2="706" WEIGHT="71.96671290602639" Z="2.2765572373318412">
<NAME>B</NAME>
<DICH_DATA CI_END="2.5353315664125016" CI_START="0.0069775135542235805" EFFECT_SIZE="0.1330049261083744" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4040347636879149" LOG_CI_START="-2.156299311196366" LOG_EFFECT_SIZE="-0.8761322737542256" ORDER="637" O_E="0.0" SE="1.5039529094450985" STUDY_ID="STD-Aubier-1998" TOTAL_1="86" TOTAL_2="80" VAR="2.2618743538283765" WEIGHT="2.15980948077062"/>
<DICH_DATA CI_END="3.017938598806537" CI_START="0.08881720359201564" EFFECT_SIZE="0.5177304964539007" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.47971039963083384" LOG_CI_START="-1.0515029047006816" LOG_EFFECT_SIZE="-0.285896252534924" ORDER="638" O_E="0.0" SE="0.8994422745924313" STUDY_ID="STD-Carbon-1992" TOTAL_1="94" TOTAL_2="73" VAR="0.8089964053240066" WEIGHT="2.0121949983970757"/>
<DICH_DATA CI_END="1.4988013401293931" CI_START="0.12528530149403705" EFFECT_SIZE="0.43333333333333335" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="5" LOG_CI_END="0.17574407273944134" LOG_CI_START="-0.9020998775650927" LOG_EFFECT_SIZE="-0.36317790241282566" ORDER="639" O_E="0.0" SE="0.6331308718224857" STUDY_ID="STD-Gleadhill-1986" TOTAL_1="18" TOTAL_2="13" VAR="0.4008547008547008" WEIGHT="3.4595391015680677"/>
<DICH_DATA CI_END="7.444967413103108" CI_START="0.5175608407879234" EFFECT_SIZE="1.962962962962963" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.8718628011693937" LOG_CI_START="-0.28603859028579015" LOG_EFFECT_SIZE="0.29291210544180174" MODIFIED="2011-10-11 21:58:39 +1000" MODIFIED_BY="[Empty name]" ORDER="496" O_E="0.0" SE="0.6801570090451025" STUDY_ID="STD-Hong_x002d_yun-2007" TOTAL_1="54" TOTAL_2="53" VAR="0.4626135569531796" WEIGHT="1.804133475397179"/>
<DICH_DATA CI_END="1.585802058877472" CI_START="0.07971975592963187" EFFECT_SIZE="0.35555555555555557" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="5" LOG_CI_END="0.20024897736864225" LOG_CI_START="-1.0984340396074799" LOG_EFFECT_SIZE="-0.4490925311194189" ORDER="640" O_E="0.0" SE="0.7628528327563872" STUDY_ID="STD-Kobayashi-1984" TOTAL_1="18" TOTAL_2="16" VAR="0.5819444444444444" WEIGHT="3.154285651429708"/>
<DICH_DATA CI_END="1.9055335749897033" CI_START="0.5785781024645328" EFFECT_SIZE="1.05" ESTIMABLE="YES" EVENTS_1="18" EVENTS_2="15" LOG_CI_END="0.28001660532770684" LOG_CI_START="-0.23763800718783065" LOG_EFFECT_SIZE="0.021189299069938092" ORDER="641" O_E="0.0" SE="0.304072881823285" STUDY_ID="STD-Lephonte-2004" TOTAL_1="72" TOTAL_2="63" VAR="0.09246031746031746" WEIGHT="9.532952190987563"/>
<DICH_DATA CI_END="0.9612615559614982" CI_START="0.31440603045500926" EFFECT_SIZE="0.5497512437810945" ESTIMABLE="YES" EVENTS_1="26" EVENTS_2="16" LOG_CI_END="-0.01715842621766975" LOG_CI_START="-0.502509132581049" LOG_EFFECT_SIZE="-0.25983377939935937" ORDER="642" O_E="0.0" SE="0.2850974074425929" STUDY_ID="STD-Lode-1995" TOTAL_1="201" TOTAL_2="68" VAR="0.08128053173048783" WEIGHT="14.246270560509295"/>
<DICH_DATA CI_END="1.884262844457118" CI_START="0.41230131050481167" EFFECT_SIZE="0.8814102564102564" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="8" LOG_CI_END="0.27514148440970854" LOG_CI_START="-0.3847852847860689" LOG_EFFECT_SIZE="-0.05482190018818015" ORDER="643" O_E="0.0" SE="0.3876442509157917" STUDY_ID="STD-Miki-1984" TOTAL_1="39" TOTAL_2="25" VAR="0.15026806526806527" WEIGHT="5.809142741383046"/>
<DICH_DATA CI_END="1.5940435798834631" CI_START="0.4525391402183927" EFFECT_SIZE="0.8493333333333334" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="15" LOG_CI_END="0.20250019048806714" LOG_CI_START="-0.34434385260076633" LOG_EFFECT_SIZE="-0.0709218310563496" ORDER="644" O_E="0.0" SE="0.32121889783205076" STUDY_ID="STD-Romanelli-2002" TOTAL_1="50" TOTAL_2="49" VAR="0.10318158032443746" WEIGHT="9.027416847526101"/>
<DICH_DATA CI_END="1.1003415865017987" CI_START="0.202547849995716" EFFECT_SIZE="0.4720930232558139" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="15" LOG_CI_END="0.041527527070885896" LOG_CI_START="-0.6934723624036331" LOG_EFFECT_SIZE="-0.32597241766637364" ORDER="645" O_E="0.0" SE="0.43174257338546324" STUDY_ID="STD-Tremolieres-1998" TOTAL_1="86" TOTAL_2="87" VAR="0.1864016496735021" WEIGHT="8.885482894778871"/>
<DICH_DATA CI_END="3.451100616756805" CI_START="0.6397554605159247" EFFECT_SIZE="1.4858870967741935" ESTIMABLE="YES" EVENTS_1="11" EVENTS_2="8" LOG_CI_END="0.5379576213214099" LOG_CI_START="-0.19398599858370186" LOG_EFFECT_SIZE="0.171985811368854" ORDER="646" O_E="0.0" SE="0.42994730551161503" STUDY_ID="STD-Tremolieres-2005" TOTAL_1="62" TOTAL_2="67" VAR="0.18485468551669804" WEIGHT="4.581728960009527"/>
<DICH_DATA CI_END="1.500822730106864" CI_START="0.24711290567245311" EFFECT_SIZE="0.6089931573802542" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="11" LOG_CI_END="0.17632939851715265" LOG_CI_START="-0.6071045726231337" LOG_EFFECT_SIZE="-0.21538758705299052" ORDER="647" O_E="0.0" SE="0.46019299270850594" STUDY_ID="STD-Vanderdonckt--1990" TOTAL_1="93" TOTAL_2="89" VAR="0.21177759053801098" WEIGHT="6.697946491332607"/>
<DICH_DATA CI_END="20.552567517689006" CI_START="0.19462288575660025" EFFECT_SIZE="2.0" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.3128660835898294" LOG_CI_START="-0.710806092261867" LOG_EFFECT_SIZE="0.3010299956639812" ORDER="648" O_E="0.0" SE="1.1887150534341144" STUDY_ID="STD-Vogel-1991" TOTAL_1="23" TOTAL_2="23" VAR="1.4130434782608696" WEIGHT="0.5958095119367227"/>
</DICH_SUBGROUP>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="30.426245579421384" CI_END="1.1270225146923218" CI_START="0.9302924386053373" CI_STUDY="95" CI_TOTAL="95" DF="22" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0239436134652335" ESTIMABLE="YES" EVENTS_1="564" EVENTS_2="536" I2="27.69400370948306" I2_Q="0.0" ID="CMP-001.21" LOG_CI_END="0.05193259209665503" LOG_CI_START="-0.03138050896381424" LOG_EFFECT_SIZE="0.010276041566420388" METHOD="MH" MODIFIED="2012-07-02 22:20:07 +1000" MODIFIED_BY="[Empty name]" NO="21" P_CHI2="0.10846715907708526" P_Q="1.0" P_Z="0.6287453762844891" Q="0.0" RANDOM="NO" SCALE="35.49871572093805" SORT_BY="STUDY" STUDIES="24" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2467" TOTAL_2="2451" WEIGHT="100.0" Z="0.4834934990404995">
<NAME>Adverse events - total</NAME>
<GROUP_LABEL_1>Atypical ABx</GROUP_LABEL_1>
<GROUP_LABEL_2>Non-atypical ABx</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours atypical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-atypical</GRAPH_LABEL_2>
<DICH_DATA CI_END="1.3540037335253923" CI_START="0.46325081841777754" EFFECT_SIZE="0.7919869555089681" ESTIMABLE="YES" EVENTS_1="20" EVENTS_2="27" LOG_CI_END="0.13161986187293676" LOG_CI_START="-0.33418380474730397" LOG_EFFECT_SIZE="-0.10128197143718365" ORDER="649" O_E="0.0" SE="0.2736153795380661" STUDY_ID="STD-Aubier-1998" TOTAL_1="159" TOTAL_2="170" VAR="0.07486537591975995" WEIGHT="4.7976301080253"/>
<DICH_DATA CI_END="210.00660637526255" CI_START="0.744024212842122" EFFECT_SIZE="12.5" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="0" LOG_CI_END="2.322232956958649" LOG_CI_START="-0.12841293094253603" LOG_EFFECT_SIZE="1.0969100130080565" ORDER="650" O_E="0.0" SE="1.4395215254459457" STUDY_ID="STD-Bohte-1995" TOTAL_1="35" TOTAL_2="29" VAR="2.0722222222222224" WEIGHT="0.10027446194907082"/>
<DICH_DATA CI_END="2.520605945665843" CI_START="0.8964049538940647" EFFECT_SIZE="1.503157894736842" ESTIMABLE="YES" EVENTS_1="30" EVENTS_2="19" LOG_CI_END="0.4015049563470984" LOG_CI_START="-0.047495752044482704" LOG_EFFECT_SIZE="0.1770046021513078" ORDER="651" O_E="0.0" SE="0.2637452386985667" STUDY_ID="STD-Carbon-1992" TOTAL_1="125" TOTAL_2="119" VAR="0.06956155093616392" WEIGHT="3.5787845880047473"/>
<DICH_DATA CI_END="5.996430187181651" CI_START="0.3273889726552333" EFFECT_SIZE="1.4011299435028248" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7778927818175774" LOG_CI_START="-0.4849359528887581" LOG_EFFECT_SIZE="0.14647841446440962" ORDER="652" O_E="0.0" SE="0.7417918498695547" STUDY_ID="STD-Chuard-1989" TOTAL_1="59" TOTAL_2="62" VAR="0.5502551485328959" WEIGHT="0.5378357504541071"/>
<DICH_DATA CI_END="1.8125866923692278" CI_START="0.5976534143901836" EFFECT_SIZE="1.0408163265306123" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="14" LOG_CI_END="0.2582987871697635" LOG_CI_START="-0.223550595030918" LOG_EFFECT_SIZE="0.017374096069422723" ORDER="653" O_E="0.0" SE="0.28304071229759015" STUDY_ID="STD-Feldman-2001" TOTAL_1="35" TOTAL_2="34" VAR="0.08011204481792719" WEIGHT="2.611011352200443"/>
<DICH_DATA CI_END="2.5983769423254333" CI_START="0.007854196568971131" EFFECT_SIZE="0.14285714285714285" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.4147021537028376" LOG_CI_START="-2.1048982337313515" LOG_EFFECT_SIZE="-0.8450980400142568" ORDER="654" O_E="0.0" SE="1.4800257398019099" STUDY_ID="STD-Fourrier-1986" TOTAL_1="20" TOTAL_2="20" VAR="2.1904761904761907" WEIGHT="0.6434277975065378"/>
<DICH_DATA CI_END="2.944984521260322" CI_START="0.8512589544516804" EFFECT_SIZE="1.5833333333333333" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="12" LOG_CI_END="0.46908301649191664" LOG_CI_START="-0.06993830668150842" LOG_EFFECT_SIZE="0.1995723549052041" ORDER="655" O_E="0.0" SE="0.3166237934306518" STUDY_ID="STD-Genne-1997" TOTAL_1="56" TOTAL_2="56" VAR="0.10025062656641603" WEIGHT="2.2060381628795582"/>
<DICH_DATA CI_END="3.0777531928802615" CI_START="0.10339090982447963" EFFECT_SIZE="0.5641025641025641" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.4882337905221721" LOG_CI_START="-0.985517642930758" LOG_EFFECT_SIZE="-0.24864192620429298" ORDER="656" O_E="0.0" SE="0.865688887197502" STUDY_ID="STD-Gleadhill-1986" TOTAL_1="26" TOTAL_2="22" VAR="0.7494172494172494" WEIGHT="0.5974686691132136"/>
<DICH_DATA CI_END="0.0" CI_START="0.0" EFFECT_SIZE="0.0" ESTIMABLE="NO" EVENTS_1="0" EVENTS_2="0" LOG_CI_END="0.0" LOG_CI_START="0.0" LOG_EFFECT_SIZE="0.0" ORDER="657" O_E="0.0" SE="0.0" STUDY_ID="STD-Kalbermatter-2000" TOTAL_1="28" TOTAL_2="56" VAR="0.0" WEIGHT="0.0"/>
<DICH_DATA CI_END="6.476758197751008" CI_START="0.44462153202405724" EFFECT_SIZE="1.696969696969697" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="3" LOG_CI_END="0.8113576834762027" LOG_CI_START="-0.3520095092195769" LOG_EFFECT_SIZE="0.22967408712831294" ORDER="658" O_E="0.0" SE="0.6833676477499809" STUDY_ID="STD-Khan-1989" TOTAL_1="66" TOTAL_2="56" VAR="0.466991341991342" WEIGHT="0.5967152407788968"/>
<DICH_DATA CI_END="1.9332139342693773" CI_START="0.32109896032999063" EFFECT_SIZE="0.7878787878787878" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="10" LOG_CI_END="0.28627991679711934" LOG_CI_START="-0.4933611006112585" LOG_EFFECT_SIZE="-0.10354059190706953" ORDER="659" O_E="0.0" SE="0.45796499291095905" STUDY_ID="STD-Kobayashi-1984" TOTAL_1="132" TOTAL_2="130" VAR="0.20973193473193474" WEIGHT="1.8523984573797816"/>
<DICH_DATA CI_END="1.1742573329767063" CI_START="0.7575630177937214" EFFECT_SIZE="0.943172268907563" ESTIMABLE="YES" EVENTS_1="73" EVENTS_2="70" LOG_CI_END="0.06976328093650914" LOG_CI_START="-0.12058123458575018" LOG_EFFECT_SIZE="-0.02540897682462052" MODIFIED="2012-07-02 22:20:07 +1000" MODIFIED_BY="[Empty name]" ORDER="991" O_E="0.0" SE="0.11180931063832289" STUDY_ID="STD-Kohno-2011" TOTAL_1="136" TOTAL_2="123" VAR="0.012501321945416985" WEIGHT="13.514468024847742"/>
<DICH_DATA CI_END="1.0179079408535068" CI_START="0.4492273857805602" EFFECT_SIZE="0.676218990590248" ESTIMABLE="YES" EVENTS_1="31" EVENTS_2="42" LOG_CI_END="0.00770850237480843" LOG_CI_START="-0.347533776162033" LOG_EFFECT_SIZE="-0.16991263689361227" ORDER="660" O_E="0.0" SE="0.2086710728901798" STUDY_ID="STD-Lephonte-2004" TOTAL_1="167" TOTAL_2="153" VAR="0.043543616661138734" WEIGHT="8.058933163769385"/>
<DICH_DATA CI_END="5.668983240487474" CI_START="0.3050644301303142" EFFECT_SIZE="1.3150684931506849" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="3" LOG_CI_END="0.7535051730653097" LOG_CI_START="-0.5156084272270847" LOG_EFFECT_SIZE="0.11894837291911249" ORDER="661" O_E="0.0" SE="0.7454836110253921" STUDY_ID="STD-Miki-1984" TOTAL_1="73" TOTAL_2="72" VAR="0.5557458143074581" WEIGHT="0.5553130547938198"/>
<DICH_DATA CI_END="1.1507530259784486" CI_START="0.8601293708398252" EFFECT_SIZE="0.9948851573055395" ESTIMABLE="YES" EVENTS_1="169" EVENTS_2="165" LOG_CI_END="0.060982125572542165" LOG_CI_START="-0.06543622222586581" LOG_EFFECT_SIZE="-0.002227048326661824" ORDER="662" O_E="0.0" SE="0.07425876327769894" STUDY_ID="STD-Norrby-1998" TOTAL_1="314" TOTAL_2="305" VAR="0.005514363923533328" WEIGHT="30.774054178457163"/>
<DICH_DATA CI_END="2.1256236089204403" CI_START="0.20908896691741605" EFFECT_SIZE="0.6666666666666666" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="6" LOG_CI_END="0.3274863650599791" LOG_CI_START="-0.6796688831713416" LOG_EFFECT_SIZE="-0.17609125905568127" ORDER="663" O_E="0.0" SE="0.5916079783099616" STUDY_ID="STD-Peterson-1988" TOTAL_1="30" TOTAL_2="30" VAR="0.35" WEIGHT="1.1030190814397791"/>
<DICH_DATA CI_END="1.9674501667931" CI_START="0.9773281564628589" EFFECT_SIZE="1.3866666666666667" ESTIMABLE="YES" EVENTS_1="56" EVENTS_2="42" LOG_CI_END="0.29390374100017114" LOG_CI_START="-0.009959589186010497" LOG_EFFECT_SIZE="0.14197207590708033" ORDER="664" O_E="0.0" SE="0.1784908242991061" STUDY_ID="STD-Petitpretz-2001" TOTAL_1="200" TOTAL_2="208" VAR="0.03185897435897436" WEIGHT="7.569738794194563"/>
<DICH_DATA CI_END="3.001687373795342" CI_START="0.42086384414040845" EFFECT_SIZE="1.1239669421487604" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="7" LOG_CI_END="0.47736545842501815" LOG_CI_START="-0.3758583823174833" LOG_EFFECT_SIZE="0.05075353805376744" ORDER="665" O_E="0.0" SE="0.5011879075782731" STUDY_ID="STD-Rizzato-1997" TOTAL_1="121" TOTAL_2="119" VAR="0.2511893187026876" WEIGHT="1.2975793916381846"/>
<DICH_DATA CI_END="3.418068734917304" CI_START="0.4141374349578208" EFFECT_SIZE="1.1897689768976898" ESTIMABLE="YES" EVENTS_1="7" EVENTS_2="6" LOG_CI_END="0.5337807918239088" LOG_CI_START="-0.382855510717623" LOG_EFFECT_SIZE="0.07546264055314283" ORDER="666" O_E="0.0" SE="0.5384367015357719" STUDY_ID="STD-Romanelli-2002" TOTAL_1="101" TOTAL_2="103" VAR="0.28991408156072196" WEIGHT="1.0922051688766439"/>
<DICH_DATA CI_END="2.7240340806144987" CI_START="0.9093260898586409" EFFECT_SIZE="1.573859987154785" ESTIMABLE="YES" EVENTS_1="29" EVENTS_2="18" LOG_CI_END="0.43521253676873134" LOG_CI_START="-0.041280348207674976" LOG_EFFECT_SIZE="0.19696609428052816" ORDER="667" O_E="0.0" SE="0.27989427931296196" STUDY_ID="STD-Tremolieres-1998" TOTAL_1="173" TOTAL_2="169" VAR="0.07834080759212235" WEIGHT="3.3477596682295045"/>
<DICH_DATA CI_END="1.9989511724174471" CI_START="0.8576548128382296" EFFECT_SIZE="1.3093548387096774" ESTIMABLE="YES" EVENTS_1="41" EVENTS_2="31" LOG_CI_END="0.3008021859096852" LOG_CI_START="-0.06668747094365976" LOG_EFFECT_SIZE="0.11705735748301273" ORDER="668" O_E="0.0" SE="0.21586524353879438" STUDY_ID="STD-Tremolieres-2005" TOTAL_1="200" TOTAL_2="198" VAR="0.04659780336806301" WEIGHT="5.727569769620293"/>
<DICH_DATA CI_END="1.480000311345353" CI_START="0.4058985755173341" EFFECT_SIZE="0.7750677506775068" ESTIMABLE="YES" EVENTS_1="13" EVENTS_2="18" LOG_CI_END="0.17026180675681857" LOG_CI_START="-0.3915824728168533" LOG_EFFECT_SIZE="-0.11066033303001736" ORDER="669" O_E="0.0" SE="0.33003011099561297" STUDY_ID="STD-Vanderdonckt--1990" TOTAL_1="82" TOTAL_2="88" VAR="0.1089198741637766" WEIGHT="3.1922669886374777"/>
<DICH_DATA CI_END="1.4022866463077546" CI_START="0.31925693601810734" EFFECT_SIZE="0.6690962099125365" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="14" LOG_CI_END="0.14683679835620506" LOG_CI_START="-0.4958596586951859" LOG_EFFECT_SIZE="-0.17451143016949042" ORDER="670" O_E="0.0" SE="0.3775230802707584" STUDY_ID="STD-Vogel-1991" TOTAL_1="49" TOTAL_2="51" VAR="0.14252367613712152" WEIGHT="2.5222369662256283"/>
<DICH_DATA CI_END="0.9034060413488858" CI_START="0.21308420985603962" EFFECT_SIZE="0.43875" ESTIMABLE="YES" EVENTS_1="9" EVENTS_2="20" LOG_CI_END="-0.04411700950662425" LOG_CI_START="-0.6714487315456148" LOG_EFFECT_SIZE="-0.3577828705261195" ORDER="671" O_E="0.0" SE="0.36849775886780944" STUDY_ID="STD-Zeluff-1988" TOTAL_1="80" TOTAL_2="78" VAR="0.13579059829059825" WEIGHT="3.723271160978157"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="23.88794843087262" CI_END="0.9210889418996164" CI_START="0.5262333712268542" CI_STUDY="95" CI_TOTAL="95" DF="15" EFFECT_MEASURE="RR" EFFECT_SIZE="0.6962095511378821" ESTIMABLE="YES" EVENTS_1="83" EVENTS_2="92" I2="37.20683028344911" I2_Q="0.0" ID="CMP-001.22" LOG_CI_END="-0.03569843157165223" LOG_CI_START="-0.27882161447887793" LOG_EFFECT_SIZE="-0.15726002302526507" METHOD="MH" MODIFIED="2012-07-02 22:21:49 +1000" MODIFIED_BY="[Empty name]" NO="22" P_CHI2="0.06702099055731003" P_Q="1.0" P_Z="0.011227488667212676" Q="0.0" RANDOM="NO" SCALE="137.31576024441432" SORT_BY="STUDY" STUDIES="16" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2279" TOTAL_2="1850" WEIGHT="100.00000000000001" Z="2.5355375629075705">
<NAME>Adverse events - gastrointestinal events</NAME>
<GROUP_LABEL_1>Atypical ABx</GROUP_LABEL_1>
<GROUP_LABEL_2>Non-atypical ABx</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours atypical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-atypical</GRAPH_LABEL_2>
<DICH_DATA CI_END="5.578360437450627" CI_START="0.46108345641728155" EFFECT_SIZE="1.6037735849056605" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="4" LOG_CI_END="0.7465065721277003" LOG_CI_START="-0.33622045990069294" LOG_EFFECT_SIZE="0.20514305611350372" ORDER="672" O_E="0.0" SE="0.6359992181987251" STUDY_ID="STD-Aubier-1998" TOTAL_1="159" TOTAL_2="170" VAR="0.40449500554938955" WEIGHT="3.6311589481126605"/>
<DICH_DATA CI_END="133.7792177696585" CI_START="0.42046889597494475" EFFECT_SIZE="7.5" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="0" LOG_CI_END="2.1263886522287083" LOG_CI_START="-0.37626612544530813" LOG_EFFECT_SIZE="0.8750612633917001" ORDER="673" O_E="0.0" SE="1.4700718047466632" STUDY_ID="STD-Bohte-1995" TOTAL_1="35" TOTAL_2="29" VAR="2.1611111111111114" WEIGHT="0.5122861466248135"/>
<DICH_DATA CI_END="69.4530657591536" CI_START="0.11753642862117385" EFFECT_SIZE="2.857142857142857" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.8416914208856852" LOG_CI_START="-0.9298275095862363" LOG_EFFECT_SIZE="0.4559319556497244" ORDER="674" O_E="0.0" SE="1.6280039389991736" STUDY_ID="STD-Carbon-1992" TOTAL_1="125" TOTAL_2="119" VAR="2.6503968253968253" WEIGHT="0.481049186464764"/>
<DICH_DATA CI_END="22.569170503407612" CI_START="0.1957148365793326" EFFECT_SIZE="2.1016949152542375" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.353515597517598" LOG_CI_START="-0.7083762504774164" LOG_EFFECT_SIZE="0.3225696735200909" ORDER="675" O_E="0.0" SE="1.2111654780415277" STUDY_ID="STD-Chuard-1989" TOTAL_1="59" TOTAL_2="62" VAR="1.4669218151995627" WEIGHT="0.9159055348746667"/>
<DICH_DATA CI_END="20.44550139093341" CI_START="0.1846222210635008" EFFECT_SIZE="1.9428571428571428" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="1" LOG_CI_END="1.310597765349912" LOG_CI_START="-0.7337160286379905" LOG_EFFECT_SIZE="0.28844086835596067" ORDER="676" O_E="0.0" SE="1.2008400421049796" STUDY_ID="STD-Feldman-2001" TOTAL_1="35" TOTAL_2="34" VAR="1.4420168067226893" WEIGHT="0.9528027364761027"/>
<DICH_DATA CI_END="3.919915520931636" CI_START="0.0102043015433387" EFFECT_SIZE="0.2" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="2" LOG_CI_END="0.5932767075335775" LOG_CI_START="-1.991216716205615" LOG_EFFECT_SIZE="-0.6989700043360187" ORDER="677" O_E="0.0" SE="1.5181442305531794" STUDY_ID="STD-Fourrier-1986" TOTAL_1="20" TOTAL_2="20" VAR="2.304761904761905" WEIGHT="2.3479781720303956"/>
<DICH_DATA CI_END="8.011428948229007" CI_START="0.01386907527098185" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9037099853704585" LOG_CI_START="-1.8579524948097836" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="678" O_E="0.0" SE="1.6222142113076252" STUDY_ID="STD-Genne-1997" TOTAL_1="56" TOTAL_2="56" VAR="2.631578947368421" WEIGHT="1.4087869032182374"/>
<DICH_DATA CI_END="4.79035787562254" CI_START="0.2024747551835692" EFFECT_SIZE="0.9848484848484849" ESTIMABLE="YES" EVENTS_1="3" EVENTS_2="3" LOG_CI_END="0.6803679596780884" LOG_CI_START="-0.6936291174761146" LOG_EFFECT_SIZE="-0.006630578899013093" ORDER="679" O_E="0.0" SE="0.8070926845156022" STUDY_ID="STD-Kobayashi-1984" TOTAL_1="132" TOTAL_2="130" VAR="0.6513986013986014" WEIGHT="2.8390820034321735"/>
<DICH_DATA CI_END="1.0981211872360188" CI_START="0.21187493927442566" EFFECT_SIZE="0.4823529411764706" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="15" LOG_CI_END="0.04065027093705263" LOG_CI_START="-0.6739204089261671" LOG_EFFECT_SIZE="-0.31663506899455723" MODIFIED="2012-07-02 22:21:49 +1000" MODIFIED_BY="[Empty name]" ORDER="992" O_E="0.0" SE="0.4197423545335675" STUDY_ID="STD-Kohno-2011" TOTAL_1="136" TOTAL_2="123" VAR="0.17618364418938307" WEIGHT="14.794982149627822"/>
<DICH_DATA CI_END="1.1405207267376016" CI_START="0.25465305722488" EFFECT_SIZE="0.5389221556886228" ESTIMABLE="YES" EVENTS_1="10" EVENTS_2="17" LOG_CI_END="0.05710318213873079" LOG_CI_START="-0.5940511055552475" LOG_EFFECT_SIZE="-0.2684739617082584" ORDER="680" O_E="0.0" SE="0.3824912518571511" STUDY_ID="STD-Lephonte-2004" TOTAL_1="167" TOTAL_2="153" VAR="0.1462995577472506" WEIGHT="16.664775075985734"/>
<DICH_DATA CI_END="0.6445591775226632" CI_START="0.20044449874019546" EFFECT_SIZE="0.3594417077175698" ESTIMABLE="YES" EVENTS_1="22" EVENTS_2="20" LOG_CI_END="-0.19073720353677176" LOG_CI_START="-0.6980058585931155" LOG_EFFECT_SIZE="-0.44437153106494365" ORDER="681" O_E="0.0" SE="0.297972119000436" STUDY_ID="STD-Lode-1995" TOTAL_1="609" TOTAL_2="199" VAR="0.08878738370161002" WEIGHT="28.315221916168536"/>
<DICH_DATA CI_END="1.0692048517127375" CI_START="0.16207868004687592" EFFECT_SIZE="0.41628753412192904" ESTIMABLE="YES" EVENTS_1="6" EVENTS_2="14" LOG_CI_END="0.029060920779682045" LOG_CI_START="-0.7902741088217291" LOG_EFFECT_SIZE="-0.3806065940210235" ORDER="682" O_E="0.0" SE="0.4812814521616761" STUDY_ID="STD-Norrby-1998" TOTAL_1="314" TOTAL_2="305" VAR="0.23163183619485175" WEIGHT="13.339854015180123"/>
<DICH_DATA CI_END="4.244117314212884" CI_START="0.7804685296768993" EFFECT_SIZE="1.82" ESTIMABLE="YES" EVENTS_1="14" EVENTS_2="8" LOG_CI_END="0.6277873799915894" LOG_CI_START="-0.1076446040214397" LOG_EFFECT_SIZE="0.2600713879850748" ORDER="683" O_E="0.0" SE="0.43199638785628647" STUDY_ID="STD-Petitpretz-2001" TOTAL_1="200" TOTAL_2="208" VAR="0.1866208791208791" WEIGHT="7.36620602989928"/>
<DICH_DATA CI_END="8.246084574500596" CI_START="0.014007997026340448" EFFECT_SIZE="0.33986928104575165" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="1" LOG_CI_END="0.9162477847523345" LOG_CI_START="-1.8536239591179335" LOG_EFFECT_SIZE="-0.46868808718279964" ORDER="684" O_E="0.0" SE="1.627036373435657" STUDY_ID="STD-Romanelli-2002" TOTAL_1="101" TOTAL_2="103" VAR="2.6472473604826545" WEIGHT="1.3951093604685458"/>
<DICH_DATA CI_END="13.448952462949551" CI_START="0.5352161360550285" EFFECT_SIZE="2.682926829268293" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="2" LOG_CI_END="1.1286884585185213" LOG_CI_START="-0.271470801641542" LOG_EFFECT_SIZE="0.4286088284384896" ORDER="685" O_E="0.0" SE="0.8224604803181391" STUDY_ID="STD-Vanderdonckt--1990" TOTAL_1="82" TOTAL_2="88" VAR="0.6764412416851441" WEIGHT="1.8120866833552232"/>
<DICH_DATA CI_END="2.8037512393518735" CI_START="0.00787283446475005" EFFECT_SIZE="0.14857142857142858" ESTIMABLE="YES" EVENTS_1="0" EVENTS_2="3" LOG_CI_END="0.44773947856376095" LOG_CI_START="-2.103868879994714" LOG_EFFECT_SIZE="-0.8280647007154764" ORDER="686" O_E="0.0" SE="1.4988273804823278" STUDY_ID="STD-Vogel-1991" TOTAL_1="49" TOTAL_2="51" VAR="2.2464835164835164" WEIGHT="3.222715138080935"/>
</DICH_OUTCOME>
<DICH_OUTCOME CHI2="5.606918634085573" CI_END="1.4064298156709312" CI_START="0.7243720999197145" CI_STUDY="95" CI_TOTAL="95" DF="11" EFFECT_MEASURE="RR" EFFECT_SIZE="1.0093455894624246" ESTIMABLE="YES" EVENTS_1="77" EVENTS_2="63" I2="0.0" I2_Q="0.0" ID="CMP-001.23" LOG_CI_END="0.14811806467231936" LOG_CI_START="-0.1400382854207309" LOG_EFFECT_SIZE="0.004039889625794211" METHOD="MH" MODIFIED="2008-06-22 17:08:10 +1000" MODIFIED_BY="[Empty name]" NO="23" P_CHI2="0.8982634729903869" P_Q="1.0" P_Z="0.956173086504729" Q="0.0" RANDOM="NO" SCALE="99.18752779765958" SORT_BY="STUDY" STUDIES="12" SUBGROUPS="NO" SUBGROUP_TEST="YES" SWAP_EVENTS="NO" TAU2="0.0" TOTALS="YES" TOTAL_1="2121" TOTAL_2="1685" WEIGHT="100.0" Z="0.05495654123545632">
<NAME>Adverse events - requiring discontinuation of treatment</NAME>
<GROUP_LABEL_1>Atypical ABx</GROUP_LABEL_1>
<GROUP_LABEL_2>Non-atypical ABx</GROUP_LABEL_2>
<GRAPH_LABEL_1>Favours atypical</GRAPH_LABEL_1>
<GRAPH_LABEL_2>Favours non-atypical</GRAPH_LABEL_2>
<DICH_DATA CI_END="11.514307575848953" CI_START="0.39712365695332363" EFFECT_SIZE="2.138364779874214" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="2" LOG_CI_END="1.0612378263619364" LOG_CI_START="-0.4010742409183291" LOG_EFFECT_SIZE="0.33008179272180366" ORDER="687" O_E="0.0" SE="0.858969346881903" STUDY_ID="STD-Aubier-1998" TOTAL_1="159" TOTAL_2="170" VAR="0.7378283388827229" WEIGHT="2.899846838356972"/>
<DICH_DATA CI_END="3.108197920948923" CI_START="0.0357477592923649" EFFECT_SIZE="0.3333333333333333" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="3" LOG_CI_END="0.4925086656112446" LOG_CI_START="-1.4467511750505695" LOG_EFFECT_SIZE="-0.47712125471966244" ORDER="688" O_E="0.0" SE="1.1391308298957796" STUDY_ID="STD-Genne-1997" TOTAL_1="56" TOTAL_2="56" VAR="1.2976190476190477" WEIGHT="4.500234008582282"/>
<DICH_DATA CI_END="3.0777531928802615" CI_START="0.10339090982447963" EFFECT_SIZE="0.5641025641025641" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="3" LOG_CI_END="0.4882337905221721" LOG_CI_START="-0.985517642930758" LOG_EFFECT_SIZE="-0.24864192620429298" ORDER="689" O_E="0.0" SE="0.865688887197502" STUDY_ID="STD-Gleadhill-1986" TOTAL_1="26" TOTAL_2="22" VAR="0.7494172494172494" WEIGHT="4.8752535092974725"/>
<DICH_DATA CI_END="61.43832368815652" CI_START="0.10602377362642179" EFFECT_SIZE="2.5522388059701493" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="0" LOG_CI_END="1.7884393576921533" LOG_CI_START="-0.9745967423094986" LOG_EFFECT_SIZE="0.4069213076913274" ORDER="690" O_E="0.0" SE="1.6230210823902491" STUDY_ID="STD-Khan-1989" TOTAL_1="66" TOTAL_2="56" VAR="2.6341974338832155" WEIGHT="0.8105260176747658"/>
<DICH_DATA CI_END="4.186840800465536" CI_START="0.31324453126998797" EFFECT_SIZE="1.1452095808383234" ESTIMABLE="YES" EVENTS_1="5" EVENTS_2="4" LOG_CI_END="0.6218864476851652" LOG_CI_START="-0.5041165023290215" LOG_EFFECT_SIZE="0.05888497267807194" ORDER="691" O_E="0.0" SE="0.661419706642829" STUDY_ID="STD-Lephonte-2004" TOTAL_1="167" TOTAL_2="153" VAR="0.43747602833548593" WEIGHT="6.262825661943676"/>
<DICH_DATA CI_END="3.282245654752407" CI_START="0.4697509626191205" EFFECT_SIZE="1.2417077175697866" ESTIMABLE="YES" EVENTS_1="19" EVENTS_2="5" LOG_CI_END="0.5161710820525188" LOG_CI_START="-0.3281323212652359" LOG_EFFECT_SIZE="0.09401938039364147" ORDER="692" O_E="0.0" SE="0.4959479984780995" STUDY_ID="STD-Lode-1995" TOTAL_1="609" TOTAL_2="199" VAR="0.245964417194433" WEIGHT="11.306280986908456"/>
<DICH_DATA CI_END="1.3963805297103438" CI_START="0.38006609147409093" EFFECT_SIZE="0.7285031847133758" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="20" LOG_CI_END="0.14500378464349464" LOG_CI_START="-0.42014087531295263" LOG_EFFECT_SIZE="-0.13756854533472904" ORDER="693" O_E="0.0" SE="0.33196877076960163" STUDY_ID="STD-Norrby-1998" TOTAL_1="314" TOTAL_2="305" VAR="0.11020326476628033" WEIGHT="30.437770138822543"/>
<DICH_DATA CI_END="5.224499169520386" CI_START="0.047851476646507" EFFECT_SIZE="0.5" ESTIMABLE="YES" EVENTS_1="1" EVENTS_2="2" LOG_CI_END="0.7180446644790353" LOG_CI_START="-1.3201046558069978" LOG_EFFECT_SIZE="-0.3010299956639812" ORDER="694" O_E="0.0" SE="1.1972189997378646" STUDY_ID="STD-Peterson-1988" TOTAL_1="30" TOTAL_2="30" VAR="1.4333333333333331" WEIGHT="3.0001560057215215"/>
<DICH_DATA CI_END="2.7177046893100805" CI_START="0.3979829023566855" EFFECT_SIZE="1.04" ESTIMABLE="YES" EVENTS_1="8" EVENTS_2="8" LOG_CI_END="0.4342022637390573" LOG_CI_START="-0.40013558514149655" LOG_EFFECT_SIZE="0.01703333929878037" ORDER="695" O_E="0.0" SE="0.4900941824713977" STUDY_ID="STD-Petitpretz-2001" TOTAL_1="200" TOTAL_2="208" VAR="0.24019230769230768" WEIGHT="11.765317669496163"/>
<DICH_DATA CI_END="6.868145496849276" CI_START="0.14082627611575518" EFFECT_SIZE="0.9834710743801653" ESTIMABLE="YES" EVENTS_1="2" EVENTS_2="2" LOG_CI_END="0.8368394868105836" LOG_CI_START="-0.8513163046584222" LOG_EFFECT_SIZE="-0.007238408923919298" ORDER="696" O_E="0.0" SE="0.9916310684148338" STUDY_ID="STD-Rizzato-1997" TOTAL_1="121" TOTAL_2="119" VAR="0.9833321758455449" WEIGHT="3.0251573057692007"/>
<DICH_DATA CI_END="34.60266162535094" CI_START="0.44125707291107796" EFFECT_SIZE="3.907514450867052" ESTIMABLE="YES" EVENTS_1="4" EVENTS_2="1" LOG_CI_END="1.5391095058663262" LOG_CI_START="-0.3553083202406453" LOG_EFFECT_SIZE="0.5919005928128405" ORDER="697" O_E="0.0" SE="1.1127904085747131" STUDY_ID="STD-Tremolieres-1998" TOTAL_1="173" TOTAL_2="169" VAR="1.238302493415877" WEIGHT="1.5176227748240447"/>
<DICH_DATA CI_END="2.3379642186462486" CI_START="0.5581209727242458" EFFECT_SIZE="1.1423076923076922" ESTIMABLE="YES" EVENTS_1="15" EVENTS_2="13" LOG_CI_END="0.3688378602204313" LOG_CI_START="-0.2532716575276425" LOG_EFFECT_SIZE="0.05778310134639437" ORDER="698" O_E="0.0" SE="0.36543021021699684" STUDY_ID="STD-Tremolieres-2005" TOTAL_1="200" TOTAL_2="198" VAR="0.13353923853923852" WEIGHT="19.599009082602905"/>
</DICH_OUTCOME>
</COMPARISON>
</ANALYSES_AND_DATA>
<FIGURES MODIFIED="2012-07-24 08:43:53 +1000" MODIFIED_BY="[Empty name]">
<FIGURE FILENAME="Risk of bias graph.png" FILE_TYPE="PNG" ID="FIG-01" MODIFIED="2012-07-24 08:43:53 +1000" MODIFIED_BY="[Empty name]" NO="1" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_GRAPH_PLOT">
<CAPTION>
<P>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Risk of bias summary.png" FILE_TYPE="PNG" ID="FIG-02" MODIFIED="2012-07-24 08:43:53 +1000" MODIFIED_BY="[Empty name]" NO="2" SHORT_VERSION_FIGURE="YES" TYPE="QUALITY_TABLE_PLOT">
<CAPTION>
<P>Risk of bias summary: review authors' judgements about each risk of bias item for each included study.</P>
</CAPTION>
<FILE>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</FILE>
</FIGURE>
<FIGURE FILENAME="Other figure.jpg" FILE_TYPE="JPG" ID="FIG-03" MODIFIED="2012-01-12 10:47:28 +1000" MODIFIED_BY="[Empty name]" NO="3" SHORT_VERSION_FIGURE="YES" TYPE="OTHER">
<CAPTION/>
<FILE>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</FILE>
</FIGURE>
</FIGURES>
<FEEDBACK MODIFIED="2008-06-22 16:37:09 +1000" MODIFIED_BY="[Empty name]"/>
<APPENDICES MODIFIED="2012-07-23 10:36:08 +1000" MODIFIED_BY="[Empty name]">
<APPENDIX ID="APP-01" MODIFIED="2012-07-18 13:46:42 +1000" MODIFIED_BY="[Empty name]" NO="1">
<TITLE MODIFIED="2012-07-18 13:43:34 +1000" MODIFIED_BY="[Empty name]">CENTRAL and MEDLINE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2012-07-18 13:46:42 +1000" MODIFIED_BY="[Empty name]">
<P>
<B>MEDLINE (PUBMED)</B>
<BR/>1 exp Pneumonia/<BR/>2 (pneumon* or cap).tw.<BR/>3 1 or 2<BR/>4 exp Anti-Bacterial Agents/<BR/>5 antibiotic*.tw.<BR/>6 exp Quinolones/<BR/>7 exp Macrolides/<BR/>8 exp Tetracyclines/<BR/>9 exp Chloramphenicol/<BR/>10 exp Streptogramins/<BR/>11 Ketolides/<BR/>12 (quinolon* or fluoroquinolon* or macrolid* or doxycyclin* or tetracyclin* or chloramphenicol* or streptogramin* or ketolid* or erythromycin* or roxithromycin* or azithromycin* or clarithromycin* or ciprofloxacin* or ofloxacin* or levofloxacin* or trovafloxacin* or moxifloxacin* or grepafloxacin* or tigecyclin* or minocyclin* or pristinamycin* or quinupristin* or telithromycin*).tw,nm.<BR/>13 or/4-12<BR/>14 3 and 13</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-02" MODIFIED="2012-07-23 10:36:08 +1000" MODIFIED_BY="[Empty name]" NO="2">
<TITLE MODIFIED="2012-07-23 10:36:08 +1000" MODIFIED_BY="[Empty name]">EMBASE search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2011-06-02 16:00:12 +1000" MODIFIED_BY="[Empty name]">
<P>#13. #9 AND #12 3,993 1 Jun 2011<BR/>#12. #10 OR #11 866,353 1 Jun 2011 <BR/>#11. random*:ab,ti OR placebo*:ab,ti OR factorial*:ab,ti OR crossover*:ab,ti OR 'cross over':ab,ti OR 'cross-over':ab,ti OR volunteer*:ab,ti OR assign*:ab,ti OR allocat*:ab,ti OR ((singl* OR doubl*) NEAR/1 blind*):ab,ti AND [embase]/lim 826,523 1 Jun 2011<BR/>#10. 'randomized controlled trial'/exp OR 'single blind procedure'/exp OR 'double blind procedure'/exp OR 'crossover procedure'/exp AND<BR/>[embase]/lim 242,926 1 Jun 2011<BR/>#9. #3 AND #8 54,097 1 Jun 2011<BR/>#8. #4 OR #5 OR #6 OR #7 788,217 1 Jun 2011<BR/>#7. quinolon*:ab,ti OR fluoroquinolon*:ab,ti OR macrolid*:ab,ti OR doxycyclin*:ab,ti OR tetracyclin*:ab,ti OR chloramphenicol*:ab,ti OR<BR/>streptogramin*:ab,ti OR ketolid*:ab,ti OR erythromycin*:ab,ti OR roxithromycin*:ab,ti OR azithromycin*:ab,ti OR clarithromycin*:ab,ti OR<BR/>ciprofloxacin*:ab,ti OR ofloxacin*:ab,ti OR levofloxacin*:ab,ti OR trovafloxacin*:ab,ti OR moxifloxacin*:ab,ti OR grepafloxacin*:ab,ti OR<BR/>tigecyclin*:ab,ti OR minocyclin*:ab,ti OR pristinamycin*:ab,ti OR quinupristin*:ab,ti OR telithromycin*:ab,ti AND [embase]/lim 95,680 1 Jun 2011<BR/>#6. 'quinolone derivative'/exp OR 'macrolide'/exp OR 'tetracycline derivative'/exp OR 'chloramphenicol'/exp OR 'streptogramin<BR/>derivative'/exp OR 'ketolide'/exp AND [embase]/lim 230,698 1 Jun 2011<BR/>#5. antibiotic*:ab,ti AND [embase]/lim 176,808 1 Jun 2011<BR/>#4. 'antibiotic agent'/exp AND [embase]/lim 706,809 1 Jun 2011<BR/>#3. #1 OR #2 169,385 1 Jun 2011<BR/>#2. pneumon*:ab,ti OR cap:ab,ti AND [embase]/lim 122,834 1 Jun 2011<BR/>#1. 'pneumonia'/de OR 'infectious pneumonia'/exp AND [embase]/lim 92,744 1 Jun 2011</P>
</APPENDIX_BODY>
</APPENDIX>
<APPENDIX ID="APP-03" MODIFIED="2012-07-18 13:47:26 +1000" MODIFIED_BY="[Empty name]" NO="3">
<TITLE MODIFIED="2012-07-18 13:41:43 +1000" MODIFIED_BY="[Empty name]">Previous search strategy</TITLE>
<APPENDIX_BODY MODIFIED="2012-07-18 13:47:26 +1000" MODIFIED_BY="[Empty name]">
<P>We searched the Cochrane Central Register of Controlled Trials (CENTRAL) (<I>The Cochrane Library</I> 2007, Issue 2) which includes the Acute Respiratory Infection Group's specialized register, MEDLINE (January 1966 to June 2007), and EMBASE (January 1980 to June 2007).</P>
<P>We ran the following search strategy over MEDLINE and CENTRAL and adapted it for EMBASE.</P>
<P>
<B>MEDLINE (PUBMED)</B>
<BR/>1 exp Anti-Bacterial Agents/<BR/>2 exp Quinolones/<BR/>3 exp Fluoroquinolones/<BR/>4 exp Macrolides/<BR/>5 exp Doxycycline/<BR/>6 exp Tetracycline/<BR/>7 exp Chloramphenicol/<BR/>8 exp Streptogramins/<BR/>9 exp Ketolides/<BR/>10 (Quinolon$ or Fluoroquinolon$ or Macrolide$ or Doxycycline$ or Tetracycline$ or Chloramphenicol$).ti,ab.<BR/>11 empirical antibiotic$.ti,ab.<BR/>12 empiric antibiotic$.ti,ab.<BR/>13 or/1-12<BR/>14 exp Community-Acquired Infections/<BR/>15 exp Pneumonia/<BR/>16 and/14-15<BR/>17 (community acquired pneumonia or CAP).mp.<BR/>18 16 or 17<BR/>19 exp Inpatients/<BR/>20 inpatient$.ti,ab.<BR/>21 exp Hospitalization/<BR/>22 ((hospitaliz$ or hospitalis$) adj patient$).mp.<BR/>23 or/17-20<BR/>24 13 and 18 and 23</P>
<P>We inspected the references of all identified studies for more trials. In addition to this, we contacted the first or corresponding author of each included trial and researchers active in the field for information regarding unpublished trials or complementary information on their own trial. We imposed no language or publication restrictions.</P>
</APPENDIX_BODY>
</APPENDIX>
</APPENDICES>
<EXTENSIONS MODIFIED="2008-06-22 16:37:09 +1000" MODIFIED_BY="[Empty name]">

<EXTENSION ID="AFF_DF01004C82E26AA201DAB7D8FF669BD7_1" NAME="PERSON" REVMAN_VERSION="5.1.0" TYPE="ADDRESS"><ALIAS ALIAS_ID="DF01004C82E26AA201DAB7D8FF669BD7"><ADDRESS><DEPARTMENT>Department of Medicine E</DEPARTMENT><ORGANISATION>Beilinson Hospital, Rabin Medical Center</ORGANISATION><ADDRESS_1>39 Jabotinski Street</ADDRESS_1><CITY>Petah Tikva</CITY><ZIP>49100</ZIP><COUNTRY CODE="IL">Israel</COUNTRY></ADDRESS></ALIAS></EXTENSION></EXTENSIONS>
</COCHRANE_REVIEW>